🥚 Hatched from Shells (Super 8-K Filers)
đź“š What is a Super 8-K — aka The Reverse Merger?
When a shell company — one with no real business operations — completes a reverse merger with a private operating company, it must file a special SEC Form 8-K disclosing the transaction under Item 2.01 (Completion of Acquisition or Disposition of Assets). Because this filing must include full company disclosures equivalent to a Form 10 registration, it runs 50–500 pages and is known informally as a Super 8-K. It marks the moment a shell company ceases to exist and a real business takes its place — sometimes overnight. For the company involved, this is a once-in-a-lifetime transformation — often overlooked by retail investors, and can precede significant price movement. The companies listed below have all crossed that threshold.
644 Super 8-K filings identified across our universe since April 2025 — the full history, latest first.
October 2026
21 filings
▲
TCRT
NASDAQ
▲ SUPER 8-K
Alaunos Therapeutics, Inc. Common Stock
EDGAR Items: 1.01,2.01,3.02,5.02,5.03,7.01,9.01
# Summary of Alaunos Therapeutics 8-K Filing
Alaunos Therapeutics completed its acquisition of Velaris Therapeutics on October 13, 2026, issuing 105,286 shares of Series B Non-Voting Convertible Preferred Stock and 33,054 shares of Series C Non-Voting Convertible Preferred Stock to Velaris stockholders, each convertible into 1,000 common shares subject to conditions. The transaction is structured as a tax-free reorganization and requires stockholder approval for conversion of the preferred shares into common stock, authorization of additional shares, a name change to "Velaris Therapeutics, Inc.," and a reverse stock split. Following stockholder approval of the conversion, the lead investor will designate three of five board seats, and board directors elected by Series B holders will have three votes per matter, providing significant control to the financing investor. The company's development of Velaris programs will be subject to the lead investor's consent regarding adherence to a mutually agreed development plan and operating budget for up to twelve months post-closing.
LGMK
OTC
▲ SUPER 8-K
LogicMark, Inc.
EDGAR Items: 2.01,3.03,5.01,5.02,5.03,9.01
# LogicMark, Inc. - Form 8-K Summary
LogicMark, Inc. completed its acquisition by Langham Project LLC on October 13, 2026, with the company becoming a wholly owned subsidiary of the acquirer. Under the merger agreement, each share of LogicMark common stock was converted into $1.31 per share in cash, representing a change of control transaction. All four board directors resigned effective October 7, 2026 (unrelated to any operational disagreements), and both of the company's stock incentive plans were terminated, with all equity awards accelerated and converted to their applicable merger consideration. Stockholders who did not exercise dissenters' rights under Nevada law will receive the per-share cash consideration, while those who properly exercised appraisal rights are entitled to pursue fair value determinations through legal proceedings. This transaction eliminates LogicMark as a public company and provides shareholders a fixed liquidation value of $1.31 per share.
DAIC
NASDAQ
▲ SUPER 8-K
CID HoldCo, Inc. Common Stock
EDGAR Items: 1.01,2.01,3.01,3.02,3.03,5.03,7.01,9.01
# SEC 8-K Summary: CID HoldCo, Inc.
On October 9, 2026, CID HoldCo, Inc. closed its acquisition of Envoy Technologies, Inc. from Israeli-listed BladeRanger Ltd., with Envoy becoming a wholly owned subsidiary. The Company issued 233,543 shares of common stock and 8,433,123 shares of Series C Convertible Preferred Stock to BladeRanger at closing, with an aggregate deal value of approximately $65 million based on a $6.00 reference price per share (10.8 million shares on a fully diluted basis).
A First Amendment to the Securities Purchase Agreement was also executed on the closing date, modifying how Blink Charging Co.'s $12.5 million convertible note converts into shares. Instead of converting prior to closing as originally planned, the note will now convert into 2,166,667 common shares upon satisfaction of specified "Blink Conversion Conditions" that include shareholder approval under Nasdaq rules. The Company represents it maintains at least $2.5 million in stockholders' equity, meeting Nasdaq Capital Market listing requirements.
**Investor Impact:** The deal significantly dilutes existing shareholders through substantial issuance of preferred and common stock. The delayed conversion of Blink's note creates uncertainty around future dilution timing, and the deal's success is contingent on shareholder approval of Nasdaq-required proposals, adding execution risk.
AHT
NYSE
▲ SUPER 8-K
Ashford Hospitality Trust, Inc.
EDGAR Items: 2.01,9.01
# Summary
Ashford Hospitality Trust completed the sale of the Embassy Suites Philadelphia Hotel on October 6, 2026, for approximately $26.0 million in cash to SSN 9000 Bartram Road LLC. This asset disposition represents a strategic deleveraging move by the hospitality REIT to reduce its portfolio size and generate liquidity. The transaction was executed pursuant to an agreement dated July 27, 2026, and was subject to customary prorations and adjustments. While the sale amount is modest relative to a typical REIT portfolio, the proceeds provide capital flexibility for debt reduction or reinvestment in higher-performing properties.
TRUG
NASDAQ
▲ SUPER 8-K
TruGolf Holdings, Inc. Class A Common Stock
EDGAR Items: 1.01,2.01,3.02,5.02,8.01,9.01
# TruGolf Holdings, Inc. - 8-K Summary
TruGolf Holdings, Inc. completed its acquisition of Polymath Research Inc. on October 8, 2026, with Polymath amalgamating into a wholly owned subsidiary of TruGolf. Polymath shareholders received 257,494 shares of Class A common stock (19.99% of outstanding shares) and 136,956 shares of newly designated Series C convertible preferred stock with a $1,000 stated value per share and a conversion price of $11.82. The Series C preferred stock will automatically convert to Class A common stock following stockholder approval and Nasdaq approval, subject to a 19.99% beneficial ownership limitation until regulatory clearance is obtained. TruGolf has committed to reserving $2.5 million for Polymath operations and compliance costs, allocating 20% of future equity proceeds to golf operations, and completing $500,000 in golf-related financing within six months. The transaction expands TruGolf's portfolio but creates near-term shareholder dilution and requires regulatory approvals for full conversion of the preferred stock into common equity.
HEPA
OTC
▲ SUPER 8-K
Hepion Pharmaceuticals, Inc.
EDGAR Items: 1.01,2.01,3.02,5.02,9.01
# Summary of Hepion Pharmaceuticals 8-K Filing
On October 6, 2026, Hepion Pharmaceuticals completed its acquisition of all membership interests in Gravitas Life Sciences (GLS), a clinical-stage biotechnology company, for $2.0 million in cash and approximately 25 million shares of common stock (subject to a 19.99% ownership cap). The transaction closed immediately and made GLS a wholly-owned subsidiary of Hepion. GLS is developing GV104, a transmucosal buccal film formulation of nalmefene (an opioid antagonist) licensed from Avior Inc., with FDA IND approval granted in February 2023.
The acquisition is a related-party transaction, as four current Hepion directors (Vincent LoPriore, Gary Stetz, Sireesh Appajosyula, and Chase LoPriore) hold officer and/or shareholder positions in GLS and its parent entity. These directors recused themselves from the approval process, and the disinterested board members approved the deal after obtaining a fairness opinion from Ryan Valuation Services. Additionally, Hepion assumed GLS's outstanding debt obligation to Canton Strategic Holdings (approximately $1.125 million remaining after $1.125 million prepayment).
**Investor Impact:** The acquisition significantly dilutes existing shareholders through the issuance of ~25 million shares while adding a pre-clinical asset with modest development progress; however, related-party concerns and the substantial stock dilution relative to the modest cash outlay warrant scrutiny of valuation assumptions and potential insider benefit.
COLAR
NASDAQ
▲ SUPER 8-K
Columbus Acquisition Corp Rights
EDGAR Items: 1.01,2.01,3.01,3.03,5.01,5.02,5.03,9.01
# Summary of Columbus Acquisition Corp 8-K Filing
On October 1, 2026, Columbus Acquisition Corp (CAC) completed its business combination with WISeSat.Space Holdings Corp., resulting in the merged entity trading on Nasdaq under the new ticker symbol "SAIQ" as of October 2, 2026. CAC's original securities (ticker symbols COLAU, COLA, and COLAR) were permanently delisted and suspended from trading, with deregistration becoming effective 10 days after the Form 25 filing on October 1, 2026. The business combination resulted in 16.8 million ordinary shares and 13.0 million Class F shares outstanding immediately post-closing, with 2.5 million public shares redeemed by CAC stockholders prior to completion. Investors holding CAC securities experienced an automatic conversion to WISeSat.Space Holdings shares under the new SAIQ ticker, marking a significant change in security structure and listing status.
GNLN
NASDAQ
▲ SUPER 8-K
Greenlane Holdings, Inc. Class A Common Stock
EDGAR Items: 1.03,2.01,9.01
# SEC 8-K Summary: Greenlane Holdings, Inc.
Greenlane Holdings, Inc. announced that four of its subsidiaries—Greenlane Holdings LLC, Warehouse Goods LLC, KIM International LLC, and Kush Supply Co. LLC—executed assignments for the benefit of creditors under Florida Chapter 727 Statutes on September 30, 2026, transferring substantially all assets to an assignee for liquidation. This action represents a formal insolvency proceeding (not a traditional bankruptcy chapter, but a creditor receivership under Florida law) in which an independent assignee now controls the deconsolidated entities' assets and creditor distributions, while the parent company retains no authority over these operations. The Company expects to recognize a preliminary gain of approximately $3.2 million from deconsolidating these entities, though the final amount will be determined upon completion of quarterly closing procedures and may differ materially. The affected subsidiaries comprised the Company's legacy wholesale distribution business, which had been substantially wound down prior to this action, and the parent company (Greenlane Holdings, Inc.) itself is not a party to the assignments and remains separate from the receivership proceedings.
BDN
NYSE
▲ SUPER 8-K
Brandywine Realty Trust
EDGAR Items: 2.01,9.01
# Summary of Brandywine Realty Trust 8-K Filing
Brandywine Realty Trust completed the sale of its office building located at 3151 Market Street in Philadelphia on September 30, 2026, for $240.0 million, generating net proceeds of approximately $233.7 million after debt repayment. The 441,000 square foot property sale resulted in the retirement of a $57.3 million Commercial Property Assessed Clean Energy Loan that had encumbered the asset. This disposition represents a significant deleveraging transaction that reduces the company's debt burden and improves its liquidity position. The filing includes pro forma financial statements reflecting the impact of this asset sale on the company's financial position and performance metrics.
CNDT
NASDAQ
▲ SUPER 8-K
Conduent Incorporated Common Stock
EDGAR Items: 1.01,2.01,7.01,9.01
# Conduent Inc. - 8-K Summary
Conduent completed the sale of its public transit and fare collection business (Transit Solutions) to Modaxo France Holdings SAS on October 1, 2026, for $164 million in total consideration, receiving $140 million in cash at closing with the remainder held back pending certain conditions and adjustments. The transaction involved a first amendment to the original purchase agreement executed on September 30, 2026, which removed the U.S. buyer as a party and separated out Indian assets for future sale pending regulatory approval. After transaction costs ($3 million) and taxes ($7 million), Conduent expects net proceeds of approximately $125 million, which it intends to use to repay its revolving credit facility, reducing debt and improving financial flexibility. The sale represents a strategic divestiture that allows the company to focus on its remaining business segments while providing capital for debt reduction.
CLVT
NYSE
▲ SUPER 8-K
Clarivate Plc
EDGAR Items: 2.01,5.02,8.01,9.01
# Clarivate PLC - 8-K Summary
Clarivate completed the sale of its Life Sciences and Healthcare business to an Altaris affiliate on October 6, 2026, for $500 million in cash plus a $75 million senior note, with an additional $25 million deferred consideration payable by January 31, 2028. The transaction represents a significant portfolio restructuring, reducing Clarivate to its core remaining business segments. Henry Levy, President of the divested Life Sciences & Healthcare division, terminated employment upon closing and received separation benefits per a pre-negotiated retention agreement. Investors should expect pro forma financial statements within four business days showing the company's revised financial position and operational scope post-divestiture.
ADIA
OTC
▲ SUPER 8-K
Adia Med, Inc.
EDGAR Items: 1.01,2.01,9.01
# ADIA MED, INC. 8-K Summary
**Material Event:** On September 30, 2026, Adia Med, Inc. sold a 30% membership interest in its subsidiary Adia Labs LLC to Live Oak Health LLC (doing business as QCM Biologics) for $1.5 million, consisting of $1 million in cash and a $500,000 promissory note bearing 7% interest payable over 48 months.
**Key Terms & Investor Impact:** While the Company retains 70% economic ownership, the purchase agreement provides the buyer with equal voting power (50%) on all material member decisions including budgets, debt, manager appointments, and unit issuances. The buyer also holds a five-year option to purchase up to 10 additional units at $50,000 per unit, which could dilute the Company's control to 60% ownership if fully exercised. This represents a significant shift in governance control despite majority economic retention.
**Implications for Investors:** The loss of unilateral decision-making authority over a key operating subsidiary (Labs Company) poses operational risks through potential deadlock scenarios, though dispute resolution procedures are in place. The $1 million cash infusion provides liquidity, but the secured $500,000 note liability and dilution risk from the buyout option may impact shareholder value. Investors should monitor the Labs Company's performance and the buyer's potential exercise of the option.
AREC
NASDAQ
▲ SUPER 8-K
AMERICAN RESOURCES CORP
EDGAR Items: 1.01,2.01,9.01
# Summary of American Resources Corporation 8-K Filing
American Resources Corporation completed a material asset acquisition on September 29, 2026, purchasing real property, structures, equipment, and mineral rights from Wyoming County Coal LLC located in West Virginia for a $40 million purchase price, which was satisfied through settlement of pending litigation rather than cash payment. The company explicitly did not acquire WCC's mining operations, permits, licenses, or historical mining and environmental liabilities, positioning this as a selective asset purchase focused on critical minerals and legacy refuse materials evaluation. The transaction aligns with the company's critical-mineral feedstock strategy, with future development subject to applicable regulatory requirements and permitting. For investors, this acquisition provides real estate and mineral rights assets without assuming significant environmental and operational liabilities, though the actual value realization depends on the company's ability to economically recover and process critical elements from the property under future regulatory frameworks.
PUSA
NASDAQ
▲ SUPER 8-K
Powerus Corporation Common Stock
EDGAR Items: 2.01,3.03,4.01,5.01,5.02,5.03,5.05,7.01,9.01
# SEC 8-K Summary: Powerus Corporation Merger Completion
On October 1, 2026, Powerus Corporation (formerly Aureus Greenway Holdings, Inc.) completed its merger with Autonomous Power Corporation (Legacy Powerus), issuing approximately 134.6 million shares of common stock plus 21.8 million replacement options and 28.6 million replacement warrants as merger consideration. Following the transaction, Legacy Powerus stockholders control approximately 93% of the combined company's voting power, representing a significant control shift that substantially dilutes pre-merger Aureus shareholders. Concurrently, the company changed its independent auditor from WWC, P.C. to BDO USA, P.C., and disclosed material weaknesses in internal controls related to inadequate staffing and limited accounting expertise in GAAP and SEC reporting—issues that may persist post-merger and could affect financial reporting quality. Investors should note the substantial ownership dilution and the control transfer to Legacy Powerus stakeholders, along with the ongoing internal control deficiencies that represent operational and compliance risks for the combined entity.
MGRX
NASDAQ
▲ SUPER 8-K
Mangoceuticals, Inc. Common Stock
EDGAR Items: 1.01,2.01,3.02,7.01,9.01
# Summary of Mangoceuticals, Inc. 8-K Filing
On September 30, 2026, Mangoceuticals, Inc. completed a private placement investment in its wholly-owned subsidiary MangoRx IP Holdings, LLC, selling a 25% ownership stake to two accredited investors for $2.5 million total. The company has already received $1.75 million as of the filing date, with the remaining $750,000 due within 60 days from the initial closing. This capital injection into the subsidiary that holds the company's MGX-0024 antiviral technology patent portfolio provides critical funding for the business. The securities were issued under Regulation D exemptions (Section 4(a)(2) and Rule 506) and are subject to transfer restrictions. This transaction represents a material dilution of Mangoceuticals' ownership in its subsidiary but provides necessary liquidity for its antiviral technology development.
LRHC
NASDAQ
▲ SUPER 8-K
La Rosa Holding Corp. Common Stock
EDGAR Items: 1.01,2.01,3.02,3.03,5.02,5.03,8.01,9.01
# La Rosa Holdings Corp. (LRHC) - 8-K Summary
On September 28-30, 2026, La Rosa Holdings Corp. completed three material transactions: (1) an exchange agreement converting $1.5 million in debt and 1,410 shares of Series C, D, and E preferred stock into 3,410 shares of newly issued Series F Convertible Preferred Stock; (2) a settlement agreement converting outstanding tokens valued at $5.7 million into 500 Series F Preferred Shares, with potential for an additional 5,500 shares if the company raises $100,000+ at prices exceeding $4.50 per share; and (3) an asset contribution and securities purchase agreement (details truncated in filing). All transactions required stockholder approval via written consent on September 30, 2026, in compliance with Nasdaq Capital Market rules. The exchanges significantly increase dilution and preferred stock outstanding but convert problematic debt and token liabilities into equity, potentially improving the company's balance sheet while creating substantial conversion pressure on existing common shareholders.
FEAV
OTC
▲ SUPER 8-K
5E Advanced Materials, Inc.
EDGAR Items: 1.01,2.01,2.02,2.03,9.01
# 5E Advanced Materials, Inc. (FEAM) - 8-K Summary
5E Advanced Materials completed a significant asset acquisition on October 1, 2026, purchasing Searles Valley Minerals' real property, production facilities, and brine resources for $3.4 million in cash, 8.3 million shares of common stock, and a $6.2 million promissory note. To finance the transaction, the company also secured a $10.0 million bridge facility (with $7.0 million funded immediately) at 8% interest, maturing in 270 days, which is secured by substantially all assets and guaranteed by the parent company. The acquisition significantly increases the company's debt burden—the promissory note carries 14.5% interest and matures in five years with a $1.2 million payment due at 24 months—while diluting existing shareholders by approximately 8.3 million new shares (bringing total outstanding shares to 49.6 million). Investors should note the near-term maturity pressure from the bridge facility and the high interest rates on both financing instruments, which pose refinancing risks if operations do not generate sufficient cash flow over the next 270 days.
FEAM
NASDAQ
▲ SUPER 8-K
5E Advanced Materials, Inc. Common Stock
EDGAR Items: 1.01,2.01,2.02,2.03,9.01
# Summary of 5E Advanced Materials, Inc. 8-K Filing
5E Advanced Materials, Inc. (NASDAQ: FEAM) completed a material acquisition on October 1, 2026, purchasing real property, production facilities, brine resources, and related assets from Searles Valley Minerals Inc. and affiliates for approximately $9.6 million in total consideration: $3.4 million in cash, 8.3 million shares of common stock (diluting existing shareholders by ~16.7%), and a $6.2 million senior unsecured promissory note bearing 14.5% interest. The company simultaneously secured $10.0 million in bridge financing from Karnavati Holdings, Inc., with $7.0 million funded at closing, structured as senior secured debt guaranteed by the parent company and maturing in 270 days, adding significant near-term refinancing risk. The acquisition materially increases the company's leverage, with the Bridge Facility maturing in less than one year at a time when the company reported only $19.6 million in total cash post-transaction, and increases shareholder dilution substantially. The company expects to file complete financial statements and pro forma information within 71 days, leaving investors with incomplete disclosure regarding the acquired assets' financial performance and integration plans.
AMOD
NASDAQ
▲ SUPER 8-K
Alpha Modus Holdings, Inc. Class A Common Stock
EDGAR Items: 2.01,8.01
# Alpha Modus Holdings, Inc. (AMOD) - 8-K Summary
Alpha Modus Holdings completed a private investment in public equity (PIPE) transaction on September 30, 2026, issuing 51.6 million shares of Class A Common Stock and 51.6 million warrants to non-U.S. investors in exchange for 3,170 bitcoin (valued at approximately $250 million). This transaction has resolved a critical Nasdaq listing compliance issue: the company previously failed to meet minimum net income, market value, and stockholders' equity requirements and was on notice of potential delisting, but the bitcoin infusion has brought stockholders' equity to well over $200 million, substantially exceeding Nasdaq's $2.5 million minimum requirement. However, the company remains at risk of future delisting if it fails to maintain compliance at the time of its next periodic report filing. The significant dilution from issuing over 100 million new securities and the company's continued dependence on bitcoin valuation to maintain listing compliance presents ongoing investor risks.
LIFD
OTC
▲ SUPER 8-K
LFTD PARTNERS INC.
EDGAR Items: 1.02,2.01,7.01,9.01
# LFTD Partners Inc. (LIFD) - 8-K Summary
On September 29, 2026, LFTD Partners completed the sale of its only real property asset, the 5511 Building in Kenosha, Wisconsin, to Ad Real Estate Group LLC for $1.5 million in cash. The company simultaneously used $841,109.63 of the proceeds to fully repay its $910,000 bank loan from Surety Bank (which included a $9,100 prepayment penalty), eliminating all outstanding bank debt. After accounting for loan payoff, brokerage commissions, transfer taxes, and closing costs, the company netted approximately $592,485 in cash proceeds, which management intends to deploy toward working capital and general corporate purposes.
**Investor Impact:** While the debt elimination is positive, investors should note that the company has now divested its only owned real property and consolidated operations into leased facilities, potentially increasing future operating leverage to rental costs. The accounting treatment and financial impact (gain or loss) of the sale have not yet been determined and will be reflected in Q3 2026 results. This transaction represents a significant operational restructuring for the OTCQB-listed company.
AHT
NYSE
▲ SUPER 8-K
Ashford Hospitality Trust, Inc.
EDGAR Items: 2.01,9.01
# Summary of Ashford Hospitality Trust 8-K Filing
Ashford Hospitality Trust completed the sale of the Embassy Suites Las Vegas property on September 25, 2026, for approximately $43.5 million in cash to 4315 Hospitality LLC. This asset disposition represents a strategic reduction in the company's real estate portfolio, with the transaction subject to customary adjustments and pro-rations. The filing includes pro forma financial statements reflecting the impact of this divestiture on the company's financial position as of June 30, 2026, and for the year ended December 31, 2025. For investors, this sale provides liquidity that may be used for debt reduction or reinvestment, though the ultimate impact on shareholder value depends on how proceeds are deployed and the current carrying value versus sale price of the property.
September 2026
37 filings
▼
EZRA
NASDAQ
▲ SUPER 8-K
Reliance Global Group, Inc. Common Stock
EDGAR Items: 1.01,1.02,2.01,9.01
# Summary of Reliance Global Group, Inc. 8-K Filing
On September 23, 2026, Reliance Global Group sold substantially all assets of its employee benefits insurance agency business (Altruis Benefit Consultants, Inc.) to Altruis Benefit Management, LLC for $8 million, with $4.44 million paid in cash, $3.1 million via a secured promissory note due September 30, 2026, and $461,729 held back for indemnification and working capital adjustments. The transaction includes potential earnout payments of up to $1 million over three years based on revenue growth targets of 10-20%, subordinated to the buyer's senior debt. Simultaneously with closing, the company repaid $2.18 million in outstanding credit facilities to Oak Street Funding LLC without penalty, using cash proceeds from the asset sale. This divestiture represents a significant restructuring of the company's operating portfolio and improves liquidity, though investors should monitor the buyer's ability to pay the $3.1 million note due in early October and the realization of contingent earnout payments.
OPNW
NASDAQ
▲ SUPER 8-K
OpenWorld, Inc. Common Stock
EDGAR Items: 1.01,1.02,2.01,3.02,5.01,5.02,5.03,7.01,8.01,9.01
# VerifyMe, Inc. (Now OpenWorld, Inc.) - Form 8-K Summary
VerifyMe, Inc. completed its merger with Open World Ltd. on September 30, 2026, fundamentally transforming the company into a blockchain and digital assets technology firm. The company changed its name to OpenWorld, Inc. and its Nasdaq ticker symbol from VRME to OPNW, effective October 1, 2026. Legacy OpenWorld securityholders received approximately 85.48% of the combined company's fully diluted equity (11.6 million shares), while VerifyMe shareholders retained approximately 10%, resulting in approximately 13.4 million shares outstanding on a fully diluted basis of 16 million shares.
**Key impacts for investors:** The merger represents a complete business pivot from VerifyMe's previous operations. Notably, 76% of post-merger shares issued to Legacy OpenWorld shareholders are subject to staggered transfer restrictions, with full lockup lasting 180 days from closing, which may create significant selling pressure as restrictions lift. The exchange ratio of 1:77.27 (Legacy OpenWorld shares to VerifyMe shares) and the 1:10 reverse stock split implemented prior to closing substantially dilute existing VerifyMe shareholders, who now hold only ~10% of the combined entity.
ONEN
NASDAQ
▲ SUPER 8-K
ONE Nuclear Energy Inc. Common Stock
EDGAR Items: 1.01,2.01,3.02,3.03,5.01,5.02,5.03,5.05,5.06,8.01,9.01
# Summary of ONE Nuclear Energy Inc. Form 8-K (September 23, 2026)
ONE Nuclear Energy Inc. completed its business combination with Hennessy Capital Investment Corp. VII on September 23, 2026, whereby the SPAC was renamed ONE Nuclear Energy Inc. and merged with ONE Nuclear Energy, LLC. The company issued 94.3 million shares to ONE Nuclear members as merger consideration (valued at $1 billion) and is eligible to issue up to 13 million additional earnout shares if stock price milestones of $12.50, $15.00, and $17.50 are achieved. As of the closing date, 108.3 million shares were outstanding, with approximately $1.7 million remaining in the trust account after public shareholders redeemed 13.8 million shares at $10.61 per share, and New Circle Capital Solutions purchased 5 million redeemed shares under a forward purchase agreement. The company's stock began trading on Nasdaq under ticker "ONEN" on September 24, 2026, marking the successful conclusion of the de-SPAC transaction.
SGLA
OTC
▲ SUPER 8-K
Sino Green Land Corp.
EDGAR Items: 2.01,3.02
# SEC 8-K Summary: Sino Green Land Corporation
On September 29, 2026, Sino Green Land Corporation completed two significant acquisitions that substantially dilute existing shareholders. The company acquired 60% of Xing Da Plastics Sdn. Bhd. for 4.8 million shares and 100% of Invent Fortune Sdn. Bhd. for approximately 36.5 million shares, issuing a combined 41.3 million new common shares as consideration. Both acquisitions were funded through unregistered equity issuances under Section 4(a)(2) of the Securities Act, meaning these shares were not subject to public offering restrictions. This massive share issuance—potentially representing substantial dilution depending on the company's existing share count—significantly impacts the ownership stake of current shareholders and may negatively affect future earnings per share and voting power.
LXEO
NASDAQ
▲ SUPER 8-K
Lexeo Therapeutics, Inc. Common Stock
EDGAR Items: 2.01,3.02,9.01
# Summary of Lexeo Therapeutics 8-K Filing
On September 29, 2026, Lexeo Therapeutics completed its acquisition of Mantle Therapeutics Inc., with Mantle becoming a wholly-owned subsidiary of Lexeo. Lexeo paid upfront consideration of $5.3 million in cash and $3 million in unregistered Lexeo common stock, with additional contingent payments potentially reaching up to $13 million—consisting of a $1 million additional cash payment upon certain event achievement and up to $12 million in milestone payments over 12 years tied to development and regulatory achievements. The milestone payments may be made in cash or stock, though Lexeo has made no guarantees regarding achievement and is only obligated to devote commercially reasonable efforts to development. This acquisition expands Lexeo's pipeline with Mantle's product candidates, though investors should note that any additional milestone payments are contingent and uncertain, and the company bears no obligation to prioritize these acquired assets beyond industry-standard effort requirements.
HVIIR
NASDAQ
▲ SUPER 8-K
Hennessy Capital Investment Corp. VII Rights
EDGAR Items: 1.01,2.01,3.02,3.03,5.01,5.02,5.03,5.05,5.06,8.01,9.01
# Summary of ONE Nuclear Energy Inc. Form 8-K Filing
On September 23, 2026, ONE Nuclear Energy Inc. (formerly Hennessy Capital Investment Corp. VII) completed its business combination with ONE Nuclear Energy, LLC, creating a publicly traded nuclear energy company. The transaction involved the issuance of 94.3 million merger consideration shares to ONE Nuclear's members valued at $1 billion, plus potential earnout shares worth up to $13 million based on stock price milestones of $12.50, $15.00, and $17.50 per share. Significant shareholder redemptions of 13.8 million HVII public shares ($146.5 million) reduced the cash available to fund the business combination, with only $1.7 million remaining in the trust account post-closing. The company now has approximately 108.3 million shares outstanding and began trading on the Nasdaq Capital Market under the ticker symbol "ONEN" on September 24, 2026, marking the successful transition from a SPAC to an operating nuclear energy company.
ELME
NYSE
▲ SUPER 8-K
Elme Communities
EDGAR Items: 2.01,3.01,5.02,7.01,8.01,9.01
# ELME Communities 8-K Summary
ELME Communities announced its voluntary delisting from the NYSE in connection with its planned liquidation. The company completed the sale of two major Washington, DC properties (3801 Connecticut Avenue and The Kenmore, each for $55 million) on September 28, 2026, representing final steps in its previously announced Plan of Sale and Liquidation approved by shareholders in October 2025. The company provided notice of delisting on September 29, 2026, with the last trading day anticipated for November 5, 2026, followed by voluntary dissolution effective November 6, 2026. Shareholders will automatically receive non-transferable Beneficial Interests in a liquidating trust established to wind down remaining assets and distribute proceeds, with no further shareholder action required. This marks the completion of ELME's strategic exit as a REIT, converting shareholder ownership into passive liquidation interests as the company distributes its final assets.
SWRD
NASDAQ
▲ SUPER 8-K
Stewards, Inc. Common Stock
EDGAR Items: 1.01,2.01,2.03,3.02,9.01
# Summary of Stewards, Inc. Form 8-K Filing
On September 23, 2026, Stewards, Inc. completed a significant acquisition of Envy Pompano Beach for an aggregate purchase price of $90 million, financed through a combination of debt refinancing ($44.6 million), 14.3 million newly issued common shares ($42.8 million at a $3.00 contractual price), and a $2.0 million promissory note. The acquisition introduces substantial dilution and financial obligations, including $3.0 million monthly redemption payments over seven months through April 2027 tied to cancellation of 7 million escrowed shares, with escalating late-payment penalties ($1,000-$2,000 daily) and potential delisting liquidated damages of $5.5 million per year (capped at $33 million) if the stock is removed from Nasdaq.
The deal structure includes significant related-party guarantees and contingencies that pose execution risks for investors: the Company's Chairman and CEO personally guarantee certain obligations, and multiple affiliated entities (Stewards International Funds PCC and the Private Credit Fund) guarantee core payment and delisting obligations. The requirement to file and obtain effectiveness of a resale registration for the escrowed shares within 60-90 days adds near-term capital market pressure, and the sellers retain vendee's lien and payment-priority rights against the property itself.
IPEXR
NASDAQ
▲ SUPER 8-K
Inflection Point Acquisition Corp. V Rights
EDGAR Items: 1.01,2.01,3.01,3.02,3.03,5.01,5.02,5.03,7.01,9.01
# Summary of Inflection Point Acquisition Corp. V 8-K Filing
Inflection Point Acquisition Corp. V (a SPAC) completed its business combination with GOWell Technology Limited on September 24-25, 2026, creating a publicly traded company now operating under GOWell Energy Technology. The transaction involved a two-step merger process where the SPAC merged with a public company vehicle (PubCo), followed by a second merger integrating GOWell as a subsidiary.
Key structural changes include the conversion of SPAC shares into ordinary shares of the new PubCo entity, with GOWell shareholders receiving shares valued at $300 million (subject to a $10.50 per share cap on the redemption price calculation). Public shareholders who held SPAC units had their shares redeemed, while insider shares, restricted shares, and warrant holders received conversion rights into the new company's securities.
For investors, this completion signals the transition from a blank-check SPAC to an operating energy technology company, with ownership now distributed among former GOWell shareholders, SPAC insiders, and remaining public shareholders. The redemption mechanism and tiered conversion structure mean that public shareholder stakes were diluted based on redemption levels, while GOWell shareholders and preferred investors received defined equity positions in the combined entity.
HUCK
NASDAQ
▲ SUPER 8-K
Huckleberry.ai, Inc. Class B Common Stock
EDGAR Items: 1.02,2.01,5.03,7.01,8.01,9.01
# SEC 8-K Filing Summary: Huckleberry.ai, Inc.
On September 22, 2026, Huckleberry.ai, Inc. (formerly Domo, Inc.) completed the sale of substantially all of its business assets and employees to Progress Software Corporation for approximately $221 million in cash. The company has undergone a strategic transformation, divesting its core software business (business intelligence, data visualization, analytics, and AI-powered data products) while retaining net operating loss carryforwards, positioning itself as a cash-holding entity. The company simultaneously changed its name from Domo to Huckleberry.ai and its trading symbol from "DOMO" to "HUCK" on Nasdaq effective September 24, 2026. Additionally, all outstanding debt under the company's Loan and Security Agreement was repaid in full at closing, and warrant holders received approximately $10 million in repurchase proceeds. Investors should note this represents a fundamental shift in the company's business model and structure, with future value dependent on how management deploys the $221 million in cash proceeds.
DOMO
NASDAQ
▲ SUPER 8-K
Domo, Inc. Class B Common Stock
EDGAR Items: 1.02,2.01,5.03,7.01,8.01,9.01
# Summary of Huckleberry.ai, Inc. Form 8-K Filing
On September 22, 2026, Huckleberry.ai, Inc. (formerly Domo, Inc.) completed the sale of substantially all of its business assets and employees to Progress Software Corporation for approximately $221 million in cash. The company has undergone a complete strategic transformation: it sold its core business intelligence and analytics software platform while retaining net operating loss carryforwards, and simultaneously changed its name and trading symbol from DOMO to HUCK on the Nasdaq Global Market. Additionally, the company repurchased all outstanding warrants for approximately $10 million and paid off its loan obligations in full.
**Investor Impact:** This represents a fundamental change for shareholders—the company is now a shell entity with $221 million in cash and substantial NOL carryforwards, positioning itself as a potential acquisition target or investment vehicle rather than an operating software company. The asset sale eliminates the company's previous business operations but provides liquidity for potential capital return or new strategic initiatives.
ACRE
NYSE
▲ SUPER 8-K
Ares Commercial Real Estate Corporation
EDGAR Items: 2.01,9.01
# SEC 8-K Summary: ARES Commercial Real Estate Corporation (ACRE)
On September 18, 2026, ACRE completed the sale of a multi-building office property in North Carolina for $64 million in cash, representing a significant asset disposition. The property had been acquired through a deed in lieu of foreclosure in September 2024 and was classified as held for sale since Q1 2026, indicating the company's effort to reduce distressed assets from its portfolio. This transaction demonstrates ACRE's strategy to monetize non-performing assets and generate liquidity, though the sale price may reflect market challenges in the commercial real estate sector. For investors, this disposal reduces ACRE's asset base but improves cash position and potentially reduces future loss exposure on a problem asset.
SGMOQ
OTC
▲ SUPER 8-K
SANGAMO THERAPEUTICS, INC
EDGAR Items: 1.03,2.01,9.01
# Sangamo Therapeutics 8-K Summary
Sangamo Therapeutics, Inc. has completed a Chapter 11 bankruptcy restructuring, with the company emerging from proceedings initiated on June 23, 2026, by selling substantially all assets to PTC Therapeutics for $111 million in cash plus up to $100 million in milestone-based contingent payments. The sale, which closed on September 17, 2026, primarily involves its ST-920 gene therapy product candidate for Fabry disease and certain specified liabilities. Additionally, the company's common stock has been delisted from the Nasdaq Capital Market (violation of listing standards resulted in trading suspension on May 5, 2026) and now trades on the OTC Basic Market under ticker "SGMOQ," with the delisting becoming officially effective on September 27, 2026. The company explicitly warns existing and prospective shareholders that trading in its common stock is highly speculative, as recovery for equity holders in bankruptcy is uncertain and current market prices may bear little relationship to actual recovery value.
RIME
NASDAQ
▲ SUPER 8-K
Algorhythm Holdings, Inc. Common Stock
EDGAR Items: 1.01,2.01,2.03,3.02,3.03,5.02,5.03,7.01,9.01
# Summary of Algorhythm Holdings, Inc. 8-K Filing
On September 15, 2026, Algorhythm Holdings, Inc. completed a material asset acquisition of substantially all assets from Azure Energy, LLC, a renewable energy company focused on waste-to-power and biomass-to-power infrastructure, for $23 million in stock consideration (4.08 million shares of common stock representing 19.99% ownership plus 22,038 shares of Series B Preferred Stock). Concurrently, the company granted sellers a three-year option to sell an additional 79.03% stake in Azure Energy's Costa Rican subsidiary (Azure S.R.L.) for $30 million, payable in up to 50% cash and 50% Series B Preferred Stock, representing significant potential future dilution.
The transaction also included substantial leadership changes, with the company terminating its CEO Gary Atkinson and CFO/General Counsel Alex Andre effective immediately after closing. The acquired business's assets include renewable energy permits, power purchase agreements, intellectual property, and tangible property, though the sellers retain significant restrictions including a two-year non-compete in North Carolina and a six-month lock-up on received securities.
**Investor Impact:** While the acquisition expands Algorhythm's business into renewable energy infrastructure, the immediate 19.99% dilution plus the contingent 79.03% option creates substantial forward-looking dilution risk. The simultaneous departure of top executives signals potential strategic reorientation, and investors should monitor the company's ability to integrate the Azure Energy operations and execute on the optional future acquisition.
NCMI
NASDAQ
▲ SUPER 8-K
National CineMedia, Inc.
EDGAR Items: 1.01,1.02,2.01,2.03,7.01,9.01
# Summary of National CineMedia 8-K Filing
National CineMedia completed its acquisition of Captivate Holdings on September 18, 2026, and simultaneously secured $300 million in new debt financing ($275 million term loan and $25 million revolving credit facility) to fund the transaction and refinance existing obligations. The new credit agreement matures in September 2031 and carries interest margins of 7.00% for SOFR borrowings and 6.00% for base rate borrowings, with the option to pay-in-kind up to 2.00% additional margin for the first two years. The company refinanced its previous U.S. Bank credit facility and is subject to a maximum Total Net Leverage Ratio covenant of 5.00x (stepping down to 4.75x in mid-2028 and 4.50x by end-2029), with prepayment penalties declining from 3.00% in year one to 1.00% in year three. For investors, this transaction increases NCM's debt load significantly but expands its advertising network capabilities, though the highly leveraged structure (evidenced by the high leverage covenant thresholds) carries execution risk as the company integrates Captivate and services the substantial debt obligations.
ELME
NYSE
▲ SUPER 8-K
Elme Communities
EDGAR Items: 1.02,2.01,9.01
# ELME Communities 8-K Summary
ELME Communities completed the sale of Riverside Apartments for $250 million on September 14, 2026, and used proceeds to fully repay and terminate its $520 million Goldman Sachs term loan (with ~$198.6 million outstanding), releasing all liens on remaining properties. The company is in an active liquidation phase, having sold 19 multifamily assets to Cortland Partners in November 2025 and subsequently disposing of additional properties, with two more Washington D.C. properties (3801 Connecticut Avenue and Kenmore) expected to close by early October 2026. The elimination of secured debt materially improves the company's financial flexibility and reduces leverage risk as it continues its portfolio wind-down. Investors should note the company is operating on a liquidation basis and all remaining proceeds will flow to shareholders as assets are sold.
LSTA
NASDAQ
▲ SUPER 8-K
Lisata Therapeutics, Inc. Common Stock
EDGAR Items: 1.01,2.01,3.02,5.02,5.03,7.01,9.01
# Summary of Lisata Therapeutics 8-K Filing (September 17, 2026)
Lisata Therapeutics, Inc. completed an acquisition of Marea Therapeutics, Inc. through a two-step merger structure, issuing 1.79 million shares of common stock and 211,365 shares of Series C Non-Voting Convertible Preferred Stock (convertible into ~211 million common shares) to Marea stockholders. Following the merger and a planned financing, pre-transaction Lisata shareholders will hold only 2.39% of the combined company on a fully-diluted basis, while Marea equityholders will control 59.54% and new investors 38.07%—representing a significant dilution of existing Lisata shareholders. The company must obtain stockholder approval for the preferred stock conversion, change-of-control under Nasdaq rules, potential reverse stock split, and new equity incentive plans before the transaction is fully effective. This transaction effectively represents a reverse acquisition with Marea shareholders taking control of the company, substantially diminishing the economic interest of Lisata's pre-merger shareholders.
HOST
AMEX
▲ SUPER 8-K
Host Digital Inc.
EDGAR Items: 1.01,2.01,2.02,3.02,3.03,4.01,5.01,5.02,5.03,9.01
# Summary of SEC 8-K Filing – Healthy Choice Wellness Corp.
On September 17, 2026, Healthy Choice Wellness Corp. (now Host Digital Inc.) completed a merger with Host Digital Infrastructure LLC, with Host DI surviving as a wholly owned subsidiary. The legacy Host DI members received 25.1 million shares of Class A common stock and pre-funded warrants to purchase 19.9 million additional shares, resulting in Host DI members owning approximately 96.4% of the combined company post-closing.
In connection with the merger, the company entered into registration rights agreements obligating it to file a shelf registration statement within 30 days to enable resale of the merger consideration shares, along with indemnification agreements for directors and officers. Additionally, the company agreed to preferential rights with Host Infrastructure Holdings LLC (controlled by CEO Harmol Samra and major shareholder Hans Thomas), granting the company first offer and first refusal rights on project acquisitions for two years—a related-party transaction requiring disclosure under Regulation S-K.
**Investor Impact:** This merger fundamentally transforms the company's ownership and business focus toward digital infrastructure. The massive dilution (legacy shareholders now represent ~3.6% of the company) and the significant related-party preferential rights arrangement warrant careful review of governance implications and conflict-of-interest management going forward.
INVE
NASDAQ
▲ SUPER 8-K
INVE Technologies, Inc. Common Stock
EDGAR Items: 2.01,5.03,5.07,7.01,9.01
# Summary of INVE Technologies, Inc. 8-K Filing
On September 15, 2026, INVE Technologies, Inc. (formerly Identiv, Inc.) completed the sale of its specialty Internet of Things business to Trackonomy Systems, Inc. for $50 million in Series C Preferred Stock of the buyer, plus the assumption of certain liabilities and transfer of $25 million in cash. The transaction was approved by stockholders on September 10, 2026, with 17.6 million votes in favor.
Concurrent with the asset sale closing, the company changed its corporate name from Identiv, Inc. to INVE Technologies, Inc., reflecting its transformation into a holding company. Leadership changes include the appointment of James Greenwell as Interim CEO effective September 21, 2026, with departing CEO Kirsten Newquist remaining through September 30, 2026.
**Investor Impact:** The company has divested its core operating business and now holds illiquid preferred stock in a private company, significantly reducing its asset base and operational substance. This represents a material restructuring that fundamentally changes the company's business profile and investment characteristics, with investors holding equity in a shell-like entity going forward.
EZRA
NASDAQ
▲ SUPER 8-K
Reliance Global Group, Inc. Common Stock
EDGAR Items: 2.01,7.01,9.01
# Summary of Reliance Global Group, Inc. 8-K Filing
On September 11, 2026, Reliance Global Group, Inc. completed the sale of Southwestern Montana Insurance Center, LLC (SMI) and its insurance business to Scali, LLC for $2.625 million in upfront cash consideration, with additional contingent payments possible based on EBITDA performance through August 31, 2027. The company used approximately $1.21 million of the sale proceeds to pay down its term loan with Oak Street Funding LLC, which simultaneously released SMI from the credit facility. This divestiture represents a strategic asset sale that will result in the loss of SMI's historical revenue and operating cash flow, though the debt reduction may improve the company's financial flexibility. Investors should note that contingent consideration payments are subordinated and may not be fully realized, and the transaction's benefits depend on the company's ability to replace lost revenue from this divested business segment.
BRN
AMEX
▲ SUPER 8-K
Barnwell Industries, Inc.
EDGAR Items: 2.01,7.01,9.01
# Summary of Barnwell Industries 8-K Filing
On September 15, 2026, Barnwell Industries completed the sale of its remaining Hawaii real estate development interests to David Johnston for $1.77 million in gross proceeds, resulting in approximately $1.7 million in total cash receipts to the company after accounting for minority interests and pre-closing distributions. The sale includes limited partner and general partner interests in two development partnerships and associated project rights, effectively marking the company's complete exit from its known Hawaii real estate operations, with only minimal administrative wind-down activities remaining. The transaction carries limited seller protections with representations and warranties surviving only six months post-closing and capped liability at 10% of allocated purchase price, though the buyer has agreed to indemnify sellers against potential commission claims from a historical partner arrangement. This strategic divestment allows Barnwell to redeploy capital away from its non-core Hawaii operations, though the modest proceeds ($1.7 million) suggest limited financial material impact relative to typical enterprise valuations.
HBUV
OTC
▲ SUPER 8-K
Hubilu Venture Corp
EDGAR Items: 1.01,2.01
# Summary of Hubilu Venture Corporation Form 8-K Filing
Hubilu Venture Corporation completed the acquisition of a vacant residential property located at 5717 4th Ave in Los Angeles for $600,000 on September 11, 2026, through its subsidiary Elata Investments, LLC. The company financed the purchase with a $550,000 first-position loan from Orchard Funding at 9.99% annual interest, with interest-only monthly payments of $4,578.75 beginning October 1, 2026, and the full principal balance due by November 26, 2027. This acquisition represents the company's expansion into real estate holdings, though investors should note the relatively short repayment timeline and interest-rate exposure on the leveraged financing structure.
SOAR
AMEX
▲ SUPER 8-K
Volato Group, Inc.
EDGAR Items: 1.01,2.01,2.03,3.02,3.03,5.02,5.03,9.01
# Volato Group, Inc. (SOAR) - 8-K Summary
Volato Group completed its merger with Alignment Engine Inc. on September 11, 2026, with Aligned securityholders receiving 95% ownership of Volato's Class A common stock on a fully diluted basis, based on an Aligned valuation of $500 million and resulting in a combined post-closing valuation of approximately $508.5 million. Prior to closing, the parties amended the merger agreement twice (on September 4 and September 10, 2026) to clarify the calculation of merger consideration and extend the deadline, while establishing 180-day lock-up provisions for Aligned securityholders and company insiders. The transaction was approved by Volato's board without shareholder approval and included a fairness opinion from an independent third party. This represents a significant dilution for existing Volato shareholders, as they will own only approximately 5% of the combined entity post-closing, fundamentally altering the company's ownership structure and control.
KULR
AMEX
▲ SUPER 8-K
KULR Technology Group, Inc.
EDGAR Items: 2.01,5.02
# KULR Technology Group 8-K Summary
KULR Technology Group completed the sale of approximately 764 bitcoin through open market transactions during August-September 2026, generating approximately $58.6 million in gross proceeds at a weighted average price of $76,633 per BTC, and now holds no bitcoin holdings. Simultaneously, the company's Compensation Committee approved a grant of 200,000 time-vesting restricted stock units to CFO Michael Kimel, vesting over four years in semi-annual installments beginning December 2026. The bitcoin liquidation represents a significant shift in the company's treasury management strategy, converting cryptocurrency holdings into cash, while the executive compensation grant indicates ongoing executive retention efforts.
AIB
AMEX
▲ SUPER 8-K
AIB Data Centers Inc.
EDGAR Items: 1.01,2.01,2.03,9.01
# Summary: AIB Data Centers Inc. 8-K Filing (September 4, 2026)
AIB Data Centers Inc. completed a $17.2 million acquisition of approximately 29.4 acres of real property in Texas for data center development, structured as two concurrent transactions closing on September 11, 2026. The deal comprises Property A (5 acres, $8.25 million upfront with 15 MW existing electric service) and Property B (24.4 acres via membership interest acquisition, $2.975 million upfront plus $6 million deferred payment contingent on utility service delivery). The company secured two JPMorgan Chase standby letters of credit totaling $7.75 million—one to guarantee the deferred payment to the seller and another to secure performance obligations under a 40 MW electric service agreement with the utility provider. This expansion positions AIB Data Centers to develop new AI and high-performance computing infrastructure, though investors should note the company's exposure to $6 million in deferred obligations and the execution risk associated with utilities delivering the promised 40 MW capacity by December 31, 2028.
GPOX
OTC
▲ SUPER 8-K
GPO Plus, Inc.
EDGAR Items: 1.01,2.01,3.02,5.03,9.01
# GPO Plus, Inc. 8-K Summary
On September 7, 2026, GPO Plus, Inc. completed a material acquisition of SurgePays' ClearLine engagement platform and GPOX Wireless business for $27.5 million, paid entirely in 25 million shares of newly designated Series D Preferred Stock (convertible 1:1 to common stock). The transaction includes a three-year-plus put option allowing SurgePays to sell the shares back to investor Emerald Shoals, and warrants issued to Emerald Shoals to purchase 15 million common shares at tiered prices ($0.05-$0.25), creating significant dilution potential for existing shareholders. This acquisition represents a transformative business expansion, though the substantial share issuance (potentially 40 million common shares if all securities are exercised) meaningfully dilutes current equity holders, and the put option structure suggests contingent repayment obligations if the acquisition underperforms. Investors should closely monitor integration success and the likelihood of dilution from the warrant exercise and preferred share conversion.
SURG
NASDAQ
▲ SUPER 8-K
SurgePays, Inc. Common Stock
EDGAR Items: 1.01,2.01,8.01,9.01
# SurgePays, Inc. (SURG) 8-K Summary
SurgePays completed the sale of its ClearLine engagement platform and GPOX Wireless business to GPO Plus, Inc. on September 10, 2026, for $27.5 million in Series D Preferred Stock (25 million shares) convertible into GPO Plus common stock. The company simultaneously secured a put option agreement with Emerald Shoals Targeted Opportunities Fund LP guaranteeing the right to sell these shares back for $27.5 million within 3.25 years, effectively providing downside protection on the transaction.
The asset sale directly addresses SurgePays' Nasdaq delisting risk—the company had failed to meet Nasdaq Listing Rule 5550(b)(2) (minimum market value of listed securities) and Rule 5550(a)(2) (minimum bid price). The transaction substantially improved SurgePays' stockholders' equity position, now exceeding both the $2.5 million requirement for continued listing on Nasdaq Capital Market and the $5 million initial listing standard, positioning the company to regain compliance. Management plans to notify Nasdaq of its intent to cure the bid price deficiency during a second compliance period, including via reverse stock split if necessary.
For investors, this represents a significant strategic restructuring where SurgePays has divested core operating assets and effectively shifted to a holding company with a $27.5 million contingent asset, creating both liquidity and delisting mitigation but raising questions about the company's future business operations and strategy.
ISCO
OTC
▲ SUPER 8-K
International Stem Cell CORP
EDGAR Items: 2.01,9.01
# Summary of International Stem Cell Corporation 8-K Filing
International Stem Cell Corporation completed the sale of Lifeline Cell Technology, LLC (100% of issued and outstanding interests) to American Type Culture Collection, Inc. on September 1, 2026, concluding a transaction that was announced on July 10, 2026 and voluntarily submitted to shareholders for approval despite not being legally required. The company has divested a significant operating asset, fundamentally altering its business operations and asset base. Pro forma financial statements have been filed showing the impact of this disposition, though detailed financial terms of the transaction are not disclosed in this filing. For investors, this represents a material restructuring that will likely result in a significantly smaller operating footprint and warrants review of the complete purchase agreement and pro forma financials to assess the transaction's value and implications for the company's future direction.
SGMOQ
OTC
▲ SUPER 8-K
SANGAMO THERAPEUTICS, INC
EDGAR Items: 1.03,2.01,7.01,9.01
# Summary of Sangamo Therapeutics 8-K Filing
Sangamo Therapeutics, Inc. filed for **Chapter 11 bankruptcy** on June 23, 2026 and has now completed the sale of substantially all its assets to Eli Lilly for $50 million in cash plus assumption of certain liabilities. The company, which was **delisted from the Nasdaq Capital Market** (the Nasdaq Hearings Panel denied its listing appeal on July 14, 2026) and now trades on the OTC Basic Market under symbol "SGMOQ," sold its core technology platforms including AAV capsid engineering, zinc finger protein technology, Modular Integrase genome editing, and its prion disease program. The transaction was completed on September 4, 2026 following a court-supervised auction process where Lilly was selected as the successful bidder. Investors are cautioned that common stock trading during bankruptcy proceedings is highly speculative, with current trading prices likely bearing little relationship to any actual recovery in the bankruptcy case.
GRML
NASDAQ
▲ SUPER 8-K
Greenland Mines Ltd. Common Stock
EDGAR Items: 1.01,2.01,3.02,5.03,5.07,9.01
# Summary of Greenland Mines Ltd. 8-K Filing
On September 1, 2026, Greenland Mines Ltd. completed its acquisition of the Sarfartoq mineral project in Greenland through a merger with NNSR Holdings Inc., issuing 1,040,676 common shares and 359,324 newly designated Series R Preferred shares as consideration. The acquisition grants the company an indirect mineral license for Sarfartoq, which an independent Initial Assessment values at approximately $2.05 billion NPV and 118.6% IRR under the high case scenario, based solely on the ST1 deposit within a 191-square-kilometer license area containing five additional unexplored rare earth occurrences.
The transaction did not result in a change of control or management for Greenland Mines, and the Series R Preferred shares are convertible to common stock (1:1 ratio) upon stockholder approval, with voting rights also contingent on such approval. Additionally, the company amended its Series C Preferred Stock terms to restrict conversion until January 8, 2027 or when the common stock closes above $15.00 for five consecutive trading days, protecting against immediate dilution. For investors, the acquisition provides significant asset value and upside potential in rare earth minerals, but the deal structure involves substantial equity dilution and conversion contingencies that create near-term governance complexity.
GAMG
OTC
▲ SUPER 8-K
Global Asset Management Group, Inc.
EDGAR Items: 1.01,2.01,2.03,3.02,3.03,5.02,8.01,9.01
# SEC 8-K Summary: Global Asset Management Group, Inc.
Global Asset Management Group, Inc. completed the acquisition of G & O Landscaping, Inc. on August 26, 2026, for a stated purchase price of $1,820,000, with no cash paid at closing. The consideration consisted of 840,000 restricted common shares and a $980,000 convertible promissory note due August 31, 2029, bearing 6% annual interest with conversion rights at 85% of the 30-day volume-weighted average price (with no floor or cap). The note is secured by a pledge of the subsidiary's G&O shares, and the company committed to pursue refinancing within 90 days to generate cash proceeds. For investors, this debt-heavy acquisition creates significant dilution risk through both the issued shares and potential conversion of the note into additional shares, while the company's ability to meet obligations depends on successful refinancing and the acquired business's operational performance.
LPSN
NASDAQ
▲ SUPER 8-K
LivePerson Inc
EDGAR Items: 2.01,3.01,3.03,5.01,5.02,5.03,8.01,9.01
# LivePerson Inc. 8-K Summary
On September 4, 2026, LivePerson, Inc. completed its merger with SoundHound AI, Inc., with LivePerson becoming an indirect wholly-owned subsidiary of SoundHound. LivePerson's common stock (ticker: LPSN) was delisted from The Nasdaq Global Select Market, and shareholders received 0.4673 shares of SoundHound Class A common stock per share, with TASE-held shares receiving $3.31 in cash. All company directors resigned effective at the merger completion, and the company intends to file a Form 15 to suspend its SEC reporting obligations under Sections 13(a) and 15(d) of the Securities Exchange Act.
**Investor Impact:** LivePerson shareholders no longer hold equity in an independent public company but instead hold SoundHound shares at a fixed conversion ratio established in July 2026. The delisting and planned deregistration eliminate direct trading on Nasdaq and future financial disclosures, transferring full control to SoundHound and ending LivePerson's independent public company status.
HFFG
NASDAQ
▲ SUPER 8-K
HF Foods Group Inc. Common Stock
EDGAR Items: 2.01,2.03,8.01,9.01
# HF Foods Group Inc. (HFFG) - 8-K Summary
HF Foods Group Inc. completed its acquisition of Searay Foods Inc. and Morgan Foods Inc. on August 31, 2026, for an aggregate base purchase price of CAD$47.9 million, comprising CAD$38.4 million in cash and 1.7 million shares of common stock valued at USD$4.00 per share. The sellers are eligible for additional contingent earnout payments based on EBITDA targets over a two- to three-year period. The company also obtained lender consent from JPMorgan Chase Bank to integrate the acquired Canadian entities into its existing credit facility within five business days of closing. This acquisition expands HFFG's operational footprint into Canada and increases its capital structure through both cash and equity consideration, with future earnout obligations contingent on operational performance.
NPWR
NYSE
▲ SUPER 8-K
NET Power Inc.
EDGAR Items: 1.01,2.01,7.01,9.01
# NET POWER INC. – 8-K Summary
On August 31, 2026, Net Power Inc.'s subsidiary acquired EMPower USA's position as "Owner" under a $196.7 million Engineering, Procurement and Construction (EPC) agreement with Saulsbury Industries for a 123-megawatt natural gas power generation facility, paying total cash consideration of approximately $58.9 million ($40 million premium plus reimbursement of prior expenses). The transaction transferred contractual rights and assumed approximately $177.8 million in remaining payment commitments, with the Purchaser immediately paying $58.6 million toward milestone payments and facing an October 15, 2026 deadline for the $10.2 million mobilization payment to proceed with construction. The project is being relocated from its original Ector County, Texas site to Net Power's replacement site, with Saulsbury and equipment supplier Wärtsilä both consenting to the assignment, though Wärtsilä reserved its position on relocation costs to be addressed in future change orders. This acquisition provides Net Power with direct control over a major power generation infrastructure project in advanced development stages but locks the company into substantial future capital commitments on an accelerated timeline.
NOTE
OTC
▲ SUPER 8-K
FiscalNote Holdings, Inc.
EDGAR Items: 1.01,2.01,7.01,9.01
# FiscalNote Holdings, Inc. - 8-K Summary
FiscalNote Holdings, Inc. completed the sale of its FrontierView business (operated through Frontier Strategy Group, LLC) to Oxford Economics USA, Inc. on August 27, 2026, for total consideration of up to $9.4 million ($6.4 million in cash at closing plus up to $3.0 million in earn-out payments contingent on revenue targets). The company used $4.95 million of the proceeds to prepay term loans under its existing financing agreement with MGG Investment Group LP, with $1.0 million of the closing cash held in escrow for potential post-closing adjustments and indemnification claims. This divestiture represents a material reduction in FiscalNote's asset base and revenue streams, and the company updated its full-year 2026 guidance to reflect FrontierView's removal from consolidated results as of the closing date. For investors, the sale reduces the company's operating footprint and revenue, though it provides near-term debt reduction and liquidity relief.
XLAB
NASDAQ
▲ SUPER 8-K
Exascale Labs Holdings Inc. Class A Common Stock
EDGAR Items: 1.01,1.02,2.01,3.01,3.03,4.01,5.01,5.02,5.03,5.06,7.01,9.01
# SEC 8-K Filing Summary: Exascale Labs Holdings Inc.
**Material Event:** On August 27, 2026, Exascale Labs Holdings Inc. (formerly D. Boral ARC Merger Corporation) completed a business combination with Exascale Labs Inc., involving a two-step merger process—first a domestication of the British Virgin Islands SPAC into a Delaware corporation, followed by the acquisition of Exascale Labs as a wholly-owned subsidiary. The transaction was approved by BCAR shareholders on July 29, 2026, with 26.9 million Class A shares redeemed for cash prior to closing.
**Investor Impact:** Exascale Labs is now a publicly traded company on the Nasdaq under ticker XLAB (Class A Common Stock) and XLABW (Warrants at $11.50 exercise price). The business combination converted all Exascale equity instruments (SAFEs, common stock, and incentive awards) into PubCo Class A and Class B common shares based on implied ownership percentages. The company issued approximately 33.7 million Class A shares and 30.6 million Class B shares at closing, significantly diluting existing shareholders, though the B-class shares carry enhanced voting rights for Exascale's founders. No fractional shares were issued, and warrant holders retain their positions with adjusted terms.
ROC
NASDAQ
▲ SUPER 8-K
Rank One Computing Corporation Common stock
EDGAR Items: 2.01,8.01,9.01
# SEC 8-K Filing Summary: Rank One Computing Corporation
Rank One Computing Corporation (NASDAQ: ROC) completed its acquisition of 100% of Zuccaro Technical Consulting LLC (ZTC) on August 31, 2026, pursuant to a Purchase Agreement dated June 23, 2026. The acquisition was previously announced and represents a material business combination for the Colorado-based company. The company issued a press release on September 1, 2026, confirming the completion of the transaction. While the 8-K does not disclose the acquisition price or financial terms, investors should review the company's press release and prior filings for details on the purchase consideration, expected synergies, and integration plans.
August 2026
26 filings
▼
INTZ
NASDAQ
▲ SUPER 8-K
Intrusion Inc New
EDGAR Items: 1.01,2.01,2.03,5.07,9.01
# Summary of Intrusion Inc. 8-K Filing
On August 28, 2026, Intrusion Inc. completed a $1.5 million secured financing with Streeterville Capital and simultaneously closed the acquisition of the remaining 40% stake in OW Cyber LLC, achieving 100% ownership of the subsidiary. The financing includes a 7% annual interest rate with a concerning 17.65% monitoring fee that increases the outstanding balance after 90 days, plus redemption rights allowing the investor to withdraw up to $150,000 monthly beginning in February 2027—creating near-term liquidity pressure on the company.
The deal structure tied the acquisition funding to shareholder approval obtained on August 27, 2026, but comes with restrictive covenants including a first-priority security interest in all company assets and intellectual property, restrictions on future securities issuances without investor consent, and a 10% participation right in future financings. Investors should be concerned about the company's working capital constraints, the aggressive debt terms, and potential dilution from the investor's future financing participation rights, as these factors may limit strategic flexibility and increase financial risk.
AHT
NYSE
▲ SUPER 8-K
Ashford Hospitality Trust, Inc.
EDGAR Items: 2.01,9.01
# Summary of Ashford Hospitality Trust 8-K Filing
On August 24, 2026, Ashford Hospitality Trust completed the sale of the Embassy Suites Dulles Airport hotel in Herndon, Virginia for approximately $22.8 million in cash to Woodland Park Road LLC. This asset disposition represents a portfolio rationalization move by the hospitality REIT. The company has included unaudited pro forma financial information reflecting this transaction, which investors should review to assess the impact on the company's financial metrics, cash position, and remaining portfolio composition.
ABVC
NASDAQ
▲ SUPER 8-K
ABVC BioPharma, Inc. Common Stock
EDGAR Items: 1.01,2.01,7.01,9.01
# SEC 8-K Filing Summary: ABVC BioPharma, Inc.
ABVC BioPharma completed a partial separation of its subsidiary BioKey (Cayman), Inc. on August 21, 2026, distributing approximately 15% of BioKey's ordinary shares to ABVC shareholders as a pro rata dividend while retaining 85% controlling ownership. BioKey is now a separate Exchange Act reporting company and plans to pursue OTC Markets listing. The separation involved multiple governing agreements covering transitional services, tax matters, employee arrangements, and indemnification provisions between the two entities. For ABVC investors, this restructuring creates a tracking vehicle in BioKey while maintaining ABVC's control and allows shareholders to hold both entities independently, though the lack of current trading liquidity for BioKey shares presents near-term uncertainty regarding valuation and tradability.
NUMD
OTC
▲ SUPER 8-K
Nu-Med Plus, Inc.
EDGAR Items: 1.01,2.01,3.02,9.01
# Nu-Med Plus, Inc. - 8-K Summary
Nu-Med Plus, Inc. completed its acquisition of six Canadian gold mineral properties on August 20, 2026, through its indirect subsidiary Maritimes Gold Corp., paying consideration consisting of 500,000 Series A Preferred Shares to MegumaGold and granting 5.0% net smelter returns royalties on each property. The acquisition followed the company's earlier completion of its acquisition of Avid Gold Ltd. on July 8, 2026, and received MegumaGold shareholder approval with 84.5% voting in favor. The company also agreed to a contingent value protection mechanism requiring it to issue additional common shares if MegumaGold has not received at least $3.0 million in gross proceeds from sales of the Series A Preferred Shares within three years, though such issuance is capped at 10% of outstanding common stock and subject to exchange approval. This acquisition significantly expands Nu-Med Plus' gold exploration portfolio across three Canadian provinces, but investors should monitor the contingent share issuance obligation as a potential future dilution risk.
AIRE
NASDAQ
▲ SUPER 8-K
reAlpha Tech Corp. Common Stock
EDGAR Items: 2.01,2.03,3.02,8.01,9.01
# SEC 8-K Summary: reAlpha Tech Corp.
reAlpha Tech Corp. (NASDAQ: AIRE) completed its acquisition of InstaMortgage Inc. on August 19, 2026, for an aggregate consideration of $8.5 million. The consideration structure includes $500,000 in cash at closing, $1.5 million in company stock (119,903 shares valued at $12.51 per share), and $6.5 million in bi-annual installments over three years, with at least $1.5 million paid in cash. The company waived certain regulatory approval conditions to close the transaction.
**Key investor considerations:** The deal involves significant equity dilution, with share issuances capped at 19.99% of pre-merger outstanding shares (1,176,267 shares maximum) to comply with Nasdaq Listing Rule 5635, and individual stockholder ownership capped at 4.99% without further approval. The three-year earn-out structure creates ongoing dilution risk, and issued shares are subject to six-month transfer restrictions, reducing near-term liquidity for sellers and adding regulatory complexity.
ELUT
NASDAQ
▲ SUPER 8-K
Elutia Inc. Class A Common Stock
EDGAR Items: 2.01,7.01,9.01
# Summary of Elutia Inc. 8-K Filing
Elutia Inc. completed the sale of its SimpliDerm Business, a human acellular dermis product line for breast reconstruction, to Cellution Biologics Inc. on August 17, 2026, generating $7.7 million in immediate proceeds with potential additional contingent payments of up to $3 million over eighteen months based on technology transfer and commercial milestones. The SimpliDerm Business represented substantially all assets of Elutia's Women's Health segment, indicating a significant business restructuring. The company simultaneously amended its loan agreement with Avenue Venture Opportunities Fund II to release liens on the divested assets and entered into a five-year non-compete agreement and six-month transition services arrangement. This divestiture marks a material reduction in Elutia's operating scale, and investors should monitor whether the company deploys proceeds strategically and whether contingent payments are ultimately realized.
ETST
OTC
▲ SUPER 8-K
Earth Science Tech, Inc.
EDGAR Items: 2.01,7.01,9.01
# Summary of Earth Science Tech, Inc. Form 8-K Filing (August 17, 2026)
Earth Science Tech, Inc. completed the acquisition of Zoolzy LLC on August 17, 2026, with transaction terms described as immaterial and therefore undisclosed. The acquisition represents a related-party transaction, as the seller was Mario G. Tabraue, the Company's Chief Operations Officer and Board member, though the independent board members reviewed and approved the deal to ensure fair terms. The company trades on the OTC Bulletin Board under the symbol ETST and announced the acquisition via press release on August 19, 2026. Given the immaterial nature of the consideration and limited disclosure, this acquisition is unlikely to have a material impact on shareholders, though investors should note the related-party nature of the transaction and the board's duty to ensure fair dealing in such arrangements.
ZSTK
NASDAQ
▲ SUPER 8-K
ZeroStack Corp. Common Stock
EDGAR Items: 1.01,2.01,3.02,5.02,9.01
# ZeroStack Corp. 8-K Summary
ZeroStack Corp. completed a material $1 billion capital transaction on August 19, 2026, acquiring approximately 926 million MemeCore (M) tokens in exchange for issuing 3.5 million shares and pre-funded warrants to purchase up to 36.2 million additional shares to investors including Puple AI Inc. and Blockcat Pte. Ltd. The transaction is subject to shareholder approval under Nasdaq Listing Rule 5635, with shares exceeding the 19.99% ownership cap converted to long-term warrants with up to a 10-year lock-up period. Concurrently, the Company appointed Rudy Rong—a significant contributor of the digital assets and former Chief Growth Officer of MemeCore—as President with a $500,000 annual salary and eligibility for 125,000 restricted shares pending shareholder approval. The digital assets will be held in a multi-signature wallet and restricted from staking, introducing concentration risk around a single cryptocurrency asset and management tied directly to the source of the acquired tokens.
BHR
NYSE
▲ SUPER 8-K
Braemar Hotels & Resorts Inc. Common Stock
EDGAR Items: 2.01,9.01
# SEC 8-K Summary: Braemar Hotels & Resorts Inc.
Braemar Hotels & Resorts completed the sale of the Pier House Resort & Spa in Key West, Florida on August 12, 2026, for $190.0 million in cash ($1.3 million per room), representing a 7.3% capitalization rate on trailing 12-month net operating income. This asset disposition is material to the company's portfolio, though the filing does not specify the proportion of total assets or revenue this property represents. The sale proceeds will likely be used for debt reduction or operational purposes, and investors should review the pro forma financial information attached to understand the impact on the company's future earnings and balance sheet. The transaction appears to be part of a strategic portfolio optimization rather than a forced liquidation, suggesting normal business operations continue.
ELME
NYSE
▲ SUPER 8-K
Elme Communities
EDGAR Items: 2.01,9.01
# Summary of ELME Communities 8-K Filing
ELME Communities completed the sale of Elme Bethesda, a 193-unit multifamily property in Bethesda, Maryland, to Tilden Bethesda Hill Apartments, LLC for $58.0 million on August 11, 2026. This transaction is part of the company's broader liquidation strategy initiated after the November 2025 sale of its 19-property Cortland Portfolio for $1.606 billion, which allowed ELME to repay all major debt facilities including its revolver, term loans, and $7.25% senior notes due 2028. As of June 30, 2026, the company had completed sales of six of its remaining ten properties and is operating on a liquidation basis approved by shareholders in October 2025. The disposition reduces ELME's portfolio further as it executes its plan to systematically wind down operations and return capital to shareholders.
TMRC
OTC
▲ SUPER 8-K
DyTb, LLC
EDGAR Items: 1.02,2.01,3.03,5.01,5.02,5.03,8.01,9.01
# SEC 8-K Filing Summary: DyTb, LLC (formerly Texas Mineral Resources Corp.)
On August 7, 2026, USA Rare Earth, Inc. (USAR) completed its acquisition of Texas Mineral Resources Corp. (TMRC) through a two-step merger structure, with TMRC ultimately merging into DyTb, LLC, a USAR subsidiary that now serves as the surviving entity. TMRC shareholders received an exchange ratio of 0.043279843 shares of USAR Common Stock for each TMRC share held (based on 88.3 million fully diluted shares outstanding), with fractional shares paid in cash. The transaction was registered under an S-4 registration statement declared effective on June 29, 2026, and resulted in a complete change of control—all former TMRC directors and officers ceased their roles, with Valerie Ford Jacob assuming the position of President, Treasurer, and Secretary. Additionally, TMRC's mineral exploration and option agreement with Santa Fe Gold Corporation (relating to silver properties in New Mexico's Black Hawk Mining District) was terminated effective at closing, eliminating TMRC's previous joint venture rights.
**Investor Impact:** TMRC shareholders have been converted into USAR shareholders at a heavily diluted ratio, effectively experiencing a significant ownership reduction. The termination of the Santa Fe option agreement removes a potential growth opportunity in mineral exploration, which may be material depending on the project's development status.
NCRA
NASDAQ
▲ SUPER 8-K
Nocera, Inc. Common Stock
EDGAR Items: 2.01,3.01,9.01
# Nocera, Inc. (NCRA) 8-K Summary
Nocera, Inc. completed the sale of 231 acres of real property in Montgomery County, Alabama for $700,000 in gross proceeds ($654,604 net after settlement charges) on August 7, 2026, which the company expects will result in an approximate $178,000 loss in Q3 2026. The non-core asset sale is intended to provide working capital for the company's primary Taiwan-based fish trading and e-commerce operations. Most significantly, Nasdaq Staff confirmed on August 10, 2026, that Nocera now complies with the minimum stockholders' equity listing standard of $2.5 million, evidenced by June 30, 2026 stockholders' equity of $5.4 million, resolving the company's April 2026 delisting notification for failing to meet Nasdaq Capital Market Rule 5550(b)(1), (b)(2), and (b)(3). The resolution of the listing compliance issue removes the threat of delisting and provides investors with continued market access to NCRA shares.
ATHR
NASDAQ
▲ SUPER 8-K
Aether Holdings, Inc. Common Stock
EDGAR Items: 1.01,2.01,2.03,3.02,9.01
# Summary of Aether Holdings, Inc. Form 8-K Filing (August 5, 2026)
Aether Holdings, Inc. announced two material transactions: (1) a $3.6 million acquisition of a 60% equity stake in Noviant Inc., funded through $2.7 million in restricted common stock and $900,000 in cash, and (2) a $1.5 million secured promissory note from Streeterville Capital carrying 8% annual interest with an 18-month maturity. The Noviant acquisition includes governance provisions giving Aether Compute (the acquiring subsidiary) two of three board seats and contains standard lock-up restrictions on seller shares (50% for six months, 50% for two years). These transactions represent significant expansion of the company's operations and leverage its balance sheet with new debt obligations, potentially diluting existing shareholders through the issuance of restricted stock to Noviant sellers.
AIFC
NASDAQ
▲ SUPER 8-K
AI Financial Corporation Common Stock
EDGAR Items: 1.01,2.01
# AI Financial Corporation 8-K Summary
AI Financial Corporation completed the sale of its wholly-owned subsidiary ALT 5 Sigma Canada, Inc. to Prime Delta Corp. on August 3, 2026, for $12 million in cash (via secured promissory note) plus 11.55 million restricted shares of Prime's common stock. The promissory note carries a 4% annual interest rate with $1 million due immediately (August 11, 2026) and the remaining $11 million payable through either 20% of Prime's future equity financing proceeds or four equal annual installments of $2.75 million beginning August 2027, with full security from Prime's assets and third-party guarantees backing the obligation. This divestiture represents a significant asset reduction for AIFC and shifts the company's focus away from its Canadian subsidiary operations, with investor returns now dependent on Prime's future financial performance and equity financing activities. The restricted stock component introduces valuation uncertainty for investors, as these shares are illiquid and their value depends entirely on Prime's private company growth trajectory.
VYST
OTC
▲ SUPER 8-K
Vystar Corp
EDGAR Items: 1.01,2.01,3.02,9.01
# VyStar Corporation 8-K Summary
On August 4, 2026, VyStar Corporation entered into a joint venture with Capital Realm, Inc. to acquire a 50% interest in r3alm, Inc., a compliance-focused AI and Web3 financial ecosystem bridging traditional finance and decentralized technologies. In consideration, VyStar issued 8,371 shares of Series B Preferred Stock (convertible into 8,371,000 common shares, representing 34% ownership) to Capital Realm, fully vested upon proof of intellectual property concept. The r3alm platform comprises 22 modules designed to support digital capital formation, tokenized assets, trading infrastructure, and AI-powered financial intelligence, with planned capability to help small/micro-cap companies tokenize stocks and access 24-hour domestic and international trading. This transaction represents a significant strategic expansion into the fintech/blockchain sector for VyStar, though investors should note the substantial dilution from the 8.371 million share issuance and the early-stage nature of the underlying r3alm technology platform.
AHT
NYSE
▲ SUPER 8-K
Ashford Hospitality Trust, Inc.
EDGAR Items: 2.01,9.01
# Summary of Ashford Hospitality Trust 8-K Filing
Ashford Hospitality Trust completed the sale of the Hyatt Regency Long Island in Hauppauge, New York on July 31, 2026, for approximately $26.5 million in cash. This asset disposition represents part of the company's portfolio rationalization strategy, generating liquidity that could be deployed toward debt reduction or other corporate purposes. The filing includes unaudited pro forma financial information reflecting the impact of this divestiture as of March 31, 2026 and December 31, 2025, allowing investors to assess the company's financial position on a comparable basis post-sale. While this transaction provides near-term cash flow, investors should monitor whether proceeds are utilized effectively and whether additional dispositions may be necessary to strengthen the REIT's balance sheet and liquidity position.
ENSC
NASDAQ
▲ SUPER 8-K
Ensysce Biosciences, Inc. Common Stock
EDGAR Items: 1.01,2.01,3.02,3.03,5.02,5.03,7.01,9.01
# Summary of Ensysce Biosciences 8-K Filing
On August 5, 2026, Ensysce Biosciences, Inc. completed its acquisition of Cy Biopharma, Inc. through a two-step merger structure, with Cy becoming a wholly owned subsidiary of Ensysce. In exchange for Cy's outstanding shares, Ensysce issued 282,122 shares of Series C Preferred Stock to Cy's equityholders, with each preferred share convertible into 1,000 common shares. The Board unanimously approved the transaction without requiring stockholder approval for the merger itself.
The acquisition triggers important corporate governance actions: Ensysce must hold a stockholders' meeting to approve (1) the conversion of Series C Preferred Stock into common shares and (2) potential charter amendments to authorize sufficient common shares for conversion and/or implement a reverse stock split to maintain Nasdaq compliance. This conversion could significantly dilute existing shareholders if all preferred shares convert, potentially adding approximately 282 million common shares. The transaction is structured as a tax-free reorganization and is supported by agreements with major Ensysce and Cy shareholders to vote in favor of the required proposals.
HCAT
NASDAQ
▲ SUPER 8-K
Health Catalyst, Inc Common Stock
EDGAR Items: 1.02,2.01,2.02,7.01,9.01
# Health Catalyst 8-K Summary
Health Catalyst completed the divestiture of its VitalWare business to Med-Metrix LLC for $147 million on July 31, 2026, and immediately used the net proceeds to fully repay and terminate its $160 million credit facility (including $122.8 million principal, $37.1 million delayed draw facility, and associated fees). This elimination of debt represents a significant deleveraging event that improves the company's balance sheet and financial flexibility. The company will provide transition services to the buyer for up to six months post-closing. Investors should note that VitalWare will no longer contribute to future revenues and earnings, but Health Catalyst is now debt-free, which reduces financial risk and interest expense going forward.
HYFM
NASDAQ
▲ SUPER 8-K
Hydrofarm Holdings Group, Inc. Common Stock
EDGAR Items: 1.01,2.01,7.01,9.01
# Hydrofarm Holdings Group, Inc. - 8-K Summary
Hydrofarm Holdings Group completed the sale of Aurora Peat Products ULC (APP) to 2817049 Alberta Ltd. for $16 million on July 31, 2026, with $5 million deferred as a secured promissory note. The company will use net proceeds to reduce its $125 million senior secured term loan debt, directly improving its leverage position. Additionally, Hydrofarm LLC entered into a supply agreement with the buyer to continue producing and supplying goods post-sale, maintaining operational continuity in this business segment. This asset disposition represents a strategic debt reduction move that should strengthen the company's financial position and improve its debt servicing capacity.
TCPC
NASDAQ
▲ SUPER 8-K
BlackRock TCP Capital Corp. Common Stock
EDGAR Items: 1.01,2.01,2.02,7.01,9.01
# Summary of BlackRock TCP Capital Corp. 8-K Filing
On August 4, 2026, BlackRock TCP Capital Corp. (NASDAQ: TCPC) completed the sale of a 95% interest in a continuation vehicle holding approximately $523 million of loan assets to investment funds managed by Pantheon Ventures, generating approximately $152 million in gross proceeds while retaining a 5% equity stake. This transaction significantly strengthens the company's balance sheet by reducing net leverage from 1.38x to approximately 0.4x (potentially below 0.3x following an announced portfolio company paydown) and reducing unfunded commitments from $90 million to $36 million. However, the company estimates the transaction will reduce net asset value by approximately $57 million or $0.68 per share due to the sale occurring at roughly 95% of December 31, 2025 fair market value. Post-transaction, the Board has engaged KBW to evaluate strategic alternatives to maximize shareholder value, including potential share repurchases, strategic combinations, or orderly portfolio asset realization, positioning the company with enhanced financial and operational flexibility to pursue value-creation initiatives.
CYCU
NASDAQ
▲ SUPER 8-K
Cycurion, Inc. Common Stock
EDGAR Items: 1.01,2.01,3.02,8.01,9.01
# Summary of Cycurion, Inc. 8-K Filing (August 3, 2026)
Cycurion, Inc. completed the acquisition of substantially all assets from Kustom Entertainment's video-solutions division on August 3, 2026, adding video hardware, camera products, and software solutions to its portfolio. The total consideration includes $1.25 million in cash, a $4.25 million secured promissory note, up to $1 million in contingent earnout payments, and $600,000 in Series H Preferred Stock (which accrues 12% annual dividends and converts to common stock at $1.45 per share). The preferred stock replaced 2 million warrants originally planned, reducing potential dilution to shareholders. This strategic acquisition expands Cycurion's technology offerings, though investors should monitor the company's ability to service the debt obligation and achieve the earnout performance milestones.
KUST
NASDAQ
▲ SUPER 8-K
Kustom Entertainment, Inc. Common Stock
EDGAR Items: 1.01,2.01,8.01,9.01
# Kustom Entertainment, Inc. (KUST) – 8-K Summary
Kustom Entertainment completed the sale of its video-solutions division to Cycurion, Inc. on August 3, 2026, receiving total consideration of approximately $6.1 million consisting of $1.25 million in immediate cash, a $4.25 million secured promissory note, up to $1 million in contingent earnout payments, and $600,000 in Series H Convertible Preferred Stock. The company retained a security interest in the sold assets as collateral for the note repayment and obtained registration rights for the preferred shares. Additionally, Kustom amended its existing common stock purchase agreement with an investor to modify the share purchase mechanics based on beneficial ownership limitations and the investor's trading activity.
**Investor Impact:** This divestiture represents a significant portfolio shift for Kustom, as it exits the video-solutions business—likely a core historical segment—and becomes dependent on deferred payments for most of the transaction value. The $4.25 million note is secured only by the divested assets themselves, creating recovery risk if the buyer cannot generate adequate cash flow. The contingent earnout adds uncertainty to total proceeds, while the preferred stock subjects investors to additional dilution upon conversion.
SNBRQ
OTC
▲ SUPER 8-K
Sleep Number Corp
EDGAR Items: 2.01,9.01
# Sleep Number Corporation 8-K Summary
Sleep Number Corporation completed its **Chapter 11 bankruptcy liquidation** on July 31, 2026, with the sale of substantially all assets to SNBR, Inc. (a subsidiary of Sleep Country Canada Inc.) for $529.5 million in cash proceeds. After distributing approximately $267.4 million to repay debtor-in-possession and prepetition lender obligations and placing $10 million in escrow for post-closing adjustments, the company expects **zero proceeds for equity holders**—common stock will be cancelled upon plan effectiveness. This represents a complete loss of shareholder value, as the bankruptcy liquidation leaves no recovery for stockholders after debt repayment.
IVHI
OTC
▲ SUPER 8-K
Invech Holdings, Inc.
EDGAR Items: 1.01,2.01,5.01,5.02,9.01
# Summary of Invech Holdings, Inc. 8-K Filing
Invech Holdings, Inc. underwent a change of control on August 3, 2026, when majority shareholder Alexander M. Woods-Leo sold 88 million shares of Common Stock and 300,000 shares of Series A Preferred Stock (representing ~75.9% of common stock and 100% of preferred stock) to Stephen Ken Adair for $290,000. The Series A Preferred Stock carries 80% of total voting power, giving Adair effective control of the company. In connection with the transaction, Woods-Leo resigned from all positions (President, CEO, CFO, Treasurer, Secretary, Director), and Adair was appointed to assume all these roles. Prior to closing, the company divested its Paragon Assets—a SaaS real estate rental property management platform—to an entity controlled by Woods-Leo for nominal consideration, which may affect the company's shell company status. This transaction represents a complete management and ownership transition for the OTC-traded company.
HSTA
OTC
▲ SUPER 8-K
Hestia Insight Inc.
EDGAR Items: 1.01,2.01,9.01
# Hestia Insight Inc. 8-K Summary
On July 31, 2026, Hestia Insight Inc. completed the divestiture of its wholly-owned subsidiary, Hestia Investments Inc., transferring 100% of its equity, assets, bank accounts, and operational holdings to Chairman and President Edward C. Lee as settlement of historical executive compensation claims. In exchange for this consideration, the company's shareholders as of April 30, 2026 received the right to participate in 20% of the subsidiary's net earnings on an annual basis for 24 months following the transaction. The subsidiary was subsequently deconsolidated from the company's financial statements, representing a material restructuring of the company's asset base. This transaction was disclosed earlier to shareholders through a Schedule 14C information statement and was authorized by the Board of Directors as part of executive succession planning.
SEII
OTC
▲ SUPER 8-K
SHARING ECONOMY INTERNATIONAL INC.
EDGAR Items: 1.01,2.01,3.02,5.01,5.06,9.01
# Summary of SEC 8-K Filing - Sharing Economy International Inc.
On August 2, 2026, Sharing Economy International Inc. completed a transformative reverse merger, acquiring Light Across, Inc., an electric vehicle engineering, design, and manufacturing company, through a share exchange agreement. The company issued approximately 4.99 billion shares of common stock (representing 80% of post-transaction ownership) to Light Across shareholders, fundamentally reshaping ownership structure and business focus. CEO Ximing Huang acquired ~65.6% beneficial ownership and CFO Johnny Chen acquired ~11.5% beneficial ownership of the combined entity through their respective 82% and 14.4% stakes in Light Across.
This transaction converts the company from a shell entity into an active EV manufacturing enterprise, though Light Across has not yet produced vehicles for commercial sale and intends to initiate production in the United States. The massive share issuance significantly dilutes existing shareholders' ownership, and investors should recognize the substantial execution risk associated with a pre-revenue manufacturing venture in the highly competitive EV sector.
July 2026
52 filings
▼
VASO
OTC
▲ SUPER 8-K
VASO Corp
EDGAR Items: 1.01,2.01,9.01
# Summary of Vaso Corporation 8-K Filing
Vaso Corporation completed the sale of NetWolves Network Services LLC, its wholly owned subsidiary engaged in managed network services, to COEO Solutions LLC for a base purchase price of $14.5 million in cash on July 31, 2026. The transaction is subject to customary post-closing adjustments based on net working capital, closing cash, indebtedness, and expenses. Following the disposition, NetWolves is no longer an indirect subsidiary of Vaso, and the company will file pro forma financial information showing the impact of the divestiture within four business days. This asset sale represents a strategic portfolio rationalization that will reduce Vaso's business scope but provide immediate liquidity to the company.
LPRO
NASDAQ
▲ SUPER 8-K
Open Lending Corporation Common Stock
EDGAR Items: 1.02,2.01,3.01,3.03,5.01,5.03,9.01
# Open Lending Corporation 8-K Summary
Open Lending Corporation (NASDAQ: LPRO) completed its acquisition by ANV Group Holdings Ltd. on July 30, 2026, at $3.15 per share in an all-cash transaction. Approximately 85.57% of outstanding shares were tendered in the offer, satisfying all closing conditions, resulting in a change of control with Open Lending becoming an indirect wholly-owned subsidiary of the parent company. In connection with the merger, the company terminated its credit agreement with Wells Fargo Bank, with all outstanding obligations to be repaid in full as of the closing date. All employee equity awards, including stock options, restricted stock units, and performance-based units, were accelerated and converted to cash payments at the merger consideration price, with unvested options and performance units receiving full value based on the specified terms.
PCSA
NASDAQ
▲ SUPER 8-K
Processa Pharmaceuticals, Inc. Common
EDGAR Items: 1.01,1.02,2.01,3.02,5.02,5.03,7.01,9.01
# SEC 8-K Summary: Processa Pharmaceuticals Merger with Vidya Therapeutics
Processa Pharmaceuticals (NASDAQ: PCSA) completed a merger with Vidya Therapeutics on July 28, 2026, whereby Vidya became a wholly owned subsidiary of Processa in a tax-free reorganization. In the transaction, Processa issued 558,398 shares of common stock and 142,744.1 shares of Series A Non-Voting Convertible Preferred Stock (convertible into 1,000 common shares each, pending stockholder approval) to Vidya's former equityholders.
The merger significantly dilutes existing Processa shareholders: pre-transaction Processa shareholders will hold approximately 3% of the company immediately post-closing (or 0.9% after planned financing), while Vidya's former shareholders will own approximately 97% (or 46% post-financing), with new investors acquiring approximately 52.6%. The company must hold a stockholder meeting to approve the preferred stock conversion, equity plans, and potentially a reverse stock split, with Processa shareholders prohibited from voting on the preferred conversion per Nasdaq Rule 5635. Processa must also file a Form S-3 registration statement within 75 days post-financing to register resale of the merger-related shares.
KULR
AMEX
▲ SUPER 8-K
KULR Technology Group, Inc.
EDGAR Items: 2.01
# Summary of KULR Technology Group 8-K Filing
KULR Technology Group completed the sale of approximately 333 bitcoin between July 9-23, 2026 at a weighted average price of $64,538 per BTC, generating $21.5 million in gross proceeds. The company used the net proceeds to fully repay its $20 million credit facility with Coinbase Credit, eliminating the debt and releasing 565 BTC previously pledged as collateral. This strategic deleveraging strengthens KULR's balance sheet by reducing interest expense and liquidation risk while the company retains approximately 760 BTC and maintains a largely debt-free financial position as it scales its core battery technology business.
ZSTK
NASDAQ
▲ SUPER 8-K
ZeroStack Corp. Common Stock
EDGAR Items: 2.01
# ZeroStack Corp. (ZSTK) 8-K Summary
ZeroStack Corp. completed a private cryptocurrency financing transaction on July 20, 2026, acquiring 142.2 million native tokens from the Zero Gravity (0G) blockchain in exchange for issuing 9.1 million new common shares to investors. The transaction was facilitated through a subsidiary structure (Texas Blocker Corp.) and received shareholder approval at the company's annual meeting. Executive Chairman Michael Heinrich's affiliated entity, Zero Gravity Labs Inc., was a significant investor, acquiring approximately 4.6 million shares (50.6% of the financing) and effectively maintaining substantial control of the company post-transaction.
**Investor Impact:** The financing significantly dilutes existing shareholders while concentrating voting power in affiliated parties, and ties the company's value to cryptocurrency assets (0G tokens) rather than traditional operations, increasing volatility and speculative risk. Investors should monitor whether the 0G tokens generate meaningful value and review governance implications of the insider's substantial ownership stake.
FGMCR
NASDAQ
▲ SUPER 8-K
FG Merger II Corp. Rights
EDGAR Items: 1.01,1.02,2.01,3.01,3.02,3.03,4.01,5.01,5.02,5.03,5.06,7.01,9.01
# Summary of Boxabl Inc. Form 8-K Filing
Boxabl Inc. (trading under ticker BXBL on Nasdaq) successfully completed its merger with FG Merger II Corp. (SPAC) on July 17, 2026, with the combined company beginning trading on July 20, 2026. Under the merger agreement, former Boxabl shareholders received approximately 246.5 million shares of common stock and 103.5 million shares of preferred stock, valuing the transaction at $3.5 billion based on a $10.00 per share deemed value. Lock-up agreements restrict insiders from selling shares for 12 months (with 50% of shares able to unlock earlier if the stock reaches $12.00 for 20 trading days within any 30-day period), and all lock-up restrictions automatically terminate if the stock trades at $20.00 or above at any point. The transaction represents a significant capitalization event for the modular housing company, bringing it to public markets with substantial insider ownership restrictions in place to ensure stability during the critical post-merger period.
BXBL
NASDAQ
▲ SUPER 8-K
BOXABL, Inc. Common stock
EDGAR Items: 1.01,1.02,2.01,3.01,3.02,3.03,4.01,5.01,5.02,5.03,5.06,7.01,9.01
# SEC 8-K Summary: Boxabl Inc. Business Combination Closing
On July 17, 2026, Boxabl Inc. (formerly FG Merger II Corp.) completed its business combination with BOXABL Inc., a modular housing company, creating a combined entity trading on Nasdaq under the symbol "BXBL" as of July 20, 2026. The transaction valued Boxabl at $3.5 billion (based on a $10.00 per share deemed value) and resulted in the issuance of approximately 246.5 million shares of common stock and 103.5 million shares of preferred stock to former BOXABL shareholders. Major BOXABL shareholders, including founders Paolo Tiramani and Galiano Tiramani, agreed to lock-up arrangements restricting share sales for 12 months (with earlier release provisions tied to stock price milestones of $12.00 and $20.00 per share). The business combination is now complete, establishing Boxabl as a publicly traded company focused on modular housing technology and solutions.
CNTN
NASDAQ
▲ SUPER 8-K
Canton Strategic Holdings, Inc. Common Stock
EDGAR Items: 1.01,2.01,8.01,9.01
# Summary of Canton Strategic Holdings, Inc. Form 8-K Filing
Canton Strategic Holdings, Inc. completed the sale of its wholly-owned subsidiary Gravitas Life Sciences, LLC (a clinical-stage biotech company focused on immunology and inflammation therapeutics) to Gravitas Collective Corp. on July 17, 2026, for $3.5 million in an unsecured promissory note bearing 15% annual interest, compounded semi-annually, with a maturity date of July 17, 2029, plus potential development milestone payments. The transaction involves a related-party element, as the buyer is affiliated with three former company directors (Vincent LoPriore, Sireesh Appajosyula, and Gary Stetz), though a special committee of independent directors reviewed and approved the deal. Canton retained bispecific antibodies development assets through its subsidiary Tharimmune SPV1, mitigating complete divestiture risk.
**Investor Impact**: This disposition reduces Canton's operational biotech pipeline but preserves liquidity through the $3.5 million note receivable; however, investors should monitor note repayment risk given the buyer's affiliation with former insiders and the absence of upfront cash consideration, which may signal valuation concerns or liquidity constraints.
STCB
OTC
▲ SUPER 8-K
Starco Brands, Inc.
EDGAR Items: 1.01,2.01,2.03,7.01,9.01
# SEC 8-K Summary: Starco Brands, Inc.
Starco Brands, Inc. completed the acquisition of Custom Foods, LLC on July 15, 2026, through its subsidiary Starco Manufacturing, LLC, paying $8.0 million in cash at closing plus up to $2.5 million in earn-out consideration tied to 2027 revenue metrics. To finance this acquisition, the company secured an $11.0 million term loan from Pasadena Private Lending Inc., along with a $3.0 million revolving credit facility and an accordion feature allowing up to $4.0 million in additional borrowing, with all obligations cross-defaulted and cross-collateralized. The debt is personally guaranteed by CEO Ross Sklar and various family trusts, with security interests in substantially all company assets, and requires compliance with financial covenants including a maximum senior debt-to-EBITDA ratio of 3.0x and minimum fixed charge coverage ratio of 2.0x measured quarterly. This acquisition substantially increases Starco's leverage and tightens its financial flexibility through restrictive covenants, while the earnout structure creates upside potential but adds execution risk dependent on Custom Foods' 2027 revenue performance.
NRDE
OTC
▲ SUPER 8-K
Stark Novus Financial Inc.
EDGAR Items: 2.01,5.03,8.01,9.01
# SEC 8-K Summary: Stark Novus Financial Inc.
Stark Novus Financial Inc. (formerly Nu Ride Inc.) completed the acquisition of Affinity Advisory Network, LLC and AAN Wealth Advisors, LLC on July 15, 2026, for $6.72 million in cash, 80,000 shares of Class A common stock, and a 15% equity stake in the acquisition subsidiary, plus up to $1.31 million in contingent earnout payments tied to insurance-writing performance. The company simultaneously rebranded from "Nu Ride Inc." to reflect its new business direction in financial advisory services and announced that its Class A Common Stock will trade on the OTC under the ticker symbol "SNFI." This acquisition represents a significant strategic pivot from the company's previous operations and establishes it as a wealth advisory platform. Investors should note that detailed financial statements and pro forma information for the acquired business will be filed within 71 days.
RBOT
OTC
▲ SUPER 8-K
Vicarious Surgical Inc.
EDGAR Items: 1.01,2.01,5.02,5.07,8.01,9.01
# Summary of Vicarious Surgical Inc. Form 8-K Filing
Vicarious Surgical Inc. announced a comprehensive liquidation on July 21, 2026, transferring substantially all company assets to an assignee through an assignment for the benefit of creditors, which was approved by stockholders and authorized by the Board of Directors. The company is simultaneously pursuing voluntary deregistration by filing Form 15 with the SEC (citing fewer than 300 holders of record) and voluntary dissolution under Delaware law, with both actions expected to be finalized by late July/August 2026. All seven board members resigned effective upon Form 15 filing, and key executives—including CEO Stephen From, President Adam Sachs, CTO Sammy Khalifa, and Chief Medical Officer Dr. Barry Greene—were terminated, with severance obligations totaling approximately $2.06 million plus full equity vesting.
**Investor Impact:** This represents a complete wind-down of the company with creditors receiving priority over stockholders in asset distributions, meaning common equity holders face significant dilution risk or total loss. The immediate suspension of SEC reporting obligations upon Form 15 filing and 90-day deregistration timeline signal the end of public company status and trading liquidity for shareholders.
GIPR
NASDAQ
▲ SUPER 8-K
Generation Income Properties Inc. Common Stock
EDGAR Items: 2.01
# Summary of Generation Income Properties, Inc. 8-K Filing
On July 15, 2026, Generation Income Properties, Inc. completed the sale of its net lease property located at 991 Nut Tree Road in Vacaville, California to Taricens Medical Estates LLC for $2,475,000, generating approximately $2,356,757 in net proceeds after closing costs and commissions. The property had been leased to the U.S. Government under a lease agreement dating back to August 2010. This asset disposition represents a reduction in the company's real estate portfolio and will affect future lease income streams from this property. Investors should note this transaction reduces the company's revenue-generating assets and should monitor the impact on dividend sustainability and overall portfolio composition.
NIKI
NASDAQ
▲ SUPER 8-K
Niki BioSolutions, Inc. Common Stock
EDGAR Items: 2.01,3.03,5.02,5.03,8.01,9.01
# Summary of Niki BioSolutions 8-K Filing
On July 20, 2026, Aptorum Group Limited completed its merger with DiamiR Biosciences Corp. and simultaneously domesticated from a Cayman Islands company to a Delaware corporation, rebranding as Niki BioSolutions, Inc. (trading under ticker "NIKI" on Nasdaq Capital Market). The merger resulted in Aptorum shareholders receiving 814,375 shares of Niki common stock on a one-for-one basis, while DiamiR shareholders received 1,979,216 shares based on a conversion ratio of approximately 0.1757. As part of the transaction, Aptorum's Class A and Class B ordinary shares converted into Niki common stock and Series A preferred stock, and the company adopted a new 2026 Incentive Plan. The transaction fundamentally reshapes the company's corporate structure and ownership, with DiamiR becoming a wholly-owned subsidiary of the newly formed Niki BioSolutions.
GORO
AMEX
▲ SUPER 8-K
Goldgroup Mining Inc.
EDGAR Items: 2.01,3.01,3.03,5.01,5.02,5.03,7.01,9.01
# Summary of Gold Resource Corporation 8-K Filing
Gold Resource Corporation completed its merger with Goldgroup Mining Inc. on July 17, 2026, whereby Gold Resource shareholders received 0.3619 Goldgroup shares per share held (reflecting a four-for-one consolidation). Gold Resource is now a wholly owned subsidiary of Goldgroup, representing a change of control of the company. The company's common stock has been delisted from NYSE American, with trading suspended and a Form 25 notification filed to deregister the securities under Section 12(b) of the Securities Exchange Act; Gold Resource intends to suspend its SEC reporting obligations via Form 15. All outstanding employee awards (options, DSUs, RSUs, and PSUs) were assumed and converted by Goldgroup using the exchange ratio, while the former Board of Directors was replaced in connection with the merger.
ATER
NASDAQ
▲ SUPER 8-K
Aterian, Inc. Common Stock
EDGAR Items: 1.01,1.02,2.01,3.02,3.03,5.01,5.02,5.03,5.07,8.01,9.01
# Aterian, Inc. (ATER) 8-K Summary
Aterian completed a major restructuring on July 17, 2026, selling its core branded assets (Mueller Living, PurSteam, hOmeLabs, Squatty Potty, and others) to Trademark Global for $18.0 million and selling preferred stock to investor David Lazar for $7.0 million, while simultaneously repaying and terminating its existing credit facility with MidCap Funding. The company established a contingent value rights (CVR) structure that will distribute to shareholders any proceeds received from the asset sale, additional reserves, future asset sales, and cash releases—though there is no assurance shareholders will receive any payments. This transaction substantially transforms Aterian from a multi-brand consumer products company into a smaller entity operating only legacy brands like Vremi and Xtava, with investor returns now dependent on uncertain future liquidation proceeds rather than ongoing business operations.
BHR
NYSE
▲ SUPER 8-K
Braemar Hotels & Resorts Inc. Common Stock
EDGAR Items: 1.01,2.01,9.01
# SEC 8-K Summary: Braemar Hotels & Resorts Inc.
Braemar Hotels & Resorts announced two significant asset disposition transactions totaling approximately $627.5 million. The company completed the sale of three properties (The Ritz-Carlton Sarasota, Hotel Yountville, and Bardessono Hotel and Spa) for $437.5 million on July 14, 2026, and entered into a binding agreement to sell the Pier House Resort & Spa in Key West, Florida for $190 million, pending customary closing conditions. These large-scale divestitures represent a material shift in the company's portfolio composition and suggest a strategic deleveraging initiative to reduce debt and reposition operations. For investors, the completed sales provide near-term liquidity that may be applied to debt reduction or capital deployment, though the loss of premium resort assets in attractive markets may impact future revenue generation and operational diversification.
JSPR
NASDAQ
▲ SUPER 8-K
Jasper Therapeutics, Inc. Common Stock
EDGAR Items: 1.01,2.01,3.02,5.02,5.03,7.01,9.01
# Jasper Therapeutics 8-K Summary
Jasper Therapeutics completed its acquisition of Kira Pharmaceuticals on July 16, 2026, issuing approximately 5.2 million shares of voting common stock and 4.6 million shares of convertible preferred stock (convertible into ~283 million common shares) to Kira shareholders. The merger dramatically dilutes existing Jasper shareholders from ~11.27% to ~6.68% ownership on a fully-diluted basis, while Kira shareholders gain ~49.86% ownership post-financing. The company must seek stockholder approval within 120 days for the preferred stock conversion, board appointments, and an increase in authorized common shares to facilitate the conversion and concurrent PIPE financing. This acquisition represents a significant recapitalization of Jasper, with investors needing to monitor upcoming proxy materials and the subsequent financing details for full impact assessment.
SBIG
OTC
▲ SUPER 8-K
SBIG Holdings, Inc.
EDGAR Items: 1.01,2.01,5.02,9.01
# SpringBig Holdings, Inc. - 8-K Summary
SpringBig Holdings, Inc. completed a reorganization transaction on July 13, 2026, in which secured lenders transferred the company's collateral (including all equity interests in its operating subsidiary) to Lightbank II, L.P. and LS Round II, LLC, resulting in the company being released from approximately $12.5 million in principal and accrued interest on its Senior Secured Convertible and Term Promissory Notes. As a result of this transaction, substantially all of the company's operating assets are now owned and controlled by the transferee entities, effectively transferring control away from existing equity holders. The company has appointed Andrew Jay Glashow as a new director and Chief Executive Officer with a mandate to identify and consummate a strategic business combination; if unsuccessful, the company intends to wind down and dissolve. This represents a material restructuring that significantly dilutes existing shareholder value, as equity holders have lost control of the operating business to the secured lenders' transferees.
GCTK
NASDAQ
▲ SUPER 8-K
GlucoTrack, Inc. Common Stock
EDGAR Items: 1.01,2.01,2.03,3.02,5.01,5.02,5.03,7.01,8.01,9.01
# Summary of GlucoTrack, Inc. 8-K Filing
GlucoTrack, Inc. (NASDAQ: GCTK) completed a reverse merger transaction on July 14, 2026, acquiring Lokahi Therapeutics, Inc., with Lokahi shareholders receiving approximately 90% of GlucoTrack's fully-diluted equity in the form of common stock and Series A convertible preferred stock, while existing GlucoTrack shareholders retained a 10% floor protection. The transaction represents a substantial change in ownership and control, effectively making GlucoTrack a shell company for Lokahi's operations. GlucoTrack must obtain stockholder approval for the issuance of conversion shares and other equity securities under Nasdaq Listing Rules 5635(a), (b), and (d), requiring a proxy filing and stockholder meeting. This reverse merger materially dilutes existing shareholders and requires immediate stockholder action, creating significant investor risk depending on Lokahi's business prospects and the terms of any Bridge or PIPE financing shares that will further dilute the Company Allocation.
LGNDZ
OTC
▲ SUPER 8-K
LIGAND PHARMACEUTICALS INC
EDGAR Items: 1.01,2.01,2.03,7.01,9.01
# Ligand Pharmaceuticals 8-K Summary
On July 14, 2026, Ligand Pharmaceuticals completed its merger with XOMA Royalty Corporation, acquiring the company for $39.00 per share in cash plus contingent value rights (CVRs) tied to future XOMA Royalty LLC distributions. In connection with the acquisition, Ligand entered into an amended $125 million revolving credit facility with Citibank maturing in September 2028, featuring pricing margins of 1.75%-2.50% and financial covenants requiring a maximum consolidated senior secured net leverage ratio of 2.50x (expandable to 3.00x for material acquisitions) and minimum EBITDA of $100-150 million. The transaction represents a significant expansion of Ligand's portfolio and debt structure, with investors gaining exposure to contingent payments from XOMA's royalty streams but also facing increased financial leverage and restrictive covenants that could limit future operational flexibility.
FLYX
AMEX
▲ SUPER 8-K
flyExclusive, Inc.
EDGAR Items: 1.01,2.01,9.01
# Summary of flyExclusive, Inc. 8-K Filing (July 13, 2026)
flyExclusive, Inc. completed its merger with Jet.AI SpinCo, Inc. on July 13, 2026, with SpinCo becoming a wholly owned subsidiary of the company. SpinCo shareholders will receive approximately 7.1 million shares of flyExclusive Class A Common Stock at a closing exchange ratio of 3.6253 shares per SpinCo share, with an additional 1.4 million shares (representing 20% of consideration) held in reserve pending final net cash adjustments. Amendment No. 5 to the merger agreement modified the post-closing net cash adjustment mechanism, specifically clarifying that SpinCo's indirect equity investment in Space Exploration Technologies Corporation (SpaceX) will be valued based on actual liquidation proceeds if sold post-closing, or at its estimated value if held. The transaction represents a significant dilution to existing flyExclusive shareholders through substantial new share issuance, with the SpaceX investment stake adding meaningful valuation uncertainty and optionality depending on future liquidity events.
LGNZZ
OTC
▲ SUPER 8-K
LIGAND PHARMACEUTICALS INC
EDGAR Items: 1.01,2.01,2.03,7.01,9.01
# Summary of Ligand Pharmaceuticals 8-K Filing
On July 14, 2026, Ligand Pharmaceuticals completed its merger with XOMA Royalty Corporation, acquiring the company for $39.00 per share in cash plus contingent value rights (CVRs) tied to future performance. Simultaneously, Ligand entered into an Amended and Restated Credit Agreement providing a $125 million revolving credit facility maturing in September 2028, secured by company collateral and guaranteed by material domestic subsidiaries. The new credit facility includes financial covenants requiring a consolidated senior secured net leverage ratio of no greater than 2.50x (expandable to 3.00x under certain conditions) and minimum trailing twelve-month EBITDA of $100-150 million depending on the period. This acquisition and refinancing materially expand Ligand's asset base and financial obligations, with investors exposed to leverage risks tied to EBITDA performance and potential covenant violations that could trigger debt acceleration.
LGNYZ
OTC
▲ SUPER 8-K
LIGAND PHARMACEUTICALS INC
EDGAR Items: 1.01,2.01,2.03,7.01,9.01
# SEC 8-K Filing Summary: Ligand Pharmaceuticals Inc.
Ligand Pharmaceuticals completed its merger with XOMA Royalty Corporation on July 14, 2026, acquiring the company for $39.00 per share in cash plus contingent value rights (CVRs) representing future contingent payments. In connection with the transaction, Ligand entered into an Amended and Restated Credit Agreement providing a $125 million revolving credit facility maturing in September 2028, secured by collateral and guaranteed by material domestic subsidiaries. The new credit facility carries interest margins of 1.75%-2.50% for SOFR-based borrowings and includes restrictive covenants requiring maintenance of a maximum consolidated senior secured net leverage ratio of 2.50x (expandable to 3.00x for material acquisitions) and minimum EBITDA of $100-150 million depending on the period. For investors, this acquisition expands Ligand's royalty portfolio while the new financing structure provides liquidity through 2028, though the leverage and EBITDA maintenance covenants create operational constraints on future financial flexibility.
LGNXZ
OTC
▲ SUPER 8-K
LIGAND PHARMACEUTICALS INC
EDGAR Items: 1.01,2.01,2.03,7.01,9.01
# Ligand Pharmaceuticals 8-K Summary
On July 14, 2026, Ligand Pharmaceuticals completed its merger with XOMA Royalty Corporation, acquiring the company for $39.00 per share in cash plus contingent value rights (CVRs) tied to future XOMA Royalty LLC distributions. In connection with the acquisition, Ligand entered into an amended credit agreement providing a $125 million revolving credit facility maturing September 2028, with interest rates tied to SOFR plus margins of 1.75%-2.50% and financial covenants requiring a maximum consolidated senior secured net leverage ratio of 2.50x (expandable to 3.00x) and minimum EBITDA of $100-150 million depending on the period. The acquisition expands Ligand's portfolio but increases leverage; investors should monitor the company's ability to maintain required financial covenants and generate sufficient EBITDA to support the enlarged debt obligations.
ESPR
NASDAQ
▲ SUPER 8-K
Esperion Therapeutics, Inc.
EDGAR Items: 1.01,1.02,2.01,2.03,3.01,3.03,5.01,5.02,5.03,9.01
# Summary of Esperion Therapeutics 8-K Filing
Esperion Therapeutics, Inc. completed its acquisition by Essence Parent Inc. on July 13, 2026, with Esperion becoming a wholly owned subsidiary of Parent. Shareholders received $3.16 per share in cash, while also receiving Contingent Value Rights (CVRs) that provide eligibility for up to $100 million in additional contingent cash payments upon achievement of specified milestones. The company simultaneously entered into new financing arrangements with BioPharma Credit entities and refinanced its debt obligations, replacing its prior credit agreement with a new loan facility. Convertible note holders have modified conversion rights post-merger, with the ability to receive cash ($1,032.68-$1,232.62 per $1,000 principal depending on conversion timing) plus CVRs upon conversion. For investors, this acquisition concludes Esperion's public company status but creates potential upside through the milestone-contingent CVR payments, though realization of the full $100 million contingent pool depends on achievement of undisclosed operational milestones.
FSP
AMEX
▲ SUPER 8-K
Franklin Street Properties Corp
EDGAR Items: 2.01,9.01
# Summary of Franklin Street Properties Corp. 8-K Filing
Franklin Street Properties Corp. completed the sale of two office buildings located in Englewood, Colorado (approximately 196,236 square feet) to University of Colorado Health for $19.356 million on July 8, 2026. The company allocated roughly $8.5 million of the proceeds toward debt repayment, with the remaining balance retained for tenant improvements, leasing commissions, and general corporate purposes. This asset disposition represents a strategic deleveraging move for the REIT, reducing its debt burden while maintaining liquidity for operational investments. Investors should monitor the company's updated pro forma financials to assess the impact on leverage ratios and future cash flow generation capacity.
BDN
NYSE
▲ SUPER 8-K
Brandywine Realty Trust
EDGAR Items: 2.01,9.01
# Summary of Brandywine Realty Trust Form 8-K Filing
On July 9, 2026, Brandywine Realty Trust completed the disposition of a 206,000 square-foot office building and 520-space parking garage in Austin, Texas for $151.0 million in sales proceeds ($146.1 million net). This asset sale represents a material reduction in the company's real estate portfolio and generates significant liquidity that could be deployed toward debt reduction, dividend payments, or strategic reinvestment. The filing includes unaudited pro forma financial statements reflecting the impact of this divestiture on the company's financial position as of March 31, 2026, which investors should review to assess changes to the company's balance sheet, net operating income, and key metrics like FFO and occupancy rates.
NUMD
OTC
▲ SUPER 8-K
Nu-Med Plus, Inc.
EDGAR Items: 1.01,2.01,3.02,3.03,5.01,5.02,5.03,7.01,9.01
# Nu-Med Plus, Inc. Form 8-K Summary
Nu-Med Plus, Inc. completed a share exchange transaction on July 8, 2026, acquiring 100% ownership of Avid Gold Ltd (a UK-formed private company) in exchange for issuing 4.5 million shares of Series A Preferred Stock to Avid Gold shareholders and assuming a $100,000 promissory note. The company also entered into a Registration Rights Agreement obligating it to file a registration statement within 30 days of shareholder approval and maintain effectiveness for three years, with holders receiving piggyback rights for 18 months.
Material changes for investors include a reverse 1-for-27 stock split of common shares, an increase in authorized common stock from 90 million to 500 million shares, and a potential redomiciliation from Utah to Nevada—all requiring shareholder approval through a proxy vote to be held within 50 days of SEC clearance. The transaction involves significant dilution and voting control implications, as existing shareholders (the Voting Shareholders including CEO William Hayde) committed to voting in favor of director elections and other matters designated by Avid Gold shareholder Fred Tejada, who joined the board, effectively transferring governance influence to the transaction sellers.
SUIC
OTC
▲ SUPER 8-K
SUIC Worldwide Holdings Ltd.
EDGAR Items: 1.01,2.01,5.01,5.02,9.01
# SUIC Worldwide Holdings Ltd. - 8-K Summary
SUIC Worldwide Holdings Ltd. completed a material acquisition on July 10, 2026, acquiring 51% of Taiwan Vision Renu Corporation in exchange for 30 million shares of SUIC common stock, which will represent approximately 35% of total outstanding shares on a fully-diluted basis. Vision Renu is a medical device manufacturer focused on innovative ophthalmic and neurological treatments, including a Scleral Micro-Ablation Laser System for presbyopia (currently in FDA certification) and a Transcranial Magnetic Stimulation device for depression treatment (already approved and generating orders). The transaction resulted in a complete change of control, with three existing directors and officers resigning and two new executives (Chen King Te as Chairman/CEO and Shan Hua Peng as CFO) appointed from Vision Renu's leadership. **For investors, this represents significant dilution (35% stake going to Vision Renu shareholders) and a strategic pivot toward high-tech medical devices, though execution risks exist given Vision Renu's early commercialization stage and the company's small workforce of just 7 full-time employees.**
NXH
NASDAQ
▲ SUPER 8-K
Neighborhood Intelligence, Inc. Common Stock
EDGAR Items: 1.01,2.01,2.03,3.02,9.01
# Summary of Bed Bath & Beyond 8-K Filing
Bed Bath & Beyond, Inc. completed its acquisition of The Container Store Holdings, LLC on July 8, 2026, pursuant to a merger agreement dated April 2, 2026, with The Container Store becoming a wholly owned subsidiary. To finance the transaction, the company issued $112.553 million in 5.00% Convertible Senior Notes due 2033, convertible at an initial price of approximately $9.10 per share, with interest rates escalating to 10% or 12% if stockholder approval for the share issuance is not obtained by the three- and six-month anniversaries, respectively. The company also granted registration rights and lock-up agreements to the transaction's Initial Holders, requiring registration of resale shares within 60 days and restricting two-thirds of merger-related shares from transfer for up to 270 days or until the stock price reaches $14.00 per share. For investors, this acquisition expands BBBY's retail portfolio but introduces debt obligations and potential equity dilution, while the contingent interest rate increases create pressure to obtain shareholder approval quickly.
AHT
NYSE
▲ SUPER 8-K
Ashford Hospitality Trust, Inc.
EDGAR Items: 2.01,9.01
# Summary of Ashford Hospitality Trust 8-K Filing
Ashford Hospitality Trust completed the sale of the Marriott Fremont Silicon Valley hotel in Fremont, California on July 1, 2026, for $53.0 million in cash. This asset disposition represents the company's continued portfolio optimization strategy, generating liquidity that could be deployed toward debt reduction or reinvestment in higher-performing properties. The filing includes unaudited pro forma financial information reflecting the impact of this divestiture on the company's financial position as of March 31, 2026, and for the year ended December 31, 2025. For investors, this sale signals management's focus on streamlining operations and improving financial flexibility in the competitive hospitality sector.
AETN
OTC
▲ SUPER 8-K
AETERNUM HEALTH, INC.
EDGAR Items: 2.01,3.02,5.01,5.02,9.01
# SEC 8-K Filing Summary: Aeternum Health, Inc.
On June 30, 2026, Aeternum Health, Inc. (formerly Shorepower Technologies) completed a merger with Aeternum Health LLC, resulting in a significant change of control and strategic direction. Paul Mann, Manager of Aeternum Health, became President, CEO, and sole board member, replacing former leadership. In exchange for the merger, Mann received 49 million common shares (51% ownership) and 2 million Series B preferred shares with 40 votes each per share.
The company is pivoting away from its previous transportation electrification business to focus on two new areas: mining critical minerals for U.S. government needs and developing longevity/health-related products and services. Aeternum Health contributed minimum assets of $1.5 million (including $300,000 in cash and mineral sourcing expertise/intellectual property) to support this transition.
Following the merger, the company has 96.1 million common shares outstanding and 2 million Series B preferred shares outstanding, with authorized shares increased to 250 million. The stock now trades under ticker AETN on OTC Markets. This represents a substantial dilution to existing shareholders and a complete business transformation with significant execution risk in unfamiliar industries.
BNZI
NASDAQ
▲ SUPER 8-K
Banzai International, Inc. Class A Common Stock
EDGAR Items: 1.01,2.01,2.03,3.02,7.01,9.01
# Summary of Banzai International, Inc. 8-K Filing
Banzai International, Inc. announced two significant material events on July 7, 2026: (1) execution of a $2.1 million subordinated loan agreement with Agile Capital Funding, LLC, providing $2 million in net proceeds repayable in 32 weekly installments by February 10, 2027 at a 1.44x payment multiplier, and (2) completion of an asset purchase agreement to acquire substantially all assets of ConnectAndSell, Inc., an AI-powered sales enablement software company, for up to $15.2 million in total consideration (including earn-out payments). The ConnectAndSell acquisition consideration comprises $8.45 million in closing payments ($750,000 cash plus $5.9 million in stock representing 9.99% dilution, plus an $1.8 million note), $4.75 million in deferred cash payments, and performance-based earn-out payments contingent on revenue targets. The subordinated debt is secured by substantially all company assets but ranks behind existing senior lenders (CP BF Lending, 3i, LP, and Hudson Global Ventures), and default rates spike 5% above the base rate, creating execution risk if the company cannot generate sufficient cash flow from the ConnectAndSell acquisition to service both debt obligations.
GGRP
NASDAQ
▲ SUPER 8-K
The Glimpse Group, Inc. Common Stock
EDGAR Items: 1.01,2.01,7.01,9.01
# Summary of The Glimpse Group, Inc. Form 8-K Filing
The Glimpse Group, Inc. completed the sale of its wholly-owned subsidiary, Glimpse Learning, LLC, to Glimpse Learning, Inc. on June 30, 2026, in exchange for a 19.99% equity stake in the buyer, royalty payments, and assumption of specified liabilities. The transaction involves a related party interest, as former CEO Lyron Bentovim (who owns ~5% of Glimpse Group) owns approximately 50.6% of the buyer company. The company will receive royalty payments of 7% of revenues through December 2027 and 10% thereafter, capped at $1.2 million in aggregate, with a buyout option available to the buyer for $1 million. Investors should note the company incurred $200,000 in upfront working capital adjustment payments and faces additional contractual obligations of $76,000 through March 2027, while the long-term value depends on the buyer's revenue generation and the related-party nature of the transaction warrants close monitoring.
HODO
NASDAQ
▲ SUPER 8-K
House of Doge Inc. Common Stock
EDGAR Items: 2.01,3.02,5.01,5.02,5.03,8.01,9.01
# SEC 8-K Filing Summary: House of Doge Inc.
House of Doge Inc. (formerly Brag House Holdings, Inc.) completed its merger with House of Doge Inc., a Texas corporation, on June 30, 2026, resulting in a significant ownership shift and leadership transition. The merger converted approximately 329.9 million shares of the target company into 64 million common shares plus preferred shares convertible into 5 billion shares, with former HOD stockholders now owning approximately 90.66% of outstanding Common Stock (83.32% on a fully diluted basis). The company executed a complete management and board overhaul, installing new CEO Marco Margiotta and CFO Charles Park, while transferring the pre-merger Brag House business to a subsidiary under previous management's control. The company also completed a name change to House of Doge Inc. and issued 1.125 million additional consideration shares to former executives. This transaction fundamentally restructures the company from Brag House Holdings into a holding company, resulting in substantial shareholder dilution for existing investors who now control less than 10% on a fully diluted basis.
MGNX
NASDAQ
▲ SUPER 8-K
MacroGenics, Inc.
EDGAR Items: 2.01,7.01,9.01
# MacroGenics, Inc. (MGNX) - 8-K Summary
MacroGenics completed the sale of its GMP manufacturing and CDMO (contract development and manufacturing organization) business operations to Bora Pharmaceuticals Co., Ltd. and Bora Biologics USA, LLC for $122.5 million in cash (before transaction fees and expenses and subject to post-closing adjustments) as of June 30, 2026. The divestiture includes the company's Rockville, Maryland manufacturing facility and Frederick, Maryland warehouse operations, while retaining all research and related assets. This strategic asset sale allows MacroGenics to refocus on its core therapeutic development programs and should improve cash flow, though investors should monitor the post-closing financial adjustments and the company's use of proceeds for R&D investments.
OLPX
NASDAQ
▲ SUPER 8-K
Olaplex Holdings, Inc. Common Stock
EDGAR Items: 1.02,2.01,3.01,3.03,5.01,5.02,5.03,8.01,9.01
# Summary of Olaplex Holdings, Inc. 8-K Filing
Olaplex Holdings, Inc. completed its acquisition by Henkel US Operations Corporation on July 7, 2026, with shareholders receiving $2.06 per share in cash. The company paid approximately $357.6 million to fully repay and terminate its credit agreement with no early termination penalties, and the common stock was delisted from Nasdaq effective July 7, 2026. All employee equity awards (options and restricted stock units) were converted into cash payments based on the merger consideration, and security holders' rights in the company ceased upon the merger's completion. The company intends to file Form 15 with the SEC to terminate its public reporting obligations following the delisting process, transitioning from a public to a wholly owned private subsidiary of Henkel.
PARA
NASDAQ
▲ SUPER 8-K
Banzai International, Inc. Class A Common Stock
EDGAR Items: 1.01,2.01,2.03,3.02,7.01,9.01
# Banzai International, Inc. - 8-K Summary
Banzai International, Inc. completed a material acquisition of ConnectAndSell, Inc.'s assets on July 2, 2026, a Software-as-a-Service and AI-powered sales enablement business, with total consideration of approximately $16.2 million comprising cash, equity, and contingent earn-out payments. To finance the acquisition, the company secured a $2.1 million subordinated loan from Agile Lending, LLC on July 1, 2026, with aggressive terms including a 1.44x payment multiplier and weekly installments due by February 10, 2027. The company's obligations are subordinate to existing senior debt holders (CP BF Lending, Hudson Global Ventures, and 3i LP), and the acquisition funding depends partially on future private placement proceeds, creating additional liquidity risks. Investors should note the company is taking on significant near-term debt obligations while relying on the acquired ConnectAndSell business to generate revenue to meet earn-out targets and repay the subordinated debt within eight months.
TBH
NASDAQ
▲ SUPER 8-K
Brag House Holdings, Inc. Common Stock
EDGAR Items: 2.01,3.02,5.01,5.02,5.03,8.01,9.01
# SEC 8-K Summary: House of Doge Inc. (Formerly Brag House Holdings, Inc.)
On June 30, 2026, House of Doge Inc. completed its merger with House of Doge Inc. (a Texas corporation), with the former Brag House Holdings, Inc. acquiring HOD's business and becoming a holding company renamed House of Doge Inc. The merger resulted in HOD's stockholders obtaining approximately 90.66% ownership of the combined company on a fully diluted basis, representing a significant shift in control. Simultaneously, the company's board was reconstituted with six new directors and new executive leadership, including Marco Margiotta as CEO and Charles Park as CFO, while the previous management team continues to operate the legacy Brag House business as a subsidiary. For existing Brag House shareholders, this transaction substantially dilutes their ownership stake from controlling the company to holding only ~9% post-merger, representing a material negative impact despite receiving merger consideration in the form of Class C preferred shares convertible into 5 million common shares each.
MIDDV
NASDAQ
▲ SUPER 8-K
Middleby Corp. Common Stock Ex-Distribution When Issued
EDGAR Items: 1.01,2.01,5.02,7.01,9.01
# Summary of Middleby Corporation 8-K Filing
The Middleby Corporation completed a spin-off of its food processing business as Midera Food Processing, Inc. on July 6, 2026, distributing 100% of Midera's shares to Middleby stockholders on a one-for-one basis; Midera commenced trading on Nasdaq under the symbol "MFP" on July 7, 2026. To facilitate the separation and ongoing relationship, the companies executed five material agreements: a Separation and Distribution Agreement, Tax Matters Agreement, Employee Matters Agreement, Intellectual Property Matters Agreement, and Transition Services Agreement, which collectively govern tax obligations, employee benefits, IP licensing, and transitional service provisions. Key personnel transitions include two Middleby board members (Robert Nerbonne and Cathy McCarthy) and the Chief Development Officer (Matthew Fuchsen) departing to join Midera's leadership. For Middleby investors, this spin-off represents a strategic narrowing of the company's focus and portfolio, while creating a separate publicly traded entity for shareholders to evaluate independently; the transition agreements ensure operational continuity during the separation period.
EVTV
NASDAQ
▲ SUPER 8-K
Azio AI Holdings, Inc. Common Stock
EDGAR Items: 1.01,2.01,3.02,3.03,5.02,5.03,9.01
# Summary of Envirotech Vehicles, Inc. 8-K Filing
Envirotech Vehicles, Inc. (EVTV) completed its acquisition of Azio AI Corporation on July 2, 2026, through a two-step merger structure, issuing 2,460,351 shares of common stock (capped at 19.9% of pre-merger outstanding shares) and 973,450 shares of Series A Non-Voting Convertible Preferred Stock to Azio AI shareholders, along with assuming $150,000 in convertible notes. The company intends to rebrand as "Azio AI Holdings, Inc." and will seek stockholder approval for converting the Series A Preferred Stock into common shares, adopting a new equity incentive plan, and amending its certificate of incorporation. The merger was approved by EVTV's board without requiring stockholder authorization, though company officers and directors have committed via a support agreement to vote in favor of the transaction proposals at an upcoming stockholder meeting. For investors, this represents a significant strategic pivot toward AI operations, though the exact operational and financial implications depend on Azio AI's business performance and the subsequent stockholder vote on the conversion and corporate name change.
AZIO
NASDAQ
▲ SUPER 8-K
Azio AI Holdings, Inc. Common Stock
EDGAR Items: 1.01,2.01,3.02,3.03,5.02,5.03,9.01
# Summary of Envirotech Vehicles, Inc. 8-K Filing
On July 2, 2026, Envirotech Vehicles, Inc. (EVTV) completed its acquisition of Azio AI Corporation through a two-step merger structure, issuing 2,460,351 shares of common stock (capped at 19.9% of outstanding shares) and 973,450 shares of Series A Non-Voting Convertible Preferred Stock to Azio AI shareholders. The transaction was structured as a tax-free reorganization under Section 368(a) of the Internal Revenue Code and was approved by the Company's board without requiring shareholder approval. The Company assumed $150,000 of Azio AI convertible notes and plans to hold a stockholders meeting to approve the conversion of Series A Preferred Stock into common shares (at 100:1 ratio), adoption of an equity incentive plan, and a name change to "Azio AI Holdings, Inc." Officers and directors have committed via support agreements to vote in favor of these proposals.
**Investor Impact:** The acquisition significantly dilutes existing shareholders, with new Azio AI shareholders receiving up to 19.9% ownership plus convertible preferred shares that could further increase dilution. The completion without shareholder approval and the planned name change indicate a substantial strategic pivot toward AI-focused operations, though the lack of disclosed financial metrics or valuation details limits assessment of deal fairness.
AHT
NYSE
▲ SUPER 8-K
Ashford Hospitality Trust, Inc.
EDGAR Items: 2.01,9.01
# Summary of Ashford Hospitality Trust 8-K Filing
Ashford Hospitality Trust completed the sale of the Hyatt Regency Savannah on June 30, 2026, for $158.0 million in cash to C&C Bay Hotel Owner, LLC. This asset disposition represents a strategic reduction in the company's portfolio, with the sale price subject to customary closing adjustments and pro-rations. The filing includes pro forma financial statements reflecting the impact of this divestiture for the three-month period ended March 31, 2026, and the full year 2025. For investors, this sale reduces the company's asset base and could affect future revenue and earnings, though the proceeds may be used for debt reduction, distribution enhancement, or reinvestment in higher-yielding properties.
CETX
NASDAQ
▲ SUPER 8-K
CEMTREX INC.
EDGAR Items: 2.01,3.02,8.01,9.01
# Summary of Cemtrex, Inc. Form 8-K Filing
Cemtrex, Inc. completed the acquisition of substantially all assets of Plant Engineering Services, Inc. (PES) on July 1, 2026, for $3.5 million in cash, with an additional $1.75 million in contingent earnout payments possible over three years based on gross profit targets. The acquired business has been integrated into the company's Industrial Services Segment through its wholly owned subsidiary AIS Engineering, Inc. Additionally, the company disclosed that since its June 5, 2026 reverse stock split (1-for-10), it has issued approximately 609,000 unregistered common shares in private placements and exempt transactions, bringing total outstanding shares to approximately 1.72 million as of July 2, 2026. Financial statements and pro forma information for the acquisition will be filed by amendment within 71 days, as required by SEC regulations.
MSS
NASDAQ
▲ SUPER 8-K
Maison Solutions Inc. Class A Common Stock
EDGAR Items: 1.01,2.01,9.01
# Summary of Maison Solutions Inc. Form 8-K Filing
Maison Solutions Inc. completed the sale of a 91.67% equity stake in its subsidiary, Super HK of El Monte, Inc., to DNL Management Inc. on July 2, 2026, for only $1.00. The buyer acquired the asset "as-is, where-is" and assumed all known and unknown debts and liabilities of the subsidiary, effectively transferring the company's operational and financial obligations. This transaction represents a material disposition of assets for the company, though the nominal purchase price suggests the subsidiary may carry significant liabilities that made it effectively worthless to retain. Investors should note that this divestiture could significantly impact the company's operational scope and financial position, depending on the subsidiary's contribution to overall revenues and the extent of liabilities transferred.
LIMN
NASDAQ
▲ SUPER 8-K
Liminatus Pharma, Inc. Class A Common Stock
EDGAR Items: 1.01,2.01,3.02,5.03,9.01
# SEC 8-K Filing Summary: Liminatus Pharma, Inc.
On June 29, 2026, Liminatus Pharma, Inc. entered into an Amended and Restated Merger Agreement with InnocsAI LLC to restructure a previously announced transaction, allowing the deal to close before stockholder approval by issuing merger consideration as a combination of common stock and newly created Series A Non-Voting Convertible Preferred Stock. The company will issue approximately 11.2 million common shares (capped at ~19.99% of outstanding stock under Nasdaq rules) plus ~158,881 shares of Series A Preferred Stock (each convertible into 10,000 common shares) to InnocsAI members, representing 1.6 billion total common shares of consideration. The merger closed on July 2, 2026, and the company has committed to seeking stockholder approval for the conversion of preferred shares and obtained registration rights agreements with the former InnocsAI members. This structure allows the acquisition to proceed immediately while deferring the dilutive impact of the full common stock issuance pending shareholder approval, potentially protecting existing shareholders from immediate voting control dilution but creating significant future conversion risk if approved.
LHAI
NASDAQ
▲ SUPER 8-K
Linkhome Holdings Inc. Common stock
EDGAR Items: 2.01,3.01,7.01,9.01
# Summary of Linkhome Holdings Inc. (LHAI) 8-K Filing
Linkhome Holdings Inc. completed its acquisition of Mortgage One Group on July 1, 2026, issuing 300,000 common shares and offering up to $750,000 in earnout payments to acquire the mortgage services company as a wholly owned subsidiary. However, this positive development is significantly overshadowed by a critical delisting notice from Nasdaq: on June 29, 2026, the company received notification that it has failed to maintain the $1.00 minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2) for 30 consecutive business days. The company has 180 calendar days (until December 28, 2026) to regain compliance by achieving a closing bid price of at least $1.00 for ten consecutive business days, or it faces delisting. For investors, this dual development presents a mixed signal—the acquisition may strengthen operations long-term, but the immediate delisting risk poses a serious threat to stock liquidity and market accessibility unless the share price recovers substantially and quickly.
NMAD
NASDAQ
▲ SUPER 8-K
Nomad Power Solutions, Inc. Common Stock
EDGAR Items: 1.01,2.01,3.02,5.02,5.03,7.01,8.01,9.01
# LIXTE BIOTECHNOLOGY HOLDINGS, INC. – 8-K SUMMARY
Lixte Biotechnology Holdings, Inc. (NASDAQ: LIXT) completed its merger with Nomad Transportable Power Systems, Inc. on July 1, 2026, with Nomad becoming a wholly-owned subsidiary. NOMAD shareholders received approximately 3 million common shares and 50,366 Series D Convertible Preferred Shares (convertible at $1.00 per share) valued at a 60-day VWAP of $5.57, while unaccredited shareholders received cash consideration. The transaction requires stockholder approval by September 4, 2026 to convert the preferred shares into common stock and increase authorized shares, with registration statements for resale of shares to be filed within 30 days of approval or six months post-closing, whichever is later. Supporting shareholders have committed voting power to approve the merger-related matters, ensuring stockholder quorum and support for the transaction.
INIS
OTC
▲ SUPER 8-K
RADNOSTIX INC
EDGAR Items: 1.01,2.01,2.03,3.02,9.01
# Radnostix, Inc. 8-K Summary
Radnostix completed a $900,000 asset acquisition on June 25, 2026, purchasing the Lara System technology platform and Ellexa Explorer Software from Lucerno Dynamics, LLC, paying $150,000 cash and $750,000 in common stock, with potential earn-out payments up to $750,000 based on regulatory approval and sales milestones. Simultaneously, the company secured $500,000 in financing through a convertible promissory note from a related party (a company owned by Chairman Christopher Grosso) at 5% interest, convertible at $0.07 per share. Additionally, the company amended four historic promissory notes totaling $1.62 million, extending their maturity to March 31, 2031, adding voluntary conversion rights at $0.07 per share, and permanently releasing all security interests on company assets. These transactions significantly increase shareholder dilution through substantial equity issuances and create conversion pressure if the stock reaches $0.12 per share.
NXH
NASDAQ
▲ SUPER 8-K
Neighborhood Intelligence, Inc. Common Stock
EDGAR Items: 1.01,2.01,3.02,9.01
# Summary of Bed Bath & Beyond 8-K Filing (June 30, 2026)
Bed Bath & Beyond completed its acquisition of TwoPonds, Inc. (parent of SFV Services) on June 30, 2026, issuing 7.2 million shares of common stock to the sellers as consideration. The company must file a resale registration statement within 90 days and keep it continuously effective, with liquidated damages of $35,000 per 30-day period (capped at $175,000) if registration deadlines are missed. The sellers have agreed to lock up 3.75 million shares for 12 months and accept standstill restrictions preventing them from making hostile acquisition proposals, initiating stockholder actions, or soliciting proxies during that period, though they must vote with the board's recommendations on all matters.
**Investor Impact:** The significant share issuance (7.2 million new shares) will dilute existing shareholders, while the registration obligation creates a timeline for potential share sales by the sellers. The standstill provisions and voting agreement protect management from activist actions, but investors should monitor the resale registration to assess selling pressure on the stock.
SITC
NYSE
▲ SUPER 8-K
SITE Centers Corp. Common Shares
EDGAR Items: 2.01
# Summary of SITE Centers Corp. 8-K Filing
SITE Centers Corp. completed the sale of its ground leasehold interest and other assets in The Pike Outlets (Long Beach, California) to Pike Long Beach Owner LLC on June 30, 2026, for $50.0 million in cash. The company received net proceeds of approximately $46.5 million after closing costs, representing a $3.5 million reduction from the gross sale price. This divestiture allows the company to monetize a non-core or underperforming property asset and generate liquidity that can be used for debt reduction, capital allocation, or other strategic purposes. The transaction may signal a portfolio optimization strategy as SITE Centers continues to manage its real estate holdings.
MCHX
NASDAQ
▲ SUPER 8-K
Marchex, Inc. Class B
EDGAR Items: 1.01,2.01,2.03,3.02,5.07,9.01
# Summary of Marchex, Inc. 8-K Filing (July 1, 2026)
Marchex, Inc. completed its acquisition of Archenia, Inc. on July 1, 2026, paying $10 million in convertible promissory notes to shareholders including Chairman Russell Horowitz and Vice Chairman Michael Arends. The notes bear 6% interest, are payable in three equal tranches over 24 months, and are convertible into Marchex Class B common stock at $1.80 per share. Additionally, the sellers are eligible to receive up to 2 million shares per year for the first two years if Archenia meets specified revenue, EBITDA, and integration targets. The acquisition, approved by stockholders with 99.9% support, brings Archenia's AI-powered performance marketing technology focused on customer qualification and high-intent consumer identification into Marchex's portfolio. For investors, this deal creates potential upside through earnout provisions tied to Archenia's post-acquisition performance, though the convertible structure and contingent equity issuances could dilute existing shareholders' ownership depending on financial results and conversion activity.
June 2026
32 filings
▼
GXAI
NASDAQ
▲ SUPER 8-K
Gaxos.ai Inc. Common Stock
EDGAR Items: 2.01,7.01,9.01
# SEC 8-K Summary: Gaxos.ai Inc.
On June 18, 2026, Gaxos.ai Inc. completed the sale of substantially all its gaming assets, including its mobile games portfolio and Gaxos Gaming Lab, to Game Foundry AI in exchange for 2.2 million shares of the buyer's common stock valued at approximately $1.76 million. This asset disposition represents a significant strategic shift, indicating the company is divesting its gaming operations, which were apparently a material part of its business. The transaction was completed on the same day it was entered into, with the buyer's shares issued under Securities Act Section 4(a)(2) exemption. Pro forma financial information has been filed reflecting the impact of this asset sale on the company's financial position as of year-end 2025.
**Investor Impact:** This divestiture likely signals a pivot in business strategy for Gaxos.ai, with the company potentially repositioning itself or facing liquidity considerations given the relatively modest valuation of its gaming operations. Shareholders should monitor upcoming disclosures to understand management's plans for deploying proceeds and the company's future direction, as the sale of "substantially all" gaming assets represents a fundamental change to operations.
HTCR
NASDAQ
▲ SUPER 8-K
Heartcore Enterprises, Inc. Common Stock
EDGAR Items: 1.01,2.01,7.01,9.01
# HeartCore Enterprises 8-K Summary
On June 22, 2026, HeartCore Enterprises divested its 51% majority stake in subsidiary Sigmaways, Inc. to Semaphore Technologies, Inc., completing a strategic exit from the business. The transaction involved selling 229,500 shares and $2.19 million in outstanding debt obligations for up to $650,000 in total consideration—comprising $1,000 at closing plus an earn-out of up to $649,000 based on 10% of Sigmaways' gross revenue exceeding $5.5 million over the next 12 months. Additionally, the company contributed a $350,000 SAFE note from Heart-Tech Health as mutual consideration for releasing claims. This divestiture signals HeartCore's strategic repositioning and eliminates future operational involvement with Sigmaways, though investors should note the highly contingent nature of the earn-out and the relatively modest upfront cash recovery ($1,000) relative to the company's historical investment.
AHT
NYSE
▲ SUPER 8-K
Ashford Hospitality Trust, Inc.
EDGAR Items: 2.01,9.01
# Summary of Ashford Hospitality Trust 8-K Filing
Ashford Hospitality Trust completed the sale of the Hilton Garden Inn Austin Downtown on June 18, 2026, for $26.85 million in cash to JMIR Acquisitions, LLC. This asset disposition represents a continuing strategy of portfolio optimization for the hospitality REIT. The company has provided pro forma financial information reflecting the impact of this divestiture on its financial position as of March 31, 2026, and for the year ended December 31, 2025. For investors, the sale generates liquidity that could be used for debt reduction, distributions, or reinvestment in higher-performing properties, though the significance of this transaction's impact depends on the hotel's historical performance and contribution to overall EBITDA.
KOS
NYSE
▲ SUPER 8-K
Kosmos Energy Ltd.
EDGAR Items: 2.01,9.01
# Kosmos Energy Ltd. - 8-K Summary
Kosmos Energy completed the sale of its participating interests in the Ceiba Field and Okume Complex production assets in Equatorial Guinea to a Panoro Energy subsidiary on June 16, 2026, receiving approximately $127 million in cash consideration. The company is also eligible for up to $39.5 million in contingent payments through 2029, contingent on production performance and oil price thresholds. This significant asset disposition represents a strategic shift in the company's portfolio, reducing its production asset base in the region. Investors should monitor the company's use of the proceeds and track whether contingent payments are realized, as this transaction reflects management's reassessment of asset value and strategic priorities.
FABTQ
OTC
▲ SUPER 8-K
Fat Brands, Inc
EDGAR Items: 1.01,2.01,9.01
# SEC 8-K Summary: FAT Brands Inc. and Twin Hospitality Group Inc.
FAT Brands Inc. and its subsidiaries, including Twin Hospitality Group Inc., filed this 8-K to report the completion of asset sales pursuant to Chapter 11 bankruptcy proceedings initiated on January 26, 2026, in the U.S. Bankruptcy Court for the Southern District of Texas. Following an April 27, 2026 auction and May 19, 2026 final hearing, the Bankruptcy Court approved the sale of substantially all assets to four separate purchasers: FBG Bid Co. LLC acquired the FAT Brands portfolio (Round Table Pizza, Fatburger, Johnny Rockets, Fazoli's, and nine other brands) for approximately $595 million in a credit bid; Amazing Brands, LLC acquired Hot Dog on a Stick for $8 million; TABCO International acquired Elevation Burger for $2.5 million; and TWNPKS Bid Co. LLC acquired Twin Hospitality assets. These asset sales represent the restructuring outcome for investors, with existing equity holders likely facing significant dilution or elimination as the company exits bankruptcy through asset disposition rather than reorganization.
FATAQ
OTC
▲ SUPER 8-K
Fat Brands, Inc
EDGAR Items: 1.01,2.01,9.01
# Summary of FAT Brands Inc. and Twin Hospitality Group Inc. Form 8-K Filing
FAT Brands Inc. and its subsidiaries, including Twin Hospitality Group Inc., initiated **Chapter 11 bankruptcy cases** on January 26, 2026, in the U.S. Bankruptcy Court for the Southern District of Texas. On May 19, 2026, the bankruptcy court approved the sale of substantially all company assets through an auction process, with four separate purchasers acquiring different brand portfolios. The largest transaction involves FBG Bid Co. LLC acquiring the FAT Brands Assets (including Round Table Pizza, Fatburger, Johnny Rockets, Fazoli's, and 9 other brands) for approximately $595 million via credit bid against debt obligations, while Amazing Brands acquired Hot Dog on a Stick for $8 million and TABCO International acquired Elevation Burger for $2.5 million. These asset sales represent a comprehensive restructuring of the company's operations, with all material assets being transferred to new ownership entities, effectively ending the current company's operational control of its restaurant brands. For investors, this signals the company's inability to restructure operations independently and a significant equity dilution or elimination, as proceeds will be used to satisfy creditor obligations.
ATXG
NASDAQ
▲ SUPER 8-K
Addentax Group Corp. Common Stock
EDGAR Items: 2.01,3.02,9.01
# SEC 8-K Summary: Addentax Group Corp.
On June 15, 2026, Addentax Group Corp. completed a share exchange acquisition, with its Hong Kong subsidiary acquiring a 41.67% equity stake in Riches Family Office Limited in exchange for issuing 33,500 shares of common stock to Mr. Wu Rui, the Company's Chief Operating Officer. The transaction involved the transfer of equity interests from Riches FO Holdings Limited (Mr. Wu Rui's holding company) to Addentax's subsidiary, creating a strategic ownership position in the target entity. The shares were issued under Regulation S, an offshore transaction exemption, since Mr. Wu Rui is not a U.S. person, thereby avoiding SEC registration requirements. This acquisition expands the Company's asset base and operational footprint in Asia through a related-party transaction, though investors should note the involvement of company insiders and the relatively modest dilution of approximately 33,500 new shares.
TWNPQ
OTC
▲ SUPER 8-K
Twin Hospitality Group Inc.
EDGAR Items: 1.01,2.01,9.01
# Summary of FAT Brands Inc. and Twin Hospitality Group Inc. Form 8-K Filing
FAT Brands Inc. and its subsidiaries, including Twin Hospitality Group Inc., are proceeding with Chapter 11 bankruptcy asset sales approved by the Southern District of Texas Bankruptcy Court on May 19, 2026. The company completed an auction on April 27, 2026, with four separate winning bidders acquiring substantially all assets: FBG Bid Co. LLC acquired the FAT Brands portfolio (14 restaurant brands including Fatburger, Johnny Rockets, and Ponderosa Steakhouse) for approximately $595 million in credit bid; TWNPKS Bid Co. LLC acquired Twin Hospitality Group assets; Amazing Brands LLC acquired Hot Dog on a Stick for $8 million; and TABCO International acquired Elevation Burger for $2.5 million. The sale orders authorize these transactions and the assumption of specified liabilities by the purchasers, with the FAT Brands Purchase Agreement expected to close on June 15, 2026. This asset sale represents a liquidation of the company's operating restaurant portfolio and signals the end of FAT Brands' independent operations, likely resulting in significant value recovery for secured creditors but equity holders receiving minimal to no recovery.
FATPQ
OTC
▲ SUPER 8-K
Fat Brands, Inc
EDGAR Items: 1.01,2.01,9.01
# Summary of FAT Brands Inc. and Twin Hospitality Group Inc. 8-K Filing
FAT Brands Inc. and its subsidiaries, including Twin Hospitality Group Inc., entered **Chapter 11 bankruptcy** on January 26, 2026, and have now completed the sale of substantially all assets following a bankruptcy auction held on April 27, 2026, with final court approval issued on May 19, 2026. The company sold four major asset portfolios: Hot Dog on a Stick for $8 million, Elevation Burger for $2.5 million, a portfolio of 13 restaurant brands (Round Table Pizza, Fatburger, Johnny Rockets, Fazoli's, and others) for approximately $595 million in credit bid, and Twin Hospitality assets through separate purchase agreements. These asset sales represent the liquidation of the company's core business operations through the Chapter 11 bankruptcy process, with proceeds intended to satisfy creditor claims. For equity investors, this filing signals the likely elimination of shareholder value as the Chapter 11 reorganization converts to liquidation through asset sales, making common shares unlikely to recover any value.
PLAG
AMEX
▲ SUPER 8-K
Planet Green Holdings Corp.
EDGAR Items: 2.01,9.01
# Planet Green Holdings Corp. - 8-K Summary
On June 15, 2026, Planet Green Holdings Corp. completed the disposition of its entire equity interest in Bless Chemical Co., Ltd. HK (and its subsidiary Jingshan Sanhe Luckysky New Energy Technologies) to an unaffiliated third party for nominal consideration. The Board determined that divesting this non-operating subsidiary—which had ceased active operations and generated no revenue—would streamline operations, reduce future funding requirements and liabilities, and allow management to concentrate on the company's core consumer products and digital advertising businesses. Following the disposition, Bless HK and Jingshan will no longer be consolidated in the company's financial statements. This strategic exit allows Planet Green to reallocate capital and management resources toward higher-priority business segments while eliminating exposure to the unprofitable subsidiary's obligations.
AVAT
NASDAQ
▲ SUPER 8-K
Avalanche Treasury Corporation Class A Common Stock
EDGAR Items: 1.01,2.01,3.02,3.03,5.01,5.02,5.03,5.05,5.06,9.01
# Summary of Avalanche Treasury Corporation 8-K Filing
On June 11, 2026, Avalanche Treasury Corporation (AVAT) completed its business combination with Avalanche Treasury Company LLC, a cryptocurrency-focused digital asset company. The transaction involved the domestication of Mountain Lake Acquisition Corp. (a Cayman Islands SPAC) into a Delaware corporation, followed by mergers that resulted in Avalanche Treasury Company becoming the operating subsidiary. The company received approximately $216 million in capital from Company Unit Investors through a private placement of units converted into Class A common stock, along with a commitment from the Avalanche Foundation to sell a minimum of $200 million in AVAX tokens to the company.
The transaction structure created two classes of stock: Pubco Class A (non-voting) held by MLAC shareholders and Company Unit Investors, and Pubco Class B (voting) held by the Seller Related Parties and Dragonfly venture funds, giving the founders significant voting control despite a diluted economic stake. Investors should note that the company operates in the cryptocurrency sector with exposure to AVAX token holdings and that voting control remains concentrated with the original sellers, which may impact corporate governance dynamics and shareholder influence on future strategic decisions.
SDCO
OTC
▲ SUPER 8-K
SDR Drone, Inc.
EDGAR Items: 1.01,2.01,2.03,3.02,5.01,5.02,5.06,5.07,9.01
# Summary of Hallmark Venture Group, Inc. 8-K Filing
On June 9, 2026, Hallmark Venture Group, Inc. completed a change of control transaction in which EQUORIX LLC acquired 100,000 shares of Series A Preferred Stock (100% of outstanding Series A) and 50,000,000 common shares (75.55% of outstanding common stock), resulting in a majority board change and transfer of control. The company acquired a portfolio of drone technology from Cho Sun Sik and Sundori Drone Co., Ltd., comprising twelve Korean patents and associated manufacturing know-how, positioning the company to transition from a shell company to an active drone development, manufacturing, and training business. The transaction included financing through an 8% convertible promissory note ($17,070 advanced as of filing) with conversion pricing subject to discounts and increased penalties if the company loses market listing eligibility. The board has approved a corporate name change to "SDR Drone Inc." to reflect the new business direction.
**Investor Impact:** This represents a significant operational shift from inactive shell status to an active business with established technology assets and operational support from Korea-based operations, though investors face substantial dilution (75.55% common ownership shift) and conversion risk tied to market listing status.
HLLK
OTC
▲ SUPER 8-K
SDR Drone, Inc.
EDGAR Items: 1.01,2.01,2.03,3.02,5.01,5.02,5.06,5.07,9.01
# Summary of Hallmark Venture Group 8-K Filing
On June 9, 2026, Hallmark Venture Group, Inc. completed a change of control transaction in which EQUORIX LLC acquired 100% of the Series A Preferred Stock (from Selkirk Global Holdings) and approximately 75.55% of outstanding common stock, resulting in new board leadership and a shift from shell company status to an active drone technology business. The company simultaneously acquired a portfolio of drone-related intellectual property—including 12 Korean patents and associated trade secrets—from Cho Sun Sik and Sundori Drone Co., Ltd., while granting Sundori Korea an exclusive royalty-free license to operate domestically in South Korea and providing manufacturing/engineering services. EQUORIX also funded the transaction through an 8% convertible promissory note with a $100,000 face value and flexible conversion pricing that adjusts based on regulatory compliance, creating potential dilution for existing shareholders. The company intends to rebrand as "SDR Drone Inc." and pursue drone development, manufacturing, and training operations, marking a fundamental business transformation with significant control concentration risk and execution uncertainty in a competitive technology sector.
AHT
NYSE
▲ SUPER 8-K
Ashford Hospitality Trust, Inc.
EDGAR Items: 2.01,9.01
# SEC 8-K Summary: Ashford Hospitality Trust, Inc.
**Material Event:** Ashford Hospitality Trust completed the sale of the Hilton Garden Inn Jacksonville - Deerwood Park in Jacksonville, Florida on June 11, 2026, for $11.3 million in cash to Maco Properties, LLC.
**Investor Impact:** This asset divestiture represents portfolio reduction and likely reflects the company's strategy to manage its real estate holdings. The sale generates $11.3 million in proceeds that could be used for debt reduction, dividend payments, or other capital allocation priorities. As a hospitality REIT, individual property sales are routine portfolio management activities, though investors should monitor whether this aligns with broader strategic direction and whether proceeds are effectively deployed to enhance shareholder value.
NTRP
NASDAQ
▲ SUPER 8-K
NextTrip, Inc. Common Stock
EDGAR Items: 1.01,2.01,3.02,7.01,9.01
# NextTrip, Inc. (NTRP) - 8-K Summary
NextTrip, Inc. completed its acquisition of a 51% controlling stake in Yada Commerce Inc. on June 10, 2026, paying 50,000 restricted shares of NTRP common stock as consideration. Under a concurrent Cooperation and Earnout Agreement, the founding shareholders retain operational control of Yada while NextTrip gains exclusive rights as Yada's preferred travel provider, booking processor, and gift card distributor, with profits shared between the parties over a three-year term. The earnout agreement establishes an incentive pool of up to 225,000 restricted shares and 225,000 warrants (exercise price $2.75) to be awarded to founding shareholders based on their share of net profits generated from specified activities. The transaction involves significant equity dilution to existing shareholders and creates contingent future equity obligations dependent on Yada's operational performance.
BIRD
NASDAQ
▲ SUPER 8-K
Smartbird, Inc. Class A Common Stock
EDGAR Items: 2.01,9.01
# Summary of Allbirds, Inc. Form 8-K Filing
Allbirds, Inc. has completed the sale of its footwear business assets to American Exchange Group affiliate Allbirds IP LLC for $40.7 million in cash, with the transaction closing on June 9, 2026. The asset sale included intellectual property (trademarks, patents, domain names), inventory, customer lists, and related business assets, while the buyer assumed certain liabilities including accounts payable. The company established a $3.0 million escrow fund to cover potential purchase price adjustments and breaches of representations for 60 days post-closing. Management plans to distribute a portion of the sale proceeds to shareholders as a special dividend, with a record date set for June 25, 2026 and payment expected within 60 days. This represents a significant strategic transformation for the company, essentially monetizing its core footwear business operations while maintaining other potential business activities.
AHT
NYSE
▲ SUPER 8-K
Ashford Hospitality Trust, Inc.
EDGAR Items: 2.01,9.01
# Summary of Ashford Hospitality Trust 8-K Filing
Ashford Hospitality Trust completed the sale of the Sheraton Mission Valley hotel in San Diego, California on June 9, 2026, for approximately $45.3 million in cash. This asset disposition represents a portfolio reduction by the hospitality REIT but provides liquidity that could be used for debt reduction, capital improvements, or distributions. The company has included pro forma financial information reflecting the sale's impact for the three months ended March 31, 2026, and the full year 2025. While the sale generates near-term cash, investors should monitor how management deploys these proceeds and assess whether this disposition signals broader portfolio optimization or financial restructuring needs.
RCKT
NASDAQ
▲ SUPER 8-K
Rocket Pharmaceuticals, Inc. Common Stock
EDGAR Items: 2.01,7.01,9.01
# Rocket Pharmaceuticals SEC 8-K Summary
Rocket Pharmaceuticals completed the sale of its Rare Pediatric Disease Priority Review Voucher (PRV) to a large pharmaceutical company on June 10, 2026, receiving $180 million in gross proceeds. The PRV was originally earned through FDA approval of KRESLADI, the company's gene therapy for severe leukocyte adhesion deficiency-I in pediatric patients. This asset sale represents a significant liquidity event that provides the company with substantial cash to support operations and future development initiatives. For investors, the $180 million injection provides near-term financial resources but also indicates the company's shift in monetizing regulatory assets rather than leveraging them for commercial advantage of its own pipeline programs.
LBUYD
OTC
▲ SUPER 8-K
DATZ WORLD HOLDINGS CORP.
EDGAR Items: 1.01,2.01,3.02,5.01,5.02,5.03,9.01
# Summary of SEC 8-K Filing: DATZ World Holdings Corp.
On June 8, 2026, DATZ World Holdings Corp. (formerly LeafBuyer Technologies, Inc.) completed its merger with RagingBull.com, LLC, with RagingBull surviving as a wholly-owned subsidiary. The company issued 15 million shares to RagingBull's equityholders, who now control approximately 95% of outstanding common stock, and executed a 1-for-156 reverse stock split. The former LeafBuyer leadership (CEO Kurt Rossner, CFO Mark Breen, and CTO Michael Goerner) resigned, replaced by Anthony Bell as CEO.
In related transactions, the company disposed of LB Media Group LLC to Foundation AI for $750,000 in cash, restructured $991,878 in existing debt into convertible notes bearing 3% interest with a $0.05 conversion price, and sold Series A Preferred Stock to Jeff Bishop for $1,000. The combined effect creates substantial dilution for existing shareholders, with control shifting entirely to the RagingBull owners and major investors like Jeff Bishop (63.9% beneficial ownership) and Jason Bond LLC (23.9%), while the reverse split and equity issuance significantly reduce proportional ownership for pre-merger shareholders.
BOTX
OTC
▲ SUPER 8-K
DATZ WORLD HOLDINGS CORP.
EDGAR Items: 1.01,2.01,3.02,5.01,5.02,5.03,9.01
# Summary of DATZ World Holdings Corp. 8-K Filing
On June 8, 2026, DATZ World Holdings Corp. (formerly LeafBuyer Technologies, Inc.) completed its merger with RagingBull.com, LLC, acquiring the trading education platform in exchange for 15 million newly issued shares, with RagingBull's equity holders obtaining approximately 95% ownership post-transaction. The company simultaneously executed a 1-for-156 reverse stock split and completely reconstituted its board and management, with Anthony Bell appointed as CEO following the departures of all previous executives. In conjunction with the merger, the company raised $750,000 cash through the spinoff of its LB Media subsidiary to Foundation AI and exchanged approximately $992 million in debt obligations into convertible promissory notes bearing 3% interest, convertible at $0.05 per share.
**Investor Impact:** Existing LeafBuyer shareholders experienced severe dilution, with their ownership reduced to approximately 5% of the combined entity post-reverse split. The transaction represents a complete change of control and business pivot to the online trading education sector, creating significant risk from the concentrated ownership structure and debt refinancing obligations.
ADIL
NASDAQ
▲ SUPER 8-K
Adial Pharmaceuticals, Inc
EDGAR Items: 1.01,2.01,2.03,3.02,5.02,5.03,7.01,9.01
# Summary of Adial Pharmaceuticals 8-K Filing
On June 11, 2026, Adial Pharmaceuticals, Inc. completed its acquisition of Azora Therapeutics, Inc. through a two-step merger structure, issuing 437,474 shares of common stock and 12,930.617 shares of Series A Non-Voting Convertible Preferred Stock (each convertible into 1,000 common shares) to Azora shareholders. The transaction results in a significant shift in ownership control: pre-merger Adial shareholders will hold approximately 13.1% of fully diluted common stock while former Azora shareholders will hold approximately 86.9%, constituting a change of control under Nasdaq rules. The company plans to raise additional capital through a concurrent financing and has assumed Azora's outstanding stock options (convertible into 1,177,782 shares) and agreed to issue pre-funded and common warrants subject to stockholder approval and future milestone achievements. Investors should note that Adial will hold a stockholder meeting to approve the conversion of preferred stock, warrant exercises, charter amendments (potentially including a reverse stock split to maintain Nasdaq compliance), and new equity incentive plans—all material items that could affect share value and equity dilution.
VSEE
OTC
▲ SUPER 8-K
VSEE HEALTH, INC.
EDGAR Items: 1.01,2.01,3.02,5.02,9.01
# VSee Health, Inc. – 8-K Summary
VSee Health, Inc. completed a significant corporate restructuring on May 31, 2026, in which co-CEO and Chairman Milton Chen purchased all equity securities of the company's wholly-owned subsidiary VSee Lab in exchange for transferring his 2,870,069 common shares to the company. Chen resigned from his executive and board positions effective at closing, with Dr. Imoigele Aisiku assuming sole control as CEO and Chairman. The transaction effectively separates VSee Lab as an independent entity under Chen's ownership while allowing the parent company to divest a major operating subsidiary. This restructuring materially alters the company's asset base and governance structure, reducing investor exposure to VSee Lab's operations and liabilities while concentrating leadership under Aisiku; however, the company retains all pre-closing liabilities and obligations of VSee Lab, which could represent a significant financial burden for remaining shareholders.
IONI
OTC
▲ SUPER 8-K
I-ON Digital Corp.
EDGAR Items: 1.01,2.01,9.01
# I-ON Digital Corp. Form 8-K Summary
On June 1, 2026, I-ON Digital Corp. completed an assignment of rights to acquire 21 gold mining claims located on Bureau of Land Management (BLM) land in the southwestern United States, with an estimated 1 to 1.5 million ounces of in situ gold reserves plus platinum, rare earth elements, and other minerals. The company assumed a $25 million purchase obligation (with initial $500,000 escrow deposit plus deferred installment payments) and all associated development and feasibility study obligations, receiving the assignment at no cost from Tall Ship Resource Development LLC—an entity owned and controlled by the company's CEO and majority shareholder, Carlos Montoya. This transaction presents a significant related-party transaction risk, as the CEO transferred assets he controlled to the company without compensation while the company assumes substantial financial and operational obligations. Investors should monitor the company's ability to fund the $25 million purchase price and complete required technical work, as failure to meet payment or development obligations could result in loss of the claims.
AHT
NYSE
▲ SUPER 8-K
Ashford Hospitality Trust, Inc.
EDGAR Items: 2.01,9.01
# Summary of Ashford Hospitality Trust 8-K Filing
Ashford Hospitality Trust completed the sale of the Silversmith Hotel Chicago Downtown on June 1, 2026, for $16 million in cash to SHH Chicago LLC. This asset disposition represents a portfolio rationalization move by the hospitality REIT. The filing includes pro forma financial statements reflecting the impact of this property sale, though the transaction's materiality to the company's overall portfolio and financial position would need to be assessed against total assets. For investors, this sale could indicate management's strategy to reduce debt, improve liquidity, or optimize the property portfolio, though the limited disclosure suggests the transaction is not considered a major event relative to the company's scale.
CEIN
OTC
▲ SUPER 8-K
Viking Global Technologies, Inc.
EDGAR Items: 1.01,2.01,9.01
# Camber Energy, Inc. – 8-K Summary (June 1, 2026)
Camber Energy completed an amalgamation of its subsidiary Viking Energy Group's minority-owned Canadian generator services company, Simson-Maxwell Ltd., with T&T Power Group Inc., resulting in a consolidated entity (T&T Power Group Inc.) in which Viking now holds only non-voting preferred shares. Viking's ownership stake was converted from 49% common equity to 5.75 million Class A Preference Shares with no voting rights, while T&T's sole shareholder gained 100% voting control through 100,000 Class A Common Shares. This transaction materializes a significant loss of operational control for Camber/Viking despite retaining a financial interest in the business.
The restructuring includes protective provisions for Viking: the preferred shares carry a redemption price of CDN$5.75 million (approximately US$4.15 million) through March 31, 2028, increasing to CDN$7.75 million thereafter, with an 8% conditional cumulative dividend and priority liquidation rights. However, Viking has limited influence—it cannot appoint directors and faces restricted retraction rights until 2028, with the operator having significant discretion over redemptions and the ability to defer payments up to 12 months.
**Investor Impact:** While Camber maintains a financial claim on the Amalgamated Corporation, the loss of operational control and voting power represents a diminished strategic position. The conditional dividend and deferred payment options create earnings uncertainty, and the transaction effectively transforms an operating subsidiary investment into a subordinated claims position, increasing financial risk for shareholders.
ANY
NASDAQ
▲ SUPER 8-K
Sphere 3D Corp. Common Shares
EDGAR Items: 1.01,2.01,3.02,3.03,5.02,5.03,7.01,9.01
# Summary of Sphere 3D Corp. 8-K Filing
On June 1, 2026, Sphere 3D Corp. completed its acquisition of Cathedra Bitcoin Inc. in a stock-for-stock transaction, with Cathedra becoming a wholly-owned subsidiary of Sphere. The acquisition was announced on March 5, 2026, and executed pursuant to a plan of arrangement under British Columbia law. Concurrent with closing, Sphere entered into an employment agreement with Joel Block as Chief Executive Officer, providing for a base salary of $425,000, a target annual bonus of 125% of base salary, and an inducement grant of 500,000 restricted stock units vesting over two years. Mr. Block is also eligible for a $1.6 million transaction-related cash retention bonus tied to performance milestones and continued employment through January 1, 2027, along with comprehensive severance protections including 18 months of salary continuation and accelerated equity vesting upon termination without cause.
**Investor Impact:** The acquisition materially changes Sphere's business profile through integration with Cathedra's operations, while the significant executive compensation package (including potential total value exceeding $2.5 million in cash and equity) commits substantial resources to leadership retention and may impact near-term profitability.
RR
NASDAQ
▲ SUPER 8-K
Richtech Robotics Inc. Class B Common Stock
EDGAR Items: 2.01,8.01,9.01
# Summary of Richtech Robotics Inc. 8-K Filing
Richtech Robotics Inc. completed the acquisition of a 79,325 square foot industrial property located at 9530 S. Rainbow Boulevard in Las Vegas, Nevada for $21.18 million in cash on May 29, 2026, through its wholly-owned subsidiary Richtech Rainbow Holdings LLC. The company plans to utilize the facility for warehousing, assembly, light manufacturing, research and development, and AI/robotics training operations to support its robotics and artificial intelligence systems development. This strategic asset acquisition provides the company with dedicated domestic infrastructure to enhance its operational capabilities and product development efforts. The transaction was previously disclosed on April 7, 2026, and the purchase agreement was assigned to the subsidiary on May 15, 2026 before closing.
KLXE
NASDAQ
▲ SUPER 8-K
KLX Energy Services Holdings, Inc. Common Stock
EDGAR Items: 1.01,2.01,3.02,7.01,9.01
# KLX Energy Services 8-K Summary
KLX Energy Services Holdings, Inc. completed a $17.0 million asset acquisition from Wolf Pack Rentals, LLC on June 2, 2026, with $14.0 million paid at closing and $3.0 million in deferred payments due over the next year payable in cash or stock. The deferred payments are capped at 19.9% of outstanding shares (approximately 3.96 million shares based on April 2026 figures), limiting shareholder dilution. Additionally, the company executed debt-for-equity exchanges converting $2.19 million in principal of its Senior Secured Notes due 2030 into 627,521 common shares, reducing outstanding debt to approximately $252.5 million. These transactions reflect the company's efforts to strengthen its balance sheet and expand operations through strategic acquisitions while maintaining disciplined capital structure management.
HDRN
NASDAQ
▲ SUPER 8-K
Hadron Energy, Inc. Common Stock
EDGAR Items: 2.01,3.03,4.01,5.01,5.02,5.03,5.06,8.01,9.01
# Summary of Hadron Energy, Inc. 8-K Filing (May 22, 2026)
Hadron Energy, Inc. (formerly GigCapital7 Corp.) completed its business combination with Hadron Energy Operating Company Inc. on May 22, 2026, creating a combined public company now trading on Nasdaq under ticker HDRN (common stock) and HDRNW (warrants). The transaction involved significant shareholder redemptions, with approximately 84% of GigCapital7's public shareholders redeeming their shares for $10.71 per share (totaling $180.3 million), leaving approximately $33.9 million in the trust account for the combined company's operations. Post-closing, the combined company has 71.5 million shares outstanding, with insiders owning approximately 77.2% of equity and former GigCapital7 shareholders holding 23%. This SPAC merger marks Hadron Energy's transition from a private company to a publicly-traded nuclear energy technology company with operations now subject to SEC reporting requirements.
CYH
NYSE
▲ SUPER 8-K
Community Health Systems, Inc.
EDGAR Items: 2.01,8.01,9.01
# Summary of Community Health Systems, Inc. 8-K Filing
Community Health Systems, Inc. completed the sale of four hospital facilities and associated outpatient operations in Arkansas (Northwest Medical Center locations in Bentonville and Springdale, Willow Creek Women's Hospital, and Siloam Springs Regional Hospital) to Freeman Health System for $110 million in cash on June 1, 2026. The transaction represents a significant disposition that reduces the company's operational footprint in the Arkansas market. CHS will use proceeds from the asset sale to manage its balance sheet and capital structure, though the filing does not specify intended uses such as debt reduction or reinvestment. For investors, this divestiture signals management's strategic focus on core markets and may improve near-term liquidity, though it reduces overall revenue-generating capacity and represents an exit from the Northwest Arkansas region.
RPAY
NASDAQ
▲ SUPER 8-K
Repay Holdings Corporation Class A Common Stock
EDGAR Items: 1.01,1.02,2.01,2.03,7.01,9.01
# REPAY Holdings Corporation 8-K Summary
On June 1, 2026, REPAY Holdings completed the acquisition of KUBRA (a Canadian-U.S. customer communications software company) for approximately $372 million in cash, funded through a new $500 million senior secured term loan and $100 million revolving credit facility arranged with Truist Bank as administrative agent. The company simultaneously refinanced its existing credit agreement, repaying all prior obligations with proceeds from the new term loan facility. The new credit agreement carries a term SOFR-based margin of 5.5% on the term loan and an initial 4.25% on the revolving facility, with a maximum total net leverage covenant of 6.10x and maturities tied to the company's 2029 convertible notes. These financing activities represent a significant capital restructuring to support the KUBRA acquisition while maintaining financial flexibility for working capital and future growth.
BHR
NYSE
▲ SUPER 8-K
Braemar Hotels & Resorts Inc. Common Stock
EDGAR Items: 2.01,7.01,8.01,9.01
# Summary of Braemar Hotels & Resorts Inc. 8-K Filing
Braemar Hotels & Resorts completed the sale of the Park Hyatt Beaver Creek Resort & Spa in Colorado on May 26, 2026, for $176 million in cash, generating approximately $104.5 million in net proceeds after debt repayment and transaction costs. Using these proceeds, the company repaid in full $86.25 million of its 4.50% Convertible Senior Notes due 2026 at scheduled maturity on June 1, 2026, thereby eliminating this debt obligation and terminating the associated indenture. The company also clarified that the Hotel sale, combined with other property dispositions during the applicable lookback periods, does not trigger a Change of Control under its advisory agreement with Ashford. For investors, this sale represents a material deleveraging event that improves the company's balance sheet and financial flexibility, while the debt elimination removes near-term refinancing risk and reduces interest expense going forward.
May 2026
24 filings
▼
AHT
NYSE
▲ SUPER 8-K
Ashford Hospitality Trust, Inc.
EDGAR Items: 2.01,9.01
# Summary of Ashford Hospitality Trust 8-K Filing
Ashford Hospitality Trust completed the sale of the Sheraton Indianapolis City Centre Hotel on May 21, 2026, for a gross purchase price of approximately $32.1 million to Keystone Realty Group LLC, with the net proceeds reduced by purchaser credits of approximately $15.2 million and customary adjustments. This asset disposition represents a portfolio rationalization move by the REIT as it continues to manage its hotel holdings. The filing includes pro forma financial information reflecting the impact of this divestiture on the company's financial position as of March 31, 2026, and for the year ended December 31, 2025, though limited details on the transaction's financial impact are provided in the 8-K itself. Investors should review the attached pro forma statements to assess the implications for the company's earnings, cash flow, and debt metrics.
TMGI
OTC
▲ SUPER 8-K
Transglobal Management Group, Inc.
EDGAR Items: 1.01,2.01,3.02,9.01
# Summary: Transglobal Management Group Acquires Golf Management Software Platform
On March 20, 2026, Transglobal Management Group, Inc. (TMGI) completed its acquisition of Continuum Software Technologies, Inc. (CSTI), a developer of cloud-based golf course management software, in exchange for issuing 50.6 million shares of TMGI common stock. The CSTI Platform provides comprehensive golf operations management including tee sheet management, point-of-sale systems, payment processing, marketing tools, and hardware solutions, enabling TMGI to expand its service offerings to large golf operators across the United States. The transaction was structured as a stock-for-stock exchange with CSTI shareholders receiving TMGI common stock exempt from SEC registration under Section 4(2) of the Securities Act. The significant share issuance (50.6 million shares) represents substantial dilution to existing TMGI shareholders, which could materially impact earnings per share and voting power depending on the company's current share count.
BESS
AMEX
▲ SUPER 8-K
Bimergen Energy Corporation
EDGAR Items: 1.01,2.01,9.01
# Bimergen Energy Corporation (BESS) 8-K Summary
On May 21, 2026, Bimergen Energy's subsidiary Emergen Energy LLC contributed 100% equity interests in three battery energy storage system (BESS) project companies to a joint venture with Cerberus Capital Management's Frontier Power & Utilities platform, receiving 7.5% ownership (75 Class B Units) and a $1.18 million reimbursement in return. Concurrently, Emergen entered into a Joint Development Agreement providing up to $5.69 million in development fees and milestone-based payments for advancing the contributed BESS portfolio and identifying additional utility-scale battery projects in the ERCOT market. The transaction effectively monetizes Bimergen's existing BESS assets while maintaining ongoing involvement through development services and retained equity upside, representing a strategic partnership with a major institutional capital provider but also a dilution of direct asset ownership.
TBNRL
OTC
▲ SUPER 8-K
Tamboran Resources Corp
EDGAR Items: 2.01,3.02,7.01,8.01,9.01
# Summary of Tamboran Resources Corporation 8-K Filing
On May 28, 2026, Tamboran Resources Corporation completed its acquisition of Falcon Oil & Gas Ltd.'s subsidiaries through a plan of arrangement, acquiring approximately 98.1% of Falcon Australia and 100% of Falcon's interests in Hungary, Ireland, and South Africa. Tamboran paid $23.7 million in cash and issued 6.54 million common shares (valued at the exchange rate applicable at closing) to Falcon shareholders. The transaction was structured as a tax-efficient cross-border arrangement and received court approval from the British Columbia Supreme Court, which also addressed sanctions-related dissenting shareholder rights requiring funds to be held in a blocked account. Financial and pro forma statements will be filed within 71 days, with regulatory requirements met through Section 3(a)(10) exemption from securities registration. This acquisition expands Tamboran's global oil and gas portfolio across multiple jurisdictions, though investors should note the contingent obligation related to the dissenting shareholder's fair value determination.
ESGH
OTC
▲ SUPER 8-K
ESG Inc.
EDGAR Items: 2.01,8.01,9.01
# ESG Inc. Form 8-K Summary
On May 26, 2026, ESG Inc. completed a split-off transaction in which it transferred 100% ownership of its subsidiary ESG China Limited to shareholders in exchange for the cancellation of 10,432,800 common shares, reducing outstanding shares from approximately 25.9 million to 15.5 million shares. Following the transaction, ESG China Limited and its downstream Chinese operations are no longer consolidated with the Company, effectively divesting the company of its China operations. The Company intends to focus its business going forward on North American operations through ESG Provisions, Inc., representing a significant strategic restructuring and portfolio refocus.
**Investor Impact:** This transaction substantially reduces the company's share count, which could benefit remaining shareholders through reduced dilution, but also eliminates an entire geographic segment. Investors should review the pro forma financial statements filed on May 5, 2026 to assess the financial impact of operating as a reduced, North America-focused entity.
AHT
NYSE
▲ SUPER 8-K
Ashford Hospitality Trust, Inc.
EDGAR Items: 2.01,9.01
# Summary of Ashford Hospitality Trust 8-K Filing
Ashford Hospitality Trust completed the sale of its Lakeway Resort and Spa in Austin, Texas on May 19, 2026, for $37.75 million in cash to Trestle Studio LLC. This asset disposition represents a strategic divestiture under a purchase agreement originally dated February 10, 2026, with modifications finalized in March 2026. The company has provided unaudited pro forma financial statements reflecting the impact of this transaction as of March 31, 2026, and for the year ended December 31, 2025. For investors, this sale generates approximately $37.75 million in liquidity, which the company may deploy toward debt reduction, capital improvements, or other strategic investments in its hospitality portfolio.
GIPR
NASDAQ
▲ SUPER 8-K
Generation Income Properties Inc. Common Stock
EDGAR Items: 2.01
# Summary of Generation Income Properties, Inc. 8-K Filing
Generation Income Properties, Inc. completed the sale of a Starbucks-occupied net lease retail property located in Tampa, Florida on May 22, 2026, for a purchase price of $2,964,000, netting the company $1,959,170 after adjustments. This asset disposition represents a reduction in the company's real estate portfolio and cash-generating property holdings. The pro forma financial statements provided suggest a material impact on the company's balance sheet and operating results, with the sale now reflected as if it occurred on January 1, 2025 for operating statement purposes. For investors, this transaction indicates the company is strategically divesting assets, which may affect future rental income and property-level cash flows, though the proceeds could be deployed toward debt reduction, new acquisitions, or shareholder returns depending on management's capital allocation strategy.
HYEX
OTC
▲ SUPER 8-K
HEALTHY EXTRACTS INC.
EDGAR Items: 1.01,2.01,3.02,5.02,9.01
# Summary of Healthy Extracts Inc. 8-K Filing
Healthy Extracts Inc. completed the acquisition of Adli Gummies Inc. (doing business as Imaraÿ's Beauty) on May 15, 2026, for a total consideration of approximately $794,000 in secured promissory notes plus 3 million shares of common stock and exchangeable shares. The deal resulted in significant shareholder dilution, with the issued shares representing approximately 17.76% of total outstanding common stock on a fully-diluted basis, partially offset by the cancellation of 3 million shares held by the CEO. Aaron Hefter, the largest shareholder of Adli and a seasoned entrepreneur in the nutraceutical industry, was appointed Chief Brand Officer as a material term of the transaction and will help integrate the Imaraÿ's Beauty brand—described as a rapidly growing ingestible beauty and wellness company co-founded with fitness influencer Sommer Ray. The acquisition positions Healthy Extracts to leverage Hefter's extensive experience (over two decades in the sector, including co-CEO roles at other nutrition companies) and Imaraÿ's established product portfolio to expand its presence in the wellness market.
ATXG
NASDAQ
▲ SUPER 8-K
Addentax Group Corp. Common Stock
EDGAR Items: 2.01,3.02,9.01
# SEC 8-K Summary: Addentax Group Corp.
**Material Event:** Addentax Group Corp. (ATXG, Nasdaq Capital Market) completed an acquisition on May 15, 2026, whereby its Hong Kong subsidiary Yingxi acquired 100% equity interests in Time Is Loan Limited from seller OR Shan Shan in exchange for 137,790 newly issued shares of common stock.
**Investor Impact:** The transaction resulted in dilution to existing shareholders through the issuance of additional shares. The acquisition was completed using an offshore Regulation S exemption, indicating the shares were issued to a non-U.S. person without SEC registration requirements. This appears to be a strategic acquisition to expand the company's operations, though the filing provides limited detail on the target company's financial condition or expected contribution to future earnings. Investors should review the full Share Exchange Agreement (referenced from the April 28, 2026 8-K filing) to assess the strategic rationale and financial implications of this transaction.
SSP
NASDAQ
▲ SUPER 8-K
The E.W. Scripps Company
EDGAR Items: 2.01,9.01
# E.W. Scripps Company 8-K Summary
On May 15, 2026, The E.W. Scripps Company completed a previously announced stations swap transaction with Gray Media, Inc., acquiring five television stations (KKTV and KMVT in the Mountain West region, along with related low-power affiliates) in exchange for transferring two stations (WSYM and KATC) to Gray. The transaction involved an even exchange of comparable assets with no cash consideration paid by either party, representing a strategic reallocation of broadcast media properties. This swap allows Scripps to consolidate its presence in certain regional markets while exiting others, potentially affecting its future revenue streams and operational footprint in those geographic areas. Investors should monitor how this portfolio rebalancing impacts Scripps' profitability and market reach in the coming quarters.
FORA
NASDAQ
▲ SUPER 8-K
Forian Inc. Common Stock
EDGAR Items: 2.01,3.01,3.03,5.01,5.02,5.03,8.01,9.01
# Summary of Forian Inc. 8-K Filing (May 15, 2026)
Forian Inc. completed its acquisition by 2025 Acquisition Company, LLC on May 15, 2026, with the company merging into a subsidiary of the acquirer at $2.17 per share in cash. The tender offer closed on May 14, 2026, with approximately 91% of outstanding shares tendered, satisfying all conditions for the acquisition. Following the merger, Forian became a wholly owned subsidiary of Parent, and the company initiated delisting from The Nasdaq Capital Market. This transaction eliminates Forian as an independent public company, and shareholders who did not tender their shares during the offer will receive the $2.17 merger consideration, while option holders and RSU holders receive equivalent cash payments based on the offer price.
ELAB
NASDAQ
▲ SUPER 8-K
PMGC Holdings Inc. Common Stock
EDGAR Items: 1.01,2.01,7.01,9.01
# SEC 8-K Filing Summary: PMGC Holdings Inc.
PMGC Holdings Inc. (NASDAQ: ELAB) completed its acquisition of 100% of A&B Aerospace, Inc. on May 12, 2026, for approximately $4.5 million in cash at closing plus contingent adjustments based on final net working capital and cash balance calculations. The acquisition includes a $225,000 indemnification holdback related to pending litigation, with sellers providing six months of transition services and agreeing to three-year non-compete restrictions in California's IT packaging business. The target company will continue operating at its existing facility under a new commercial lease, with its president retained as an employee, positioning PMGC to expand into the aerospace sector. Post-closing adjustments for cash balance and net working capital variations will be settled in cash within five business days of final determination, with the net working capital target set at $855,669.
AHT
NYSE
▲ SUPER 8-K
Ashford Hospitality Trust, Inc.
EDGAR Items: 2.01,9.01
# Summary of Ashford Hospitality Trust 8-K Filing
Ashford Hospitality Trust completed the sale of its 150-room Embassy Suites by Hilton Dallas Near the Galleria property on May 6, 2026, for $17 million in cash to DG Lodging, LLC. This asset disposition represents a portfolio rationalization move by the company, reducing its property count and potentially freeing up capital. The filing includes unaudited pro forma financial information reflecting the impact of this transaction on the company's financial position as of year-end 2025. For investors, this sale generates liquidity but may signal continued portfolio optimization efforts as the company manages its real estate holdings.
GAMG
OTC
▲ SUPER 8-K
Global Asset Management Group, Inc.
EDGAR Items: 2.01,2.03,3.02,9.01
# SEC 8-K Summary: Global Asset Management Group, Inc.
On May 6, 2026, Global Asset Management Group, Inc. completed the acquisition of an 83.125% membership interest in Memorial Real Estate Group LLC (MREG), which owns a historic 385,000-square-foot former hospital property in Pawtucket, Rhode Island being redeveloped into mixed-use residential and commercial space. The company financed this $6.455 million acquisition through a $6 million convertible promissory note (6% interest, maturing April 2027, convertible at 90% of 30-day VWAP) plus $455,000 in cash, along with a separate $3.5 million convertible note issued on April 6, 2026 for a 16.875% stake in the subsidiary holding company. The MREG property is planned as a major mixed-use development with approximately 40% affordable housing, 40% market-rate luxury apartments, and 20% veteran-focused housing, featuring community amenities and proximity to Boston commuter rail. Investors should note the material debt obligations ($9.5 million in convertible notes due 2027) and dilution risk from conversion provisions, as well as the significant execution risk inherent in a large-scale real estate redevelopment project.
UDMY
NASDAQ
▲ SUPER 8-K
Udemy, Inc. Common Stock
EDGAR Items: 1.02,2.01,3.01,3.03,5.01,5.02,5.03,8.01,9.01
# SEC 8-K Summary: Udemy, Inc.
On May 11, 2026, Udemy, Inc. completed its merger with Coursera, Inc., with Udemy becoming a wholly-owned subsidiary of Coursera. Udemy shareholders received 0.800 shares of Coursera common stock for each Udemy share held, based on a merger consideration value of $3.824 per Udemy share (calculated using a $4.78 average Coursera stock price). In connection with the transaction, Udemy terminated its $200 million credit facility with Citibank with all obligations satisfied and liens released. Following the merger closing, Udemy's common stock was suspended from trading on NASDAQ and Coursera requested delisting and deregistration of Udemy shares under Section 12(b) of the Securities Exchange Act. This merger effectively consolidates the two online education platforms under Coursera's ownership, eliminating Udemy as a separately traded public company.
APADR
NASDAQ
▲ SUPER 8-K
A Paradise Acquisition Corp. Rights
EDGAR Items: 1.01,2.01,3.01,3.02,3.03,4.01,5.01,5.02,5.03,5.05,5.06,7.01,9.01
# SEC 8-K Filing Summary: Enhanced Group Inc.
Enhanced Group Inc. (formerly A Paradise Acquisition Corp.) completed a domestication and business combination on May 6-7, 2026, converting from a British Virgin Islands blank check company to a Texas corporation and merging with Enhanced Ltd. The domestication involved converting A Paradise's Class B ordinary shares to Class A shares on a one-for-one basis, then converting all ordinary shares to Class A common stock of Enhanced Group, while establishing a new Class B common stock with ten votes per share. The subsequent merger with Enhanced Ltd resulted in Enhanced shareholders receiving Enhanced Group Class A common stock at a specified exchange ratio, with Enhanced Options, Top-Up Awards, and Consultant Warrants converted into equivalent Enhanced Group equity instruments. The Business Combination resulted in the issuance of approximately 136.2 million shares of Enhanced Group Class A common stock to various security holders, fundamentally transforming the company's capital structure and ownership. Investors should note the significant dilution from this equity issuance and the shift in voting structure with the introduction of supervoting Class B shares.
SHPH
NASDAQ
▲ SUPER 8-K
Shuttle Pharmaceuticals Holdings, Inc. Common Stock
EDGAR Items: 1.01,2.01,3.02,3.03,5.02,5.03,9.01
# Summary of Shuttle Pharmaceuticals Holdings, Inc. 8-K Filing
On May 6, 2026, Shuttle Pharmaceuticals Holdings, Inc. completed its merger with United Dogecoin Inc., with United Dogecoin becoming a wholly owned subsidiary of Shuttle. Under the merger agreement, existing United Dogecoin shareholders received 8,403 shares of Series B-1 convertible preferred stock, which are convertible into approximately 33.9 million shares of Shuttle common stock at $1.24 per share, plus conditional pre-funded warrants for up to 122.9 million additional shares upon achievement of certain milestones. Simultaneously, Shuttle closed a $9.55 million PIPE financing with accredited investors who received Series B-2 convertible preferred stock convertible into 9.3 million shares at $1.03 per share, plus additional pre-funded warrants for up to 31.5 million shares conditional on milestone achievements. **For investors, this represents significant potential dilution from the combined issuance of convertible securities and warrants, with approximately 173+ million potential shares outstanding contingent on stockholder approval and milestone achievement**, fundamentally altering the company's capital structure and substantially reducing existing shareholders' ownership percentages.
GTN
NYSE
▲ SUPER 8-K
Gray Media, Inc.
EDGAR Items: 2.01,7.01,9.01
# Gray Media, Inc. 8-K Summary
Gray Media completed its acquisition of 13 television stations from Allen Media Group on May 1, 2026, in two tranches totaling $171 million in purchase price plus working capital adjustments, funded entirely from available cash. The acquisition adds major-market stations across the Southeast and Midwest, including ABC affiliates in Huntsville and Paducah, CBS/FOX stations in Terre Haute and Evansville, and NBC affiliates in Lafayette and Rockford. The SEC granted a waiver allowing Gray Media to substitute an audited Statement of Assets Acquired and Liabilities Assumed in place of full financial statements and pro forma information, which must be filed within 71 days. This strategic expansion increases Gray Media's broadcasting footprint and diversifies its station portfolio, though the significant cash outlay may impact liquidity and should be monitored by investors for debt implications and integration risks.
BWEN
NASDAQ
▲ SUPER 8-K
Broadwind, Inc. Common Stock
EDGAR Items: 1.01,2.01,2.02,9.01
# Summary of Broadwind, Inc. 8-K Filing
**Key Event:** Broadwind completed the sale of its Abilene, Texas production facility to Freeman Enclosure Systems (a subsidiary of IES Holdings) on April 30, 2026, for up to $19.5 million in cash, with a $1 million escrow holdback. The company retained a short-term leaseback at below-market rates through approximately September 5, 2026.
**Strategic Shift:** This transaction represents Broadwind's complete exit from the wind energy market, following a prior sale of its Manitowoc, Wisconsin facility in September 2025. The company has made a deliberate strategic decision to abandon wind-related manufacturing operations.
**Financial Impact:** Broadwind withdrew its previously announced 2026 financial guidance in connection with this transaction, indicating material impacts on expected financial performance. Updated guidance is expected during the company's Q1 2026 earnings call on May 12, 2026.
**Investor Implications:** This marks a significant strategic pivot that will reshape Broadwind's business model and operational footprint, though the long-term direction remains unclear pending the earnings call disclosure.
FARM
NASDAQ
▲ SUPER 8-K
Farmer Brothers Company Common Stock
EDGAR Items: 1.02,2.01,3.01,3.03,5.01,5.02,5.03,7.01,9.01
# Summary of Farmer Bros. Co. 8-K Filing
On May 5, 2026, Farmer Bros. Co. (ticker: FARM) completed its acquisition by Royal Cup, Inc. in an all-cash merger transaction valued at approximately $28.3 million. Each share of Farmer Bros. common stock was converted into $1.29 in cash, and all equity awards (RSUs, CSRSUs, PBRSUs, and stock options) were converted to cash payments based on the merger consideration. The company's shares have been delisted from the Nasdaq Global Select Market, and Farmer Bros. is now a wholly-owned subsidiary of Royal Cup. This represents a material change of control event, and the company intends to terminate its SEC reporting obligations by filing a Form 15.
OTLC
OTC
▲ SUPER 8-K
Oncotelic Therapeutics, Inc.
EDGAR Items: 1.01,2.01,3.02,9.01
# Summary of Oncotelic Therapeutics 8-K Filing (May 1, 2026)
Oncotelic Therapeutics completed a significant merger transaction where its subsidiary merged a patent holding company (Neurobridge IP Holdings) into Lunai Bioworks, Inc., receiving $20 million in Series B Convertible Preferred Stock (with Oncotelic receiving 62.5% or $12.5 million). Concurrent with the merger, Oncotelic assigned its intellectual property portfolio to the holding company while retaining an exclusive, royalty-free license to use most of the assets, except in the Biodefense and Alzheimer's Disease fields—which are now exclusively held by Lunai. The transaction effectively restructures Oncotelic's IP ownership and creates a partnership with Lunai around its therapeutic intellectual property, particularly regarding OT-101 applications.
**For investors:** This represents a material capital infusion and strategic repositioning that provides Oncotelic with funding while carving out potential upside in biodefense and Alzheimer's applications for Lunai. The exclusive license-back ensures Oncotelic retains control of its core therapeutic development (OT-101), though the company has ceded significant patent rights in specialized fields that could represent future value.
UHG
NASDAQ
▲ SUPER 8-K
United Homes Group, Inc Class A Common Stock
EDGAR Items: 1.02,2.01,3.01,3.02,3.03,5.01,5.02,5.03,8.01,9.01
# United Homes Group, Inc. - Form 8-K Summary
United Homes Group, Inc. completed its merger with Stanley Martin Homes, LLC on May 4, 2026, with shareholders receiving $1.18 per share in cash for both Class A and Class B common stock. The company simultaneously delisted from Nasdaq and repaid all outstanding debt under its credit facilities with Wells Fargo and Kennedy Lewis. Employee equity awards (stock options, RSUs, and PSUs) were canceled and converted to cash payments based on the per-share merger price, with performance stock units deemed 100% vested. Additionally, the company issued 21.9 million shares to satisfy prior earn-out obligations before the merger closed. For investors, this represents the conclusion of United Homes Group's public life as it becomes a wholly owned subsidiary of Stanley Martin Homes, eliminating any further public equity investment opportunities in the standalone company.
ADVB
NASDAQ
▲ SUPER 8-K
Advanced Biomed Inc. Common Stock
EDGAR Items: 2.01,3.02,5.02,9.01
# SEC 8-K Summary: Advanced Biomed Inc.
Advanced Biomed Inc. (NASDAQ: ADVB) completed a strategic pivot from life sciences to artificial intelligence development, acquiring Acellent Technologies (Hong Kong) Co. Limited for $1.08 million in stock (270,000 shares at $4.00/share) on April 30, 2026. The company simultaneously replaced Chief Executive Officer Yi Lu with Xiaomin Chen, the target company's former owner and a Google veteran with two decades of AI/fintech experience; Chen will lead development of financial-domain large language models and AI verification systems. Lu received 39,999 shares as severance, while Chen will receive $12,000 monthly salary plus the acquisition consideration, representing significant leadership and operational changes.
**Investor Impact:** This signals a fundamental business model transformation with concentrated leadership risk, as Chen now holds both CEO/Chairman roles and a major equity stake following the acquisition, while the company's shift from established life sciences to AI development carries execution risk and valuation implications.
LNAI
NASDAQ
▲ SUPER 8-K
Lunai Bioworks Inc. Common Stock
EDGAR Items: 1.01,2.01,3.01,3.02,3.03,5.03,9.01
# Summary of Lunai Bioworks 8-K Filing (April 27, 2026)
Lunai Bioworks completed a merger with Neurobridge IP Holdings on May 1, 2026, acquiring a multi-jurisdictional patent portfolio from two shareholders (Oncotelic and Pelerin) in exchange for 8 shares of newly created Series B Convertible Preferred Stock valued at $20 million total ($12.5M to Oncotelic, $7.5M to Pelerin). The Series B Preferred Stock is convertible into up to 13.3 million common shares at $1.50 per share, but conversion is contingent on obtaining stockholder approval under Nasdaq Listing Rule 5635, which the company has committed to seek within 180 days. The transaction involves significant protections for the company, including a beneficial ownership blocker (4.99%), indemnification set-off rights, and an IP clawback mechanism that allows the company to forfeit shares if patent validity claims arise. For investors, this represents a dilutive event pending stockholder approval, with the actual impact dependent on the patent portfolio's strategic value and whether conversion ultimately occurs.
April 2026
21 filings
▼
SOBR
NASDAQ
▲ SUPER 8-K
SOBR Safe, Inc. Common Stock
EDGAR Items: 1.01,2.01,5.01,5.02,7.01,9.01
# SOBR Safe, Inc. 8-K Summary
SOBR Safe, Inc. announced a merger agreement with Clean World Ventures, Inc. (CWV) on April 24, 2026, in which CWV will merge into a SOBR subsidiary, with CWV becoming a wholly owned subsidiary of SOBR. Upon closing, pre-Merger CWV stockholders are expected to own approximately 98.3% of the combined company while pre-Merger SOBR stockholders will own only 1.7%, representing a significant change of control. The transaction, expected to close in Q3 2026, requires approval from both companies' stockholders, Nasdaq listing approval, and an effective S-4 registration statement, with SOBR's board and executive officers to be determined by CWV post-closing. Additionally, SOBR will pay $1.5 million to terminate its financial advisor agreement with H.C. Wainwright & Co. upon merger completion.
**Investor Implications:** Current SOBR shareholders face substantial dilution, with their ownership stake declining from 100% to approximately 1.7%, effectively making this a reverse merger where CWV becomes the controlling entity. The transaction structure suggests SOBR is the publicly listed shell being acquired by CWV, requiring a reverse stock split to maintain Nasdaq compliance.
FCUV
NASDAQ
▲ SUPER 8-K
Focus Universal Inc. Common Stock
EDGAR Items: 1.01,2.01,2.03,9.01
# Focus Universal Inc. (FCUV) 8-K Summary
Focus Universal Inc. completed a significant $17.7 million acquisition of a Class A office and commercial property in Monterey Park, California on April 17, 2026, financed through an $11.05 million term loan from East West Bank and $5.8 million in cash. The 464,955 sq. ft. property, assessed at approximately $28.4 million, is currently 99.2% occupied by 16 tenants with lease terms of 5-8 years, and includes a four-level parking structure with solar panels. The company secured the property with a floating-rate loan at 6.25% for the first three years, then Prime + 0.25% thereafter, with principal and interest payments beginning May 2026 and a substantial balloon payment due in April 2036.
**For investors:** This acquisition signals Focus Universal's strategic pivot into real estate investment, adding a substantial income-generating asset to its portfolio. However, the high leverage ratio (65% debt financing) and personal guarantee by CEO Dr. Desheng Wang increase financial risk, while the 99% occupancy rate provides near-term cash flow stability that should help service the $11.05 million debt obligation.
MDLK
OTC
▲ SUPER 8-K
ModuLink Inc.
EDGAR Items: 2.01,7.01,9.01
# Summary of ModuLink Inc. 8-K Filing
ModuLink Inc. completed its acquisition of a 60% equity stake in ASA Robotics Limited, a Hong Kong-based robotics and artificial intelligence company, on April 23, 2026, for approximately $641,026 (HKD 5 million) in Series A Convertible Preferred Stock. Following the transaction, ASA Robotics became a majority-owned subsidiary of ModuLink, with the remaining 40% held by existing minority shareholders, and the company will consolidate ASA Robotics' financial results going forward. The board of ASA Robotics will be reconstituted to reflect the new ownership structure, and the parties plan to execute an amended shareholders' agreement to formalize governance arrangements. While this acquisition expands ModuLink's portfolio into robotics and AI solutions, the company states its core business operations remain unchanged.
TELO
NASDAQ
▲ SUPER 8-K
Telomir Pharmaceuticals, Inc. Common Stock
EDGAR Items: 1.01,2.01,3.02,9.01
# Telomir Pharmaceuticals 8-K Summary
**Material Event:** Telomir Pharmaceuticals completed its acquisition of TELI Pharmaceuticals on April 22, 2026, issuing 34.4 million restricted shares to TELI shareholders as consideration, with valuations determined by independent third parties.
**Key Changes:** The transaction consolidates global rights to Telomir-1 (Telomir-Zn) under a single corporate entity, eliminating the previous geographic fragmentation where North American and international rights were held separately. This provides unified development and commercialization control across major markets.
**Additional Consideration:** Bayshore Trust, a TELI shareholder, contributed $1 million at closing and entered into an option agreement to invest up to $4 million more upon achievement of key milestones, including FDA acceptance of an IND application and initiation of Phase 1/2 clinical trials for Telomir-1.
**Investor Implications:** While the deal consolidates IP rights and demonstrates shareholder support (through Bayshore's additional commitments), the substantial share issuance (34.4M shares) causes dilution, and success is contingent on achieving early-stage clinical development milestones, which carry significant execution risk for this emerging growth company.
MSGM
NASDAQ
▲ SUPER 8-K
Motorsport Games Inc. Class A Common Stock
EDGAR Items: 1.01,2.01,3.03,5.01,5.02,5.03,5.07,9.01
# Motorsport Games Inc. (MSGM) - 8-K Summary
**Key Events:**
Motorsport Games Inc. completed a significant corporate restructuring on April 22, 2026, repurchasing 904,395 shares from its largest shareholder, Driven Lifestyle Group LLC, at $4.11 per share, which simultaneously triggered the cancellation of all Class B Common Stock held by that entity. This transaction caused a major shift in control: Driven Lifestyle's voting power dropped from majority control to just 6.10%, while Sharp Arrow Global Tech Ventures L.P. became the new largest shareholder with 32.15% voting power.
**Material Changes:**
The company also implemented significant governance amendments to its Certificate of Incorporation and Bylaws, including elimination of shareholder written consent rights (requiring all stockholder actions to occur at formally called meetings), simplified amendment procedures for charter and bylaws, and increased the equity incentive plan share authorization from 100,000 to 600,000 shares.
**Investor Implications:**
These changes represent a fundamental shift in ownership structure and corporate control, reducing founder/early investor concentration and potentially making the company more accessible to future investors. However, the elimination of written consent rights may limit minority shareholders' ability to force certain corporate actions, while the expanded equity plan could create dilution concerns depending on future grant decisions.
IVHI
OTC
▲ SUPER 8-K
Invech Holdings, Inc.
EDGAR Items: 1.01,2.01,3.02,8.01,9.01
# Invech Holdings, Inc. - 8-K Summary
Invech Holdings, Inc. completed the acquisition of the sports betting platform www.sportypick.com from Arpita Day on April 21, 2026, paying 5 million restricted shares of common stock for the website and associated code. The company simultaneously created a wholly owned subsidiary, Sporty Pick, Inc., to house the acquired assets. The share issuance was conducted as a private placement under SEC regulations (Section 4(a)(2) and Regulation D Rule 506), meaning it was not a public offering and the shares carry resale restrictions.
**For investors:** This represents a significant equity dilution event, as the company issued 5 million shares for a single asset acquisition. The lack of disclosed financial details about the platform's current value, user base, or revenue-generating potential makes it difficult to assess whether this was a fair exchange or strategic necessity. The substantial share issuance to acquire a relatively niche sports betting website warrants investor caution regarding dilution and management's capital allocation decisions.
NXGL
NASDAQ
▲ SUPER 8-K
NexGel, Inc Common Stock
EDGAR Items: 1.01,2.01,2.03,3.02,8.01,9.01
# NexGel Inc. (NXGL) 8-K Summary
**Material Events:**
NexGel amended its Asset Purchase and Exclusive License Agreement with Celularity Inc. on April 17, 2026, restructuring the consideration for acquiring Celularity's regenerative biomaterials portfolio. The total consideration was adjusted to $13.3 million, consisting of an $8.3 million upfront cash payment and a $5 million convertible promissory note from NexGel to Celularity.
**Key Changes:**
Simultaneously, NexGel completed a private placement raising $6.9 million through convertible notes and warrants from accredited investors, with an additional $475,000 in commitments. The convertible notes feature a 10% interest rate, 18-month maturity, and $0.60 conversion price with full-ratchet anti-dilution protection and automatic price adjustments at 12 and 18 months.
**Investor Implications:**
The financing and restructured deal enable NexGel to complete the Celularity acquisition while securing capital, though the aggressive conversion terms (particularly the automatic downward price adjustments and full-ratchet anti-dilution) suggest significant dilution risk for existing shareholders if the stock underperforms. The $0.60 conversion price will likely reset lower in 12 months based on trading volume metrics, potentially increasing dilution.
HRZN
NASDAQ
▲ SUPER 8-K
Horizon Technology Finance Corporation
EDGAR Items: 1.01,2.01,5.02,7.01,9.01
# Horizon Technology Finance Corporation (HRZN) - 8-K Summary
**Key Events:**
Horizon Technology Finance Corporation completed its acquisition of Monroe Capital Corporation (MRCC) on April 14, 2026, issuing approximately 20.4 million shares at a 0.9402 exchange ratio and receiving ~$141 million in cash proceeds from MRCC's asset sale. The transaction combined two BDC (business development company) platforms and was structured to comply with Investment Company Act safe harbor provisions.
**Material Changes:**
The company's board was restructured, with five directors resigning effective at closing and one new independent director (Thomas J. Allison) being appointed, reducing the board size to four members. Additionally, the investment adviser (HRZN Advisor) agreed to waive $4 million in management and incentive fees ($1 million per quarter through June 30, 2027) to help offset merger-related costs.
**Investor Implications:**
The merger significantly expands HRZN's asset base and diversifies its portfolio through MRCC's acquisition, though shareholders face dilution from the 20+ million new shares issued. The fee waiver provides near-term earnings support, but investors should monitor the combined entity's portfolio performance and how effectively management integrates the two platforms over the coming quarters.
CCTC
OTC
▲ SUPER 8-K
LataMed AI Corp.
EDGAR Items: 1.01,2.01,7.01,9.01
# SEC 8-K Summary: Catalyst Crew Technologies Corp.
**Key Events:** Catalyst Crew Technologies acquired AI-enabled healthcare analytics intellectual property and operational assets from its CEO Kevin Rodan Levy in a series of transactions between February and April 2026. The company acquired proprietary software, machine learning models, and three registered AI platforms (CardioAI, PulmoAI, and NeuroAI) through an Asset Purchase Agreement, followed by acquiring a 100% stake in a Venezuelan subsidiary to house these assets and serve as the company's Latin American operating entity.
**Material Implications for Investors:** This transaction consolidates control of potentially valuable healthcare AI technology within the company and establishes operational infrastructure in Latin America, positioning the company to commercialize its AI healthcare solutions. However, investors should note that the CEO was the seller, raising potential concerns about related-party transaction valuation and pricing. The limited financial disclosure regarding acquisition consideration and the company's micro-cap status (no exchange listing) suggest higher risk and less transparency than typical public companies.
LMED
OTC
▲ SUPER 8-K
LataMed AI Corp.
EDGAR Items: 1.01,2.01,7.01,9.01
# SEC 8-K Summary: Catalyst Crew Technologies Corp.
Catalyst Crew Technologies Corp. completed a series of related transactions to acquire artificial intelligence-enabled healthcare analytics assets from its CEO Kevin Rodan Levy, including intellectual property for CardioAI, PulmoAI, and NeuroAI platforms registered in Venezuela. The company first acquired proprietary software, machine learning models, and datasets via an Asset Purchase Agreement (February 17, 2026), then acquired 100% of Venezuelan subsidiary Inversiones Long 33, C.A. (March 23, 2026), and finally formalized an internal IP assignment to the subsidiary (April 7, 2026). These transactions establish the company's operating structure in Latin America around its healthcare AI technology portfolio.
**Investor Impact:** The filings reveal material concern regarding related-party transactions with the CEO and the company's operational concentration in Venezuela, a jurisdiction with significant geopolitical and economic risks. No acquisition consideration amounts are disclosed, limiting transparency on valuation and deal terms. Investors should note the company has no registered securities on major exchanges and is an emerging growth company, indicating early-stage status with heightened execution and regulatory risks.
LMEDD
OTC
▲ SUPER 8-K
LataMed AI Corp.
EDGAR Items: 1.01,2.01,7.01,9.01
# Summary of Catalyst Crew Technologies Corp. Form 8-K Filing
Catalyst Crew Technologies Corp. completed a series of related acquisitions from its CEO Kevin Rodan Levy between February and April 2026, acquiring artificial intelligence-enabled healthcare analytics assets and establishing a Venezuelan operating subsidiary. The company acquired proprietary software, machine learning models, datasets, and three patented AI technologies (CardioAI, PulmoAI, and NeuroAI) through an Asset Purchase Agreement in February, followed by 100% ownership of Inversiones Long 33, C.A., a Venezuelan subsidiary, in March. The intellectual property was then internally reorganized by assigning it from the parent company to the subsidiary for operational alignment in Venezuela and Latin America.
**Investor Impact:** This transaction is significant because it substantially expands Catalyst Crew's healthcare technology portfolio and establishes operational infrastructure in Latin America; however, the lack of disclosed consideration amounts, the self-dealing nature of the CEO transactions, and the Venezuelan location of operations present risks including regulatory uncertainty and geopolitical exposure that investors should monitor carefully.
PHGE
AMEX
▲ SUPER 8-K
BiomX Inc.
EDGAR Items: 1.01,2.01,3.02,7.01,9.01
# BiomX Inc. (PHGE) - 8-K Summary
BiomX Inc. completed its acquisition of a 60% majority stake in DR. Frucht Systems Ltd. (DFSL), an Israeli developer of proprietary LADAR-based detection systems for security and defense applications, on April 13, 2026. The total consideration package includes $750,000 in cash, a $3 million convertible promissory note, 923,000 common shares, pre-funded warrants for 923,000 shares, and five-year warrants for 3.69 million shares—all at a $12.00 conversion/exercise price. The issuance of securities is contingent on stockholder approval within 120 days, as required by NYSE American listing rules, with the company committing to obtain such approval using "commercially reasonable efforts."
The acquisition also includes a revenue bonus provision whereby Mandragola (the seller) receives 5% of DFSL's annual revenues if they exceed $25 million in any fiscal year starting in 2027, and Mandragola will provide a credit line for DFSL's development and debt repayment. **Investor impact:** The significant dilution from the warrant and convertible note issuances, combined with the contingency on stockholder approval and the revenue-based earn-out obligation, increases both near-term equity dilution risk and future cash flow obligations if DFSL achieves projected revenue targets.
AHT
NYSE
▲ SUPER 8-K
Ashford Hospitality Trust, Inc.
EDGAR Items: 2.01,9.01
# 8-K Summary: Ashford Hospitality Trust
Ashford Hospitality Trust completed the sale of the Embassy Suites by Hilton Palm Beach Gardens property in Florida on April 7, 2026, for $41 million in cash. This asset disposition represents a strategic property divestiture, though the filing provides limited detail on the company's rationale or financial impact beyond the transaction price. The company has filed unaudited pro forma financial information reflecting the post-sale balance sheet as of December 31, 2025, to show investors the adjusted financial position following this transaction. For investors, this sale indicates management's continued portfolio optimization efforts, though the materiality relative to the company's total asset base would require review of comparative financial metrics to fully assess the impact.
NWBO
OTC
▲ SUPER 8-K
NORTHWEST BIOTHERAPEUTICS INC
EDGAR Items: 2.01
# Northwest Biotherapeutics 8-K Summary
Northwest Biotherapeutics completed its acquisition of Advent BioServices Ltd., a UK-based contract manufacturing organization (CDMO) that had previously provided manufacturing and cryostorage services for the company's DCVax® product platform, on October 24, 2025. The total consideration includes approximately $1.9 million in purchase price plus $8.3 million in outstanding accounts payable owed to Advent for prior services, payable in installments over two years at 7.5% annual interest, with potential acceleration following regulatory approval of DCVax®-L. As part of the transaction, the company recovered 12 million treasury shares and 5.5 million options that had been previously issued to Advent as service compensation.
**Key Investor Implications:** This is a related-party transaction (the CEO is the seller's controlling member) that vertically integrates manufacturing capabilities into the company, potentially reducing costs and improving control over the critical manufacturing process for its lead therapeutic candidate. However, investors should note the modest valuation and the contingent payment structure tied to regulatory approval, which introduces execution risk.
BRR
NASDAQ
▲ SUPER 8-K
ProCap Financial, Inc. Common Stock
EDGAR Items: 1.01,2.01,3.02,5.02,7.01,9.01
# SEC 8-K Summary: ProCap Financial, Inc.
**Material Event:** ProCap Financial, Inc. completed its acquisition of CFO Silvia, Inc. on April 6, 2026, following stockholder approval on March 27, 2026. The transaction was structured as a merger with CFO Silvia becoming a wholly-owned subsidiary.
**Deal Structure:** The acquisition consideration totaled approximately 7.5 million shares at closing (reduced from 8.1 million to account for liabilities), plus 900,000 escrow shares held for 12 months as indemnification security, and up to 9 million earnout shares contingent on the company's stock price reaching $9.00 per share during a five-year period.
**Key Terms for Investors:** The sellers are subject to lock-up restrictions until either six months post-closing or when the stock reaches $9.00 (whichever is later), and face a two-year restriction on participating in any stock repurchases. The earnout structure aligns seller interests with stock price performance, incentivizing operational success.
**Implications:** This acquisition expands ProCap Financial's capabilities in financial services. However, investors should note the significant dilution from approximately 16.4 million potential new shares (closing + escrow + earnout) and the relatively ambitious $9.00 earnout threshold, which will require substantial stock appreciation to achieve full value.
NXH
NASDAQ
▲ SUPER 8-K
Neighborhood Intelligence, Inc. Common Stock
EDGAR Items: 2.01,8.01,9.01
# Summary of Bed Bath & Beyond 8-K Filing (April 2, 2026)
Bed Bath & Beyond completed its acquisition of The Brand House Collective (TBHC) on April 2, 2026, pursuant to a merger agreement dated November 24, 2025, with TBHC becoming a wholly owned subsidiary of BBBY. TBHC shareholders received 0.1993 shares of BBBY common stock for each TBHC share, with fractional shares paid in cash at $4.66 per share (the closing price on April 1, 2026). All TBHC restricted stock units fully vested and converted into BBBY shares at the exchange ratio, while out-of-the-money options were cancelled. Simultaneously with closing, BBBY contributed $30 million in capital to TBHC for general corporate purposes, including partial repayment of TBHC's Bank of America debt. The company will file audited financial statements and pro forma financial information by amendment within 71 days.
AHT
NYSE
▲ SUPER 8-K
Ashford Hospitality Trust, Inc.
EDGAR Items: 2.01,9.01
# Summary of Ashford Hospitality Trust 8-K Filing
Ashford Hospitality Trust completed the sale of the Hilton Alexandria Old Town in Alexandria, Virginia on March 31, 2026, for $58 million in cash to Lodging Capital Partners LLC. This asset disposition represents a strategic portfolio reduction as the company continues to optimize its hotel holdings. The transaction was executed under an agreement dated February 25, 2026, and is subject to standard purchase price adjustments. For investors, this sale generates immediate liquidity that could be deployed toward debt reduction, capital returns, or strategic reinvestment, though the impact will depend on the company's capital allocation priorities and the property's contribution to prior earnings.
AGIG
AMEX
▲ SUPER 8-K
Abundia Global Impact Group Inc.
EDGAR Items: 1.01,2.01,2.03,3.02,8.01,9.01
# Summary of Abundia Global Impact Group, Inc. 8-K Filing
On April 1, 2026, Abundia Global Impact Group, Inc. completed the acquisition of all membership interests in RPD Technologies Americas, LLC from its controlling shareholder Abundia Financial for $4.04 million, financed entirely through a senior secured convertible note. The convertible note carries a 10% annual interest rate, matures in one year, and can be converted into common stock at 80% of the three-day volume-weighted average price (with a $0.29 floor) after maturity.
The transaction presents potential dilution risk for existing shareholders, as conversion could substantially increase share count, and the note is secured by all of RPD's membership interests. Additionally, the controlling shareholder (Abundia Financial, holding 63% of shares) serves as both seller and creditor, raising related-party transaction concerns and governance questions about protecting minority shareholders' interests.
BMNM
OTC
▲ SUPER 8-K
BIMINI CAPITAL MANAGEMENT, INC.
EDGAR Items: 2.01,7.01,9.01
# Summary of Bimini Capital Management 8-K Filing
Bimini Capital Management completed its acquisition of 80% of Tom Johnson Investment Management LLC (TJIM) on April 1, 2026, for $12.3 million (2.5x 80% of TJIM's 2025 revenue), with $12 million paid in cash at closing and the remaining $318,492 due in one year with 5% interest. The seller, Richard's Trust, retained a 20% equity stake and has a put right to force Bimini to buy the remaining interest after three years (contingent on Richard's continued employment and TJIM achieving at least 30% EBITDA margins), while Bimini has a corresponding call right after three years.
**Key implications for investors:** This acquisition expands Bimini's asset management capabilities through a registered investment adviser, with management continuity ensured through new employment agreements for TJIM's team. However, the deferred payment structure and conditional put/call options on the remaining 20% stake create ongoing financial and operational contingencies that could affect future earnings and share dilution depending on TJIM's performance and Richard Parry's employment status.
SSP
NASDAQ
▲ SUPER 8-K
The E.W. Scripps Company
EDGAR Items: 2.01,8.01,9.01
# E.W. Scripps Company (SSP) 8-K Summary
On March 31, 2026, The E.W. Scripps Company completed the sale of its WRTV television station to Circle City Broadcasting for $83 million in cash. Although Scripps does not consider the transaction material on a standalone basis, the sale met SEC quantitative thresholds for a "significant disposition" when compared against the company's market capitalization, triggering mandatory 8-K disclosure and pro forma financial reporting requirements. The company provided unaudited pro forma financial statements reflecting the asset sale as of December 31, 2025 and for the year ended December 31, 2025. This transaction represents a portfolio optimization move with modest financial impact, generating $83 million in liquidity while reducing the company's broadcast television holdings.
CYH
NYSE
▲ SUPER 8-K
Community Health Systems, Inc.
EDGAR Items: 2.01,8.01,9.01
# Summary of Community Health Systems 8-K Filing
Community Health Systems, Inc. completed the sale of Crestwood Medical Center in Huntsville, Alabama and associated outpatient operations to Huntsville Hospital Health System on April 1, 2026, for $459 million in cash (subject to post-closing working capital adjustments). This represents a significant disposition of assets as the transaction was previously announced in January 2026. The company has provided pro forma financial statements reflecting the impact of this divestiture on its consolidated financial position as of December 31, 2025, and results for the full year 2025.
For investors, this asset sale represents a material reduction in the company's operating footprint and generates substantial cash proceeds that could be deployed for debt reduction, capital investments, or other strategic initiatives, though the filing does not specify intended use of proceeds.
March 2026
34 filings
▼
MFON
OTC
▲ SUPER 8-K
MOBIVITY HOLDINGS CORP.
EDGAR Items: 2.01,3.02,5.03,9.01
# SEC 8-K Filing Summary
Based on this March 31, 2026 8-K filing, the company reported several material events: **completion of an acquisition or disposition of assets** (Item 2.01), **unregistered sales of equity securities** (Item 3.02), and **amendments to articles of incorporation or bylaws** (Item 5.03). These concurrent items suggest the company completed a significant corporate transaction, likely financed through equity issuance and involving structural changes to the organization. The filing includes amended governance documents and XBRL financial data, indicating a substantial capital event. Investors should review the full 8-K document to understand the acquisition details, the terms and scope of equity dilution, and any strategic implications for the company's future direction.
CYAB
NASDAQ
▲ SUPER 8-K
Cyabra, Inc. Common Stock
EDGAR Items: 1.01,2.01,2.03,3.02,3.03,4.01,5.01,5.02,5.03,5.06,7.01,9.01
# SEC 8-K Filing Summary: Cyabra, Inc.
**Filing Date:** March 31, 2026 | **Period:** March 26, 2026
This 8-K filing indicates **substantial corporate restructuring** at Cyabra, Inc., with the company reporting multiple material events including a change in control, acquisition/disposition of assets, creation of financial obligations, and issuance of convertible preferred stock (Series A, B, and C). The filing also documents changes in certifying accountants, modifications to articles of incorporation, and transition from shell company status.
**Key Material Events:** The company entered into material definitive agreements, completed asset transactions, and made unregistered equity sales while modifying security holder rights. Additionally, there were changes in the registrant's certifying accountant and directorate/officer composition, suggesting significant governance restructuring.
**Investor Implications:** This filing signals a major corporate transformation with potential dilution from new convertible preferred stock issuances and new debt obligations. The multiple simultaneous changes—including control shift, accounting firm replacement, and shell status transition—warrant careful review of the detailed 8-K document to understand valuation impact and new ownership structure, as such comprehensive restructuring can significantly affect existing shareholders' interests and future company direction.
ORMP
NASDAQ
▲ SUPER 8-K
Oramed Pharmaceuticals Inc.
EDGAR Items: 1.01,2.01
# 8-K Filing Summary: Oramed Pharmaceuticals Inc.
**Filing Date:** March 31, 2026 | **Period:** March 25, 2026
This 8-K filing by Oramed Pharmaceuticals (CIK: 1176309) reports two material events: the **entry into a material definitive agreement** (Item 1.01) and the **completion of an acquisition or disposition of assets** (Item 2.01). While the HTML document provided does not contain the detailed substance of these agreements, the dual reporting of both execution and completion suggests the company has finalized a significant corporate transaction.
**For investors:** This filing indicates Oramed has undertaken a major strategic action—either acquiring assets/a business or divesting operations. Shareholders should review the full 8-K document (available via the iXBRL link) to understand the financial terms, strategic rationale, and potential impact on the company's operations and financial position. The materiality of this transaction warrants careful analysis of how it affects Oramed's pipeline, cash position, and future earnings potential.
AIV
NYSE
▲ SUPER 8-K
Apartment Investment and Management Company
EDGAR Items: 2.01,9.01
# Summary
Aimco completed the sale of its seven-property Chicago apartment portfolio (1,495 units) to LaTerra Capital Management on March 27, 2026, for a gross sale price of $455 million, with the buyer assuming $282.5 million in non-recourse property debt. This transaction was previously announced on December 10, 2025, and represents a significant portfolio disposition as part of what appears to be a capital redeployment strategy. The sale reduces Aimco's debt obligations while generating proceeds, though the filing does not specify the net proceeds available or their intended use. Investors should monitor upcoming quarterly filings for details on capital allocation, updated guidance, and the impact on the company's leverage ratios and portfolio composition.
ATXG
NASDAQ
▲ SUPER 8-K
Addentax Group Corp. Common Stock
EDGAR Items: 2.01,9.01
# Summary of Addentax Group Corp. Form 8-K Filing
On March 30, 2026, Addentax Group Corp. completed the acquisition of 34.2 million shares (62.18% voting control) of Keemo Fashion Group Limited for approximately $5.5 million, funded by transferring a portion of an existing bond held by the company. Keemo Fashion has become a controlled subsidiary of Addentax following the transaction, which was originally announced in February 2026. The acquisition expands Addentax's portfolio into the fashion sector, though investors should note the company financed the deal through asset reallocation rather than cash, potentially affecting liquidity and existing bondholders' positions. The transaction has been incorporated by reference into the company's Form S-8 registration statements, suggesting equity compensation implications for employees.
GLND
NASDAQ
▲ SUPER 8-K
Greenland Energy Company Common Stock
EDGAR Items: 1.01,1.02,2.01,3.01,3.02,3.03,4.01,5.01,5.02,5.03,5.06,7.01,9.01
# Summary of Greenland Energy Company 8-K Filing
On March 25, 2026, Greenland Energy Company (formerly Pelican Holdco, Inc.) completed a SPAC merger combining Pelican Acquisition Corporation with two operating companies—Greenland Exploration Limited and March GL Company. The combined entity, now trading on Nasdaq under the symbol "GLND," issued 21.5 million shares valued at $215 million to the former stockholders of the acquired companies. Additionally, PubCo assumed 1.5 million warrants (exercisable at $15.00 per share for 10 years) from Greenland shareholders. Investors should note that the transaction resulted in substantial equity dilution through new share issuance and introduced significant warrant overhang that could further dilute ownership if exercised.
ATLN
NASDAQ
▲ SUPER 8-K
Atlantic International Corp. Common Stock
EDGAR Items: 1.01,2.01,5.03,9.01
# SEC 8-K Filing Summary: Atlantic Interest, Inc.
**Filing Date:** March 26, 2026 | **Period:** March 20, 2026
Atlantic Interest, Inc. completed a material securities transaction on March 20, 2026, involving the entry into a definitive securities purchase agreement and the issuance of Series B preferred stock with associated warrants. The company also amended its articles of incorporation to establish the new preferred stock class with specific designations, preferences, and rights. This transaction represents a significant capital-raising event that will dilute existing shareholders' ownership stakes and potentially introduce new governance considerations through the preferred stock structure. Investors should review the Securities Purchase Agreement and Certificate of Designations to understand the terms, liquidation preferences, voting rights, and warrant exercise prices, as these preferred securities typically have priority over common equity in liquidation scenarios.
CIRC
NASDAQ
▲ SUPER 8-K
Circle8 Group, Inc. Common Stock
EDGAR Items: 1.01,2.01,5.03,9.01
# Summary of Atlantic International Corp 8-K Filing
Atlantic International Corp completed a $5.6 million preferred stock financing on March 20, 2026, issuing 5,600 shares of Series B 5% Convertible Preferred Stock (with a $1,070 stated value per share) and warrants to purchase an additional 5,600 preferred shares to an institutional investor. The preferred stock carries a 5% dividend, ranks senior to common stock in liquidation events, and is convertible into common stock at an initial conversion price of $4.38 (fixed for 30 days post-closing). The company netted $5.565 million in proceeds after transaction expenses for working capital and general corporate purposes. Key investor considerations include the company's redemption option at 110% of preferred value beginning 30 business days after closing, the investor's 25% participation rights in future financings for 24 months, and anti-dilution protections for the preferred holders in fundamental transactions (mergers, asset sales, or change-of-control events).
CDLX
NASDAQ
▲ SUPER 8-K
Cardlytics, Inc. Common Stock
EDGAR Items: 2.01,9.01
# SEC 8-K Filing Summary
**Company & Filing:** Cardlytics Inc. (CDLX) filed an 8-K on March 24, 2026, reporting the completion of an acquisition or disposition of assets.
**Material Event:** The company completed a significant acquisition or asset transaction, as indicated by Item 2.01. The filing includes unaudited pro forma financial statements (Exhibit 99.1), suggesting the transaction will have material impacts on the company's financial position and results going forward.
**Key Implications for Investors:** This acquisition could represent a strategic expansion of Cardlytics' business operations or a significant capital deployment. The pro forma financials should help investors understand the combined entity's projected financial metrics. Investors should review the full 8-K details and pro forma statements to assess the acquisition's terms, integration risks, and potential impact on earnings, debt levels, and growth prospects.
MRLN
NASDAQ
▲ SUPER 8-K
Merlin, Inc. Common Stock
EDGAR Items: 1.01,2.01,3.02,3.03,4.01,5.01,5.02,5.03,5.06,8.01,9.01
# Summary of Merlin, Inc. 8-K Filing
On March 16, 2026, Merlin, Inc. (formerly Inflection Point Acquisition Corp. IV) completed its business combination with Merlin Labs, Inc., a Delaware corporation, through a merger in which Merlin Labs became a wholly-owned subsidiary of the newly domesticated Delaware corporation Merlin, Inc. Prior to the merger, Inflection Point was domesticated from a Cayman Islands exempted company to a Delaware corporation on March 13, 2026, and founder shareholders converted their Class B shares to Class A shares on a one-for-one basis. As part of the transaction, all convertible securities and warrants of Legacy Merlin were automatically converted or exercised, combining the two entities into a single public company trading under the ticker symbol MRLN on Nasdaq. This business combination allows Merlin Labs to access public capital markets and provides liquidity to existing shareholders of both entities.
BGS
NYSE
▲ SUPER 8-K
B&G Foods, Inc.
EDGAR Items: 2.01,7.01,9.01
# B&G Foods 8-K Summary
B&G Foods, Inc. completed its acquisition of the College Inn and Kitchen Basics broth and stock business from Del Monte Foods Holdings Limited on March 19, 2026, for approximately $110 million in cash. The purchase included trademarks, intellectual property, customer information, supply agreements, and inventory, with Del Monte affiliates providing up to 180 days of transition services post-closing. B&G Foods funded the acquisition through existing cash, divestiture proceeds, and additional revolving credit facility borrowings; the purchase price was established through a competitive auction process conducted in Del Monte's Chapter 11 bankruptcy proceedings. This strategic acquisition expands B&G Foods' portfolio in the broth and stock category with established brands, though investors should monitor the integration execution and any impact on leverage from the debt financing used.
AHT
NYSE
▲ SUPER 8-K
Ashford Hospitality Trust, Inc.
EDGAR Items: 2.01,9.01
# Summary of Ashford Hospitality Trust 8-K Filing
Ashford Hospitality Trust completed the sale of La Posada de Santa Fe, a hotel property in Santa Fe, New Mexico, to Jay Land Ltd. Co. for $57.5 million in cash on March 17, 2026. This asset disposition represents a portfolio rationalization action by the REIT, which included customary pro-rations and adjustments at closing. The company has filed unaudited pro forma financial information reflecting the impact of this disposition on its financial position as of September 30, 2025 and for the year ended December 31, 2024. For investors, this sale represents a potential deleveraging opportunity and capital redeployment, though the overall materiality depends on the property's contribution to the company's total portfolio and financial metrics.
BATL
AMEX
▲ SUPER 8-K
Battalion Oil Corporation
EDGAR Items: 2.01,7.01,9.01
# Battalion Oil Corp 8-K Summary (March 19, 2026)
Battalion Oil Corporation completed an all-stock acquisition of approximately 7,090 net acres in Ward County, Texas from RoadRunner Resource Holding LLC, issuing 485,000 shares of common stock as consideration. The transaction closed on March 19, 2026 and was effective as of March 1, 2026, representing the company's expansion of its acreage position in the Permian Basin. This asset acquisition is subject to customary closing adjustments and was funded entirely through equity issuance rather than debt, which avoids balance sheet leverage but dilutes existing shareholders. For investors, the deal indicates management's confidence in the value of the Ward County assets and the company's growth strategy, though the equity dilution reduces ownership stakes for current shareholders.
AIB
AMEX
▲ SUPER 8-K
AIB Data Centers Inc.
EDGAR Items: 1.01,2.01,3.03,4.01,5.02,5.03,5.05,7.01,9.01
# SEC 8-K Summary: Blockchain Digital Infrastructure, Inc.
Blockchain Digital Infrastructure, Inc. (trading as AIB on NYSE American) completed a business combination on March 16, 2026, merging with Signing Day Sports, Inc. and One Blockchain LLC. Signing Day Sports shareholders received approximately 3.2 million BlockchAIn common shares at an exchange ratio of 0.09334 shares per Signing Day Sports share, while One Blockchain members received approximately 33.2 million shares. The transaction also includes performance-based earnout provisions where One Blockchain securityholders could receive up to an additional 3.9 million shares if 2026 EBITDA reaches $25 million, plus advisory shares issued to Maxim Group representing 3.5% of One Blockchain merger consideration. For investors, this combination significantly dilutes existing shareholders while creating substantial contingent equity obligations tied to future earnings performance.
GAMG
OTC
▲ SUPER 8-K
Global Asset Management Group, Inc.
EDGAR Items: 2.01,3.02,9.01
# SEC 8-K Summary: Global Asset Management Group, Inc.
On March 13, 2026, Global Asset Management Group, Inc. completed five share exchange agreements to acquire 100% ownership of specialized asset entities in exchange for approximately 35.8 million shares of common stock. The acquired portfolio includes industrial manufacturing facilities, health and wellness production infrastructure, and crucially, options to purchase Illinois cannabis craft grow, infuser, and transportation licenses contingent on federal rescheduling of cannabis products. The company positions itself to provide non-plant-touching services (real estate development, equipment rentals, brand development) to the cannabis industry while holding valuable state-licensed options exercisable for nominal $1.00 consideration over ten years. This transaction significantly dilutes existing shareholders through massive stock issuance but provides strategic positioning in the cannabis sector pending potential federal legalization, representing a speculative bet on industry expansion rather than immediate operational impact.
TRNR
NASDAQ
▲ SUPER 8-K
Interactive Strength Inc. Common Stock
EDGAR Items: 2.01,3.02,9.01
# SEC 8-K Filing Summary
Based on this March 16, 2026 8-K filing, the company completed a significant acquisition or disposition of assets (Item 2.01) and also conducted an unregistered sale of equity securities (Item 3.02) as of March 11, 2026. The filing indicates material corporate activity involving both asset transactions and equity issuance, though the specific details of the transaction, valuation, and terms would require reviewing the full document. For investors, this suggests strategic repositioning through M&A activity, though the unregistered equity sale indicates potential dilution to existing shareholders. **To fully assess the investment impact, investors should review the complete 8-K document to understand the transaction details, financing structure, and management's strategic rationale.**
ADTX
OTC
▲ SUPER 8-K
Aditxt, Inc.
EDGAR Items: 1.01,2.01,2.03,3.02,5.03,8.01,9.01
# Summary of Aditxt, Inc. Form 8-K Filing (March 10, 2026)
Aditxt, Inc. completed a significant acquisition of Ignite Proteomics, LLC from IMAC Holdings, Inc. in exchange for 36,000 shares of newly created Series A-2 Convertible Preferred Stock valued at $36 million plus $475,000 in cash. Simultaneously, the company secured $2.875 million in debt financing through 10% original issue discount promissory notes maturing in nine months at 6% interest (escalating to 12% upon default). The preferred shares are convertible into common stock at $2.731 per share, subject to a 9.99% ownership cap per investor.
**Investor Impact:** This transaction significantly dilutes existing shareholders through the substantial preferred stock issuance and introduces near-term refinancing risk given the nine-month note maturity. The conversion mechanism and the requirement for stockholder approval to adjust conversion prices if market conditions warrant creates uncertainty for equity holders. The company's ability to meet obligations is critical, as multiple default triggers (including delisting from Nasdaq or SEC filing failures) could accelerate the $2.875 million debt obligation.
PFSA
NASDAQ
▲ SUPER 8-K
Profusa, Inc. Common Stock
EDGAR Items: 1.02,2.01,3.01,9.01
# SEC 8-K Filing Summary - ProFUSA Inc. (March 13, 2026)
ProFUSA Inc. reported three material events: **(1) Termination of a Material Definitive Agreement** - the company terminated an Account Control Agreement with Ascent Partners on March 12, 2026; **(2) Completion of Acquisition or Disposition of Assets** - indicating the company has divested or completed a significant asset transaction; and **(3) Delisting Notice** - the company faces potential delisting or transfer of its listing status, suggesting compliance issues with continued listing standards.
**For investors:** These combined events signal potential financial distress or a major strategic restructuring. The loss of the control agreement with Ascent Partners, coupled with asset dispositions and delisting concerns, suggests the company may be addressing liquidity challenges or undergoing a significant business transition. Investors should review the full filing details to understand the implications for ownership and shareholder value.
LSF
AMEX
▲ SUPER 8-K
Laird Superfood, Inc.
EDGAR Items: 1.01,2.01,3.02,3.03,5.01,5.02,5.03,5.07,7.01,9.01
# Laird Superfood, Inc. - 8-K Summary
On March 12, 2026, Laird Superfood completed its $38.5 million acquisition of Navitas LLC and Global Superfoods Corp., funded primarily through a concurrent $50 million private placement of Series A Preferred Stock to Nexus Capital Management affiliates. The company also entered into a Registration Rights Agreement giving Nexus the ability to require registration of conversion shares and conduct underwritten offerings, with customary demand and piggyback registration rights. Additionally, Nexus has an option to purchase up to 60,000 additional Series A Preferred shares at $1,000 per share (up to $60 million) through 270-360 days post-closing for strategic acquisitions, providing the company with significant capital for future growth but diluting existing shareholders. This transaction substantially expands Laird Superfood's product portfolio while creating a significant new investor with meaningful governance rights and future funding availability.
IDAI
NASDAQ
▲ SUPER 8-K
T Stamp Inc. Class A Common Stock
EDGAR Items: 1.01,2.01,5.02,7.01,9.01
# SEC 8-K Filing Summary
Based on this March 12, 2026 8-K filing (for events occurring March 6, 2026), the company has announced **multiple material events**: completion of an acquisition or disposition of assets, entry into a material definitive agreement, and officer/director changes with new compensatory arrangements. The filing includes a share purchase agreement, shareholder agreement, and consulting agreement as exhibits, indicating a significant M&A transaction has closed.
**Key implications for investors**: This represents a potentially transformative corporate event—likely an acquisition or major asset sale—that may alter the company's business structure, financial profile, and management. Investors should review the full agreements (Exhibits 10.1-10.3) and disclosure documents to understand deal terms, consideration paid, and any new strategic direction or leadership changes that could impact future performance and shareholder value.
GRML
NASDAQ
▲ SUPER 8-K
Greenland Mines Ltd. Common Stock
EDGAR Items: 1.01,2.01,3.02,5.03,9.01
# SEC 8-K Filing Summary: Klotho (CIK: 1907223)
**Filing Date:** March 10, 2026 | **Period:** March 4, 2026
## Key Material Events:
Klotho announced multiple significant corporate transactions including: (1) entry into a material definitive agreement, (2) completion of an acquisition or asset disposition, (3) unregistered equity issuance, and (4) amendments to articles of incorporation. The filing includes an Agreement and Plan of Merger and a Subscription, Joint Venture and Option Agreement, along with a new Series C Preferred Stock designation.
## Investor Implications:
These concurrent filings suggest Klotho is undergoing a major strategic restructuring involving merger activity, new equity issuance, and joint venture arrangements. The combination of structural changes and equity dilution (unregistered securities) warrants careful review of the merger terms and new capital structure to assess valuation impact and ownership dilution. Investors should review the detailed merger agreement and subscription documents to understand the financial terms and strategic rationale.
AHT
NYSE
▲ SUPER 8-K
Ashford Hospitality Trust, Inc.
EDGAR Items: 2.01
# Summary of Ashford Hospitality Trust 8-K Filing
Ashford Hospitality Trust completed the sale of the Hilton St. Petersburg Bayfront hotel in Florida on March 5, 2026, to Kolter Group Acquisitions LLC for $96 million in cash. This asset disposition represents a strategic reduction of the company's real estate portfolio and will impact both the company's balance sheet and ongoing revenue-generating capacity. The transaction was executed pursuant to an agreement dated December 12, 2025, and included standard pro-rations and adjustments. The company has provided unaudited pro forma financial information reflecting the impact of this sale on its financial position as of September 30, 2025, and for the year ended December 31, 2024.
IVFH
OTC
▲ SUPER 8-K
INNOVATIVE FOOD HOLDINGS INC
EDGAR Items: 2.01
# SEC 8-K Filing Summary
**Company & Filing Details:**
This 8-K was filed on March 9, 2026, by a company (CIK 312257) reporting a material event from March 6, 2026.
**Material Event - Item 2.01: Completion of Acquisition or Disposition of Assets**
The company completed an acquisition or disposition of assets, representing a significant corporate transaction. While the specific details of the assets, valuation, and counterparty are not visible in this document header, this is a material event that required immediate disclosure to shareholders.
**Investor Implications:**
This acquisition/disposition could materially impact the company's financial position, operational structure, and future earnings potential. Investors should review the full 8-K filing document (available via the linked iXBRL file) to understand the transaction's financial terms, strategic rationale, and potential effects on shareholder value. The timing and nature of such transactions often influence stock price movements and warrant careful analysis.
GAMG
OTC
▲ SUPER 8-K
Global Asset Management Group, Inc.
EDGAR Items: 2.01,9.01
# SEC 8-K Summary: Global Asset Management Group, Inc.
Global Asset Management Group, Inc. completed the acquisition of AMT Management LLC on March 4, 2026, paying 200,000 shares of common stock for 100% ownership of the Washington, D.C.-based property management company. The acquisition is designed to vertically integrate GAMG's real estate operations by bringing property management in-house, which management expects will improve operational efficiencies and support long-term asset value creation. Michael Taylor has been appointed as Owner's Representative and Manager of AMT, with compensation structured entirely through Non-Qualified Stock Options (NQSOs) over a five-year initial term, aligning executive pay with shareholder interests and company growth. For investors, this represents a significant strategic shift toward operational integration but involves dilution from the 200,000 new shares issued, with financial impact dependent on AMT's management performance and the company's ability to execute its vertically integrated real estate strategy.
HWNI
OTC
▲ SUPER 8-K
HIGH WIRE NETWORKS, INC.
EDGAR Items: 1.01,2.01,3.02,5.01,5.02,9.01
# SEC 8-K Filing Summary
**Company & Filing Details:** HighWire (CIK: 1413891) filed an 8-K on March 6, 2026, reporting material corporate events as of March 3, 2026.
**Key Material Events:**
The filing discloses a **change in control of the company** along with a **material acquisition/disposition of assets** and an associated **securities exchange agreement**. Additionally, there was a **global settlement and mutual release agreement** executed, and changes in the company's board or officer compensation arrangements occurred.
**Investor Implications:**
This combination of items—particularly the change of control, asset transaction, and settlement agreement—suggests HighWire underwent a significant corporate restructuring or merger/acquisition that may substantially alter its business operations, ownership structure, and strategic direction. Investors should carefully review the full filing documents, especially the Securities Exchange Agreement and Settlement Agreement exhibits, to understand the transaction terms, dilution impacts, and any contingent liabilities resolved. The management changes disclosed could also signal shifts in company strategy or leadership priorities.
CAMP
NASDAQ
▲ SUPER 8-K
CAMP4 Therapeutics Corporation Common Stock
EDGAR Items: 2.01,7.01,9.01
# SEC 8-K Filing Summary
Based on this March 5, 2026 8-K filing, **the company completed an acquisition or disposition of assets** (Item 2.01), which represents a material corporate event. The filing includes supplemental disclosures (Item 7.01) and financial statements/exhibits documenting the transaction details across 36 supporting documents.
**For investors, this signals a strategic business development**, though the specific nature, size, and financial impact of the acquisition/disposition cannot be determined from this filing summary alone—these details would be found in the actual 8-K document and exhibits. Investors should review the full filing to understand how this transaction affects the company's future growth prospects, financial position, and strategic direction.
IDAI
NASDAQ
▲ SUPER 8-K
T Stamp Inc. Class A Common Stock
EDGAR Items: 1.01,2.01,9.01
# SEC 8-K Filing Summary
**Company & Filing Details:** This 8-K was filed on March 5, 2026 (for the period ending February 27, 2026) by a company with CIK 1718939, covering three material items.
**Key Material Events:** The filing discloses two significant corporate actions: (1) entry into a material definitive agreement (Item 1.01), and (2) completion of an acquisition or disposition of assets (Item 2.01). The specific terms and details are contained in Exhibit 10.1, which appears to be a substantial agreement document.
**Investor Implications:** The simultaneous reporting of both a new material agreement and a completed acquisition suggests the company has engaged in significant M&A activity or strategic business restructuring. Investors should review the full agreement in Exhibit 10.1 to understand the financial impact, any potential dilution, debt obligations, or changes to the company's business operations that could affect future earnings and shareholder value.
HAIN
NASDAQ
▲ SUPER 8-K
Hain Celestial Group Inc
EDGAR Items: 2.01,7.01,9.01
# SEC 8-K Filing Summary: The Hain Celestial Group (March 4, 2026)
The Hain Celestial Group completed a significant acquisition or disposition of assets as of March 2, 2026, which is the primary material event disclosed in this Form 8-K filing. The filing includes Item 2.01 (Completion of Acquisition or Disposition of Assets), supplemented by Regulation FD disclosures and financial statements, though specific transaction details are not visible in this cover page excerpt. Investors should review the full 8-K document (hain-20260227.htm) and attached exhibits to understand the transaction's financial impact, purchase price, strategic rationale, and any pro forma financial effects on The Hain Celestial Group's future earnings and balance sheet.
SITC
NYSE
▲ SUPER 8-K
SITE Centers Corp. Common Shares
EDGAR Items: 2.01
# SEC 8-K Summary: SITE Centers Corp.
SITE Centers Corp. completed the sale of its interest in the 3030 North Broadway property located in Chicago, Illinois on March 3, 2026, generating $50.1 million in cash proceeds (subject to closing adjustments). This asset disposition represents a capital-generating transaction that will provide liquidity to the real estate investment trust. The sale demonstrates SITE Centers' ongoing portfolio optimization strategy and may be used for debt reduction, reinvestment in higher-performing assets, or distributions to shareholders. Investors should monitor the company's use of proceeds and any impact on future earnings guidance or dividend sustainability.
IVHI
OTC
▲ SUPER 8-K
Invech Holdings, Inc.
EDGAR Items: 1.01,2.01,9.01
# SEC 8-K Filing Summary
**InVivo Technologies** filed an 8-K on March 4, 2026, reporting two material events: (1) entry into a material definitive agreement and (2) completion of an acquisition or disposition of assets. The filing includes an Asset Purchase Agreement and a Convertible Promissory Note as key exhibits, indicating the company has either acquired or divested significant assets and secured financing through a convertible debt instrument. Without access to the detailed agreement text, the specific transaction terms, valuation, and strategic rationale remain unclear, but investors should note that convertible debt can dilute existing shareholders upon conversion. This appears to be a significant corporate transaction that could materially impact the company's capital structure, financial position, and strategic direction, warranting careful review of the complete filing documents.
KSCP
NASDAQ
▲ SUPER 8-K
Knightscope, Inc. Class A Common Stock
EDGAR Items: 1.01,2.01,3.02,8.01,9.01
# SEC 8-K Filing Summary
**Filing Details:** This 8-K was filed on March 3, 2026, by a company (CIK 1600983) reporting material events as of February 27, 2026.
**Material Events:**
The filing indicates multiple significant corporate actions including:
- **Entry into a Material Definitive Agreement** (Item 1.01)
- **Completion of an Acquisition or Disposition of Assets** (Item 2.01)
- **Unregistered Sales of Equity Securities** (Item 3.02)
**Key Implications for Investors:**
This 8-K signals that the company has completed a significant M&A transaction and issued equity securities, likely as part of the deal consideration. The combination of acquisition completion and equity issuance suggests potential dilution to existing shareholders. Investors should review the detailed agreement (Exhibit 2.1) and press release (Exhibit 99.1) to understand the transaction terms, valuation, and strategic rationale. The unregistered equity sale raises questions about the shareholder base composition changes and any lock-up periods on new securities.
KOS
NYSE
▲ SUPER 8-K
Kosmos Energy Ltd.
EDGAR Items: 2.01,7.01,9.01
# Summary of Kosmos Energy Ltd. 8-K Filing (March 2, 2026)
Kosmos Energy Ltd. filed an 8-K on March 2, 2026 to disclose its financial results for the fourth quarter and full year ended December 31, 2025. The filing references a news release (Exhibit 99.1) containing the company's operational and financial results, though the specific metrics and performance details are not included in the 8-K document itself. This is a routine earnings disclosure filing for the oil and gas exploration and production company, which trades on the New York Stock Exchange and London Stock Exchange under ticker KOS. Investors should review the attached news release for details on production volumes, revenue, profitability, capital expenditures, and management guidance that would inform investment decisions.
BRR
NASDAQ
▲ SUPER 8-K
ProCap Financial, Inc. Common Stock
EDGAR Items: 2.01,9.01
# 8-K Summary
Based on this SEC filing from February 27, 2026, the company (CIK 2076163) completed an acquisition or disposition of assets, which is the material event disclosed in this Form 8-K. The filing indicates Item 2.01 was triggered, signaling a significant corporate transaction. However, the specific details of the acquisition—including the target company, transaction value, and strategic rationale—are contained in the full form8-k.htm document referenced in this index.
**For investors:** This represents a material corporate action that could affect the company's capital structure, operational scope, and financial performance. Without access to the detailed disclosure, investors should review the complete 8-K filing to understand the transaction's size, financing, expected synergies, and impact on earnings and guidance. Such transactions typically warrant portfolio review to assess alignment with investment thesis.
TLRY
NASDAQ
▲ SUPER 8-K
Tilray Brands, Inc. Common Stock
EDGAR Items: 1.01,2.01,8.01,9.01
# Summary of Tilray Brands 8-K Filing
Tilray Brands completed the acquisition of BrewDog's business operations and assets through a pre-packaged administration process in Scotland on March 2, 2026, for approximately ÂŁ33 million ($44.1 million USD). The acquisition includes BrewDog's Scottish brewery in Ellon, 11 strategic brewpubs across Scotland, England and Ireland, the online and retail businesses, and all intellectual property rights to the BrewDog brand and its sub-brands (Punk IPA, Hazy Jane, Elvis Juice, etc.). Tilray UK, a wholly-owned subsidiary, assumed substantially all acquired assets and operations while predecessor liabilities remained with the BrewDog Group under the administration process. This transaction represents a significant expansion of Tilray's beverage portfolio beyond cannabis into the established beer market through an established European brand portfolio.
February 2026
28 filings
▼
BATL
AMEX
▲ SUPER 8-K
Battalion Oil Corporation
EDGAR Items: 1.01,2.01,9.01
# Battalion Oil Corp 8-K Summary (February 24, 2026)
Battalion Oil completed the sale of its West Quito Assets in the Delaware Basin for approximately $60.1 million, representing 12.4% of its year-end 2024 proved reserves. The company simultaneously amended its credit agreement with lenders to permit this transaction and obligated itself to use $40 million of the sale proceeds for mandatory debt prepayment, with remaining proceeds available for reinvestment and general corporate purposes. This asset sale reduces Battalion's reserve base but meaningfully improves its liquidity and debt position, with the forced debt paydown strengthening the company's leverage ratios and financial flexibility going forward.
CCTC
OTC
▲ SUPER 8-K
LataMed AI Corp.
EDGAR Items: 1.01,2.01,3.02,5.01,5.02,5.06,9.01
# SEC 8-K Filing Summary
This 8-K filing from February 25, 2026 (for period ending February 17, 2026) reports multiple material corporate events for the company (ticker: CCTC). The filing indicates a significant **acquisition or asset purchase transaction**, evidenced by Items 1.01 (material agreement), 2.01 (asset completion), and 3.02 (equity issuance), along with a **change in control of the registrant** (Item 5.01). Additionally, the company underwent a **shell company status change** (Item 5.06) and experienced **management changes** with departures/appointments of directors and officers (Item 5.02), suggesting a potential reverse merger or transformational business combination.
**For investors:** This represents a major structural shift for the company. The combination of control change, asset acquisition completion, equity issuance, and shell company status change suggests the company either emerged from shell status or underwent significant recapitalization. The accompanying intellectual property and asset purchase agreements indicate the transaction involves material business operations. Investors should review the full 8-K and attached agreements to understand valuation, dilution, and how the new business aligns with their investment thesis.
LMEDD
OTC
▲ SUPER 8-K
LataMed AI Corp.
EDGAR Items: 1.01,2.01,3.02,5.01,5.02,5.06,9.01
# SEC 8-K Summary: Catalyst Crew Technologies Corp.
**Catalyst Crew Technologies Corp. completed a change of control transaction on February 17, 2026, acquiring AI-driven healthcare analytics and telehealth platforms from sole director Kevin Rodan Levy in exchange for 12 million restricted common shares, transitioning the company from a shell company to an operating digital health technology business.** The company issued restricted stock at par value ($0.0001/share) with no assumed liabilities, and plans to file for a corporate name and trading symbol change pending board and regulatory approval. As a shell company that has now acquired operating assets, the company is providing Form 10 disclosures required for non-shell companies. The transaction is a related-party deal requiring careful investor scrutiny given that the seller is also the company's sole director and executive officer. Key investor risks include the company's lack of operating history and revenue, ongoing capital needs, regulatory uncertainties, unproven AI model performance, and significant competition in the crowded digital health sector.
LMED
OTC
▲ SUPER 8-K
LataMed AI Corp.
EDGAR Items: 1.01,2.01,3.02,5.01,5.02,5.06,9.01
# Summary of Catalyst Crew Technologies Corp. 8-K Filing
Catalyst Crew Technologies Corp. completed an asset acquisition on February 17, 2026, acquiring artificial intelligence-based healthcare analytics and technology-enabled medical services platforms from Kevin Rodan Levy (the company's sole director and executive officer) in exchange for 12 million restricted common shares. The company has transitioned from a shell company to an operating digital health technology company and plans to change its corporate name and trading symbol, subject to board and regulatory approval. This related-party transaction is material to the company's operations and represents a significant strategic pivot toward the healthcare technology sector. Key investor risks include the company's lack of operating history and revenue, dependence on future capital raises, regulatory compliance uncertainties, AI model validation challenges, and competitive pressures in the digital health market.
CRDF
NASDAQ
▲ SUPER 8-K
Cardiff Oncology, Inc. Common Stock
EDGAR Items: 2.01,9.01
# 8-K Filing Summary - CardioFlow Inc. (CIK: 1213037)
**Filing Date:** February 24, 2026
This 8-K filing reports the **completion of an acquisition or disposition of assets** (Item 2.01), indicating CardioFlow has either acquired or divested a significant business asset or subsidiary. The filing includes supplementary financial statements and exhibits (Item 9.01) to detail the transaction's terms and financial impact.
**Key Implications for Investors:**
- The completion of this M&A transaction represents a material corporate restructuring that could alter the company's business profile, revenue streams, and growth trajectory
- Investors should review the full 8-K document and attached exhibits to understand acquisition/divestiture details, purchase price, financing terms, and any associated risks or synergies
- Depending on whether this was an acquisition (expanding operations) or divestiture (streamlining operations), this could signal management's strategic direction and capital allocation priorities
Without access to the detailed filing content, investors should examine the exhibits closely to assess the transaction's financial materiality and strategic rationale.
PTIX
OTC
▲ SUPER 8-K
Protagenic Therapeutics, Inc.\new
EDGAR Items: 1.01,1.02,2.01,3.02,8.01,9.01
I appreciate your request, but I'm unable to provide a meaningful summary of this 8-K filing based on the HTML provided. The document shown is only the **filing index page** from the SEC's EDGAR system, which displays metadata (filing date, accession number, item categories) but not the actual content of the filing.
To summarize this 8-K properly, I would need access to the actual filing document itself (form8-k.htm or the exhibits). The index indicates this filing covers several significant items including:
- **Item 1.01 & 1.02**: Entry into and termination of material agreements
- **Item 2.01**: Completion of acquisition/disposition of assets
- **Item 3.02**: Unregistered equity sales
- **Item 8.01**: Other events
**What I can tell you:** This is a material filing with multiple significant corporate actions (acquisitions, agreements, equity issuance) filed on February 24, 2026, but the specific details, dollar amounts, and investor implications require reviewing the actual filing documents.
**Recommendation:** Click the "form8-k.htm" link in the document table to view the full filing content, and I'd be happy to summarize it then.
IVF
NASDAQ
▲ SUPER 8-K
INVO Fertility, Inc. Common Stock
EDGAR Items: 1.01,2.01,3.02,5.03,8.01,9.01
# 8-K Filing Summary
Based on this SEC 8-K filing dated February 24, 2026, the company has disclosed several material events:
**Key Changes & Events:**
The filing indicates completion of a significant acquisition or disposition of assets (Item 2.01), entry into material definitive agreements (Item 1.01), and unregistered equity issuances (Item 3.02). Additionally, the company amended its articles of incorporation or bylaws (Item 5.03), suggesting potential structural or governance changes.
**Investor Implications:**
This multi-item filing signals a major corporate transaction—likely an acquisition, merger, or substantial asset sale—coupled with equity dilution from unregistered securities issuance. The amendments to corporate governance documents indicate this transaction may have reshaped the company's capital structure or ownership composition. Investors should review the attached exhibits (particularly EX-10.1 through EX-10.4, which contain the definitive agreements) to understand deal terms, financing structure, and potential impacts on earnings and shareholder value.
GIPR
NASDAQ
▲ SUPER 8-K
Generation Income Properties Inc. Common Stock
EDGAR Items: 2.01
# SEC 8-K Filing Summary
**Company & Filing Details:**
This is an 8-K filing from GIPR (CIK: 1651721) filed on February 23, 2026, reporting on a material event from May 29, 2025.
**Material Event:**
The filing reports the completion of an acquisition or disposition of assets (Item 2.01), with 19 supporting documents including purchase agreements and related transaction documents attached as exhibits.
**Key Implications for Investors:**
Without access to the actual filing content, the completion of this acquisition represents a significant corporate action that likely involves strategic repositioning, potential changes to the company's asset base, revenue streams, or business operations. Investors should review the detailed exhibits (particularly EX-10.1 and EX-10.2, which appear to be substantial transaction documents) to understand the deal terms, valuation, financing structure, and expected impacts on future financial performance and shareholder value.
AETN
OTC
▲ SUPER 8-K
AETERNUM HEALTH, INC.
EDGAR Items: 2.01,3.02,5.01,5.02,5.03,9.01
# SEC 8-K Filing Summary
**Filing:** Form 8-K for company CIK 764630, filed February 23, 2026
**Material Events:**
This filing reports several significant corporate actions: (1) completion of an acquisition or disposition of assets, (2) unregistered sales of equity securities, (3) a change in control of the registrant, (4) changes in the company's board and officer compensation arrangements, and (5) amendments to the company's articles of incorporation or bylaws.
**Key Implications for Investors:**
The combination of these items—particularly the change in control, asset acquisition/disposition, and equity issuance—indicates a major corporate restructuring or M&A transaction. The unregistered equity sales and board changes suggest new ownership/management post-transaction. Investors should review the attached acquisition agreement (EX-2.1) and detailed 8-K filing to understand the transaction terms, deal structure, and potential impacts on share value and control.
**Recommendation:** Review the complete filing documents (form8-k.htm and merger agreement) for full details on pricing, dilution, and governance implications.
SEGG
NASDAQ
▲ SUPER 8-K
Sports Entertainment Gaming Global Corporation Common Stock
EDGAR Items: 1.01,2.01
# SEC 8-K Filing Summary
**Company & Filing Details:**
This 8-K was filed on February 23, 2026 (CIK: 1673481) for the period ending February 17, 2026, covering two material events.
**Key Material Events:**
The filing reports two significant corporate actions: (1) **Entry into a Material Definitive Agreement** (Item 1.01) and (2) **Completion of an Acquisition or Disposition of Assets** (Item 2.01). These dual disclosures suggest the company has both signed a major deal and already closed a transaction involving asset acquisition or divestiture.
**Investor Implications:**
Without access to the full document content, the specific details cannot be determined from this index page alone. However, the concurrent reporting of both a new agreement and a completed transaction suggests active M&A activity. Investors should review the complete 8-K filing (form8-k.htm) to understand: the nature of the transaction, financial impact, strategic rationale, and any contingent obligations or risks that could affect shareholder value.
ALBT
NASDAQ
▲ SUPER 8-K
Avalon GloboCare Corp. Common Stock
EDGAR Items: 1.01,2.01,9.01
# SEC 8-K Summary: Avalon Holdings Corporation
**Filing Date:** February 19, 2026 | **Period:** February 18, 2026
Avalon Holdings Corporation completed a material acquisition and entered into a definitive agreement on February 18, 2026, as detailed in this 8-K filing. The company amended an unsecured bridge note dated December 11, 2025, and executed an amended and restated membership interest purchase agreement, indicating refinancing or restructuring of the transaction financing.
**Key Implications for Investors:** This filing suggests Avalon is actively pursuing growth through acquisition while managing debt obligations. The amendment to the bridge note may indicate negotiated changes to financing terms, which could affect the company's capital structure and debt burden. Investors should review the complete purchase agreement and note amendment documents to understand deal terms, valuation, expected synergies, and any impact on near-term financial performance or shareholder equity.
CHGA
NASDAQ
▲ SUPER 8-K
Change Agents Corporation Common Stock
EDGAR Items: 1.01,2.01,9.01
# SEC 8-K Summary: Avalon Globocare Corp.
On February 18, 2026, Avalon Globocare Corp. completed the sale of 100% of its subsidiary Avalon RT9 Properties, LLC (owner of its Freehold, New Jersey headquarters) to Chairman Wenzhao Lu for $9 million total consideration—comprising $3.1 million in cash already advanced plus assumption of approximately $5.9 million in mortgage debt. This transaction eliminates the company's mortgage guarantee obligations on the property and represents a material asset disposition that fundamentally changes the company's real estate position and liability structure. Additionally, the company amended an unsecured bridge note dated December 11, 2025 (originally $375,000), extending payment deadlines by one month each (now due March, April, and May 2026), indicating potential liquidity pressures. For investors, the sale of the headquarters property raises questions about operational continuity at the company's principal office, while the bridge note amendment suggests ongoing cash flow challenges.
AHT
NYSE
▲ SUPER 8-K
Ashford Hospitality Trust, Inc.
EDGAR Items: 2.01,9.01
# Ashford Hospitality Trust 8-K Summary
Ashford Hospitality Trust completed the sale of the Embassy Suites Houston Near the Galleria property on February 9, 2026, for $13.5 million in cash to Galleria Lodging, LP and Arboretum Lodging. This asset disposition represents a continued portfolio rationalization strategy for the REIT, though the modest sale price suggests potential challenges in the hospitality market or the property's condition. The company provided pro forma financial information reflecting the impact of this transaction on results for the nine months ended September 30, 2025, and the full year 2024. For investors, this sale generates liquidity but also reduces the company's revenue-generating asset base, with the ultimate impact on shareholder value depending on Ashford's use of proceeds and overall portfolio quality.
BURU
AMEX
▲ SUPER 8-K
Nuburu, Inc.
EDGAR Items: 1.01,2.01,2.03,3.02
# Summary of Nuburu, Inc. 8-K Filing (February 6, 2026)
Nuburu announced three material transactions aimed at building its Defense & Security Platform and addressing NYSE listing compliance issues. The company acquired approximately 0.8% of Heckler & Koch AG (a NATO firearms manufacturer) for $15 million via a subordinated convertible note, and exchanged 844,938 shares of Series A Preferred Stock with Indigo Capital LP for a pre-funded warrant representing 55.7 million common shares exercisable at $0.0001. Additionally, Nuburu amended its related-party acquisition of Orbit S.r.l. from CEO Alessandro Zamboni to issue 50 million common shares instead of preferred shares as consideration, subject to stockholder approval. These transactions significantly increase share dilution and reflect the company's efforts to regain compliance with NYSE stockholder equity requirements, though the massive warrant and share issuance pose substantial downside risk to existing shareholders through potential ownership dilution.
AQMS
NASDAQ
▲ SUPER 8-K
Aqua Metals, Inc. Common Stock
EDGAR Items: 1.01,2.01,8.01,9.01
# SEC 8-K Filing Summary
**Company & Filing Details:**
This 8-K was filed on February 11, 2026, by Aquamarine Technologies (CIK: 1621832), reporting events as of February 6, 2026.
**Material Events:**
The filing discloses two significant corporate actions: (1) **Entry into a Material Definitive Agreement** (Item 1.01) and (2) **Completion of an Acquisition or Disposition of Assets** (Item 2.01). The company has also attached substantive exhibits including an agreement document and underwriting-related materials, suggesting either a significant acquisition, divestiture, or financing transaction.
**Investor Implications:**
Without access to the full document text, the specific nature of the transaction cannot be determined from the filing structure alone. However, the presence of both a definitive agreement and completion disclosure indicates this was an already-executed material transaction. Investors should review the full 8-K document and attached exhibits (particularly Exhibits 1.1 and 10.1) to understand the financial impact, terms, and strategic rationale for this transaction, as it could materially affect the company's financial position and future prospects.
CETX
NASDAQ
▲ SUPER 8-K
CEMTREX INC.
EDGAR Items: 2.01,8.01,9.01
# SEC 8-K Filing Summary
Based on the filing metadata dated February 11, 2026, this 8-K reports the **completion of an acquisition or disposition of assets** (Item 2.01), with the transaction period ending February 5, 2026. The filing includes a purchase agreement (EX-2.1), related agreements (EX-10.1), and a press release (EX-99.1), though the specific details of the deal are not visible in this document index.
**Key implications for investors:** This material transaction signals a significant strategic shift for the company. Investors should review the complete agreement and press release to understand the acquisition target/divested asset, purchase price, financing structure, and management's rationale. The deal's impact on future earnings, debt levels, and company direction will be critical to assessing whether this creates or destroys shareholder value.
LRHC
NASDAQ
▲ SUPER 8-K
La Rosa Holding Corp. Common Stock
EDGAR Items: 1.01,2.01,9.01
# SEC 8-K Filing Summary
**LaRosa Holdings Corp.** filed an 8-K on February 10, 2026, announcing a material acquisition and establishment of licensing agreements. The company entered into a Membership Interest Purchase Agreement to acquire assets from Horeb Kissimmee Realty and simultaneously established a Trademark and Brand Licensing Agreement with the same party, indicating a strategic expansion of the LaRosa brand.
**Key implications for investors:** This acquisition suggests the company is pursuing growth through asset purchases and brand extension, though the specific financial terms and strategic rationale would require review of the actual agreement documents. The timing and structure—pairing an asset acquisition with a licensing agreement—suggests a phased or partnership-based expansion strategy rather than a full integration.
PHGE
AMEX
▲ SUPER 8-K
BiomX Inc.
EDGAR Items: 2.01,5.02,9.01
# BiomX Inc. (PHGE) 8-K Summary
BiomX Inc. has undergone a significant restructuring following its Israeli subsidiary BiomX Ltd.'s entry into insolvency proceedings in the Central District Court in Lod, Israel on January 25, 2026, with a court-appointed trustee taking control. On February 4, 2026, the trustee terminated the roles of BiomX Ltd.'s Chief Executive Officer and Chief Financial Officer, constituting a change of control that requires the company to deconsolidate BiomX Ltd. from its consolidated financial statements—a disposition of significant assets. The three terminated officers (Jonathan Solomon, Marina Wolfson, and Merav Bassan) will receive severance payments ranging from six to nine months while retaining their positions at the parent company BiomX Inc., which trades on NYSE American under ticker PHGE. This restructuring materially alters the company's financial reporting and likely signals operational challenges at its Israeli operations, with investors now seeing only the remaining parent company operations reflected in future consolidated financials.
BRR
NASDAQ
▲ SUPER 8-K
ProCap Financial, Inc. Common Stock
EDGAR Items: 1.01,2.01,3.02,5.02,7.01,8.01,9.01
# SEC 8-K Filing Summary
Based on this February 9, 2026 8-K filing, the company disclosed **multiple significant corporate events**, including the completion of an acquisition or disposition of assets, entry into material definitive agreements, unregistered equity issuances, and management/compensation changes. The filing contains seven key disclosure items with substantial supporting documentation (24 total exhibits), including a merger/acquisition agreement (EX-2.1) and several material contracts (EX-10.1 through EX-10.6).
**Key implications for investors:** This is a comprehensive transaction announcement affecting the company's capital structure, leadership, and strategic direction. The mix of items—particularly the acquisition completion, equity issuances, and officer compensation arrangements—suggests a transformative deal. Investors should review the detailed agreements (especially the purchase agreement and employment/compensation contracts in the exhibits) to understand valuation, earnout provisions, dilution impact, and new management incentives, as these will directly affect shareholder value and future company direction.
CWGL
OTC
▲ SUPER 8-K
Crimson Wine Group, Ltd
EDGAR Items: 1.01,2.01,7.01,9.01
# SEC 8-K Filing Summary
**Company & Filing:** Crimson Wine Group (CWGL) filed an 8-K on February 9, 2026, reporting a significant corporate transaction.
**Material Events:**
The filing discloses the completion of an acquisition or disposition of assets (Item 2.01) and entry into a material definitive agreement (Item 1.01), with a press release included as Regulation FD Disclosure (Item 7.01). The specific details appear to involve "Crimson Wine Extra" based on the exhibit filenames, suggesting the company has either acquired or divested a wine-related asset or business line.
**Investor Implications:**
Without access to the actual filing content, the full impact cannot be assessed, but the multiple items filed indicate this is a substantial transaction that could affect the company's operational scope, financial position, or strategic direction. Investors should review the complete 8-K and press release (Exhibit 99.1) to understand the transaction structure, financial terms, and management's rationale for the deal.
TPST
NASDAQ
▲ SUPER 8-K
Tempest Therapeutics, Inc. Common Stock
EDGAR Items: 1.01,2.01,3.02,5.01,5.02,9.01
# Tempest Therapeutics, Inc. (TPST) - 8-K Summary
Tempest Therapeutics completed a material asset acquisition on February 3, 2026, acquiring four CAR T-cell therapy programs (ERI-2003, ERI-2206, ERI-3003, and ERI-3206) from Erigen LLC and Factor Bioscience Inc. in exchange for 8,268,495 shares of common stock, resulting in a **change of control** where Erigen's members now own approximately 61.3% of the company immediately post-closing (expected to decline to ~35.9%-25.5% after concurrent distributions). Concurrently, the company issued 6,784,989 warrants as a dividend to shareholders with an $18.48 exercise price expiring in February 2031, contingent upon filing an effective registration statement. Significant board changes occurred with the resignation of director Geoff Nichol and the apparent departure of Chair Michael Raab, though the filing text appears incomplete regarding Raab's status.
**Investor Impact:** This transaction substantially dilutes existing shareholders' ownership stakes and introduces substantial dilution risk from warrant exercises, while the change of control signals a strategic pivot toward cellular immunotherapy. The unregistered share issuance and warrant structure create timing and execution risks around the registration statement filing.
ELAB
NASDAQ
▲ SUPER 8-K
PMGC Holdings Inc. Common Stock
EDGAR Items: 2.01,8.01,9.01
# SEC 8-K Summary: PMGC Holdings Inc. - Acquisition Completion
**Filing Details:** PMGC Holdings Inc. filed an 8-K on February 6, 2026, reporting the completion of an acquisition of assets as of February 2, 2026.
**Material Event:** The company completed the acquisition of SVM Machining, Inc., as evidenced by the executed Stock Purchase Agreement dated February 2, 2026. The filing includes audited combined financial statements for SVM Machining and unaudited pro forma condensed combined financial statements showing the integrated entity's financial position post-acquisition.
**Key Implications for Investors:** This acquisition marks a significant expansion of PMGC Holdings' operations into the machining sector. The inclusion of pro forma financial statements suggests material changes to the company's balance sheet and operating profile. Investors should review the detailed purchase agreement and pro forma financials to understand the acquisition cost, integration strategy, and expected earnings impact, as well as any financing arrangements or contingent obligations related to the transaction.
MSS
NASDAQ
▲ SUPER 8-K
Maison Solutions Inc. Class A Common Stock
EDGAR Items: 1.01,2.01,9.01
# SEC 8-K Filing Summary: Maison Solutions, Inc.
**Filing Date:** February 4, 2026 | **Period:** January 31, 2026
Maison Solutions, Inc. reported the entry into a material definitive agreement and completion of an acquisition or disposition of assets as of January 31, 2026. The company executed a Buy-Sell Agreement on this date, indicating a significant corporate transaction. The filing includes the full agreement text and supporting documentation, though the specific financial terms and counterparty details require review of the actual agreement document.
**For Investors:** This filing signals a material corporate event that could substantially impact the company's operations, financial position, or strategic direction. Investors should review the complete Buy-Sell Agreement (available in the filing) to understand the transaction's scope, financial implications, earn-out provisions (if any), and how it aligns with the company's growth strategy. The nature of this agreement—whether it represents an acquisition, divestiture, or partnership—will be critical in assessing the investment implications.
MVIS
NASDAQ
▲ SUPER 8-K
Microvision Inc
EDGAR Items: 2.01,9.01
# SEC 8-K Filing Summary: MVIS (February 3, 2026)
**Material Event:** MicroVision (MVIS) announced the completion of an acquisition or disposition of assets on February 3, 2026, as disclosed in Item 2.01 of this 8-K filing.
**Key Details:** The filing itself does not provide the specific details of the transaction in this preview, but the company has officially completed a significant asset transaction that warrants SEC disclosure as a material event.
**Investor Implications:** This acquisition or asset sale could represent a strategic shift for the company, potentially affecting its business operations, financial position, and future revenue streams. Investors should review the full 8-K document (form8-k.htm) to understand the transaction terms, whether it expands or contracts the company's operations, the financial impact, and management's strategic rationale for the move.
NTRP
NASDAQ
▲ SUPER 8-K
NextTrip, Inc. Common Stock
EDGAR Items: 1.01,2.01,3.02,7.01,9.01
# SEC 8-K Filing Summary
**Company & Filing:** Entered into a Material Definitive Agreement (Item 1.01), completed an Acquisition or Disposition of Assets (Item 2.01), and conducted an Unregistered Sale of Equity Securities (Item 3.02) on February 3, 2026.
**Key Changes:** The filing indicates a significant corporate transaction involving acquisition activity, asset changes, and equity issuance. The company issued unregistered securities as part of the transaction structure, suggesting deal consideration may have included stock.
**Material Events:** This represents a substantive M&A event with multiple components—a definitive agreement, asset acquisition completion, and equity financing. The substantial size of the attached agreement (800+ KB) and the inclusion of multiple exhibits indicate this is a material transaction requiring comprehensive disclosure.
**Investor Implications:** Investors should review the full 8-K filing and exhibits to assess the acquisition's strategic rationale, financial impact, and whether it creates dilution concerns. The unregistered equity issuance requires careful analysis of the terms and potential future registration requirements. This transaction could materially alter the company's capital structure and operational profile.
PACB
NASDAQ
▲ SUPER 8-K
Pacific Biosciences of California, Inc.
EDGAR Items: 1.01,2.01,7.01,9.01
# Summary of Pacific Biosciences 8-K Filing
On January 30, 2026, Pacific Biosciences (PACB) completed the sale of its short-read DNA sequencing technology assets and related intellectual property to Illumina Cambridge Limited for $50 million in cash, netting approximately $48.1 million after payment obligations to Apton Biosystems' former equity holders. The asset sale represents a strategic divestment of the company's short-read sequencing business line, including clustering, sequencing reagent, and detection technologies, while Pacific Biosciences retains a non-exclusive license to the sold intellectual property. The company will pay 4% of net proceeds (approximately $1.9 million) to Apton's former equity holders in the first quarter of 2026 to waive remaining milestone obligations from its August 2023 acquisition of that company. This transaction reshapes Pacific Biosciences' business focus away from short-read sequencing toward its core long-read sequencing platform, though investors should note the relatively modest cash proceeds and the company's ongoing exposure to milestone liabilities from previous acquisitions.
SPWR
NASDAQ
▲ SUPER 8-K
SunPower Inc. Common Stock
EDGAR Items: 1.01,2.01,3.02,9.01
# SunPower Inc. (SPWR) 8-K Summary
SunPower Inc. completed its acquisition of Cobalt Power Systems, Inc. on February 2, 2026, paying 1.8 million shares of common stock at closing plus $6.66 million in additional shares payable at 12 and 18-month anniversaries, with the number of deferred shares determined by volume-weighted average pricing. The company also committed up to $2 million in restricted stock units for employee retention and inducement grants. This acquisition will dilute existing shareholders through significant equity issuance, with the extent of future dilution dependent on SunPower's stock price performance at the payment dates.
CYH
NYSE
▲ SUPER 8-K
Community Health Systems, Inc.
EDGAR Items: 2.01,8.01,9.01
# Summary of Community Health Systems, Inc. 8-K Filing
Community Health Systems, Inc. completed the sale of its 80% ownership interest in Clarksville Health System joint ventures (which operate Tennova Healthcare - Clarksville) to Vanderbilt University Medical Center on February 1, 2026, for $623 million in cash plus an additional $23 million distribution to the purchaser for amounts owed by CHS to the joint ventures. This significant asset disposition represents a material strategic restructuring that reduces CHS's operating footprint in Tennessee while generating substantial proceeds that could be deployed toward debt reduction or other capital allocation priorities. The transaction was previously announced in October 2025 and concluded with pro forma financial statements reflecting the company's reduced operational scale going forward. For investors, this divestiture signals management's focus on portfolio optimization and potential deleveraging, though the impact on overall financial performance will depend on how proceeds are utilized and the relative profitability of the divested assets.
January 2026
20 filings
▼
LAB
NASDAQ
▲ SUPER 8-K
Standard BioTools Inc. Common Stock
EDGAR Items: 2.01,2.02,7.01,9.01
# SEC 8-K Filing Summary
**Company:** (CIK 1162194) filed an 8-K on January 30, 2026
**Key Material Events:**
- **Completion of Acquisition:** The company completed an acquisition or disposition of assets (Item 2.01)
- **Operational Results:** Filed operational and financial condition results (Item 2.02)
- **Additional Disclosures:** Includes Regulation FD disclosure and financial statements/exhibits (Items 7.01 and 9.01)
**Investor Implications:**
This filing signals a completed M&A transaction that materially affects the company's asset base and operating structure. The inclusion of updated financial condition results suggests investors should review the specific transaction details and pro forma financials to understand the deal's financial impact on earnings, cash flow, and balance sheet composition. The timing and nature of this acquisition could significantly influence future growth prospects and shareholder value.
**Recommendation:** Investors should review the detailed 8-K filing and Exhibit 99.1 for complete transaction terms, purchase price, financing details, and management's forward guidance regarding the acquisition's strategic rationale and expected synergies.
ESMC
OTC
▲ SUPER 8-K
ESCALON MEDICAL CORP
EDGAR Items: 1.01,2.01,9.01
# Summary of Escalon Medical Corp. 8-K Filing
Escalon Medical Corp. completed the sale of its AXIS platform software-related assets to Optos Public Limited Company for a total purchase price of $3,000,000, structured as milestone installments. The company received the first milestone payment of $1,000,000 upon closing on January 23, 2026, with two additional installments to follow based on conditions outlined in the Asset Purchase Agreement. This asset disposition reduces Escalon's product portfolio but provides near-term liquidity and allows the company to refocus resources on its remaining business operations. Investors should note that the company's receipt of the remaining $2,000,000 is contingent on meeting unspecified milestone conditions, creating uncertainty around the full realization of expected proceeds.
CIRC
NASDAQ
▲ SUPER 8-K
Circle8 Group, Inc. Common Stock
EDGAR Items: 1.01,2.01,2.03,3.02,5.02,8.01,9.01
# SEC 8-K Summary: Atlantic International Corp. (ATLN)
Atlantic International Corp. completed its acquisition of Circle8 Group B.V., a Netherlands-based IT staffing and recruiting firm with approximately $780 million in 2025 revenues, on January 23, 2026. The purchase price consisted of 12.5 million shares (19.99% of outstanding stock) issued to seller Guus Franke plus a convertible promissory note for $162 million convertible into 53.3 million additional shares, granting Franke effective control post-acquisition as Executive Chairman. The deal includes potential contingent payments: a $2.5 million bonus if Circle8 exceeds €600 million in 2026 revenue, plus payment of Circle8's 2025 net profits within three years. A shareholder vote on the convertible note conversion is required under Nasdaq rules, though management and insiders have already secured voting agreements representing a majority of outstanding shares to approve the transaction. This highly dilutive acquisition significantly alters the company's capital structure, with the combined consideration representing roughly 65.8 million shares on a fully diluted basis, and transfers control to a single new shareholder.
ATLN
NASDAQ
▲ SUPER 8-K
Atlantic International Corp. Common Stock
EDGAR Items: 1.01,2.01,2.03,3.02,5.02,8.01,9.01
# SEC 8-K Filing Summary: Atlantic International
**Company:** Atlantic International (CIK: 1605888)
**Filing Date:** January 28, 2026
**Period of Report:** January 22, 2026
## Key Material Events:
Atlantic International has disclosed a significant acquisition transaction completed on January 22, 2026, along with material financing and executive compensation arrangements. The filing indicates the company entered into a definitive acquisition agreement, created new financial obligations through a convertible promissory note issued on January 23, 2026, and completed unregistered equity sales. Additionally, the company made changes to its board and executive officer compensation structure, including new employment agreements and amendments to existing executive arrangements.
## Investment Implications:
The multiple concurrent actions—particularly the combination of debt financing via convertible notes, equity issuances, and executive hiring/restructuring—suggest Atlantic International is executing a significant strategic expansion or pivot. Investors should carefully review the acquisition agreement and convertible note terms to assess dilution risk, debt burden, and whether the new leadership appointments align with long-term value creation. The unregistered equity sales and executive compensation details will be critical to evaluating whether insider interests are properly aligned with shareholder interests.
OSRH
OTC
▲ SUPER 8-K
OSR Health, Inc.
EDGAR Items: 2.01,7.01,9.01
# 8-K Summary: OSR Holdings - Woori IO Acquisition Completion
**Material Event:** OSR Holdings completed its acquisition of Woori IO on January 26, 2026, as reported in this 8-K filing dated January 27, 2026. The filing includes Item 2.01 (Completion of Acquisition), Item 7.01 (Regulation FD Disclosure), and a press release detailing the transaction completion.
**Key Implications for Investors:** The completed acquisition represents a significant corporate action that may impact OSR Holdings' capital structure, operational scope, and financial position going forward. Investors should review the full press release and accompanying documents to understand the acquisition terms, financing method, and expected synergies or strategic benefits. This merger activity could affect future earnings, debt levels, and the company's competitive positioning in its market.
SONM
NASDAQ
▲ SUPER 8-K
DNA X, Inc. Common Stock
EDGAR Items: 1.01,1.02,2.01,5.03,7.01,8.01,9.01
# SEC 8-K Filing Summary
This 8-K filing from January 27, 2026 (for period ending January 23, 2026) reports multiple material corporate events for the filing company. The filing includes significant items covering entry into and termination of material agreements, completion of an asset acquisition or disposition, amendments to corporate governance documents, and regulatory disclosures. The breadth of items disclosed—particularly the combination of new agreements, terminations, and acquisition completion—suggests substantial strategic restructuring or a major corporate transaction. Investors should review the detailed exhibits, especially the material definitive agreement (EX-2.1) and amended bylaws (EX-3.1), to understand the full scope and financial impact of these changes on the company's operations and capital structure.
DVLT
NASDAQ
▲ SUPER 8-K
Datavault AI Inc. Common Stock
EDGAR Items: 2.01,8.01,9.01
# Datavault AI Inc. (DVLT) - 8-K Summary
Datavault AI Inc. completed its acquisition of API Media Innovations Inc. on January 22, 2026, for $14 million in cash, as previously announced in the October 28, 2025 Stock Purchase Agreement. The acquisition adds API Media's operations and assets to Datavault's portfolio, marking a significant expansion for the Delaware-incorporated company trading on Nasdaq Capital Market under ticker DVLT. While the filing does not detail API Media's financial performance or strategic rationale, the $14 million outlay represents a material deployment of capital that may affect Datavault's liquidity and balance sheet. Investors should monitor upcoming quarterly earnings reports to assess the integration's impact on profitability and whether synergies justify the acquisition cost.
CMCT
NASDAQ
▲ SUPER 8-K
Creative Media & Community Trust Corporation Common stock
EDGAR Items: 2.01,7.01,9.01
# Summary of Creative Media & Community Trust Corporation 8-K Filing
Creative Media & Community Trust Corporation completed the sale of its First Western SBLC, LLC subsidiary to PG FR Holding, LLC on January 21, 2026, for approximately $44.9 million in gross proceeds, generating net cash proceeds of approximately $31.2 million after debt payoff and transaction expenses. The transaction significantly reduces the company's asset base, with total pro forma assets declining from $871.8 million to $835.3 million and eliminates $51.5 million in loans receivable and related lending operations from the company's balance sheet. The sale also reduces total debt by approximately $30.6 million, improving the company's leverage profile. This divestiture represents a strategic shift for the REIT, indicating management's decision to exit the lending business and focus on its core real estate operations.
BURU
AMEX
▲ SUPER 8-K
Nuburu, Inc.
EDGAR Items: 1.01,2.01,2.03,3.02
# Summary of Nuburu, Inc. Form 8-K Filing (January 13, 2026)
Nuburu, Inc. completed three significant acquisitions and partnerships on January 13-15, 2026, expanding its portfolio in laser technology, software platforms, and defense capabilities. The **Lyocon Acquisition** closed on January 15 for $2.0 million upfront ($750,000 cash plus $1.25 million in subordinated convertible notes), with potential earn-out payments up to $1.0 million over five years based on achievement of milestones, plus $1.0 million in committed funding to Lyocon through 2027. The company also **closed a second tranche of the Orbit SaaS acquisition**, increasing ownership to approximately 22%, and **executed definitive agreements with Tekne S.p.A.**, including a €13 million shareholder loan, a 2.9% equity stake, and a Network Contract establishing joint ventures across the Americas, NATO regions, and Italy. Investors should note that the convertible notes issued to Lyocon sellers include dilution potential if converted at $0.295 per share, and the management equity incentive plan creates additional dilution opportunities tied to stock price milestones in 2026 (requiring stock prices of $0.70, $1.00, or $2.00). The substantial committed capital ($1.0-1.25 million in funding and $13 million shareholder loan) and contingent earn-out obligations present material cash and financial obligations for the company.
KUST
NASDAQ
▲ SUPER 8-K
Kustom Entertainment, Inc. Common Stock
EDGAR Items: 1.01,2.01,8.01,9.01
# SEC 8-K Filing Summary
Based on the filing metadata from January 12, 2026, this 8-K reports **material business developments** including the entry into a material definitive agreement (Item 1.01) and the completion of an acquisition or disposition of assets (Item 2.01). The filing contains 17 documents with multiple exhibits, including what appears to be significant transaction agreements (EX-1.1 and EX-1.2) and supplemental information materials.
**Key Takeaway for Investors:** While the HTML metadata alone doesn't provide full details, the combination of a "Material Definitive Agreement" entry and "Completion of Acquisition or Disposition" indicates the company has either completed a major M&A transaction or entered into a significant business arrangement. Investors should review the actual 8-K document (form8-k.htm) and exhibits to understand the transaction's financial impact, terms, and strategic implications for the company's future earnings and competitive position.
HGBL
NASDAQ
▲ SUPER 8-K
HERITAGE GLOBAL INC
EDGAR Items: 1.01,2.01,7.01,9.01
# Summary of SEC 8-K Filing (January 12, 2026)
Based on this 8-K filing by Hecla Mining Company (ticker: HGBL), the company entered into a material definitive agreement and completed an acquisition or disposition of assets as of January 9, 2026. The filing includes multiple exhibits (two substantial agreements and supplemental disclosures), indicating a significant transaction, though the specific details of the deal are contained in the linked documents. The company has also made additional regulatory filings disclosures under Regulation FD.
For investors, this represents a potentially material corporate action that could affect Hecla's operational scope, financial position, or strategic direction—details about whether this represents an accretive or dilutive transaction, the purchase price, and asset composition would be critical to understanding the investment implications.
CETX
NASDAQ
▲ SUPER 8-K
CEMTREX INC.
EDGAR Items: 2.01,8.01,9.01
# SEC 8-K Filing Summary
**Company & Filing Details:** This 8-K was filed on January 8, 2026 (CIK 1435064), reporting on material events that occurred on the same date.
**Key Material Events:** The filing reports the completion of an acquisition or disposition of assets (Item 2.01), along with other events (Item 8.01) and related financial statements/exhibits (Item 9.01). The specific transaction details are contained in the attached documents but are not visible in this header information.
**Investment Implications:** Investors should review the full 8-K document (form8-k.htm) and Exhibit 99.1 for specifics on the acquisition/disposition, including purchase price, financing structure, expected synergies, and integration plans. Such transactions can materially impact shareholder value, depending on whether the deal is accretive or dilutive to earnings and the company's strategic positioning.
**Next Steps:** To fully assess the impact, analysts should examine the complete filing documents, particularly the transaction terms and management's commentary on expected outcomes.
TRSO
OTC
▲ SUPER 8-K
TRANSUITE.ORG INC.
EDGAR Items: 1.01,2.01,3.02,9.01
# Summary of Transuite.Org Inc. 8-K Filing
Transuite.Org Inc. (TRSO) completed a material acquisition on December 31, 2025, acquiring a 51% equity interest in Goldfinch Group Co., Limited (Goldfinch HK) for 5 million shares of restricted common stock. Goldfinch HK owns Goldfinch-Chong, a Chinese e-bike charging solutions provider operating over 100,000 charging terminals and serving 1.6 million active users in Fuzhou. The company plans to launch an innovative real-world assets (RWA) tokenization initiative using Web3 technologies to monetize its charging infrastructure. The 5 million restricted shares issued represent significant equity dilution for existing shareholders, though the 51% controlling stake positions TRSO to capture upside from this emerging charging infrastructure business, which includes IoT applications and blockchain-based asset revenue rights.
LOTT
OTC
▲ SUPER 8-K
Techlott Inc.
EDGAR Items: 1.01,2.01,3.02,5.02,5.03,9.01
# Summary of AppYea Inc. Form 8-K Filing
AppYea Inc. completed its acquisition of blockchain-based lottery technology from Cyprus-based Techlott Ltd. on December 31, 2025, issuing 1,277,922,611 common shares (35% dilution on a fully diluted basis) as consideration, with 49,117 Series B Preferred shares issued pending shareholder approval to increase authorized shares. The company appointed Techlott's leadership—Mark Katzenelson as President and Ben Harris as Chief Technology Officer—to its board of directors, with each receiving $30,000 monthly consulting fees retroactive to August 20, 2025, plus 36-month severance protection. Additionally, convertible note holders converted approximately $0.8 million in debt into 245,013,836 common shares, while another noteholder extended maturity to February 2028. This transaction represents a significant capital restructuring with substantial shareholder dilution, combined with leadership changes that shift the company's strategic focus to blockchain-based lottery platforms.
AIHS
NASDAQ
▲ SUPER 8-K
Senmiao Technology Limited Common Stock
EDGAR Items: 1.01,2.01,5.02,9.01
# SEC 8-K Summary: Senmiao Technology Limited
**Filing Date:** January 7, 2026 (Period ending December 31, 2025)
**Material Events:**
Senmiao Technology Limited completed a material acquisition of assets on December 31, 2025, as reported in this 8-K filing. The filing includes a definitive acquisition agreement, pro forma balance sheet, and indicates changes to the company's officer and director compensation arrangements, suggesting significant corporate restructuring alongside the transaction.
**Key Implications for Investors:**
The completion of this acquisition represents a substantial strategic shift for the company and warrants careful review of the acquisition terms, financing structure, and pro forma financial impact. Investors should examine the pro forma balance sheet to assess how the deal affects the company's leverage, liquidity, and earnings potential. Additionally, the concurrent executive compensation changes may signal new management direction or potential dilution concerns that warrant further investigation into the acquisition's terms and the company's future strategic direction.
RNGE
OTC
▲ SUPER 8-K
RANGE IMPACT, INC.
EDGAR Items: 1.01,2.01,2.03,8.01,9.01
# SEC 8-K Filing Summary
Based on this Form 8-K filing dated January 7, 2026 (for period ending December 31, 2025), the company has reported **multiple material events**: entry into a material definitive agreement, completion of an acquisition or disposition of assets, and creation of direct financial obligations. The filing includes six significant exhibits (EX-10.1 through EX-10.6) documenting detailed agreements and transaction terms, with the main 8-K document exceeding 98KB in size, suggesting substantial transaction complexity.
**For investors:** This multi-item 8-K indicates a significant corporate transaction was completed at year-end 2025. The combination of new agreements, asset completion items, and new financial obligations suggests either a major acquisition, divestiture, or substantial restructuring that will materially impact the company's balance sheet and operations going forward. Investors should review the full filing and exhibits to understand the transaction's financial terms, strategic rationale, and implications for future earnings and cash flow.
NCRA
NASDAQ
▲ SUPER 8-K
Nocera, Inc. Common Stock
EDGAR Items: 2.01
# SEC 8-K Filing Summary: Nocera, Inc.
**Filing Details:**
- **Company:** Nocera, Inc. (CIK: 1756180)
- **Filing Date:** January 5, 2026
- **Report Period:** January 1, 2026
- **Material Event:** Item 2.01 - Completion of Acquisition or Disposition of Assets
**Key Takeaway for Investors:**
Nocera, Inc. has completed an acquisition or disposition of assets as of January 1, 2026. While the HTML document provided does not contain the detailed substance of the transaction, this 8-K filing indicates a significant corporate event that could materially impact the company's operations, financial position, or strategic direction. Investors should review the complete 8-K document (nocera_8k.htm) to understand the specific details of the transaction, including the target asset/company, purchase price, financing terms, and expected impact on earnings and operations. This type of event typically signals either an expansion strategy or a divestiture of assets that warrant careful evaluation of the company's future prospects.
FCCN
OTC
▲ SUPER 8-K
SPECTRAL CAPITAL Corp
EDGAR Items: 1.01,2.01,3.02,9.01
# Summary of Spectral Capital Corporation 8-K Filing (January 5, 2026)
**Material Events:**
Spectral Capital Corporation completed the acquisition of Telvantis, Inc., with closing occurring on December 31, 2025. The filing includes a definitive stock purchase agreement and closing certificate, indicating this was a significant M&A transaction.
**Key Filing Items:**
The 8-K reports entry into a material definitive agreement (Item 1.01), completion of an acquisition (Item 2.01), and unregistered equity sales (Item 3.02), suggesting Spectral Capital issued stock as consideration for the Telvantis acquisition.
**Investor Implications:**
This acquisition represents a strategic expansion for Spectral Capital, though the specific financial terms and strategic rationale are detailed in the attached purchase agreement. Investors should review the definitive stock purchase agreement and press release for deal valuation, financing structure, and management's strategic vision for integrating Telvantis operations.
TPET
AMEX
▲ SUPER 8-K
Trio Petroleum Corp.
EDGAR Items: 1.01,2.01,3.02,7.01,9.01
# Summary of Trio Petroleum Corp 8-K Filing
Trio Petroleum Corp completed an asset purchase transaction on December 30, 2025, acquiring oil and gas assets in the Lloydminster, Saskatchewan heavy oil region from Novacor Exploration Ltd. for CAD$1 million (approximately US$730,300) plus 912,875 restricted common shares. The acquisition was executed through the company's Canadian subsidiary and includes working interests, leases, permits, and mineral rights, with Novacor continuing as the on-site operator under specified terms for at least two years.
The company issued restricted shares to the seller subject to registration rights, with an obligation to file a registration statement by March 31, 2026, if the shares are not included in another offering. This transaction expands Trio Petroleum's heavy oil operations in Western Canada and represents a material asset acquisition, though the relatively modest purchase price and share issuance suggest a modest-sized asset base for this emerging growth company.
TMGI
OTC
▲ SUPER 8-K
Transglobal Management Group, Inc.
EDGAR Items: 1.01,2.01,3.02,5.01,5.02,9.01
# Summary: The Marquie Group, Inc. Form 8-K (October 20, 2025)
The Marquie Group completed a transformative acquisition and change-of-control transaction on October 20, 2025, in which GetGolf.com, LLC acquired 80% voting control of the company for $500,000 payable over 12 months by purchasing Series A Preferred Stock, a $2 million promissory note, and 666,700 common shares from the Angell family. Jeff Foster and Kelly L. Kirchhoff were appointed to the Board of Directors and now collectively control 80% of voting power, with Foster becoming Chairman and CEO, while founder Marc Angell transitioned to a part-time advisory role. As part of the strategic realignment, the company divested its "Music of Your Life" media business back to the Angells and acquired golf-related technology and operating assets, including the "Stand By Golf" cloud-based platform and two revenue-producing golf courses. This represents a fundamental shift in the company's business focus from media to golf technology and operations, with previous shareholders substantially diluted by the control transfer.
December 2025
27 filings
▼
ACH
NYSE
▲ SUPER 8-K
Accendra Health, Inc.
EDGAR Items: 1.01,2.01,2.03,5.02,5.03,7.01,9.01
# Owens & Minor, Inc. – 8-K Summary
On December 31, 2025, Owens & Minor completed the sale of its Products & Healthcare Services (P&HS) business to Dominion Healthcare Acquisition Corporation for $375 million in cash (subject to closing adjustments), representing a significant portfolio restructuring. Simultaneously, the company amended and restated its receivables purchase agreement with PNC Bank, expanding the accounts receivable securitization program to $150 million to support liquidity and general corporate purposes. The P&HS sale entities were released from certain credit facility obligations, reducing the company's debt burden, while Owens & Minor will continue providing transition services and maintaining a performance guaranty on the receivables program through October 2027. This transaction materially reduces the company's operational scope but enhances financial flexibility, though investors should monitor the execution of transition services and the company's ability to deploy proceeds from the asset sale for strategic reinvestment.
EZRA
NASDAQ
▲ SUPER 8-K
Reliance Global Group, Inc. Common Stock
EDGAR Items: 1.01,2.01,9.01
# SEC 8-K Filing Summary
**Filing Details:** This Form 8-K was filed on December 30, 2025, reporting material events that occurred on December 23, 2025.
**Material Events:**
The filing discloses two significant corporate actions under Items 1.01 and 2.01:
- **Entry into a Material Definitive Agreement** – The company has entered into a binding contract with unspecified terms (detailed in Exhibit 10.1)
- **Completion of Acquisition or Disposition of Assets** – The company has completed an asset transaction
**Key Implications for Investors:**
While the precise nature of the transaction is not evident from this summary page alone, the concurrent reporting of both a definitive agreement and its completion suggests a significant M&A activity or substantial asset transaction. Investors should review the attached exhibits, particularly EX-10.1 (the definitive agreement) and the press release (EX-99.1), to understand the transaction's size, strategic rationale, and potential impact on earnings, cash flow, and shareholder value. This type of disclosure typically signals material changes to the company's operations or financial position that warrant careful analysis.
BAER
NASDAQ
▲ SUPER 8-K
Bridger Aerospace Group Holdings, Inc. Common Stock
EDGAR Items: 2.01,7.01,9.01
# SEC 8-K Filing Summary
**Company & Filing Details:**
Bridger Aerospace (CIK 1941536) filed an 8-K on December 30, 2025, reporting a material event that occurred on December 23, 2025.
**Key Material Events:**
The filing discloses the **completion of an acquisition or disposition of assets** (Item 2.01), along with additional regulatory disclosures and financial statements. A press release dated December 30, 2025, was included as an exhibit, providing public announcement of the transaction.
**Investor Implications:**
Without access to the detailed content of the press release and 8-K body, the specific nature of the acquisition/disposition cannot be confirmed; however, investors should review the complete filing to understand the transaction terms, impact on financial position, and strategic rationale. The inclusion of Item 7.01 (Regulation FD Disclosure) suggests material information was simultaneously disclosed to the public, indicating this is a significant corporate event that could affect stock valuation and future operations.
ADVB
NASDAQ
▲ SUPER 8-K
Advanced Biomed Inc. Common Stock
EDGAR Items: 1.01,2.01,7.01,9.01
# Summary of Advanced Biomed Inc. Form 8-K Filing
Advanced Biomed Inc. completed the sale of its Hong Kong subsidiary (Advanced Biomed (HK) Limited) and all associated intellectual property to third party Wei Ha Hui for $23,000 on December 23, 2025. The transaction includes transfer of IP assets held by Shanghai Sglcell Biotech Co., Ltd., a sub-subsidiary, and was unanimously approved by the board of directors. This divestiture represents a significant reduction in the company's asset base and operating subsidiaries, though the nominal sale price suggests the subsidiary was not generating substantial value. Investors should monitor upcoming financial disclosures to understand the impact on the company's remaining operations, cash position, and strategic direction following this asset disposal.
AMPY
NYSE
▲ SUPER 8-K
Amplify Energy Corp.
EDGAR Items: 2.01,7.01,9.01
# Summary of Amplify Energy Corp. Form 8-K Filing
Amplify Energy Corp. completed the sale of certain oil and gas properties and equipment located in Oklahoma to Revolution Resources III, LLC on December 29, 2025, for $92.5 million in cash. The asset sale involved two subsidiaries (Amplify Oklahoma Operating LLC and Magnify Energy Services LLC) and was previously announced on November 4, 2025. The company has characterized this as a non-discontinued operation, and the filing includes unaudited pro forma financial statements reflecting this disposition alongside a previously announced sale of assets in East Texas and Louisiana. This transaction represents a strategic portfolio rationalization for Amplify Energy as the company generates approximately $92.5 million in proceeds to strengthen its balance sheet and potentially fund debt reduction or other capital allocation priorities.
TGL
NASDAQ
▲ SUPER 8-K
Treasure Global Inc. Common Stock
EDGAR Items: 1.01,2.01,8.01,9.01
# SEC 8-K Summary: Treasure Global Inc.
On December 22, 2025, Treasure Global Inc. agreed to sell 100% of Tadaa Ventures Sdn. Bhd. (which owns the Bowlcrafted food and beverage subsidiary) to Maison de Cuisine Sdn. Bhd. for US$1.4 million in shares of Reveillon Group Limited, expected to close within five business days. This divestiture of non-core food and beverage operations is part of the company's strategic realignment to focus on higher-growth fintech and digital-asset platforms, including the OXI Wallet and tokenization initiatives. The transaction does not constitute a significant asset disposition under SEC rules, so no pro forma financials were required. For investors, this signals management's intent to streamline the corporate structure and redirect capital and resources toward more scalable, higher-margin digital businesses with stronger growth potential.
AHT
NYSE
▲ SUPER 8-K
Ashford Hospitality Trust, Inc.
EDGAR Items: 2.01,9.01
# Summary
Ashford Hospitality Trust completed the sale of its 226-room Le Pavillon hotel in New Orleans, Louisiana on December 18, 2025, for $42.5 million in cash. This asset disposition represents a strategic reduction in the company's portfolio as a hospitality REIT. The pro forma financial information for the nine months ended September 30, 2025, and the year ended December 31, 2024, has been filed to reflect the impact of this divestiture. For investors, this sale generates liquidity that could be used for debt reduction, distributions, or other strategic purposes, though the impact on overall earnings and funds from operations will depend on the hotel's historical performance relative to the sale proceeds.
AIV
NYSE
▲ SUPER 8-K
Apartment Investment and Management Company
EDGAR Items: 1.01,2.01,9.01
# Summary of AIMCO 8-K Filing (December 22-23, 2025)
Apartment Investment and Management Company (AIMCO) completed the sale of its Brickell Assemblage in Miami for $520 million on December 22, 2025, generating approximately $220 million in net proceeds after debt payoff and transaction costs. The buyer financed $85 million through seller financing notes with compounding interest rates (12-24%) and 3% exit fees, which AIMCO plans to monetize. Additionally, AIMCO entered into an agreement on December 23 to sell two properties (660 units) in Plantation, Florida and Nashville, Tennessee to HGI Acquisitions for $155 million, with closing expected in Q1 2026. Management intends to distribute the majority of net proceeds from these asset sales to shareholders, signaling a capital return strategy as the company continues its portfolio optimization and deleveraging efforts.
AMPY
NYSE
▲ SUPER 8-K
Amplify Energy Corp.
EDGAR Items: 2.01,7.01,9.01
# Amplify Energy Corp. (AMPY) - 8-K Summary
Amplify Energy completed the sale of its East Texas and Louisiana oil and gas assets to EQV Alpha LLC on December 23, 2025, generating approximately $122 million in cash proceeds. A second asset sale of Oklahoma operations to Revolution Resources III, LLC is expected to close on or about December 29, 2025, with pro forma financials included reflecting both dispositions. These strategic asset sales represent a significant portfolio restructuring, reducing the company's operational footprint across multiple regions. The company has provided pro forma financial statements showing the expected impact of both transactions, though final proceeds from the pending Oklahoma sale may vary materially from current estimates.
MWYN
NASDAQ
▲ SUPER 8-K
Marwynn Holdings, Inc. Common stock
EDGAR Items: 2.01,5.03,9.01
# SEC 8-K Filing Summary: Marwynn (December 23, 2025)
**Material Events:** Marwynn completed an acquisition or disposition of assets and amended its Articles of Incorporation on December 22, 2025, as reported in this Form 8-K filing.
**Key Changes:** The company's second amended and restated Articles of Incorporation have been officially updated (EX-3.1), and unaudited pro forma condensed combined financial information has been included, suggesting a significant business combination or asset transaction.
**Investor Implications:** The pro forma financial statements will help investors assess the combined entity's projected financial position and performance post-acquisition. However, without access to the detailed 8-K body text, the specific terms, financial magnitude, and strategic rationale of the transaction cannot be fully evaluated. Investors should review the complete filing for transaction details, purchase price, and integration plans to assess the deal's impact on future earnings and shareholder value.
ATHR
NASDAQ
▲ SUPER 8-K
Aether Holdings, Inc. Common Stock
EDGAR Items: 1.01,2.01,8.01,9.01
# SEC 8-K Filing Summary
Based on the December 22, 2025 8-K filing (Accession No. 0001493152-25-028671), the company reported **material transactions involving entry into a definitive agreement and completion of an acquisition or disposition of assets**. The filing includes significant exhibits, notably a substantial material agreement (EX-10.1 at 474KB) and supporting documentation, indicating a substantial business transaction has been completed. While the specific details of the transaction are contained in the linked documents, the combination of Items 1.01 (material agreement), 2.01 (asset transaction completion), and 8.01 (other events) suggests a meaningful M&A or asset restructuring event that could impact the company's strategic direction and financial position. **Investors should review the full 8-K and attached agreements to understand the transaction's terms, financial impact, and implications for the company's future operations and shareholder value.**
GLTK
OTC
▲ SUPER 8-K
GlobalTech Corp
EDGAR Items: 2.01,3.02,7.01,9.01
# SEC 8-K Filing Summary
**Company & Filing Details:**
This 8-K was filed on December 18, 2025, by Global (CIK: 1938338) for the period ending December 15, 2025, reporting material events that occurred on that date.
**Material Events Reported:**
The filing discloses four significant items: (1) **Completion of an Asset Acquisition or Disposition** (Item 2.01), (2) **Unregistered Equity Issuance** (Item 3.02), (3) regulatory disclosure information (Item 7.01), and (4) financial statements and supporting exhibits (Item 9.01). The company completed a transaction involving the acquisition or sale of assets and simultaneously issued unregistered securities.
**Investor Implications:**
The combination of a completed acquisition/disposition with concurrent unregistered equity issuance suggests the company may have funded the transaction through stock issuance, potentially diluting existing shareholders. The specific details of the transaction value, asset composition, and equity terms are contained in the attached press release and financial exhibits, which would require review to fully assess the strategic and financial impact on the company and its shareholders.
SONM
NASDAQ
▲ SUPER 8-K
DNA X, Inc. Common Stock
EDGAR Items: 1.01,2.01,2.03,3.02,3.03,8.01,9.01
# SEC 8-K Filing Summary
Based on this December 18, 2025 8-K filing, the company has announced **multiple material corporate events**. The filing indicates entry into a material definitive agreement, completion of an acquisition or asset disposition, creation of direct financial obligations, unregistered equity issuance, and modifications to security holder rights. These items collectively suggest a significant corporate transaction—likely a merger, acquisition, or major financing deal—that materially impacts the company's capital structure and financial position.
**Key implications for investors:**
- The company has taken on new financial obligations (Item 2.03) and issued unregistered securities (Item 3.02), which could dilute existing shareholders
- Changes to security holder rights (Item 3.03) may affect voting power or dividend preferences
- The complexity and breadth of disclosed items indicate a transformative transaction requiring careful review of the detailed agreements and exhibits provided
Investors should review the full 8-K document and attached exhibits (particularly EX-10.1 and EX-10.2) to understand the transaction terms, financial impact, and implications for future earnings and shareholder value.
FTFT
NASDAQ
▲ SUPER 8-K
Future FinTech Group Inc.
EDGAR Items: 2.01,9.01
# SEC 8-K Filing Summary
Based on this Form 8-K filing dated December 17, 2025, **the company has completed an acquisition or disposition of assets**, as indicated by Item 2.01. The transaction was formalized through a Securities Transfer Agreement dated November 18, 2025, which is attached as an exhibit to the filing. While the specific details of the acquisition/disposition are not visible in the HTML structure provided, this represents a material corporate event that required immediate disclosure to investors.
**For investors:** This filing signals a significant strategic action by the company that could impact its business operations, financial position, and future growth trajectory. Investors should review the complete 8-K document and the Securities Transfer Agreement to understand the nature of the transaction, assets involved, consideration paid, and any potential synergies or risks. The timing between the agreement (November 18) and the completion announcement (December 16-17) suggests this was a recently executed transaction.
CIMG
OTC
▲ SUPER 8-K
CIMG Inc.
EDGAR Items: 1.01,2.01,7.01,9.01
# SEC 8-K Filing Summary
**Company & Filing Details:** Form 8-K filed on December 17, 2025, with a period of report date of October 20, 2025 (CIK 1527613).
**Material Events:** The filing discloses four significant items: (1) entry into a material definitive agreement, (2) completion of an acquisition or disposition of assets, (3) regulatory fair disclosure, and (4) financial statements and exhibits. The 56 supporting documents, including multiple exhibits and graphics, suggest a substantial corporate transaction.
**Key Implications for Investors:** This 8-K indicates a completed major acquisition or asset disposition with associated material contractual agreements. The comprehensive documentation and exhibits suggest a complex, significant deal that could materially impact the company's operations, financial position, or strategic direction. Investors should review the full filing documents (particularly EX-10.1 and EX-10.2 containing the definitive agreements) to understand the transaction's terms, valuation, and potential impact on shareholder value.
AMCI
NASDAQ
▲ SUPER 8-K
AMC Robotics Corporation Common Stock
EDGAR Items: 1.01,1.02,2.01,3.02,3.03,5.01,5.02,5.03,5.06,9.01
# SEC 8-K Summary: AMC Robotics Corporation
**Material Events:**
AMC Robotics Corporation (formerly AlphaVest Acquisition Corp.) completed its SPAC business combination on December 9, 2025, merging with AMC Corporation and resulting in the issuance of 18 million shares to the former AMC shareholders. Concurrently, the company closed an $8 million private placement at $10 per share (800,000 shares) plus warrants to purchase 2.24 million additional shares at $10 per share. The SPAC also underwent domestication from a Cayman Islands exempted company to a Delaware corporation.
**Investor Impact:**
The transaction marks the de-SPAC completion and establishes AMC Robotics as a public company on Nasdaq (ticker: AMCI). Significant shareholder dilution occurs from the 18 million shares issued to former AMC owners plus 800,000 private placement shares and potential 2.24 million warrant exercises. Lock-up agreements restrict sales by sponsors and insiders, providing near-term support for stock price stability, while registration rights agreements require the company to facilitate future secondary registrations for certain shareholders.
DTCX
NASDAQ
▲ SUPER 8-K
Datacentrex, Inc. Common Stock
EDGAR Items: 2.01,3.02,5.01,5.02,5.03,8.01,9.01
# SEC 8-K Filing Summary
**Filing Date:** December 15, 2025 | **Company CIK:** 1853825
## Key Material Events:
This 8-K reports a **change of control transaction** involving completion of an acquisition, unregistered equity issuance, and significant corporate restructuring. The filing indicates multiple major events including:
- **Acquisition completion** (Item 2.01) with asset or equity transfers
- **Change in control of the registrant** (Item 5.01), suggesting new ownership or management structure
- **Unregistered equity securities issuance** (Item 3.02), likely issued as acquisition consideration
- **Officer and director changes** (Item 5.02) with new compensatory arrangements
- **Corporate governance amendments** (Item 5.03) to articles of incorporation and/or bylaws
## Investor Implications:
This represents a **significant corporate transformation** that could substantially impact shareholder value, voting rights, and company direction. Investors should review the complete 8-K filing, exhibit documents (including amended bylaws and organizational documents), and press releases to understand: the acquisition terms, new management team, dilution from equity issuance, and any changes to shareholder rights or capital structure. The 35 accompanying documents suggest a complex transaction requiring detailed analysis.
CHGA
NASDAQ
▲ SUPER 8-K
Change Agents Corporation Common Stock
EDGAR Items: 1.01,2.01,2.03,3.02,5.02,5.03,7.01,9.01
# Summary of Avalon GloboCare Corp. Form 8-K (December 11, 2025)
Avalon GloboCare Corp. completed the acquisition of RPM Interactive, Inc., issuing 19,500 shares of Series E Non-Voting Convertible Preferred Stock valued at $19.5 million to RPM shareholders, with each share convertible into common stock at $1.50 per share subject to NASDAQ listing rule constraints. The company simultaneously raised $300,000 through a bridge note with 50% discount conversion rights, intended to bolster stockholders' equity above the $2.5 million minimum required for continued listing on NASDAQ Capital Market under Rule 5550(b)(1). The transaction includes board representation for RPM's Mike Mathews and requires stockholder approval for the preferred stock conversion at a meeting scheduled for May 12, 2026. This merger and financing activity signals Avalon's effort to meet NASDAQ listing standards and acquire strategic assets while maintaining compliance with capital requirements.
ALBT
NASDAQ
▲ SUPER 8-K
Avalon GloboCare Corp. Common Stock
EDGAR Items: 1.01,2.01,2.03,3.02,5.02,5.03,7.01,9.01
# 8-K Filing Summary
**Avalon Globo (Filing Date: December 15, 2025)**
This 8-K reveals a significant material transaction: Avalon Globo has entered into a merger agreement (dated December 12, 2025) and simultaneously completed a major financing/acquisition event. The filing includes multiple material agreements including a merger plan, bridge financing, securities purchases, and the creation of Series E convertible preferred stock, indicating the company is undergoing substantial corporate restructuring. Additionally, there are changes to the company's articles of incorporation/bylaws and officer/director compensation arrangements being disclosed.
**Key Implications for Investors:** This represents a transformative event for the company involving both M&A activity and significant equity dilution through new preferred stock issuance and securities purchases. Investors should carefully review the merger agreement terms and financing structure, as the multiple financing instruments (bridge notes, securities purchases) suggest the deal may involve complex capital structures that could impact existing shareholders' positions.
BRR
NASDAQ
▲ SUPER 8-K
ProCap Financial, Inc. Common Stock
EDGAR Items: 1.01,2.01,2.03,3.02,3.03,5.01,5.02,5.03,5.05,5.06,7.01,9.01
# SEC 8-K Filing Summary
This 8-K filing from December 11, 2025 (with a report date of December 5, 2025) indicates a **significant corporate restructuring event**. The filing covers multiple material items including a change in control of the registrant, completion of an acquisition, entry into material definitive agreements, creation of new financial obligations, unregistered equity sales, and changes to the company's certificate of incorporation and bylaws. The extensive list of items—particularly Items 5.01 (change in control), 2.01 (acquisition completion), and 5.03 (charter/bylaw amendments)—suggests this company has undergone a **merger, acquisition, or substantial recapitalization**.
**Key implications for investors:** This appears to be a transformational event that fundamentally alters the company's ownership structure and governance. The involvement of warrant amendments, registration rights agreements, and equity issuances suggests new investors or acquirers have taken control. Shareholders should carefully review the detailed filing documents to understand dilution implications, new capital structures, and any changes to voting rights or company direction.
GREE
NASDAQ
▲ SUPER 8-K
Vulcan Infrastructure and Power Inc. Class A Common Stock
EDGAR Items: 2.01,8.01,9.01
# SEC 8-K Summary: Green Thumb Industries (GREE)
**Filing Date:** December 11, 2025
Green Thumb Industries completed a significant asset acquisition or disposition, as indicated by Item 2.01 of this 8-K filing. The filing includes a press release describing the transaction closing and supplementary documentation. While the specific details require review of the complete filing documents, the company has reported the completion of what appears to be a material transaction involving the sale or purchase of assets.
**Key Points for Investors:**
- The company has closed a previously announced transaction
- This represents a material corporate event that may affect the company's asset base and financial position
- Investors should review the attached press release and full 8-K details to understand the financial terms, strategic rationale, and expected impact on future earnings and operations
The filing was accepted on December 11, 2025, and contains 15 supporting documents including financial statements and exhibits.
RLEA
OTC
▲ SUPER 8-K
Rubber Leaf Inc
EDGAR Items: 1.01,2.01,8.01,9.01
# Summary of Rubber Leaf Inc 8-K Filing
Rubber Leaf Inc completed the sale of its PRC-based operating subsidiary, Rubber Leaf Sealing Products (Zhejiang) Co., Ltd., to Shanghai Yongliansen Import and Export Trading Co., Ltd. for $3 million on November 20, 2025. This transaction is a **related-party transaction**, as the company's CEO Xingxiu Hua owns 30% of the purchaser. The company has restructured its operations by establishing a Hong Kong-based subsidiary (Rubber Leaf Limited) as its primary operating entity, which has assumed the customer contracts and supply arrangements previously held by the divested PRC subsidiary. Management states the restructuring is not expected to materially affect consolidated financial results and does not represent a change of control. Investors should note the related-party nature of this transaction and monitor future disclosures regarding the company's operational transition and financial performance under the new Hong Kong-based structure.
TUSK
NASDAQ
▲ SUPER 8-K
Mammoth Energy Services, Inc. Common Stock
EDGAR Items: 1.01,2.01,7.01,9.01
# Summary of Mammoth Energy Services 8-K Filing
Mammoth Energy Services, Inc. completed the sale of its Aquawolf LLC subsidiary to Qualus LLC for $30.0 million on December 2, 2025, with $23.5 million paid at closing and $2.5 million held in escrow for post-closing adjustments and indemnifications. The Aquawolf business, part of the Infrastructure segment, represented a continuation of the company's strategic asset disposition strategy. This transaction, combined with the previously completed sales of infrastructure services (April 2025) and hydraulic fracturing equipment (June 2025), reflects Mammoth's significant operational restructuring and pivot away from its legacy service segments. The company obtained lender consent from Fifth Third Bank and released associated collateral, facilitating the transaction without covenant violations.
CAPS
NASDAQ
▲ SUPER 8-K
Capstone Holding Corp. Common Stock
EDGAR Items: 1.01,2.01,2.03,8.01,9.01
# Summary of Capstone Holding Corp. 8-K Filing
Capstone Holding Corp. (NASDAQ: CAPS) completed its acquisition of Fraser Canyon Holdings Inc. (Canadian Stone Industries) on December 1, 2025, through dual transactions: an asset purchase of Continental Stone Industries Inc. and a share purchase of FCHI. The total deal structure includes approximately $4.45 million in upfront cash consideration, C$3.6 million (~$2.58 million) in two subordinated promissory notes due through 2028, plus contingent earn-out payments up to C$3 million based on 2026-2028 EBITDA performance. The company has guaranteed the First SPA Note and obtained representations and warranties insurance to mitigate acquisition risk. Financial statements and pro forma information will be filed within 71 days, providing investors with additional details on the acquired business's financial position and the combined company's expected performance.
APUS
AMEX
▲ SUPER 8-K
Apimeds Pharmaceuticals US, Inc.
EDGAR Items: 1.01,2.01,2.03,3.02,5.01,5.02,5.03,7.01,9.01
# Summary of Apimeds Pharmaceuticals US, Inc. 8-K Filing
Apimeds Pharmaceuticals US, Inc. (ticker: APUS, NYSE American) completed a merger on December 1, 2025, whereby it acquired MindWave Innovations Inc., with MindWave becoming a wholly owned subsidiary of Apimeds. The transaction was structured to result in MindWave's existing stockholders receiving approximately 90.9% of Apimeds' equity on a fully diluted basis through a combination of common stock (capped at 29.9% of outstanding shares) and Series A convertible preferred stock (representing 61% of equity on an as-converted basis), effectively causing a significant dilution to existing Apimeds shareholders.
To facilitate the transaction, Apimeds obtained support from majority stockholders who agreed to approve via written consent several corporate actions including: conversions of preferred stock and promissory notes into common stock, issuance of shares in compliance with NYSE American rules, a 1-for-10 reverse stock split, amendments to the certificate of incorporation, and increases to equity incentive plan shares. This merger represents a material change in Apimeds' ownership structure and capital composition, with existing shareholders experiencing substantial ownership dilution as MindWave's shareholders obtain control of the combined entity.
CYH
NYSE
▲ SUPER 8-K
Community Health Systems, Inc.
EDGAR Items: 2.01,8.01,9.01
# Summary of Community Health Systems 8-K Filing
Community Health Systems, Inc. completed the sale of its ambulatory outreach business to Laboratory Corporation of America Holdings on December 1, 2025, receiving approximately $194 million in cash proceeds. The transaction involved the divestiture of select assets including patient service centers and in-office phlebotomy locations across 13 states. This represents a significant disposition for the company, as indicated by the inclusion of pro forma financial statements showing the impact of removing this business segment from operations. The sale provides CHS with liquidity and allows the company to streamline its operations while focusing on its core hospital and health services business.
FIEE
NASDAQ
▲ SUPER 8-K
FiEE, Inc Common Stock
EDGAR Items: 1.01,2.01,7.01,9.01
# FiEE, Inc. 8-K Summary
FiEE, Inc. completed two material transactions on November 30, 2025: the acquisition of 100% equity interests in Houren-Geiju Kabushikikaisha, a Japan-based digital authentication provider for art collections using AI and blockchain technology, for $500,000, and a concurrent technology transfer agreement for $3 million. The combined $3.5 million investment positions the company to expand into the art authentication market, leveraging Houren-Geiju's proprietary technology for certification and display services. Additionally, FiEE terminated its previously disclosed letter of intent to acquire Suzhou Yixuntong Network Technology Co., Ltd., though it retained certain transferred assets and intellectual property from that target, representing a strategic pivot in the company's acquisition strategy.
November 2025
19 filings
▼
SHPH
NASDAQ
▲ SUPER 8-K
Shuttle Pharmaceuticals Holdings, Inc. Common Stock
EDGAR Items: 1.01,2.01,3.02,9.01
# SEC 8-K Summary - November 26, 2025
Based on the filing metadata, this 8-K documents **three material events** for the company (CIK: 1757499):
1. **Material Definitive Agreement (Item 1.01)**: The company entered into a significant binding agreement, though specific details require reviewing the full 8-K document.
2. **Asset Acquisition or Disposition (Item 2.01)**: The company completed an acquisition or sale of assets, representing a material business transaction.
3. **Unregistered Equity Offering (Item 3.02)**: The company issued equity securities through an unregistered offering, suggesting either private placement financing or a stock deal component related to the transaction.
**Investor Implications**: This filing indicates significant corporate activity—likely an M&A transaction or major financing event that could materially affect shareholder value, capital structure, and future earnings. Investors should review the full 8-K document (form8-k.htm) and the material agreement (Exhibit 10.1) to understand deal terms, valuation, dilution impact, and strategic rationale.
DVLT
NASDAQ
▲ SUPER 8-K
Datavault AI Inc. Common Stock
EDGAR Items: 1.01,2.01,5.03,5.07,9.01
# SEC 8-K Summary: Datavault AI Inc.
On November 24-25, 2025, Datavault AI Inc. completed a major $150 million capital raise from Scilex Holding Company, receiving payment in Bitcoin for a pre-funded warrant exercisable for approximately 264 million shares of common stock. The company also secured stockholder approval to increase authorized shares from 320 million to 2.02 billion shares, with 2 billion designated as common stock, to accommodate the significant dilution from the warrant exercise.
This transaction substantially increases the company's equity base and potential dilution to existing shareholders, with the pre-funded warrant shares representing over 20% of previously outstanding shares. The use of Bitcoin as payment currency reflects evolving corporate financing trends, though the volatility of cryptocurrency valuation introduces additional risk. For investors, this massive equity issuance will substantially dilute existing shareholdings and voting power, though it provides the company with substantial capital for operations and growth.
NMAD
NASDAQ
▲ SUPER 8-K
Nomad Power Solutions, Inc. Common Stock
EDGAR Items: 1.01,2.01,3.02,5.03,7.01,9.01
# LIXTE Biotechnology Holdings 8-K Summary
On November 24, 2025, LIXTE Biotechnology Holdings completed its acquisition of Liora Technologies Europe Ltd., which holds intellectual property and assets related to LIGHT (Linac Image Guided Hadron Therapy), a proton-based radiotherapy solution recently acquired from Advanced Oncology PLC. The consideration includes 2,700 Series C Preferred Shares (convertible into 2.7 million common shares subject to shareholder approval), $440,000 in cash, 10.56 Bitcoin and 300 Ethereum, plus a 10% royalty on net revenues from the equipment up to a $45 million cap. This acquisition positions LIXTE to develop and commercialize advanced cancer treatment technology, though investors should note the significant dilution from the preferred share conversion and the ongoing royalty obligations that will impact future profitability. The transaction is subject to customary closing conditions, with shareholder approval required at the 2026 annual meeting for full conversion of the preferred stock.
SRG
NYSE
▲ SUPER 8-K
Seritage Growth Properties Class A common shares of beneficial interest, par value $0.01
EDGAR Items: 2.01,7.01,9.01
# Summary of Seritage Growth Properties 8-K Filing
Seritage Growth Properties completed the sale of its Aventura, Florida property for $131.0 million on November 25, 2025, to Boulevard Step Ventures LLC, as previously announced in September 2025. Simultaneously, the company used proceeds from recent property sales to make a $130 million voluntary prepayment on its $1.6 billion senior secured term loan facility with Berkshire Hathaway Life Insurance Company, reducing outstanding debt to $70 million and cutting annual interest expense by approximately $9.2 million. Since December 2021, the company has repaid $1.53 billion of its original term loan, demonstrating a significant debt reduction strategy. These transactions strengthen Seritage's balance sheet by reducing leverage and annual financing costs, which should positively impact future cash flows and financial flexibility for the REIT.
FDCTD
OTC
▲ SUPER 8-K
FDCTECH, INC.
EDGAR Items: 2.01,7.01,9.01
# Summary of FDCTech, Inc. Form 8-K Filing
FDCTech, Inc. filed an 8-K on November 18, 2025, announcing its unaudited financial results for the three and nine months ended September 30, 2025, through a press release. The filing provides no specific financial metrics, performance details, or material events in the 8-K document itself; all substantive information is contained in the attached press release (Exhibit 99.1), which is not included in this filing excerpt. As an emerging growth company with no securities currently registered on any exchange, FDCTech's disclosure has limited immediate market impact for public shareholders, though the results may be material for existing stakeholders and potential investors. Investors seeking details on the company's operational and financial performance must review the accompanying press release for specifics on revenue, earnings, or strategic developments.
FDCT
OTC
▲ SUPER 8-K
FDCTECH, INC.
EDGAR Items: 2.01,7.01,9.01
# SEC 8-K Filing Summary
**Company & Filing Details:** This Form 8-K was filed on November 24, 2025 (for period ending November 18, 2025) by a company with CIK 1722731, containing 15 documents.
**Material Events Reported:**
The filing discloses the **completion of an acquisition or disposition of assets** (Item 2.01), along with supplemental information disclosure (Item 7.01) and financial statements/exhibits. The company has provided supporting documentation including exhibits and financial data files.
**Key Implications for Investors:**
This acquisition completion represents a significant corporate event that may impact the company's operational structure, financial position, and future earnings potential. Investors should review the full 8-K document and exhibits to understand the deal terms, consideration paid, expected synergies, and any material changes to business operations or financial forecasts. The timing and scope of this transaction could affect near-term financial performance and shareholder value.
SITC
NYSE
▲ SUPER 8-K
SITE Centers Corp. Common Shares
EDGAR Items: 2.01
# Summary of SITE Centers Corp. 8-K Filing
On November 21, 2025, SITE Centers Corp. completed the sale of four retail properties for a combined $263.6 million in gross proceeds. The company sold three properties (East Hanover Plaza, Southmont Plaza, and Stow Community Center) to Haverford Retail Partners for $126.0 million and Nassau Park Pavilion to B33 Nassau Park Pavilion III LLC for $137.6 million. The company used approximately $143.6 million of the proceeds to repay mortgage debt and related fees, significantly reducing its leverage and strengthening its balance sheet. These asset dispositions represent a material reduction in the company's property portfolio and signal a strategic shift toward a smaller, more focused REIT portfolio while improving its debt position.
IGC
AMEX
▲ SUPER 8-K
IGC Pharma, Inc.
EDGAR Items: 2.01,9.01
# IGC Pharma, Inc. – 8-K Summary
IGC Pharma completed the sale of its Vancouver, Washington hemp processing facility on November 13, 2025, divesting equipment, inventory, and related operating assets of its Holi Hemp LLC subsidiary to Wellness Essentials Northwest LLC for approximately $2.7 million. This asset disposition, which was previously announced on October 1, 2025, closed after satisfaction of all conditions including an auditor's valuation review. The transaction represents a strategic streamlining of the company's operations, and pro forma financial statements reflecting the impact of this disposition have been filed with the SEC. For investors, this divestiture reduces the company's asset base and operating footprint, suggesting a potential shift in business strategy or financial restructuring.
SNTL
OTC
▲ SUPER 8-K
Sentinel Holdings Ltd.
EDGAR Items: 2.01,5.02,9.01
# Sentinel Holdings Ltd - 8-K Summary
Sentinel Holdings Ltd (OTCMKTS: SNTL), a Nevada-incorporated emerging growth company, completed the acquisition of Opsec Specialized Protections, Inc.'s security services business on October 16, 2025, for $650,000 in cash plus contingent consideration and operational commitments. The acquisition includes all service contracts, workforce, and intangible assets, with the seller's principal shareholder continuing as a consultant at $50,000 monthly for six months, and an additional $150,000 performance bonus contingent on maintaining revenue levels. The acquired business generated approximately $799,000 in monthly revenues as of September 2025, representing a material expansion of Sentinel's operations, though the company assumes minimal liabilities as most were retained by the seller. Financial statements for the transaction will be filed within 71 days, and investors should monitor whether the business maintains the required revenue threshold to trigger the full contingent payment.
ELME
NYSE
▲ SUPER 8-K
Elme Communities
EDGAR Items: 1.01,1.02,2.01,2.03,5.01,7.01,9.01
# ELME Communities 8-K Summary
On November 12, 2025, ELME Communities completed a major portfolio restructuring, selling a significant real estate portfolio to Cortland Partners affiliates for $1.606 billion and securing a $520 million senior secured term loan from Goldman Sachs Bank USA. The term loan, maturing November 9, 2026 (with a one-year extension option), is secured by first mortgages on 10 remaining properties and bears interest at one-month SOFR (3.00% floor) plus a 2.25% spread (increasing to 2.75% and 4.00% in later months). Concurrently, the Company repaid and terminated three prior credit facilities (Wells Fargo revolver, Truist term loan, and senior notes) without material early termination penalties. This transaction substantially deleverages ELME's capital structure and converts it into a smaller portfolio company, with the new financing structured as a bridge vehicle intended for repayment through future property sales.
CREX
NASDAQ
▲ SUPER 8-K
CREATIVE REALITIES, INC.
EDGAR Items: 1.01,2.01,2.02,2.03,3.02,3.03,5.02,5.03,5.08,9.01
# SEC 8-K Filing Summary
**Company & Filing Details:** Crexendo, Inc. (CIK: 1356093) filed an 8-K on November 12, 2025, reporting events as of November 6, 2025, with 24 supporting documents.
**Material Events Disclosed:** This is a multi-item 8-K indicating significant corporate activity, including: entry into a material definitive agreement (Item 1.01), completion of an acquisition or asset disposition (Item 2.01), changes to financial obligations (Item 2.03), unregistered equity issuance (Item 3.02), modifications to security holder rights (Item 3.03), executive personnel changes and compensation arrangements (Item 5.02), and amendments to corporate governance documents (Items 5.03 and 5.08).
**Key Implications for Investors:** The breadth of disclosed items—spanning M&A activity, equity issuance, debt obligations, executive changes, and charter amendments—suggests Crexendo has undertaken substantial corporate restructuring or strategic transactions. The unregistered equity sale and material agreement warrant close examination of potential dilution and financial impact. Investors should review the detailed exhibits to assess the transaction's terms, financing structure, and implications for shareholder value.
CAPS
NASDAQ
▲ SUPER 8-K
Capstone Holding Corp. Common Stock
EDGAR Items: 2.01,9.01
# Summary of Capstone Holding Corp. Form 8-K (August 22, 2025)
Capstone Holding Corp. completed its acquisition of Carolina Stone Holdings, LLC and Carolina Stone Distributors, LLC on August 22, 2025, for an aggregate purchase price of $2,625,000 in cash plus a $1,250,000 seller note and contingent earn-out payments. The acquired business operates showrooms, warehouses, and staging yards selling and distributing stone products for residential and commercial applications. Capstone paid $2,501,500 in initial cash, with a final working capital adjustment to be calculated within 120 days of closing. This acquisition expands Capstone's (ticker: CAPS, trading on Nasdaq) operational footprint in the stone products distribution sector, though the contingent earn-out structure indicates performance-based risk factors investors should monitor going forward.
BFRI
NASDAQ
▲ SUPER 8-K
Biofrontera Inc. Common Stock
EDGAR Items: 1.01,2.01,7.01,9.01
# SEC 8-K Filing Summary
This 8-K filing dated November 7, 2025 (for the period ending November 6, 2025) reports a **material acquisition or asset disposition** along with related definitive agreements. The filing includes four key items: entry into a material definitive agreement (Item 1.01), completion of an acquisition or asset disposition (Item 2.01), regulatory disclosure (Item 7.01), and financial statements/exhibits (Item 9.01).
The specific details of the transaction are contained in Exhibit 2.1 (the transaction agreement) and supplemental disclosures in Exhibit 99.1, though the HTML preview doesn't display the full content. For investors, this signals a **significant corporate action** that could materially affect the company's operations, financial position, and stock value—requiring review of the complete filing documents to assess impact on earnings, cash flow, and strategic direction.
BURU
AMEX
▲ SUPER 8-K
Nuburu, Inc.
EDGAR Items: 1.01,2.01,9.01
# Nuburu, Inc. 8-K Summary
Nuburu entered into a material related-party acquisition agreement on October 31, 2025, to acquire Orbit S.r.l., an Italian software company specializing in operational resilience solutions, from Executive Chairman Alessandro Zamboni (through his holding company Vanguard). The total transaction value is approximately $17.5 million, consisting of a $5 million equity infusion plus $12.5 million purchase price ($3.75 million cash and $8.75 million in newly-issued preferred shares). The deal requires stockholder approval for the issuance of the Orbit Preferred Shares and is expected to close by December 31, 2026, with tranched payments through that date.
**Investor Impact:** This related-party transaction, which independent directors approved, dilutes existing shareholders through preferred share issuance (with 5:1 voting rights) and commits significant capital over 15 months. The deal includes execution risks tied to tranche-based funding and requires navigating NYSE American approval for the enhanced-voting preferred structure.
CRIS
NASDAQ
▲ SUPER 8-K
Curis Inc
EDGAR Items: 1.02,2.01,2.02,8.01,9.01
# SEC 8-K Filing Summary
**Company:** Crises Inc. (CIK: 1108205)
**Filing Date:** November 6, 2025
## Key Events:
This 8-K discloses multiple material events including the **termination of a material definitive agreement** (Item 1.02), **completion of an acquisition or asset disposition** (Item 2.01), and **results of operations** (Item 2.02). The filing indicates significant corporate restructuring activity with a Q3 2025 earnings press release included as an exhibit.
## Implications for Investors:
The combination of agreement termination, asset transaction completion, and financial results reporting suggests the company is undergoing substantial operational changes. Investors should review the detailed filing and earnings release to understand the financial impact of these transactions, how they affect future guidance, and whether they represent strategic repositioning or responses to business challenges. The materiality of these events warrants careful analysis of the company's updated financial position and forward-looking statements.
MITQ
AMEX
▲ SUPER 8-K
Moving iMage Technologies, Inc.
EDGAR Items: 1.01,2.01,7.01,9.01
# Summary of Moving iMage Technologies, Inc. 8-K Filing
Moving iMage Technologies, Inc. completed the acquisition of QSC's Digital Cinema Speaker Series (DCS) loudspeaker product line on October 31, 2025, for $1.5 million. The acquisition includes the DCS loudspeaker product families (SC, SR, SB, and RSM), associated intellectual property (trademarks, designs, and trade secrets), inventory, OEM supplier agreements, technical documentation, and customer service rights. This strategic purchase expands the company's product portfolio in the professional audio/cinema speaker market and provides access to an established customer base and established brand. The transaction was financed and completed immediately, positioning Moving iMage Technologies to leverage the globally recognized DCS brand and existing support infrastructure for customer retention and revenue growth.
CNFN
OTC
▲ SUPER 8-K
CFN Enterprises Inc.
EDGAR Items: 1.01,2.01,3.02,7.01,9.01
# CFN Enterprises Inc. - 8-K Summary
CFN Enterprises completed its acquisition of Prestige Worldwide Wine Company on November 3, 2025, through its subsidiary J Street Capital Partners, paying 150,000 unregistered shares of common stock to acquire 100% of the winemaking consulting company and its global trademarks, intellectual property, and distributor network. The seller has agreed to a 12-month lockup and 48-month leak-out provision on the shares. As part of the transaction, experienced wine industry executive Thomas Hinde will provide winemaking consulting services to J Street for an initial one-year period, bringing three decades of expertise from prestigious California wineries including Flowers Vineyard, Kendall-Jackson, and Stonestreet. The board views this acquisition as a key strategic complement to its recent J Street acquisition, though the company is also reviewing strategic alternatives for its Ranco subsidiary given the current regulatory environment. Investors should note that the 150,000-share issuance dilutes existing shareholdings and introduces liquidity risk after the lockup period expires.
TPET
AMEX
▲ SUPER 8-K
Trio Petroleum Corp.
EDGAR Items: 2.01,3.02,7.01,9.01
# Trio Petroleum Corp (TPET) - 8-K Summary
Trio Petroleum Corp completed the acquisition of oil and gas assets from Capital Land Services Ltd. on November 3, 2025, paying CAD $150,000 in cash plus 104,227 restricted shares (valued at CAD $150,000) for mineral leases and working interests in Alberta, Canada. The acquired assets, including certain wells previously in receivership, have been operationally transferred to Novacor Exploration Ltd., an experienced operator, to satisfy Alberta Energy Regulator licensing requirements and reduce security deposit obligations. In compensation for ongoing regulatory agent services, Trio granted the Seller a 1% gross overriding royalty on the mineral rights. The restricted shares were issued under Section 4(a)(2) private placement exemption, representing dilution to existing shareholders.
LFMD
NASDAQ
▲ SUPER 8-K
LifeMD, Inc. Common Stock
EDGAR Items: 1.01,2.01,7.01,9.01
# SEC 8-K Filing Summary
**Company & Date:** Filing dated November 4, 2025 (CIK: 948320)
**Material Events:** This 8-K reports the completion of a material acquisition or disposition of assets (Item 2.01) and the entry into a material definitive agreement (Item 1.01). The filing includes a substantial exhibit (708KB agreement document) and supplementary disclosure materials.
**Key Implications for Investors:** The company has finalized a significant transaction involving either the purchase/sale of assets or business operations. The substantial size of the attached agreement and the inclusion of regulatory FD disclosure suggests this is a material event that could meaningfully impact the company's financial position, operations, or strategic direction. Investors should review the full 8-K document and attached exhibits to understand the transaction details, financial terms, and potential impact on earnings and business strategy.
October 2025
24 filings
▼
CLDI
AMEX
▲ SUPER 8-K
Calidi Biotherapeutics, Inc.
EDGAR Items: 1.01,1.02,2.01,9.01
# Calidi Biotherapeutics 8-K Summary
Calidi Biotherapeutics has divested its majority-owned subsidiary Nova Cell, Inc., selling 100% of its equity stake (22.5 million shares representing 75% ownership) for $6 million under a Stock Repurchase Agreement executed on October 27, 2025. The transaction consideration consists of $1.21 million in debt cancellation and $4.79 million in deferred payments, with ongoing royalties on specified materials thereafter. Concurrently, Calidi transferred intellectual property and materials to Nova Cell via a Material Purchase Agreement while retaining stocks of certain cell lines for its own use. The divestiture is expected to reduce general and administrative expenses by approximately $0.5 million annually, though investors should note that future cash flow will depend on realizing the deferred consideration and royalty payments, which introduce execution risk.
HTCR
NASDAQ
▲ SUPER 8-K
Heartcore Enterprises, Inc. Common Stock
EDGAR Items: 1.01,2.01,7.01,8.01,9.01
# SEC 8-K Filing Summary
This 8-K filing from October 31, 2025 (CIK: 1892322) reports a **material acquisition or disposition of assets** along with entry into a material definitive agreement. The filing includes multiple items indicating significant corporate activity: completion of an acquisition/disposition (Item 2.01), a material definitive agreement (Item 1.01), regulatory disclosures (Item 7.01), and other events (Item 8.01).
**Key for Investors:** The presence of Items 1.01 and 2.01 suggests the company has completed a substantial M&A transaction or asset transaction. The substantial size of the attached agreement exhibit (EX-10.1 at ~545KB) indicates complex deal terms. Investors should review the actual agreement and press release (EX-99.1) to understand the transaction's financial impact, terms, and strategic rationale, as this type of event can significantly affect company valuation, debt levels, and future earnings potential.
MYCB
OTC
▲ SUPER 8-K
My City Builders, Inc.
EDGAR Items: 1.01,2.01,2.03,5.06,9.01
# Summary of My City Builders, Inc. 8-K Filing
On October 31, 2025, My City Builders, Inc. acquired 4 acres of land in Glencoe, Alabama through an asset purchase agreement with RAC Gadsden, LLC (an affiliate entity controlled by the company's existing majority shareholders), financed by a $350,000 secured promissory note due October 30, 2028 at 9.5% annual interest. The company plans to develop the property into up to 25 multi-family residential units, with an 8-unit duplex as the first phase. Critically, the company must begin construction within one year or face default, which could result in either immediate payment of the entire debt or loss of the property. This transaction also marks the company's transition from shell company status to an operating business with real estate assets.
**Investor Impact:** While the acquisition signals management's intention to operate a real estate development business, investors face significant execution risk—the aggressive one-year construction deadline creates a material default trigger, and the transaction is largely self-dealing given control by the same affiliated parties on both sides of the deal.
CLRO
NASDAQ
▲ SUPER 8-K
ClearOne, Inc. Common Stock
EDGAR Items: 1.01,2.01,9.01
# SEC 8-K Filing Summary
**Company & Event:** Celero (CIK: 840715) filed an 8-K on October 30, 2025, reporting the entry into a material definitive agreement and completion of an acquisition or disposition of assets.
**Key Material Changes:** The filing indicates two significant corporate actions: (1) execution of a material definitive agreement (Item 1.01), and (2) completion of an acquisition or asset disposition (Item 2.01). The substantial exhibits included (188 KB agreement and 307 KB supporting document) suggest a significant transaction.
**What This Means for Investors:** Investors should review the attached exhibits—particularly Exhibit 10.1 (the definitive agreement) and Exhibit 99.1 (likely a press release or transaction summary)—to understand the transaction's scope, terms, and financial impact on Celero. This could represent a strategic acquisition, divestiture, or major partnership with material implications for the company's future direction and shareholder value.
FUSE
NASDAQ
▲ SUPER 8-K
Fusemachines Inc. Common stock
EDGAR Items: 1.01,2.01,3.02,3.03,5.01,5.02,5.03,5.05,5.06,7.01,9.01
# SEC 8-K Filing Summary
This 8-K filing dated October 28, 2025 (reporting period October 22, 2025) indicates **major corporate restructuring activity** involving the company. The filing covers multiple significant items including a material definitive agreement, completion of an acquisition/disposition, unregistered equity sales, changes in control of the registrant, modifications to security holder rights, changes in directors/officers, amendments to articles of incorporation, and a change in shell company status.
**Key Material Events:**
The breadth of disclosed items—particularly Items 5.01 (Changes in Control), 5.06 (Shell Company Status), and Item 2.01 (Acquisition/Disposition)—suggests this company has undergone a **transformative transaction**, likely a merger, reverse merger, or significant asset acquisition that fundamentally altered corporate control and structure.
**Investor Implications:**
Investors should carefully review the detailed exhibits (merger agreement, new articles of incorporation, officer compensation arrangements) to understand the new ownership structure, management team, and capitalization. The change in shell company status and control shift could significantly impact voting rights, stock dilution, and company direction. This represents a high-impact event requiring thorough due diligence before making investment decisions.
BAER
NASDAQ
▲ SUPER 8-K
Bridger Aerospace Group Holdings, Inc. Common Stock
EDGAR Items: 1.01,1.02,2.01,7.01,9.01
# Summary of Bridger Aerospace 8-K Filing (October 29, 2025)
Bridger Aerospace announced multiple material financial transactions, including entry into a new credit agreement dated October 28, 2025, and completion of a sale-leaseback transaction. The filing covers Items 1.01 (material agreement entry), 1.02 (agreement termination), and 2.01 (asset disposition), indicating significant refinancing and capital structure changes. These transactions appear designed to improve liquidity and manage the company's debt obligations, suggesting potential financial restructuring to support operations or growth initiatives. Investors should review the detailed credit agreement and press releases included in the filing to understand the specific terms, interest rates, covenants, and impact on shareholder equity and future financial flexibility.
DOUG
NYSE
▲ SUPER 8-K
Douglas Elliman Inc.
EDGAR Items: 1.01,2.01,5.02,8.01,9.01
# Douglas Elliman Inc. (DOUG) - 8-K Summary
Douglas Elliman completed the sale of its property management division (DEPM) to PMG Holdings, Inc. for a base purchase price of $85 million on October 24, 2025, with closing occurring simultaneously. The company expects to recognize a substantial after-tax gain exceeding $75 million in Q4 2025 from this divestiture and related debt redemption. Post-closing, Douglas Elliman will exclude DEPM's financial results from its consolidated statements, though it will maintain a trademark license agreement and referral arrangement with the new operator to preserve the Douglas Elliman brand relationship with property management customers. The transaction includes standard representations, warranties, and five-year non-compete/non-solicitation covenants, with BofA Securities serving as exclusive financial advisor.
**Investor Impact:** The significant one-time gain provides near-term earnings accretion and capital to strengthen the balance sheet, but the divestiture reduces recurring revenue from the property management segment, representing a strategic shift toward core residential brokerage operations.
BFRI
NASDAQ
▲ SUPER 8-K
Biofrontera Inc. Common Stock
EDGAR Items: 1.01,2.01,3.02,8.01,9.01
# SEC 8-K Filing Summary
**Company & Filing Details:** This is a Form 8-K filed on October 24, 2025, covering events from October 20, 2025 (CIK: 1858685).
**Material Events Disclosed:**
The filing reports four significant items: (1) entry into a material definitive agreement, (2) completion of an acquisition or disposition of assets, (3) unregistered sales of equity securities, and (4) other events. The presence of multiple exhibits (including two substantial agreements) suggests a complex transaction.
**Key Implications for Investors:**
Without access to the actual document content, the combination of a new material agreement, asset transaction completion, and equity issuance indicates the company has completed a significant corporate action—likely an acquisition, merger, or substantial asset deal involving equity financing. Investors should review the full 8-K and attached exhibits (EX-10.1 and EX-10.2) to understand the transaction terms, financial impact, dilution effects, and strategic rationale, as these events could materially affect shareholder value and the company's future financial performance.
AHT
NYSE
▲ SUPER 8-K
Ashford Hospitality Trust, Inc.
EDGAR Items: 2.01,9.01
# Summary of Ashford Hospitality Trust 8-K Filing
Ashford Hospitality Trust completed the sale of its 150-room Residence Inn San Diego Sorrento Mesa hotel on October 15, 2025, for $42 million in cash to Lily, LP (as successor to DKN Ventures, LP). This asset disposition is part of the company's portfolio optimization strategy, generating liquidity from a non-core property. The transaction was executed under terms agreed upon in August 2025 and represents a modest capital redeployment opportunity for the hospitality REIT. Pro forma financial information reflecting the hotel disposition has been filed with the SEC and should be reviewed by investors to assess the impact on the company's portfolio composition and financial metrics.
EMPD
NASDAQ
▲ SUPER 8-K
Empery Digital Inc. Common stock
EDGAR Items: 1.01,2.01,8.01,9.01
# Empery Digital Inc. 8-K Summary
On October 15, 2025, Empery Digital Inc. divested its power sports business by transferring intellectual property assets—including the "Volcon" trademarks, patents, vehicle designs, and related marketing and sales assets—to Venom EV, LLC in exchange for a 10% equity stake in Venom on a fully diluted basis. The equity issuance is contingent on Venom's conversion to a Delaware corporation within six months; if this conversion fails, Empery retains the option to repurchase the IP for nominal consideration. Additionally, Empery secured the right to appoint one director to Venom's board for five years, providing some governance influence over the acquirer.
**Investor Impact:** This transaction represents a material exit from the power sports segment for Empery Digital, effectively pivoting the company's focus away from this business line. While the 10% ownership stake in Venom offers potential upside if that company succeeds, investors should note the equity value is contingent on corporate conversion and remains illiquid and difficult to value at this stage. The strategic realignment may indicate either a refocus of operations or financial restructuring.
HWNI
OTC
▲ SUPER 8-K
HIGH WIRE NETWORKS, INC.
EDGAR Items: 1.01,2.01,5.02,9.01
# SEC 8-K Filing Summary: High Wire Networks, Inc.
**Filing Date:** October 14, 2025 (reporting period: July 9, 2025)
High Wire Networks, Inc. completed two material asset purchase agreements: one with OW Cyber LLC and another between its Secure Voice Corp. subsidiary and Secure Voice LLC. The filing indicates significant corporate restructuring through the acquisition/disposition of assets, accompanied by changes to the company's officer and director composition with new compensatory arrangements. These transactions represent notable strategic moves that could affect the company's operational structure and shareholder value, though the specific financial details and strategic rationale would require review of the actual agreements and 8-K narrative to fully assess investor impact.
MNKD
NASDAQ
▲ SUPER 8-K
Mannkind Corporation
EDGAR Items: 1.01,2.01,2.03,9.01
# SEC 8-K Filing Summary
**Company & Filing:** Mannkind Corporation (MNKD) filed an 8-K on October 9, 2025, reporting material corporate developments dated October 7, 2025.
**Key Material Events:**
The filing discloses entry into a material definitive agreement (Item 1.01), completion of an acquisition or disposition of assets (Item 2.01), and creation of a direct financial obligation (Item 2.03). These items suggest the company executed a significant business transaction, likely involving either an acquisition, asset sale, or substantial financing arrangement.
**Financial Impact:**
The company has taken on new direct financial obligations as part of this transaction, which could materially affect the balance sheet and future cash flows. The specific terms and financial details are contained in the attached definitive agreement (Exhibit 10.1).
**Investor Implications:**
Investors should review the complete 8-K filing and attached agreements to understand the transaction's strategic rationale, funding structure, potential dilution, and impact on future financial performance. The simultaneous disclosure of a material agreement, asset transaction, and new financial obligations suggests a transformative event that warrants careful analysis of the company's financial health and strategic direction.
FOFA
OTC
▲ SUPER 8-K
FAMILY OFFICE OF AMERICA, INC.
EDGAR Items: 1.01,2.01
# Summary of Family Office of America, Inc. 8-K Filing
Family Office of America, Inc. completed the acquisition of accounting service assets from Toone & Associates, LLP for a total purchase price of $1.5 million, with $750,000 paid at closing on October 3, 2025, and the remainder due in two installments ($450,000 on October 1, 2026, and $300,000 on May 1, 2027). The purchase price is subject to downward adjustment based on the revenue and EBITDA performance of the acquired assets during the twelve-month period following closing. This acquisition represents the company's expansion into the accounting services business through asset acquisition rather than organic growth.
BRFH
NASDAQ
▲ SUPER 8-K
Barfresh Food Group Inc. Common Stock
EDGAR Items: 2.01,2.03,9.01
# SEC 8-K Filing Summary
Based on this October 7, 2025 Form 8-K filing, the company reported two significant material events: **completion of an acquisition or disposition of assets** (Item 2.01) and **creation of a direct financial obligation** (Item 2.03). While the filing itself doesn't contain the detailed content in this document index, these items indicate the company has either acquired or sold a substantial asset and taken on new debt or financial obligations related to the transaction.
For investors, this signals a meaningful corporate transaction that may impact the company's capital structure, balance sheet, and strategic direction. The filing includes related agreements (Exhibits 10.1 and 10.2) and a press release (Exhibit 99.1) that would provide specifics on the deal terms, financing, and strategic rationale. Investors should review the full 8-K document and exhibits to understand the transaction's financial impact and implications for future growth and shareholder value.
ELUT
NASDAQ
▲ SUPER 8-K
Elutia Inc. Class A Common Stock
EDGAR Items: 1.01,2.01,7.01,8.01,9.01
# SEC 8-K Filing Summary
**Company & Date:** Filing dated October 7, 2025, reporting events as of October 1, 2025 (CIK: 1708527)
**Material Events:**
This 8-K discloses multiple significant corporate transactions and agreements, including: (1) entry into a material definitive agreement, (2) completion of an acquisition or disposition of assets, and (3) other material events. The filing includes substantial exhibits, including a large agreement document (Exhibit 10.2) and detailed disclosures (Exhibits 99.1 and 99.2), suggesting a substantial business combination or major contract.
**Investor Implications:**
The filing's focus on completed acquisitions/dispositions and material agreements indicates the company has undergone significant structural or operational changes. Investors should carefully review the detailed exhibits and agreement terms to understand the deal's financial impact, funding sources, and strategic rationale, as this likely represents a transformative event for the company.
*Note: The HTML provided does not contain the actual filing content details; investors should access the full 8-K document (tm2528122d1_8k.htm) for complete specifics on the transaction terms, valuation, and implications.*
NEOV
NASDAQ
▲ SUPER 8-K
NeoVolta Inc. Common Stock
EDGAR Items: 1.01,2.01,3.02,5.02,9.01
# SEC 8-K Summary: NeoVolta, Inc.
**Filing Date:** October 7, 2025 (Period: October 1, 2025)
NeoVolta, Inc. announced a material acquisition/asset purchase and significant management changes effective October 1, 2025. The company entered into an asset purchase agreement and appointed new executives, including Amany Ibra and Thomas Enz, under new employment agreements. Additionally, the filing indicates an unregistered equity issuance occurred in connection with these transactions.
**Key Implications for Investors:** This represents a significant corporate restructuring event that could indicate a strategic pivot, change in business direction, or acquisition of new operations. Investors should review the detailed asset purchase agreement and executive compensation arrangements to assess the transaction's terms, potential dilution from equity issuance, and management's confidence in the new strategic direction. The specific nature of acquired assets and their accretion to earnings will be critical in determining whether this transaction creates or destroys shareholder value.
ALCE
OTC
▲ SUPER 8-K
Aedis Energy Inc.
EDGAR Items: 1.01,2.01,3.03,5.03,8.01,9.01
# Alternus Clean Energy 8-K Summary
Alternus Clean Energy completed a material joint venture transaction on September 30, 2025, with Hover Energy LLC involving the sale of a 49% stake in its EverOn Energy LLC subsidiary in exchange for Hover's microgrid wind power projects and the issuance of 21,150 shares of Series B Convertible Preferred Stock valued at approximately $21 million. As part of settling a prior strategic alliance, the company also agreed to repay $5.15 million in outstanding obligations to Hover through a combination of Series B shares ($1.15 million), a third-party payment ($1.7 million), and future cash payments ($2.3 million). The transaction is expected to generate over $50 million in future revenue streams from UK and US microgrid projects and should improve stockholder equity, though this represents a material acquisition exceeding 20% of consolidated assets requiring pro forma financial statements within 75 days. The Series B shares convert to common stock at $1.00 per share beginning six months after the company uplists to a national exchange (or nine months if no uplisting occurs), subject to anti-dilution adjustments and a 19.99% ownership cap restriction for the holder.
FNGR
NASDAQ
▲ SUPER 8-K
FingerMotion, Inc. Common Stock
EDGAR Items: 1.01,2.01,3.02,9.01
# SEC 8-K Filing Summary
**Company:** Fingerprint Technology (FNGR) | **Filing Date:** October 6, 2025
This 8-K filing reports three significant corporate events: (1) entry into a material definitive agreement, (2) completion of an acquisition or asset disposition, and (3) unregistered sales of equity securities. The filing indicates major business restructuring or strategic transaction activity as of September 30, 2025.
While the specific details of the agreement and acquisition require review of the full 8-K document and Exhibit 10.1, these items collectively suggest the company has undertaken a substantial business combination or capital transaction that could materially impact shareholders. Investors should review the complete filing to understand the transaction terms, financial impact, and any potential dilution from the equity issuance.
TRSO
OTC
▲ SUPER 8-K
TRANSUITE.ORG INC.
EDGAR Items: 1.01,2.01,3.02,9.01
# Summary of Transuite.Org Inc. 8-K Filing
On September 30, 2025, Transuite.Org Inc. (TRSO) completed an acquisition of 100% of Xirangsheng (Shenzhen) Health Technology Co., Ltd. (XRS), an AI-powered Traditional Chinese Medicine (TCM) healthcare technology company, through its subsidiary Crestar Holdings Limited. TRSO issued 10 million restricted common shares as initial consideration, with an earnout provision allowing for additional share issuance within 60 days based on an independent valuation of XRS. This strategic expansion positions TRSO in the AI healthcare sector, with XRS offering AI social agents leveraging TCM knowledge bases, health supervision systems, and proprietary TCM e-books. The earnout structure introduces dilution risk for existing shareholders pending the valuation outcome and stock price performance, representing a material change in the company's business focus from its prior operations.
SKYA
NASDAQ
▲ SUPER 8-K
SkyAI, Inc. Common Stock
EDGAR Items: 1.01,2.01,9.01
# Summary of Sharps Technology, Inc. 8-K Filing (October 6, 2025)
Sharps Technology, Inc. has settled outstanding litigation with Barry Berler (former co-founder and CTO) and affiliated entities (Plastomold Industries, Plasto Design Solutions, and others) through a confidential settlement agreement executed on October 6, 2025. Under the settlement, the company will divest significant assets, including its Hungarian subsidiary (Safegard Medical Kft), certain business assets, patents, and trademarks to Plasto Technology LLC, with neither party admitting fault or liability. The agreement represents a material asset disposition that could meaningfully impact the company's operational footprint and patent portfolio, though the financial terms remain confidential. Investors should monitor pro forma financial statements and future filings to assess the financial impact of losing the Hungarian subsidiary and related intellectual property on the company's growth prospects and revenue streams.
SNBH
OTC
▲ SUPER 8-K
SENTIENT BRANDS HOLDINGS INC.
EDGAR Items: 1.01,2.01,9.01
# SEC 8-K Summary: Sentient Brands Holdings Inc.
On September 30, 2025, Sentient Brands Holdings Inc.'s 51%-owned subsidiary, Aqua Emergency Inc. (Nevada), completed the acquisition of substantially all operating assets from Aqua Emergency Inc. (Florida) for $1.9 million in aggregate value. The acquired assets include machinery, equipment, inventory, accounts receivable, licenses, and prepaid expenses, with consideration paid through deferred "Acquisition Credits" rather than cash, reflecting contingent rights to future economic benefits from asset commercialization. This asset transfer consolidates Aqua Emergency operations under the Nevada subsidiary and is governed by the terms of a June 3, 2025 Share Exchange Agreement between the parent company and the Florida entity. The lack of cash consideration and reliance on future contingent credits suggest Sentient Brands may face liquidity constraints, warranting investor scrutiny regarding the company's ability to realize value from these acquired assets.
HYEX
OTC
▲ SUPER 8-K
HEALTHY EXTRACTS INC.
EDGAR Items: 1.01,1.02,2.01,3.02,5.01,5.02,9.01
# Summary of Healthy Extracts Inc. 8-K Filing
Healthy Extracts Inc. completed an acquisition of Gummy USA LLC on September 30, 2025, issuing 13.1 million shares (77.5% ownership) to sole member Donald Swanson, resulting in a change of control. Notably, the company initially executed this transaction on July 19, 2025 via a Membership Interest Purchase Agreement, then rescinded it on September 26, 2025, and re-executed it on September 30, 2025 through a merger structure, while maintaining identical economic terms. Swanson was appointed as Chairman and CEO, bringing claimed expertise in pharmaceutical-grade gummy manufacturing and international production facilities, while existing management (Kevin Pitts and Robert Madden) transitioned to President/COO and Manager roles respectively. The filing indicates financial statements and pro forma information will be filed within 71 days, and one director (William Bossung) resigned on October 1, 2025. For investors, the change of control dilutes existing shareholders substantially, with Swanson's anti-dilution rights further protecting his 77.5% stake against future equity issuances.
GDC
NASDAQ
▲ SUPER 8-K
GD Culture Group Limited Common Stock
EDGAR Items: 2.01,3.02
# SEC 8-K Filing Summary: GD Culture (CIK 1641398)
**Filing Date:** October 2, 2025 | **Period:** September 29, 2025
This 8-K reports two significant corporate events: the **completion of an acquisition or disposition of assets** (Item 2.01) and **unregistered sales of equity securities** (Item 3.02). The filing indicates material changes to the company's asset base and capitalization structure, though the specific details of the transaction would require reviewing the full disclosure document to understand the transaction value, parties involved, and strategic rationale. These transactions could materially impact shareholder value and the company's operational scope, making this a critical event for investors to analyze in detail.
SPFX
OTC
▲ SUPER 8-K
STANDARD PREMIUM FINANCE HOLDINGS, INC.
EDGAR Items: 2.01,9.01
# Summary: Standard Premium Finance Holdings, Inc. – Form 8-K Filing
Standard Premium Finance Holdings, Inc. secured a significant refinancing amendment on September 25, 2025, increasing its maximum borrowing capacity to $75 million with an additional $40 million accordion feature for a total of $115 million from a syndicate of three banks (First Horizon Bank, Flagstar Bank, and Cadence Bank). The company achieved favorable terms, including a reduction in interest rate margin to 210 basis points from 255-296 basis points previously, and extended the maturity date to September 25, 2028. This refinancing provides the company with enhanced liquidity and lower borrowing costs, demonstrating lender confidence and improving the company's financial flexibility going forward.
September 2025
23 filings
▼
MIRA
NASDAQ
▲ SUPER 8-K
MIRA Pharmaceuticals, Inc. Common Stock
EDGAR Items: 1.01,2.01,3.02,8.01,9.01
# SEC 8-K Filing Summary
**Company & Filing Details:**
This 8-K was filed by Mira Pharmaceuticals (CIK: 1904286) on September 30, 2025, reporting events as of September 29, 2025.
**Material Events Reported:**
The filing covers multiple significant items including: (1) entry into a material definitive agreement, (2) completion of an acquisition or disposition of assets, (3) unregistered sales of equity securities, and other events. The substantial size of the attached agreement document (EX-10.1 at 346KB) suggests a major transaction.
**Key Implications for Investors:**
Without access to the complete filing content, the combination of a material agreement, asset acquisition completion, and equity issuance indicates Mira Pharmaceuticals has executed a significant corporate transaction—likely a merger, acquisition, licensing deal, or major financing. Investors should review the full 8-K document to understand the deal terms, financial impact, dilution from new equity, and strategic rationale, as these transactions can materially affect shareholder value and the company's future direction.
GAMG
OTC
▲ SUPER 8-K
Global Asset Management Group, Inc.
EDGAR Items: 2.01
# 8-K Summary: Global Asset Management Group, Inc.
On September 29, 2025, Global Asset Management Group, Inc. completed its acquisition of DC Rental Portfolio Corp., a District of Columbia-based affordable housing developer, in exchange for 250 million shares of common stock. DC Rental owns or is acquiring multi-family residential properties in Washington, D.C., including three current properties valued at approximately $36.8 million (current acquisition costs of $19.7 million with projected post-renovation values exceeding $32.8 million). The company plans to acquire two additional multi-family properties in Q4 2025 and pursue a long-term strategy of expanding its real estate portfolio nationally while eventually acquiring a lending institution. For investors, this represents a significant dilution event (250 million new shares issued), though the transaction strategically pivots the company toward real estate operations in a market with strong demand fundamentals and potential for value appreciation through renovation and repositioning.
HBUV
OTC
▲ SUPER 8-K
Hubilu Venture Corp
EDGAR Items: 1.01,2.01
# Summary of Hubilu Venture Corporation 8-K Filing
Hubilu Venture Corporation completed the acquisition of real property located at 1460 Exposition Blvd. in Los Angeles on September 24, 2025, for $520,000 through its subsidiary Elata Investments, LLC. The property was vacant at purchase and is financed primarily through a $478,000 first position loan from Center Street Lending VIII SPE, LLC, bearing 9.99% annual interest with monthly payments of $3,896.10 commencing November 1, 2025, and a balloon payment due September 17, 2026. This real estate acquisition represents a material expansion of the company's asset base, though the aggressive financing structure with a short 12-month repayment horizon and relatively high interest rate presents refinancing or liquidity risk for investors if the property cannot generate sufficient income or be refinanced before the balloon payment deadline.
SPWR
NASDAQ
▲ SUPER 8-K
SunPower Inc. Common Stock
EDGAR Items: 2.01,2.03,3.02,9.01
# Complete Solaria, Inc. (SPWR) - 8-K Summary
Complete Solaria, Inc. closed the acquisition of Sunder Energy LLC on September 24, 2025, for total consideration of approximately $60 million, including $20 million in cash, a $20 million seller note, 3.3 million shares issued immediately, and up to 6.7 million additional shares subject to stockholder approval over the next 18 months. To fund the $20 million cash portion and transaction expenses, the company simultaneously closed a $22 million offering of 7.00% Convertible Senior Notes due 2029, generating net proceeds of $19.8 million. The seller note carries a 7.0% interest rate, matures by May 15, 2026, and includes customary events of default including change of control and bankruptcy triggers. This acquisition and financing materially increases the company's debt obligations and dilutes existing shareholders through significant near-term and contingent share issuances, while substantially increasing the company's asset base through the Sunder Energy acquisition.
FOXO
OTC
▲ SUPER 8-K
FOXO TECHNOLOGIES INC.
EDGAR Items: 2.01,3.02,7.01,9.01
# FOXO Technologies Inc. - 8-K Summary
FOXO Technologies Inc. completed its acquisition of Vector Bio Source Inc. on September 19, 2025, in an all-stock and cash transaction valued at approximately $2.5 million total consideration. The acquisition was settled through $500,000 in cash, 60,000 shares of Series E Cumulative Redeemable Secured Preferred Stock, and warrants to purchase up to $2 million of common stock at an exercise price of $0.00517 per share. Vector is now a wholly-owned subsidiary consolidated into FOXO's financial statements. The securities issued were unregistered under Section 4(a)(2) of the Securities Act and Regulation D Rule 506(b), indicating reliance on private placement exemptions. This acquisition expands FOXO's asset base and operational footprint, though the relatively modest deal size and emerging growth company status suggest FOXO remains an early-stage, high-risk venture requiring investor diligence on Vector's business fundamentals and synergy potential.
PWCM
NASDAQ
▲ SUPER 8-K
PowerCompute, Inc. Common Stock
EDGAR Items: 1.01,2.01,2.03,7.01,9.01
# LM Funding America, Inc. (LMFA) - 8-K Summary
LM Funding America completed two significant transactions on September 16, 2025: the acquisition of a 6.4-acre Mississippi mining property and related equipment for approximately $3.9 million, plus the purchase of bitcoin mining hardware for ~$362,000. To fund these acquisitions, the company secured an additional $2.0 million loan from SE & AJ Liebel Limited Partnership on September 15, 2025, at 12% annual interest, maturing in September 2027, with $1.3 million funded immediately and up to $700,000 available by October 15, 2025.
The new loan increases the company's total debt to existing lender from $5.0 million to $7.0 million and is secured by the same collateral as the original loan, though with increased Bitcoin collateral requirements (110% of total outstanding principal). For investors, this represents a capital-intensive expansion into bitcoin mining operations but also increases leverage and financial risk, with substantial debt obligations due within two years and ongoing monthly interest payments required.
LMFA
NASDAQ
▲ SUPER 8-K
LM Funding America, Inc. Common Stock
EDGAR Items: 1.01,2.01,2.03,7.01,9.01
# SEC 8-K Filing Summary
**Company & Filing Details:** Lemonade Inc. (LMFA) filed an 8-K on September 18, 2025, reporting events that occurred on September 15, 2025.
**Material Events:**
The filing indicates multiple significant developments: (1) entry into a material definitive agreement, (2) completion of an acquisition or disposition of assets, and (3) creation of direct financial obligations. These items are supported by substantial exhibit documents including legal agreements and financial arrangements.
**Key Implications for Investors:**
This 8-K signals major corporate activity at Lemonade, likely involving either a strategic acquisition, significant asset sale, or new financing arrangement. The multiple items filed suggest a complex transaction with material financial implications. Investors should review the detailed exhibits and press release (EX-99.1) to understand the transaction terms, financial impact, and strategic rationale before making investment decisions.
**Next Steps:** Review the full 8-K document and exhibits to assess whether this transaction strengthens or weakens the company's competitive position and financial health.
DTST
NASDAQ
▲ SUPER 8-K
Data Storage Corporation Common Stock
EDGAR Items: 1.01,2.01,5.07,7.01,9.01
# SEC 8-K Filing Summary
**Company & Filing Details:**
This 8-K was filed on September 16, 2025 (reporting period September 10, 2025) and covers multiple material events.
**Key Material Events:**
1. **Material Definitive Agreement (Item 1.01)** - The company entered into a significant binding agreement, though specific details require review of Exhibit 10.1.
2. **Acquisition/Disposition Completed (Item 2.01)** - The company completed an asset acquisition or disposition transaction, representing a substantive change to the company's business operations or asset base.
3. **Shareholder Vote (Item 5.07)** - The company submitted matters to shareholder vote, likely related to approving the transaction noted above.
4. **Additional Disclosure (Item 7.01)** - Supplementary information was provided to investors via Regulation FD.
**Investor Implications:**
This filing signals a significant corporate transaction or strategic shift. The combination of a material agreement, completed transaction, and shareholder vote suggests a major M&A event (acquisition, merger, or substantial asset sale). Investors should review the exhibits and full 8-K document to understand the transaction terms, financial impact, and strategic rationale for this material change to the company's operations.
ANGX
NYSE
▲ SUPER 8-K
Angel Studios, Inc.
EDGAR Items: 1.01,2.01,3.03,5.01,5.02,5.03,5.06,9.01
# Summary of Angel Studios, Inc. Form 8-K Filing
On September 10, 2025, Angel Studios, Inc. (formerly Southport Acquisition Corporation) completed its previously announced business combination with Angel Studios Legacy, Inc., with the SPAC merging into the legacy company, which now operates as a wholly-owned subsidiary under the Angel Studios name. The company established a dual-class share structure with Class A common stock (1 vote per share) and Class B common stock (10 votes per share), with all former Angel Legacy shareholders receiving corresponding class conversions based on a calculated merger consideration per fully diluted share. Concurrently, the company entered into ancillary agreements including an Amended and Restated Registration Rights Agreement and a Lock-Up Agreement with major shareholders and the Sponsor to govern post-closing obligations and trading restrictions. For investors, the completion of this business combination means Angel Studios is now a publicly traded company on the NYSE under ticker ANGX, though the dual-class voting structure concentrates control among Class B holders, which may limit minority shareholder influence on company direction.
MLCI
NASDAQ
▲ SUPER 8-K
Mount Logan Capital Inc. Common Stock
EDGAR Items: 2.01,2.03,3.03,5.01,5.02,5.03,7.01,9.01
# SEC 8-K Filing Summary
**Company:** Yukon Drilling (CIK: 2051820)
**Filed:** September 16, 2025 (Event Date: September 12, 2025)
## Key Material Events:
This 8-K discloses a **significant corporate transaction and restructuring**. The filing indicates a **change in control of the registrant** (Item 5.01), completion of an **acquisition or disposition of assets** (Item 2.01), and the creation of **new financial obligations** (Item 2.03). Additionally, there are **modifications to security holder rights** (Item 3.03) and **amendments to articles of incorporation/bylaws** (Item 5.03), suggesting a major merger, acquisition, or leveraged recapitalization.
## Investor Implications:
The multiple simultaneous disclosures—particularly the change of control, new debt obligations, and governance amendments—indicate a transformational event that will likely affect ownership structure, capital structure, and shareholder rights. Investors should carefully review the attached exhibits (especially the acquisition agreement in Exhibit 2.1 and new governance documents) to understand the transaction terms, debt levels, and any dilution to existing shareholdings. The breadth of items disclosed suggests this is a material event requiring thorough due diligence.
GDC
NASDAQ
▲ SUPER 8-K
GD Culture Group Limited Common Stock
EDGAR Items: 1.01,2.01,3.02,7.01,9.01
# SEC 8-K Summary: GD Culture Group
**Material Event:** GD Culture Group entered into a share exchange agreement dated September 10, 2025, to acquire an unspecified target company, representing a significant acquisition transaction requiring disclosure under Items 1.01 (material definitive agreement) and 2.01 (completion of acquisition).
**Key Details:** The filing includes a share exchange agreement, unaudited pro forma condensed combined financial statements as of June 30, 2025, and a press release announcing the transaction. The company also disclosed unregistered equity securities issuance (Item 3.02) as consideration for the deal.
**Investor Implications:** This acquisition signals GD Culture's growth strategy through M&A activity. Investors should review the pro forma financials to assess the combined entity's financial impact, scrutinize the exchange ratio and deal structure to understand dilution, and monitor for any contingencies or closing conditions that may affect the transaction completion.
HWH
NASDAQ
▲ SUPER 8-K
HWH International Inc. Common Stock
EDGAR Items: 1.01,2.01,9.01
# SEC 8-K Filing Summary
**Company & Filing Details:** This is a Form 8-K filed on September 16, 2025 (reporting period September 10, 2025) by a company with CIK 1897245, covering material corporate events.
**Material Events:** The filing reports two significant items: (1) Entry into a Material Definitive Agreement (Item 1.01) and (2) Completion of an Acquisition or Disposition of Assets (Item 2.01). These items suggest the company either completed a major acquisition/divestiture or entered into a significant binding business agreement during the reporting period.
**Key Documents:** The filing includes detailed exhibits—a definitive agreement document (EX-10.1) and what appears to be a press release or investor presentation (EX-99.1)—which contain the specifics of the transaction or agreement terms and financial implications.
**Investor Impact:** Without access to the full document text, the precise nature and materiality cannot be assessed, but the dual reporting of both a new agreement and asset completion suggests a major M&A transaction or strategic business restructuring that could significantly impact the company's financial position, operations, or shareholder value. Investors should review the complete exhibit documents for transaction terms, valuation, and financial projections.
AIV
NYSE
▲ SUPER 8-K
Apartment Investment and Management Company
EDGAR Items: 2.01,9.01
# Summary of Aimco 8-K Filing (September 9, 2025)
Aimco completed the sale of four properties from its Boston Portfolio to HGI Acquisitions, LLC for $490 million in cash on September 9, 2025, representing partial completion of a previously announced $740 million transaction. The remaining fifth property (Royal Crest Estates Nashua) remains under contract for $250 million and is expected to close in Q4 2025, with a $20 million non-refundable deposit held by the buyer to incentivize completion. This asset sale is part of Aimco's portfolio optimization strategy and will generate immediate liquidity, though the filing includes forward-looking statement disclaimers noting no assurance regarding the timing or completion of the final property sale.
COBA
OTC
▲ SUPER 8-K
Chilean Cobalt Corp.
EDGAR Items: 1.01,2.01,3.02,7.01,9.01
# SEC 8-K Filing Summary: Chilean Cobalt Corp.
**Filing Date:** September 15, 2025 | **Period:** September 12, 2025
Chilean Cobalt Corp. filed a Form 8-K disclosing material acquisitions and agreements entered into on September 12, 2025. The filing indicates the company completed an acquisition or disposition of assets and entered into a mining concession purchase agreement, with details provided in the attached agreement exhibit. The company also conducted unregistered sales of equity securities in connection with these transactions.
**Key Implications for Investors:** This filing suggests Chilean Cobalt Corp. is actively pursuing mining asset expansion in Chile, likely to strengthen its cobalt production capabilities in response to growing demand for battery metals. However, investors should review the complete mining concession purchase agreement and press release to assess the purchase price, terms, financing structure, and strategic fit. The unregistered equity issuance indicates potential dilution to existing shareholders, which warrants further scrutiny into valuation and deal structure.
TRAW
NASDAQ
▲ SUPER 8-K
Traws Pharma, Inc. Common Stock
EDGAR Items: 1.01,2.01,9.01
# Traws Pharma 8-K Summary
On September 9, 2025, Traws Pharma completed the acquisition of certain assets from Virom, Inc. for $2.35 million in cash, including intellectual property, patents, and development rights related to a pyrrolidine antiviral compound and associated pharmaceutical pipeline. The transaction involves related parties—Traws's COO Nikolay Savchuk serves as Virom's Executive Chairman and holds significant equity, while the Company's CMO sits on Virom's board—but both the Audit Committee and Board determined the purchase price was fair and in the company's best interest. This acquisition expands Traws's antiviral drug pipeline with established intellectual property and regulatory assets, potentially positioning the company for product development advancement. For investors, the $2.35 million cash outlay represents a material use of resources, and the related-party nature of the transaction warrants scrutiny regarding pricing fairness, though board approval mitigates governance concerns.
BGMS
NASDAQ
▲ SUPER 8-K
Bio Green Med Solution, Inc. Common Stock
EDGAR Items: 2.01,3.03,5.03,7.01,9.01
# SEC 8-K Filing Summary
Based on this September 12, 2025 8-K filing, the company completed a significant **acquisition or disposition of assets** (Item 2.01) and made material modifications to its capital structure, including **amendments to its articles of incorporation or bylaws** (Item 5.03) and **material modifications to security holder rights** (Item 3.03). The filing includes 23 supporting documents with detailed transaction agreements and disclosures (Items 10.1 and 99.1-99.3), suggesting a complex corporate restructuring.
**For investors:** This filing indicates a substantial corporate transaction that may affect share structure, voting rights, or ownership interests. The multiple exhibits suggest detailed transaction terms that warrant careful review. Investors should examine the attached acquisition agreements and disclosure documents to understand the transaction's financial impact, any dilution effects, and how it aligns with the company's strategic direction.
NRXP
NASDAQ
▲ SUPER 8-K
NRX Pharmaceuticals, Inc. Common Stock
EDGAR Items: 2.01,7.01,9.01
# SEC 8-K Filing Summary
**Company & Filing Date:** NRX Pharmaceuticals (CIK: 1719406) filed this 8-K on September 12, 2025, reporting events from September 8, 2025.
**Material Event:** The company completed an acquisition or disposition of assets (Item 2.01), marking a significant corporate transaction that may impact its operational structure, financial position, or strategic direction.
**Key Items Disclosed:** Beyond the asset transaction, NRX provided regulatory fair disclosure (Item 7.01) and included supporting financial statements and exhibits, indicating comprehensive disclosure of the acquisition's terms and details.
**Investor Implications:** The completion of this asset transaction represents a material corporate action that could affect the company's revenue streams, cost structure, and strategic positioning. Investors should review the detailed 8-K filing and exhibits to understand the acquisition's financial impact, financing details, and implications for future earnings and shareholder value.
MYSZ
NASDAQ
▲ SUPER 8-K
My Size, Inc
EDGAR Items: 1.01,2.01,3.02,7.01,9.01
# SEC 8-K Filing Summary
Based on the filing dated September 12, 2025 (for period ending September 8, 2025), this 8-K reports several material corporate events:
The company completed a significant acquisition or disposition of assets and entered into material definitive agreements, as evidenced by the multiple exhibits attached (EX-10.1 through EX-10.4 containing detailed contractual documents). Additionally, the filing includes unregistered sales of equity securities, suggesting the company may have issued stock as part of the transaction consideration. The breadth of items reported—spanning new agreements, asset completion, equity issuance, and regulatory disclosures—indicates a substantial corporate transaction that will impact the company's capital structure and operations.
For investors, this represents a major strategic event that could significantly affect financial position, ownership structure, and future earnings potential. The specific details of the acquisition/disposition and equity terms would be critical for investors to review in the attached exhibits to fully assess the impact on shareholder value.
ROYL
OTC
▲ SUPER 8-K
Royale Energy, Inc.
EDGAR Items: 1.01,2.01,7.01,9.01
# SEC 8-K Summary
Based on the filing dated September 9-10, 2025, this 8-K from Royal Gold, Inc. (CIK 1694617) reports material transactions including the entry into a definitive agreement and completion of an acquisition or disposition of assets. The filing contains four key item disclosures: a material definitive agreement (Item 1.01), completion of an acquisition/disposition (Item 2.01), regulatory disclosure (Item 7.01), and financial statements/exhibits (Item 9.01).
**For investors:** This filing indicates Royal Gold has completed a significant acquisition or asset transaction and entered into related agreements, though the specific details would require reviewing the full 8-K document and exhibits. The company appears to be engaged in active M&A activity, which could impact its financial position, asset base, and future operational strategy. Investors should review the complete filing to understand deal terms, financing implications, and any material risks.
PMCB
NASDAQ
▲ SUPER 8-K
PharmaCyte Biotech, Inc. Common Stock
EDGAR Items: 1.01,2.01,7.01,9.01
# SEC 8-K Filing Summary: PharmaCyte Therapeutics Inc.
**Filing Date:** September 5, 2025 (Period: September 2, 2025)
PharmaCyte Therapeutics announced a material financing transaction involving the entry into a Securities Purchase Agreement dated September 2, 2025, which included the issuance of Series H Convertible Preferred Stock and warrants. The company completed this asset/securities transaction and established registration rights for the investor, indicating a significant capital raise to fund operations or strategic initiatives. This financing includes convertible preferred stock and warrants, which dilute existing shareholders but provide the company with needed capital; investors should review the registration rights agreement and conversion terms to understand potential future dilution and the investor's exit strategy.
PLAG
AMEX
▲ SUPER 8-K
Planet Green Holdings Corp.
EDGAR Items: 2.01
# Summary of Planet Green Holdings Corp. 8-K Filing
Planet Green Holdings Corp. (ticker: PLAG, NYSE American) completed the disposal of its 100% equity interest in Promising Prospect HK Limited for nominal consideration on September 1, 2025. This transaction effectively divested the company's Chinese subsidiary Shandong Yunchu Supply Chain Co., Ltd., whose operations were previously discontinued by board resolution on April 30, 2025. The divested entity and its holding companies contain no other operating assets of the company, meaning this represents a clean exit from non-core operations. For investors, this signals the company's strategic shift away from its Chinese supply chain business and potential refocus on core operations, though the nominal consideration suggests minimal financial benefit from the sale.
SFCX
OTC
▲ SUPER 8-K
SUPA Consolidated Inc.
EDGAR Items: 1.02,2.01,3.02,9.01
# Summary of Tribal Rides International Corp. 8-K Filing
Tribal Rides International Corp. reported two significant corporate events: the termination of a material acquisition agreement with Singta Industries (initially announced February 6, 2025, but terminated August 25, 2025 without prior disclosure) and the completion of its June 30, 2025 acquisition of Supa Food Services LLC in exchange for 250 million newly issued common shares. The company acknowledged substantial delays in reporting both events, citing management changes, auditor transitions, and strategic reviews following an earlier 2025 change of control. Investors face significant dilution from the Supa acquisition's massive share issuance while losing the previously announced Singta deal, though the company has not yet provided full financial details on Supa or its operating business, promising pro forma financials and audited statements by amendment. The filing raises concerns about governance and transparency given the months-long reporting delays on material transactions.
MDCX
NASDAQ
▲ SUPER 8-K
Medicus Pharma Ltd. Common Stock
EDGAR Items: 2.01,3.02,5.02,8.01,9.01
# Summary of Medicus Pharma Ltd. 8-K Filing
On August 29, 2025, Medicus Pharma Ltd. completed its acquisition of Antev Ltd., a clinical-stage biotech company developing Teverelix for prostate cancer and urinary retention treatment, for $3.0 million in cash and 1.6 million common shares, with up to $65 million in contingent milestone payments tied to FDA approvals. The company also raised approximately $491,000 through equity advances under a standby purchase agreement with Yorkville and appointed Patrick J. Mahaffy, Antev's former chairman, to its board of directors. These transactions position Medicus to advance Teverelix through clinical development but significantly increase shareholder dilution through both the acquisition consideration shares (subject to staggered lock-up restrictions) and ongoing equity financing arrangements. Investors should monitor regulatory progress on Teverelix as the contingent consideration represents substantial future liability, and the company's reliance on equity financing suggests potential additional dilution ahead.
August 2025
15 filings
▼
FIP
NASDAQ
▲ SUPER 8-K
FTAI Infrastructure Inc. Common Stock
EDGAR Items: 1.01,1.02,2.01,2.03,3.02,3.03,8.01,9.01
# FTAI Infrastructure Inc. – 8-K Summary
FTAI Infrastructure Inc. completed the acquisition of The Wheeling Corporation for approximately $1.05 billion in cash on August 25, 2025, a previously announced transaction. The company structured the deal with a voting trust arrangement—required by the U.S. Surface Transportation Board (STB)—that places Wheeling's stock in escrow until STB approval of FTAI's control authority over the railroad subsidiaries; if approval is denied, FTAI has two years to divest. To finance the acquisition, FTAI secured a $1.25 billion 364-day bridge loan (maturing August 24, 2026) at SOFR + 4.00% and simultaneously issued $1 billion in Series A Preferred Units and Warrants to RR Holdings. The transaction is subject to customary regulatory, financing, and operational risks, with the bridge loan requiring repayment through asset sales, equity/debt issuances, or other prescribed sources, and contains standard covenants that restrict FTAI's operational flexibility.
CCLD
NASDAQ
▲ SUPER 8-K
CareCloud, Inc. Common Stock
EDGAR Items: 1.01,2.01,2.03,8.01,9.01
# Summary of 8-K Filing (August 25, 2025)
This 8-K filing indicates a significant corporate transaction involving the company (CIK: 1582982) that was completed on August 22, 2025. The filing discloses multiple material items: entry into definitive agreement(s), completion of an acquisition or asset disposition, and creation of direct financial obligations. The presence of multiple exhibits (EX-2.1 through EX-2.7) suggests complex transaction documentation, likely including purchase agreements and related contracts. Investors should review the full filing details and exhibits to understand the transaction's financial impact, including the nature of assets involved, deal consideration, financing terms, and any contingent liabilities or off-balance sheet obligations created. This transaction could materially affect the company's financial position, capital structure, and operational strategy.
AHT
NYSE
▲ SUPER 8-K
Ashford Hospitality Trust, Inc.
EDGAR Items: 2.01,7.01,9.01
# Summary of Ashford Hospitality Trust 8-K Filing
Ashford Hospitality Trust completed the sale of the 242-room Hilton Houston NASA Clear Lake hotel in Houston, Texas on August 22, 2025, for $27 million in cash to Nassau Bay Resorts LLC. The company also closed on the sale of a Residence Inn property in Evansville, Indiana on the same date, as announced in a press release on August 25, 2025. These asset dispositions represent a strategic effort to reduce the company's portfolio and generate liquidity, though the Evansville sale price was not disclosed in this filing. Pro forma financial information will be filed within four business days to show the impact of these transactions on the company's financial position.
NTHI
NASDAQ
▲ SUPER 8-K
NeOnc Technologies Holdings, Inc. Common Stock
EDGAR Items: 1.01,2.01,2.02,3.02,5.02,7.01,9.01
# 8-K Summary: Neon C Technologies
**Filing Date:** August 22, 2025 | **Period:** August 18, 2025
Based on the disclosed items, Neon C Technologies completed a **material acquisition or asset disposition and entered into significant definitive agreements** on August 18, 2025. The filing also indicates **changes in officer/director compensation arrangements** and **unregistered equity issuances**, suggesting the transaction may have involved stock consideration or new executive incentives. Additionally, the company reported **operational results and financial condition updates**, likely reflecting the impact of the transaction.
**For investors:** This appears to be a transformational M&A event that restructured the company's operations and capital structure. The multiple disclosed items—particularly the asset/acquisition completion combined with management changes and equity issuances—warrant detailed review of the full 8-K filing to understand deal terms, dilution impact, and strategic rationale. The unregistered securities issuance may also have liquidity implications for existing shareholders.
CANN
OTC
▲ SUPER 8-K
TREES Corp (Colorado)
EDGAR Items: 1.01,2.01,2.03,5.02,9.01
# Summary of Trees Corporation 8-K Filing (August 22, 2025)
Trees Corporation filed a material 8-K on August 22, 2025, reporting several significant corporate events that occurred on June 20, 2025. The filing discloses the entry into a refinancing agreement and the completion of an acquisition or disposition of assets, along with the creation of new direct financial obligations including multiple secured notes. Additionally, there were changes to the company's officer or director compensation arrangements during this period.
For investors, this filing indicates that Trees Corporation underwent substantial financial restructuring through refinancing arrangements and debt instruments, which could affect the company's capital structure and future financial obligations. The multiple secured notes and amended debt arrangements suggest the company may be managing existing liabilities or financing new operations. Investors should review the detailed refinancing agreement and note terms to understand the impact on cash flow, interest obligations, and potential dilution or constraints on future operations.
HIND
NASDAQ
▲ SUPER 8-K
Vyome Holdings, Inc. Common Stock
EDGAR Items: 2.01,3.02,3.03,5.02,5.03,9.01
# SEC 8-K Filing Summary: Vyome Therapeutics, Inc.
**Filing Date:** August 19, 2025 | **Period:** August 13, 2025
Vyome Therapeutics completed a significant acquisition and implemented substantial corporate restructuring on August 13, 2025. The filing reveals the completion of an asset acquisition (Item 2.01), unregistered equity issuances (Item 3.02), and a merger involving Raider Lifesciences into Vyome Therapeutics. Additionally, the company amended its certificate of incorporation multiple times and modified Series C convertible preferred stock terms, indicating significant changes to the capital structure and shareholder rights.
**Key Material Changes:**
- Executive leadership modifications (Item 5.02) including appointment of new officers and an interim CFO consulting arrangement
- Multiple amendments to the articles of incorporation and security designations
- Unregistered equity issuances tied to the acquisition
**Investor Implications:** These changes suggest Vyome is executing a strategic transaction to expand operations or capabilities, though the unregistered equity issuances and modifications to preferred stock rights may impact existing shareholders' positions. Investors should review the full filing details regarding dilution, governance changes, and the specific terms of the acquisition to assess the long-term strategic value.
ICU
NASDAQ
▲ SUPER 8-K
SeaStar Medical Holding Corporation Common Stock
EDGAR Items: 2.01,9.01
# SEC 8-K Filing Summary
**Company:** ICU Medical, Inc. (CIK: 1831868)
**Filing Date:** August 13, 2025
## Key Points:
ICU Medical filed a Form 8-K reporting the **completion of an acquisition or disposition of assets** (Item 2.01), indicating a material transaction has been finalized. The filing includes supplemental financial information and exhibits that provide details on the transaction structure and terms.
This acquisition completion represents a significant corporate action that could materially impact the company's balance sheet, operations, and future financial performance. Investors should review the detailed exhibit materials to understand the acquisition's size, financing method, and strategic rationale.
The timing and nature of this transaction may affect near-term earnings, debt levels, and operational integration risks, which warrant close monitoring of subsequent quarterly earnings reports and management guidance.
DWSN
NASDAQ
▲ SUPER 8-K
Dawson Geophysical Company New Common Stock
EDGAR Items: 1.01,2.01,2.03,7.01,9.01
# SEC 8-K Filing Summary
**Company & Filing Details:**
Dawson Geophysical Company (CIK: 799165) filed an 8-K on August 11, 2025, reporting material events that occurred on August 8, 2025.
**Key Material Events:**
The filing discloses four major items: (1) entry into a material definitive agreement, (2) completion of an acquisition or asset disposition, (3) creation of a direct financial obligation, and (4) other regulatory disclosures with supporting financial exhibits.
**Investor Implications:**
Without access to the full 8-K document text, the specific details of the transaction cannot be fully assessed, but the combination of a material agreement, asset transaction, and new debt obligation suggests a significant corporate restructuring, acquisition, or major financing activity. Investors should review the complete filing and attached exhibits to understand the transaction terms, financial impact, and strategic rationale, as these types of simultaneous events typically have material implications for shareholders.
CHUC
OTC
▲ SUPER 8-K
Charlie's Holdings, Inc.
EDGAR Items: 1.01,2.01,5.07,9.01
# SEC 8-K Filing Summary
Based on the filing dated August 11, 2025 (for period ending August 7, 2025), this 8-K reports significant corporate activity for the company (CIK 1134765). The filing indicates **three material events**: entry into a material definitive agreement (Item 1.01), completion of an acquisition or disposition of assets (Item 2.01), and submission of matters to a shareholder vote (Item 5.07).
While the HTML provided contains only the filing structure without the substantive content, the presence of these items suggests the company has completed a significant M&A transaction and obtained shareholder approval. Investors should review the full 8-K document and attached exhibits (particularly Exhibit 10.1) for specific details regarding the transaction terms, financial impact, and strategic implications for the company's future operations and financial position.
RIME
NASDAQ
▲ SUPER 8-K
Algorhythm Holdings, Inc. Common Stock
EDGAR Items: 1.01,2.01,7.01,9.01
# 8-K Filing Summary
Based on this August 7, 2025 SEC 8-K filing, the company has reported **multiple material events** involving a significant transaction:
The filing discloses entry into a material definitive agreement (Item 1.01) and **completion of an acquisition or disposition of assets** (Item 2.01), indicating the company has completed a major M&A transaction. The filing includes substantial supporting documentation, including a full contract (Exhibit 10.1, ~450KB) and disclosure materials (Exhibit 99.1), suggesting this is a significant business development.
**For investors:** This represents a material corporate event that could substantially alter the company's business profile, financial position, and future growth trajectory. The transaction's impact on shareholder value will depend on the deal terms, financing structure, and strategic rationale disclosed in the complete 8-K filing. Investors should review the full document and exhibits to understand the acquisition/disposition details, purchase price, funding source, and management's strategic justification.
CTSO
NASDAQ
▲ SUPER 8-K
Cytosorbents Corp.
EDGAR Items: 2.01,9.01
# SEC 8-K Filing Summary
**Company & Date:** Filed August 7, 2025 (CIK: 1175151)
**Key Material Event:** The company completed an acquisition or disposition of assets, as reported under Item 2.01 of the 8-K filing.
**What Changed:** This is a current report disclosing the completion of a significant corporate transaction involving the acquisition or disposal of assets. The filing includes 14 supporting documents and exhibits with financial statements and detailed transaction information.
**Investor Implications:** While the specific details of the transaction are not visible in this header information, the completion of an asset acquisition or disposition could materially impact the company's balance sheet, cash position, and future earning potential. Investors should review the full 8-K document and accompanying exhibits (particularly Exhibit 99-1) to understand the transaction's size, financing structure, strategic rationale, and expected financial impact on the company.
CEIN
OTC
▲ SUPER 8-K
Viking Global Technologies, Inc.
EDGAR Items: 1.01,2.01,9.01
# SEC 8-K Filing Summary: Material Acquisition/Agreement Entry
Based on this August 6, 2025 8-K filing (Period of Report: August 1, 2025), the company has entered into a material definitive agreement and completed an acquisition or disposition of assets. The filing includes three key agreements: a Securities Purchase Agreement, an Operating Agreement, and an Assignment Agreement, indicating a significant business transaction or investment arrangement.
**Key Points for Investors:**
- This is a material transaction that could meaningfully impact the company's financial position, operations, or ownership structure
- The multiple supporting agreements (operating agreement and assignment agreement) suggest a complex transaction, potentially involving equity investment, operational changes, or asset transfers
- Investors should review the full 8-K document and attached agreements to understand the financial terms, any dilution to existing shareholders, and the strategic rationale for the transaction
The specific details regarding deal value, ownership percentages, and financial impact would be found in the complete filing documents, which should be reviewed for full transparency on how this transaction affects shareholder interests.
MGRX
NASDAQ
▲ SUPER 8-K
Mangoceuticals, Inc. Common Stock
EDGAR Items: 1.01,1.02,2.01,3.02,9.01
# SEC 8-K Filing Summary
Based on this August 4, 2025 Form 8-K filing (for period ending July 30, 2025), the company reported **multiple material corporate events**, including: entry into a material definitive agreement, termination of a material agreement, and completion of an acquisition or disposition of assets. The filing also involves unregistered equity securities sales, indicating significant corporate restructuring or M&A activity.
**Key Items for Investors:**
- **Material Agreement Changes**: Both new agreements entered and existing agreements terminated suggest potential strategic pivots or deal completion
- **Asset Transaction**: The completion of an acquisition or asset disposition represents a substantial corporate action that could materially impact the company's operations, financial position, or shareholder value
- **Equity Issuance**: Unregistered securities sales indicate potential dilution to existing shareholders
Without access to the full 8-K document content, the precise financial impact cannot be determined, but investors should review the detailed disclosure documents (particularly Exhibit 10.1) to understand transaction terms, consideration paid/received, and implications for future earnings and capital structure.
FCCN
OTC
▲ SUPER 8-K
SPECTRAL CAPITAL Corp
EDGAR Items: 1.01,2.01,9.01
# SEC 8-K Filing Summary: Spectral Capital Corporation
**Filing Date:** August 4, 2025 (reporting period August 1, 2025)
Spectral Capital Corporation completed a material acquisition or disposition of assets and entered into a definitive share exchange agreement, as indicated by Items 1.01 and 2.01 in this 8-K filing. The company issued a press release on July 31, 2025 announcing the transaction, with closing documentation dated August 1, 2025, including a closing certificate and an addendum to the original share exchange agreement.
**For Investors:** This filing signals a significant corporate transaction that may materially alter the company's business structure, asset base, or shareholder composition. Investors should review the complete 8-K document and attached exhibits (including the press release and share exchange agreement) to understand the transaction's terms, value, and strategic implications for future operations and shareholder value.
BMPA
OTC
▲ SUPER 8-K
BMP AI Technologies, Inc.
EDGAR Items: 1.01,2.01,3.02,9.01
# 8-K Filing Summary: Material Acquisition/Disposition Event
Based on this SEC 8-K filing dated July 29, 2025, the company reported a significant material event involving both the acquisition and disposition of assets. The filing indicates Items 1.01 (entry into a material definitive agreement), 2.01 (completion of acquisition or disposition), and 3.02 (unregistered equity sales), suggesting the company either purchased or sold substantial assets and potentially issued equity as part of the transaction.
The presence of an Asset Purchase Agreement and Asset Transfer Agreement indicates this was a structured transaction, though the specific dollar amounts and asset details would need to be reviewed in the full 8-K document itself. For investors, this type of transaction could signal strategic repositioning, potential changes to the company's business focus, or liquidity needs if significant equity was issued. The transaction's materiality warrants careful review of the complete filing to understand potential impacts on earnings, cash flow, and shareholder value.
July 2025
12 filings
▼
AEI
NASDAQ
▲ SUPER 8-K
Alset Inc. Common Stock (TX)
EDGAR Items: 2.01,2.03,3.02,9.01
# SEC 8-K Filing Summary
**Company:** AEI (CIK: 1750106)
**Filing Date:** July 23, 2025
## Key Material Events:
This 8-K discloses four significant items: **(1) Completion of an acquisition or disposition of assets**, **(2) Creation of new financial obligations or off-balance sheet arrangements**, **(3) Unregistered equity securities sales**, and **(4) Related financial statements and exhibits**.
## What Changed:
The company has completed a major acquisition or asset sale and concurrently raised capital through unregistered equity issuance while taking on new debt or financial obligations. The timing and coordination of these transactions suggest a significant corporate restructuring or strategic pivot.
## Investor Implications:
Investors should carefully review the full filing documents to understand deal terms, acquisition price, financing structure, debt obligations, and equity dilution. The combination of asset transactions, new debt, and unregistered equity sales could materially impact the company's capital structure, financial leverage, and ownership percentages. The specific details in the exhibits and financial statements will be critical for assessing whether this transaction enhances shareholder value.
ELAB
NASDAQ
▲ SUPER 8-K
PMGC Holdings Inc. Common Stock
EDGAR Items: 2.01,8.01,9.01
# SEC 8-K Filing Summary: PMGC Holdings Inc.
**Filing Date:** July 22, 2025 | **Report Period:** July 18, 2025
**Key Event:** PMGC Holdings Inc. completed a significant acquisition of assets, as reported in this 8-K filing. The company executed an acquisition agreement dated July 18, 2025, and disclosed the transaction through a contemporaneous press release.
**Material Details:** The filing includes the full acquisition agreement and press release as exhibits, indicating this was a material transaction requiring immediate public disclosure under SEC regulations. The specific terms and financial impact of the acquisition would be detailed in the attached agreement document.
**Investor Implications:** Investors should review the acquisition agreement (Exhibit 10.1) and press release (Exhibit 99.1) to understand the strategic rationale, purchase price, financing structure, and expected impact on PMGC's financial position and future operations. This transaction may affect earnings, balance sheet strength, and the company's growth trajectory going forward.
IQST
NASDAQ
▲ SUPER 8-K
IQSTEL INC. Common Stock
EDGAR Items: 2.01,9.01
# SEC 8-K Filing Summary: iQSTEL Inc. (July 21, 2025)
**Company:** iQSTEL Inc. (CIK: 1527702)
**Key Event:** iQSTEL completed an acquisition or disposition of assets, as reported in this Form 8-K filed on July 21, 2025.
**Material Details:** The filing includes Item 2.01 (Completion of Acquisition or Disposition of Assets) and Item 9.01 (Financial Statements and Exhibits), with a press release dated July 21, 2025 providing additional context on the transaction.
**Investor Implications:** While the specific details of the acquisition or asset disposition are not visible in the HTML header provided, investors should review the full 8-K document and accompanying press release to understand the strategic rationale, financial impact, and whether this transaction materially affects the company's business operations, revenue, or competitive position. The completion of this transaction could represent a significant strategic shift for the company that warrants careful analysis.
PFSA
NASDAQ
▲ SUPER 8-K
Profusa, Inc. Common Stock
EDGAR Items: 1.01,2.01,2.03,3.02,3.03,5.01,5.02,5.06,8.01,9.01
# SEC 8-K Filing Summary - ProFUSA Inc. (July 18, 2025)
This 8-K filing indicates a **significant corporate transaction and change of control** for ProFUSA. The company entered into a material definitive agreement, completed an acquisition/disposition of assets, created new financial obligations (including a senior secured convertible note), issued unregistered equity securities through a PIPE (Private Investment in Public Equity), and experienced a change in control of the registrant, effective July 11, 2025.
**Key implications for investors:** The multiple items filed—particularly the change of control, new debt issuance, and equity dilution from the PIPE investment—suggest ProFUSA underwent a merger, acquisition, or reverse merger transaction. The senior secured convertible note and PIPE lock-up/registration rights agreements indicate dilution to existing shareholders and new creditor obligations. Investors should review the detailed documents to assess the deal's valuation, the extent of dilution, debt terms, and any management changes (Item 5.02 also filed), as these factors could materially impact shareholder value and company control structure.
OMQS
OTC
▲ SUPER 8-K
OMNIQ Corp.
EDGAR Items: 1.01,2.01,2.03,7.01,9.01
# 8-K Summary Analysis
Based on this SEC filing from July 16, 2025, the company has announced **significant M&A activity and new financing arrangements**. The filing indicates completion of an acquisition or disposition of assets, entry into material definitive agreements, and creation of direct financial obligations—suggesting the company has either acquired or divested a major asset and secured financing to support this transaction.
**Key implications for investors:**
1. **Material acquisition/disposition completed** - The company has closed a significant deal that warrants immediate disclosure to the market
2. **New debt or financial obligations** - Direct financial obligations were created, indicating the company has taken on new debt or off-balance sheet arrangements to fund the transaction
3. **Strategic shift** - This transaction likely represents a meaningful change to the company's business operations and capital structure
The multiple exhibits (10 different documents including agreements and supplemental materials) suggest this is a complex transaction. **Investors should review the full 8-K document and attached agreements to understand deal terms, financing structure, potential dilution, and strategic rationale**, as this could materially impact future earnings, cash flow, and shareholder value.
OWPC
OTC
▲ SUPER 8-K
One World Products, Inc.
EDGAR Items: 1.01,2.01,3.02,7.01,9.01
# SEC 8-K Filing Summary
Based on the July 15, 2025 8-K filing, this current report discloses several material events:
**Key Material Events:**
The filing reports the entry into material definitive agreements (Item 1.01), completion of an acquisition or disposition of assets (Item 2.01), and unregistered sales of equity securities (Item 3.02). The company has also made regulatory FD disclosures and included financial statements and exhibits.
**What This Means for Investors:**
This 8-K indicates significant corporate activity including a likely M&A transaction (acquisition/disposition) with associated equity issuances. The presence of multiple exhibits (10.1-10.3) containing detailed agreements and the unregistered equity sale suggest a material business combination that could substantially affect the company's capital structure, operations, or financial position. Investors should review the full filing documents to understand the deal terms, valuation implications, and any dilution from the equity issuance.
**Note:** To provide a more precise analysis, the actual content of the 8-K form and exhibits would need to be reviewed, as this filing index only shows the document structure and item categories rather than the specific transaction details.
FCCN
OTC
▲ SUPER 8-K
SPECTRAL CAPITAL Corp
EDGAR Items: 1.01,2.01,8.01,9.01
# SEC 8-K Filing Summary: Spectral Capital Corporation
**Filing Date:** July 15, 2025 (Period: July 13, 2025)
**Key Material Events:**
Spectral Capital Corporation entered into a definitive share exchange agreement and completed an acquisition or disposition of assets involving 42 Telecom Ltd., as indicated by Items 1.01 (Material Definitive Agreement) and 2.01 (Completion of Acquisition/Disposition) in the filing.
**What Changed:**
The company has executed a binding share exchange agreement with 42 Telecom Ltd., fundamentally altering its asset base and operational structure. A press release was issued jointly by both companies on or around July 13, 2025, to announce this transaction.
**Investor Implications:**
This M&A activity signals a strategic shift for Spectral Capital, likely expanding or reorienting its business operations. Investors should review the definitive share exchange agreement (Exhibit 10.1) for critical terms including exchange ratios, earnouts, representations/warranties, and closing conditions. The transaction's financial impact on shareholder value and future earnings will depend on the valuation terms and synergy potential with 42 Telecom.
ELAB
NASDAQ
▲ SUPER 8-K
PMGC Holdings Inc. Common Stock
EDGAR Items: 2.01,8.01,9.01
# SEC 8-K Filing Summary: PMGC Holdings Inc.
**Filing Date:** July 11, 2025 | **Report Period:** July 7, 2025
**Key Material Event:** PMGC Holdings Inc. completed the acquisition of Pacific Sun Packaging Inc., as disclosed in this 8-K filing. The company provided audited financial statements for the acquired business and unaudited pro forma combined financial statements showing the integrated entity's financial position.
**What Changed:** This acquisition represents a significant corporate transaction that expands PMGC Holdings' operations through the addition of Pacific Sun Packaging's business. The filing includes comprehensive financial documentation, including the target company's audited financials and pro forma combined statements reflecting the merged entity.
**Investor Implications:** Investors should review the pro forma financials to understand the combined company's balance sheet, profitability, and financial position post-acquisition. The acquisition may represent a strategic expansion into packaging operations, but investors should carefully examine the terms, integration plans, and any potential dilution or synergies outlined in the accompanying press release to assess impact on shareholder value.
QTRX
NASDAQ
▲ SUPER 8-K
Quanterix Corporation Common Stock
EDGAR Items: 2.01,5.02,7.01,9.01
# SEC 8-K Filing Summary
**Company & Date:** Filed July 8, 2025 (CIK: 1503274)
**Key Material Events:**
This 8-K discloses the completion of an acquisition or disposition of assets (Item 2.01), combined with significant management changes including the departure and/or appointment of directors and officers with associated compensation arrangements (Item 2.02). The filing also includes regulatory disclosures and financial statements related to these transactions.
**Investor Implications:**
The simultaneous filing of acquisition completion alongside executive departures and new compensation arrangements suggests a substantial corporate restructuring or M&A transaction that resulted in leadership changes. Investors should review the detailed exhibits and financial statements to understand the transaction's terms, valuation impact, and new management's background and compensation structure, which could affect near-term operational direction and shareholder value.
SABR
NASDAQ
▲ SUPER 8-K
Sabre Corporation
EDGAR Items: 2.01,5.02,7.01,9.01
# SEC 8-K Filing Summary
**Company & Event:** On July 3, 2025, the company completed an acquisition or disposition of assets (Item 2.01), which represents a material business transaction requiring immediate disclosure.
**Key Changes:** The filing also discloses changes in executive leadership through departures and/or appointments of officers/directors (Item 5.02), including compensatory arrangements for certain officers—suggesting potential restructuring or new management in connection with the deal.
**Material Impact for Investors:** The combination of a completed acquisition and simultaneous management changes indicates significant corporate transformation. Investors should review the detailed 8-K filing to understand the financial terms of the transaction, the strategic rationale, and how new leadership may affect future operations and shareholder value.
BLMH
OTC
▲ SUPER 8-K
BLUM HOLDINGS, INC.
EDGAR Items: 1.01,2.01,7.01,9.01
# Summary of 8-K Filing (BLMH - July 3, 2025)
Bloom Health Inc. entered into material agreements effective July 1, 2025, including a binding term sheet and a management services agreement, representing significant corporate developments. The company completed or is advancing an acquisition or disposition of assets, as indicated by Item 2.01 in the filing. These transactions involve new contractual relationships that could materially impact the company's operations, ownership structure, or strategic direction. Investors should review the detailed term sheet and management services agreement to understand the financial implications, terms, and potential dilution or synergies involved in these transactions. The specific nature and financial impact of these changes warrant careful analysis of the full filing documents.
RNGE
OTC
▲ SUPER 8-K
RANGE IMPACT, INC.
EDGAR Items: 1.01,2.01,8.01,9.01
# SEC 8-K Filing Summary
**Filing Date:** July 3, 2025 | **Period Covered:** June 30, 2025
This 8-K filing indicates the company has completed a **material acquisition or disposition of assets** and entered into one or more **material definitive agreements**. The filing includes substantial supporting documentation (17 documents total), with two significant agreements attached as exhibits, suggesting a major corporate transaction has been completed.
The presence of Items 1.01 (Material Agreement) and 2.01 (Asset Acquisition/Disposition) together signals a significant M&A event or substantial asset transaction. Without access to the specific agreement details in the exhibits, the financial impact on shareholder value, debt levels, and future earnings guidance would need to be reviewed in the full filing documents.
**For investors:** This represents a material corporate event that could meaningfully affect the company's capital structure, operational profile, and financial trajectory. Immediate review of the attached agreements and any accompanying press release (Exhibit 99.1) is recommended to assess strategic implications and synergy potential.
June 2025
12 filings
▼
HURA
NASDAQ
▲ SUPER 8-K
TuHURA Biosciences, Inc. Common Stock
EDGAR Items: 2.01,7.01,9.01
# SEC 8-K Filing Summary: Huize Holding Limited
**Filing Date:** June 30, 2025
**Key Material Event:** Huize Holding Limited (HURA) completed an acquisition or disposition of assets, as indicated by Item 2.01. The company also disclosed additional information via Regulation FD (Item 7.01), suggesting management provided material guidance or updates to investors.
**What Changed:** This 8-K reports the completion of a significant corporate transaction involving asset acquisition or disposal, along with supplementary disclosures that may include updated financial projections or strategic information contained in the attached exhibits.
**Investor Implications:** The completed transaction represents a substantive change to Huize's asset base and business structure. Investors should review the detailed disclosure documents (particularly Exhibit 99.1) to understand the transaction's financial impact, strategic rationale, and any changes to the company's future earnings potential or operational direction. The timing in late June 2025 suggests this was a priority transaction for management.
JSDA
OTC
▲ SUPER 8-K
JONES SODA CO.
EDGAR Items: 1.01,2.01,5.02,8.01,9.01
# SEC 8-K Filing Summary
Based on this June 30, 2025 8-K filing, the company completed a **material acquisition or disposition of assets** and entered into **significant definitive agreements** as of June 13, 2025. The filing also indicates **changes in executive leadership or compensation arrangements** for certain officers. With 21 supporting documents and multiple exhibit agreements (EX-10.1 through EX-10.5), this represents a substantial corporate transaction involving binding contracts and potentially restructured management incentives.
**For investors:** This signals a major strategic transaction that could materially impact the company's operations, financial position, and leadership structure. The specific terms and financial implications would require reviewing the detailed exhibits and agreements, but the breadth of documentation suggests a complex deal that warrants careful analysis of potential impacts on shareholder value.
BNKK
NASDAQ
▲ SUPER 8-K
Bonk, Inc. Common Stock
EDGAR Items: 2.01,2.03,2.04,3.02,5.02,7.01,9.01
# SEC 8-K Filing Summary
**Company & Date:** Filing dated June 27, 2025 (CIK: 1760903)
**Material Events:**
This 8-K discloses multiple significant corporate transactions: the completion of an acquisition or disposition of assets, creation of direct financial obligations, triggering events that accelerate financial obligations, unregistered equity sales, and changes in senior management/officer compensation arrangements. The filing includes 22 documents with substantial exhibits (over 1MB combined), indicating complex transaction documentation.
**Key Implications for Investors:**
The completion of an acquisition paired with new debt creation and accelerated financial obligations suggests the company has undertaken a major strategic transaction potentially funded through both equity and debt financing. The unregistered equity sales and management changes indicate potential dilution and possible leadership transitions. The multiple financial obligation triggers warrant careful review of the actual documents to assess debt levels, terms, and potential impacts on financial flexibility and shareholder value.
**Recommendation:** Investors should review the actual 8-K document (form8-k.htm) and supporting exhibits to understand the transaction details, debt structure, equity dilution impact, and management changes before making investment decisions.
DAIC
NASDAQ
▲ SUPER 8-K
CID HoldCo, Inc. Common Stock
EDGAR Items: 1.01,2.01,3.02,3.03,4.01,5.01,5.02,5.03,5.06,8.01,9.01
# SEC 8-K Filing Summary
**CID Holdco, Inc. - Material Transaction** (Filed June 26, 2025)
This 8-K reveals a **significant corporate transformation** involving multiple material events on June 18, 2025, including a change in control of the registrant, completion of an acquisition, entry into definitive agreements, and a change from shell company status. The filing documents extensive corporate restructuring with new certificate of incorporation, bylaws, and equity incentive plans, along with PIPE (Private Investment in Public Equity) subscription agreements and warrant assumption activities.
**Key implications for investors:** This appears to be a SPAC merger or similar combination transaction that fundamentally altered the company's ownership structure and capital composition. The numerous items filed—particularly changes in control, equity issuances, and accountant changes—suggest a major business combination requiring immediate investor attention to understand the new entity's ownership, management, and financial position. Investors should review the full 8-K document and referenced exhibits to assess the deal terms, dilution impact, and new company fundamentals.
ALDS
OTC
▲ SUPER 8-K
APPlife Digital Solutions Inc
EDGAR Items: 2.01,3.02,5.02,5.03,7.01,9.01
# Summary of AppLife Digital Solutions 8-K Filing (June 20, 2025)
AppLife Digital Solutions completed a significant acquisition or disposition of assets and simultaneously issued multiple series of preferred stock (Series A, B, C, and D) as of June 13, 2025. The company also underwent corporate restructuring, including amendments to its articles of incorporation and bylaws, along with changes to officer compensation arrangements. The filing includes four detailed certificates of designation for the new preferred stock series, indicating a material capital restructuring event. For investors, this suggests the company raised capital through preferred equity issuance, likely to fund the acquisition, though the specific terms and financial impact require review of the detailed certificates and press release to fully assess dilution and voting rights implications.
BINI
OTC
▲ SUPER 8-K
BOLLINGER INNOVATIONS, INC.
EDGAR Items: 2.01,7.01,9.01
# SEC 8-K Summary: Mullen Automotive (MULN)
**Filing Date:** June 12, 2025 | **Period:** June 5, 2025
Mullen Automotive filed a Form 8-K reporting the **completion of an acquisition or disposition of assets** (Item 2.01), along with regulatory disclosure information and financial exhibits. The filing includes 15 documents and interactive data files, though the specific details of the transaction are contained in the linked exhibit documents.
**Key Takeaway for Investors:** This is a material corporate transaction that may significantly impact Mullen's asset base, financial position, or operational structure. Investors should review the full 8-K document and Exhibit 99.1 to understand the nature of the acquisition/disposition, financial terms, and strategic implications for the company's future performance.
NCRA
NASDAQ
▲ SUPER 8-K
Nocera, Inc. Common Stock
EDGAR Items: 1.01,2.01,9.01
# SEC 8-K Filing Summary: Nocera Inc. (June 10, 2025)
**Material Events:**
Nocera Inc. filed an 8-K on June 10, 2025, reporting two significant transactions completed on June 5, 2025: (1) entry into a Stock Purchase Agreement and (2) completion of an Equity Transfer Agreement. These transactions represent material definitive agreements and asset acquisitions that required immediate SEC disclosure.
**Key Implications for Investors:**
The filing indicates Nocera has either acquired or divested a significant asset or equity stake. Without access to the full agreement details, investors should review the attached Stock Purchase Agreement and Equity Transfer Agreement exhibits to understand the transaction value, terms, strategic rationale, and potential impact on earnings, balance sheet, and future operations. The dual agreements suggest a complex transaction structure that could meaningfully alter the company's operational footprint or ownership structure.
BNC
NASDAQ
▲ SUPER 8-K
CEA Industries Inc. Common Stock
EDGAR Items: 2.01,8.01,9.01
# SEC 8-K Filing Summary
**Company & Filing Details:** Form 8-K filed on June 10, 2025 (reporting period June 6, 2025) by an undisclosed company (CIK: 1482541).
**Material Event:** The filing reports the completion of an acquisition or disposition of assets (Item 2.01), indicating the company has finalized a significant business transaction. Additional details are provided in exhibits and supporting documentation.
**Key Items Reported:** The 8-K covers three main areas—completion of an asset acquisition/disposition, other events, and financial statements with exhibits—suggesting a structurally complex transaction requiring comprehensive disclosure.
**Investor Implications:** The completion of this acquisition/disposition could materially impact the company's financial position, operational structure, and future earnings potential. Investors should review the full 8-K document and attached exhibits to understand the transaction's terms, financing, and expected impacts on revenue, profitability, and strategic positioning.
**Recommendation:** Access the full filing documents (particularly the main 8-K and exhibits) for detailed information on deal terms, consideration paid, synergies expected, and any risks or contingencies that could affect shareholder value.
IVF
NASDAQ
▲ SUPER 8-K
INVO Fertility, Inc. Common Stock
EDGAR Items: 2.01,9.01
# SEC 8-K Filing Summary
**Filing Details:** InvestView Inc. (CIK 1417926) filed an 8-K on June 6, 2025, reporting the completion of an acquisition or disposition of assets as of June 2, 2025.
**Key Material Event:** The filing indicates the completion of an acquisition or disposition of assets (Item 2.01), though the specific details of the transaction are contained in the attached exhibit (EX-99.1). Without access to the full exhibit content, the precise nature, terms, and financial impact cannot be determined from this summary.
**Investor Implications:** This acquisition/disposition represents a significant corporate action that could materially affect InvestView's business operations, asset base, financial position, and strategic direction. Investors should review the complete 8-K filing and exhibit to understand the transaction's scope, financing structure, expected synergies or divestitures, and management's rationale for the transaction to assess its impact on company valuation and future performance.
FBIO
NASDAQ
▲ SUPER 8-K
Fortress Biotech, Inc.
EDGAR Items: 2.01,9.01
# SEC 8-K Filing Summary: Forgium Bio Inc.
**Filing Details:** Forgium Bio Inc. filed an 8-K on June 5, 2025, reporting a material event from May 30, 2025.
**Key Event:** The filing discloses the **completion of an acquisition or disposition of assets** (Item 2.01), indicating the company has finalized a significant business transaction. The exact nature, target, valuation, and financial impact details would be contained in the full 8-K document and accompanying exhibits.
**Investor Implications:** This represents a material corporate event that could substantially alter the company's business profile, financial position, and strategic direction. Investors should review the complete filing and supplementary exhibits to understand the transaction terms, synergy expectations, integration plans, and any impact on earnings or financial guidance. The timing and terms of the deal will be critical factors in assessing whether this transaction creates shareholder value.
RENX
NASDAQ
▲ SUPER 8-K
RenX Enterprises Corp. Common Stock
EDGAR Items: 1.01,2.01,2.03,3.02,5.03,7.01,8.01,9.01
# SEC 8-K Filing Summary
This 8-K filing dated June 4, 2025 (for the period ending May 29, 2025) reveals significant corporate restructuring activities at the company. The filing documents multiple material events including entry into definitive agreements, completion of asset acquisitions, creation of financial obligations, issuance of unregistered equity securities (Series A Convertible Preferred Stock), and amendments to the company's bylaws.
**Key Material Changes:**
- The company completed an acquisition or disposition of assets and entered into amended membership interest purchase agreements
- New debt obligations were created, evidenced by promissory notes (including one to James Burnham)
- Series A Convertible Preferred Stock was issued, indicating new financing through preferred equity
- Corporate governance changes were made through bylaw amendments
**Investor Implications:**
These actions suggest the company is undergoing significant capital restructuring, likely involving debt and equity financing to support operational or acquisition activities. The conversion rights embedded in the preferred stock and multiple promissory notes indicate potential dilution to common shareholders. Investors should carefully review the detailed exhibits to understand the conversion terms, debt covenants, and governance impacts of these transactions.
CHUC
OTC
▲ SUPER 8-K
Charlie's Holdings, Inc.
EDGAR Items: 1.01,2.01,9.01
# SEC 8-K Summary
Based on this June 3, 2025 8-K filing, the company (identified as CHUC by ticker) has reported two significant corporate actions: **entry into a material definitive agreement** and **completion of an acquisition or disposition of assets**. The filing occurred on May 29, 2025, and includes exhibit documents that appear to detail the terms of these transactions. Without access to the full document content, the specific nature of the agreement and asset transaction cannot be determined from this header information alone, but the dual reporting suggests a substantial business combination or asset restructuring event. Investors should review the complete 8-K document and attached exhibits to understand the financial impact, deal terms, and strategic implications for the company's future operations and shareholder value.
May 2025
13 filings
▼
MGRX
NASDAQ
▲ SUPER 8-K
Mangoceuticals, Inc. Common Stock
EDGAR Items: 1.01,1.02,2.01,9.01
# SEC 8-K Filing Summary
Based on this May 23, 2025 8-K filing (CIK 1938046), the company has disclosed **material corporate transactions** including:
**Key Events:**
- **Entry into a Material Definitive Agreement** (Item 1.01) - A significant new contract or deal was executed
- **Termination of a Material Definitive Agreement** (Item 1.02) - An existing material agreement was ended
- **Completion of Acquisition or Disposition of Assets** (Item 2.01) - The company completed a transaction involving asset purchase/sale or acquisition
**Investor Implications:**
This filing indicates substantial strategic changes to the company's business structure. The simultaneous termination of one agreement and execution of another, coupled with asset transaction completion, suggests a potential pivot in business operations, partnership restructuring, or acquisition activity. Investors should review the detailed exhibits (EX-10.1, 10.2, 10.3) to understand the financial impact, terms, and strategic rationale of these transactions. The materiality designation means these events could significantly affect shareholder value and future earnings.
SLE
NASDAQ
▲ SUPER 8-K
Super League Enterprise, Inc. Common Stock
EDGAR Items: 1.01,2.01,8.01,9.01
# SEC 8-K Filing Summary
Based on this May 22, 2025 8-K filing by SLG (CIK: 1621672), the company reported material events occurring on May 19, 2025, including the entry into a material definitive agreement (Item 1.01) and completion of an acquisition or disposition of assets (Item 2.01). The filing contains a purchase agreement (Exhibit 2.1) and supplementary disclosures (Exhibit 99.1), suggesting the company completed a significant M&A transaction. While the specific details of the deal terms, financial impact, and strategic rationale require reviewing the full 8-K document and exhibits, investors should evaluate whether this transaction strengthens the company's market position, impacts earnings, or changes capital structure. The inclusion of multiple exhibits and financial statement references indicates this is a substantial corporate action that could materially affect shareholder value.
BLMH
OTC
▲ SUPER 8-K
BLUM HOLDINGS, INC.
EDGAR Items: 1.01,2.01,7.01,9.01
# SEC 8-K Filing Summary
**Company & Filing Details:**
This 8-K was filed on May 21, 2025 by a company (CIK 1996210) covering a material event that occurred on May 15, 2025.
**Key Material Events:**
The filing reports two significant items: (1) entry into a Material Definitive Agreement and (2) completion of an acquisition or disposition of assets. A Management Service Agreement dated May 15, 2025 has been executed, with the full text included as an exhibit.
**What Changed:**
The company has entered into a new management service agreement and completed a transaction involving acquisition or disposition of assets on May 15, 2025, which was publicly announced via press release on May 21, 2025.
**Investor Implications:**
Without access to the full agreement details and press release content, the exact nature and financial impact cannot be fully assessed from this filing header alone. However, investors should review the attached Management Service Agreement (Exhibit 10.1) and press release (Exhibit 99.1) to understand the transaction's scope, financial terms, and strategic implications for the company's operations and future performance.
PTIX
OTC
▲ SUPER 8-K
Protagenic Therapeutics, Inc.\new
EDGAR Items: 1.01,2.01,3.02,3.03,5.02,5.03,7.01,8.01,9.01
# SEC 8-K Filing Summary
Based on this May 19, 2025 8-K filing, the company experienced multiple significant corporate events. The filing discloses the completion of an acquisition or disposition of assets (Item 2.01), entry into material definitive agreements (Item 1.01), unregistered equity issuances (Item 3.02), and modifications to security holder rights (Item 3.03). Additionally, the company made changes to its articles of incorporation/bylaws (Item 5.03) and experienced officer/director changes with new compensatory arrangements (Item 5.02).
**For investors:** This filing signals major structural changes to the company, including potential ownership shifts from the acquisition activity, new equity dilution from unregistered securities, and governance restructuring. The breadth of items disclosed (9 separate material items) suggests a transformative event—possibly a merger, significant acquisition, or recapitalization. Investors should review the detailed exhibits and transaction agreements (particularly EX-2.1) to understand the financial impact, dilution levels, and new management implications.
PULM
NASDAQ
▲ SUPER 8-K
Pulmatrix, Inc. Common Stock
EDGAR Items: 2.01,9.01
# SEC 8-K Filing Summary
**Company & Filing Details:**
This Form 8-K was filed on May 15, 2025, by a company (CIK: 1574235) reporting a material event dated the same day.
**Material Event:**
The filing reports the **completion of an acquisition or disposition of assets** (Item 2.01), indicating the company has successfully closed a significant M&A transaction. The specific details of the acquired or divested assets are contained in the accompanying exhibits and disclosure documents.
**Key Implications for Investors:**
- This represents a completed transaction, meaning negotiations and conditions have been finalized and the deal has closed
- The acquisition/disposition could materially impact the company's balance sheet, revenue streams, operational structure, or market position depending on the nature and size of the transaction
- Investors should review the full 8-K filing and exhibits for transaction details, purchase price, financing structure, and management's strategic rationale for the deal
**Next Steps:**
Investors should examine Exhibit 99.1 and related documents for comprehensive details about the transaction terms, expected financial impact, and how management believes this transaction will benefit shareholders going forward.
MYSZ
NASDAQ
▲ SUPER 8-K
My Size, Inc
EDGAR Items: 1.01,2.01,7.01,9.01
# SEC 8-K Filing Summary
**Company & Filing Details:** This is a Form 8-K filed on May 12, 2025 (covering events through May 9, 2025) disclosing a material transaction for CIK 1211805.
**Key Material Events:**
The filing reports three significant items: (1) **Entry into a Material Definitive Agreement** (Item 1.01), (2) **Completion of an Acquisition or Disposition of Assets** (Item 2.01), and (3) **Regulation FD Disclosure** (Item 7.01). These items indicate the company has either entered into and/or completed a major business transaction, with supporting agreements included as exhibits.
**Investor Implications:**
Without access to the actual document content (only the filing structure is visible), the specifics of the transaction—such as deal value, strategic importance, or financial impact—cannot be determined from this summary. However, the presence of both Item 1.01 and 2.01 suggests a recently completed significant acquisition or asset sale that required formal board approval and is material enough to warrant immediate public disclosure. Investors should review the full 8-K and attached exhibits (particularly EX-10.1) to understand the transaction's terms, valuation, and potential effects on earnings and strategy.
NMEX
OTC
▲ SUPER 8-K
NORTHERN MINERALS & EXPLORATION LTD.
EDGAR Items: 2.01,5.02
# SEC 8-K Filing Summary
**Company & Filing Details:** This Form 8-K was filed on May 12, 2025, by a company (CIK 1415744) covering events from April 17, 2025.
**Material Events:** The filing reports two significant corporate actions: (1) the completion of an acquisition or disposition of assets (Item 2.01), and (2) changes in the company's executive leadership, including the departure and/or appointment of officers and modifications to executive compensation arrangements (Item 5.02).
**Investor Implications:** The asset transaction and executive changes represent material corporate restructuring that could impact the company's strategic direction, operational efficiency, and financial performance. Investors should review the detailed 8-K document to understand the acquisition/disposition terms, the identity of departing/new officers, and any modifications to executive compensation that might affect shareholder value. The specific impact will depend on whether the asset transaction is accretive or dilutive and how the leadership changes position the company for future growth.
RIME
NASDAQ
▲ SUPER 8-K
Algorhythm Holdings, Inc. Common Stock
EDGAR Items: 1.01,2.01,2.03,3.02,9.01
# SEC 8-K Filing Summary
**Filing Date:** May 8, 2025 (Period of Report: May 2, 2025)
**Key Material Events:**
This 8-K discloses multiple significant corporate transactions: (1) entry into a material definitive agreement, (2) completion of an acquisition or asset disposition, (3) creation of direct financial obligations, and (4) unregistered equity sales. The filing includes substantial exhibits (three major agreements totaling over 850KB) and supporting financial documentation, indicating a complex, multi-faceted transaction.
**What This Means for Investors:**
The simultaneous disclosure of new debt obligations, equity issuance, and asset/business transactions suggests the company is restructuring its capital or financing structure, likely to fund an acquisition. Investors should carefully review the attached agreements (Exhibits 10.1-10.3) to understand the transaction terms, debt covenants, dilution from equity issuance, and the strategic rationale. The completeness of disclosure across multiple Item categories indicates material financial impact that could affect shareholder value and the company's future cash flow and balance sheet.
LSAK
NASDAQ
▲ SUPER 8-K
Lesaka Technologies, Inc. Common Stock
EDGAR Items: 2.01,9.01
# SEC 8-K Filing Summary
Based on this May 7, 2025 8-K filing, the company reported the **completion of an acquisition or disposition of assets** (Item 2.01). While the specific details of the transaction are not visible in this document index, the filing indicates a material corporate event has been finalized. The company has included comprehensive financial statements and exhibits to support the transaction disclosure. Investors should review the full 8-K document and Exhibit 99.1 for details on the deal structure, financial impact, and strategic rationale, as acquisition completions can significantly affect shareholder value, debt levels, and future earnings guidance.
LIMN
NASDAQ
▲ SUPER 8-K
Liminatus Pharma, Inc. Class A Common Stock
EDGAR Items: 1.01,2.01,3.02,3.03,4.01,5.01,5.02,5.03,5.05,5.06,7.01,8.01,9.01
# SEC 8-K Filing Summary
Based on this Form 8-K filed on May 6, 2025 (for period ending April 30, 2025), the company underwent **significant corporate restructuring** involving multiple material events. The filing indicates a **change in control of the registrant**, completion of an **acquisition or disposition of assets**, changes in **certifying accountants**, **director/officer changes**, and **amendments to corporate governance documents** (articles of incorporation, bylaws, code of ethics). The company also appears to have changed its shell company status and conducted an **unregistered equity issuance**.
**For investors**, this represents a transformative event that could substantially alter the company's operations, management, and ownership structure. The multiple governance changes and accounting firm transition warrant careful review of the detailed exhibits to understand deal terms, new leadership implications, and any dilution from the equity issuance. This level of simultaneous change carries both opportunity (if the restructuring is strategic) and execution risk that investors should monitor closely.
DFDV
NASDAQ
▲ SUPER 8-K
DeFi Development Corp. Common Stock
EDGAR Items: 1.01,2.01,3.02,7.01,9.01
# SEC 8-K Filing Summary
**Filing:** Form 8-K filed May 5, 2025 by a company (CIK 1805526)
**Key Material Events:**
The company completed a material asset acquisition on May 1, 2025, involving the purchase of assets from SOL. The transaction included execution of three definitive agreements: an Asset Purchase Agreement, an Intellectual Property Assignment Agreement, and an Assignment and Assumption Agreement covering contracts and obligations.
**What Changed:**
The company has acquired new assets and intellectual property while assuming certain liabilities and contracts associated with the SOL operation. Additionally, the company issued unregistered equity securities as part of the transaction consideration.
**Investor Implications:**
This acquisition represents a significant corporate development that could impact the company's growth trajectory, asset base, and operational scope. Investors should review the detailed asset purchase agreement and valuation terms to assess whether the acquisition was made at reasonable valuations and whether the acquired assets will meaningfully contribute to future earnings and shareholder value. The use of unregistered securities as consideration should also be evaluated for potential dilution effects.
AHRO
OTC
▲ SUPER 8-K
Authentic Holdings, Inc.
EDGAR Items: 1.01,2.01,3.02,3.03,5.03,9.01
# SEC 8-K Filing Summary: AHRO (Filed May 2, 2025)
Aethlon Medical, Inc. (AHRO) announced a material acquisition/asset purchase and corporate restructuring on April 29, 2025. The filing includes entry into a definitive asset purchase agreement, completion of an acquisition, issuance of unregistered equity securities (Series F Preferred Stock), modifications to shareholder rights, and amendments to the company's articles of incorporation. These multiple simultaneous items indicate a significant corporate transaction that will alter the company's capital structure and potentially its ownership composition. Investors should review the detailed Asset Purchase Agreement and Certificate of Designation for Series F Preferred Stock to understand the deal terms, dilution impact, and any preferential rights granted to new investors, as the preferred stock issuance suggests potential loss of control or substantial equity dilution for existing shareholders.
GREH
OTC
▲ SUPER 8-K
Green Rain Energy Holdings Inc.
EDGAR Items: 1.01,2.01,3.02,5.02,9.01
# SEC 8-K Summary - NOW Corp (May 2, 2025)
NOW Corp filed a material 8-K on May 2, 2025, disclosing several significant corporate events effective May 1, 2025. The filing indicates the company entered into a material definitive agreement and completed an acquisition or disposition of assets, with details provided in a Purchase and Sale Agreement. Additionally, the company issued unregistered equity securities and made key management changes, including the appointment of new officers and directors and the resignation of Mark Newbauer.
**For investors:** This filing suggests NOW Corp has undergone substantial restructuring through an acquisition/asset sale and significant leadership transitions. The unregistered equity issuance may indicate dilution to existing shareholders, while the management changes suggest a shift in strategic direction. Investors should review the full Purchase and Sale Agreement and board resolutions to understand the financial impact and new leadership's strategic vision.
April 2025
3 filings
▼
ATXI
OTC
▲ SUPER 8-K
AVENUE THERAPEUTICS, INC.
EDGAR Items: 1.01,1.02,2.01,9.01
# 8-K Filing Summary
Based on this SEC 8-K filing dated April 30, 2025 (for the period ending April 24, 2025), the company reported **four material events**: entry into a material definitive agreement, termination of a material definitive agreement, completion of an acquisition or disposition of assets, and financial statements/exhibits. While the HTML provided doesn't contain the full details of these transactions, the filing indicates **significant corporate restructuring activity** involving both a new agreement and termination of an existing one, along with asset changes.
To fully assess the impact on investors, you would need to review the actual 8-K document (tm2513615d1_8k.htm) to understand the nature of the agreements, the assets involved, and the financial implications. The presence of both a new material agreement and termination suggests the company may be **pivoting its strategy or business relationships**, which could affect shareholder value depending on the terms and rationale disclosed in the full filing.
GDC
NASDAQ
▲ SUPER 8-K
GD Culture Group Limited Common Stock
EDGAR Items: 1.01,2.01,3.02,9.01
# SEC 8-K Filing Summary: GD Culture (April 30, 2025)
**Key Material Events:**
On April 28, 2025, GD Culture completed a material transaction involving a Software Purchase Agreement and unregistered equity sale. The filing indicates three significant items: entry into a definitive material agreement, completion of an asset acquisition, and issuance of unregistered equity securities.
**What Changed:**
The company acquired software assets through a structured purchase agreement dated April 28, 2025, and simultaneously issued unregistered equity securities as part of the transaction consideration. These actions represent meaningful changes to the company's asset base and capital structure.
**Investor Implications:**
Investors should review the Software Purchase Agreement details (included as Exhibit 10.1) to understand the strategic rationale, valuation metrics, and potential revenue/cost impacts. The unregistered equity issuance may have dilutive effects on existing shareholders, while the software acquisition could represent a strategic expansion or capability enhancement—though the specific nature and financial terms require examination of the complete filing documents.
MGRX
NASDAQ
▲ SUPER 8-K
Mangoceuticals, Inc. Common Stock
EDGAR Items: 1.01,2.01,3.02,5.02,7.01,9.01
# SEC 8-K Filing Summary
**Filing Date:** April 25, 2025 | **Period:** April 24, 2025
This 8-K filing indicates multiple material corporate events occurred simultaneously. The company entered into material definitive agreements, completed an acquisition or disposition of assets, conducted unregistered equity issuances, and made officer/director changes with compensatory arrangements. These combined disclosures suggest a significant business restructuring or M&A transaction.
The variety and breadth of reported items—spanning new agreements, asset transactions, equity issuances, and executive personnel changes—suggest a complex, multi-faceted corporate event rather than a routine operational matter. Investors should review the detailed exhibits and full 8-K document to understand the specific terms, financial impact, and strategic implications of these changes on the company's future performance and shareholder value.